"","X","financial_disclosure","doi","publication_date","id.tmp"
"174",174,"
        The research leading to these results has been partly funded by the European Union under grant agreements n. 045622 (FP6/2002-06: SensAction-AAL project) and n. 288940 (FP7/2007-13: FARSEEING project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037062","2012-05-16T00:00:00Z",288940
"340",340,"
        This research has received support from the Netherlands Organization of Scientific Research and is a contribution to the “European Project on Ocean Acidification” (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023010","2011-08-10T00:00:00Z",211384
"502",502,"
        This work is a contribution to the “European Project on OCean Acidification” (EPOCA), which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 211384. In addition, financial support from the German Research Foundation (DFG) as part of the priority program 1162 AQUASHIFT and the Marie Curie IRG grant n° 276917 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034737","2012-04-11T00:00:00Z",211384
"550",550,"Logistic support from the Alfred Wegener Institute for Polar and Marine Research (AWIPEV) and Kings Bay and funding from the French Polar Institute (IPEV) are gratefully acknowledged. This work is a contribution to the Svalbard 2009 experiment of the “European Project on Ocean Acidification” (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement n° 211384. The IAEA is grateful for the support provided to its Marine Environment Laboratories by the Government of the Principality of Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0011362","2010-06-29T00:00:00Z",211384
"651",651,"
        This work was performed thanks to an ASSEMBLE grant to SD and within the Linnaeus Centre for Marine Evolutionary Biology at the University of Gothenburg (http://www.cemeb.science.gu.se/), and supported by a Linnaeus-grant from the Swedish Research Councils VR and Formas. This paper is a contribution to the “European Project on Ocean Acidification” (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 211384 and the “Sub-seabed carbon storage and the marine environment” (ECO2) a Collaborative Project funded under the European Commission's Framework Seven Programme Topic OCEAN.2010.3, project number 265847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029568","2012-01-09T00:00:00Z",211384
"40",40,"
        This study was funded by EU Seventh Framework Programme as part of the project FP7-PALMS (grant agreement 212631) and by annual research budget of IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019954","2011-05-26T00:00:00Z",212631
"314",314,"
        P. Álvarez-Loayza was supported by Rutgers University Fellowship, Pre-Dissertation Travel Grant, and the Francis J. Bossuyt Fellowship from the Organization for Tropical Studies, and Amazon Conservation Association (ACA). This research was also financially supported by the New Jersey Agricultural Experiment Station, the Danish Natural Science Research Council (grants 272-06-0476 and 272-07-0242) and the European Community FP7 programme PALMS project (grant agreement 212631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016386","2011-01-31T00:00:00Z",212631
"463",463,"
        This work was supported by the Danish Council for Independent Research - Natural Sciences (grant# 272-07-0242 to JCS, #10-083348 to HB) and the European Community (FP7 grant #212631 to HB). The faculty of Natural Sciences at the University of Aarhus supported SB's PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027027","2011-11-03T00:00:00Z",212631
"147",147,"
        This work was supported in part by Grant FP7-ENV-2007-1-212844 from the European Union and Grants G33253 from the UK Medical Research Council and G0501904 (to AJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.
      ","10.1371/journal.pone.0030111","2012-01-11T00:00:00Z",212844
"176",176,"
        This work was supported in part by Grant FP7-ENV-2007-1-212844 from the European Union and Grants G33253 and G0501904 (to AJD) from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037064","2012-05-17T00:00:00Z",212844
"648",648,"
        L. Reguero is in receipt of a Predoctoral Fellowship from the Basque Country Government (BFI 07.286); I. Buceta is in receipt of a Predoctoral Fellowship from the Basque Country University. Dr. Pedro Grandes' laboratory is supported by The Basque Country Government grant GIC07/70-IT-432-07, by Ministerio de Ciencia e Innovación (SAF2009-07065) and by Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN, grant RD07/0001/2001. Dr. Giovanni Marsicano's laboratory is supported by AVENIR/INSERM (with the Fondation Bettencourt-Schueller), by ANR (ANR-06-NEURO-043-01), by European Foundation for the Study of Diabetes (EFSD), by the EU-FP7 (REPROBESITY, contract number HEALTH-F2-2008-223713) and European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026167","2011-10-11T00:00:00Z",223713
"687",687,"Dr. Pedro Grandes' laboratory is supported by The Basque Country Government grant GIC07/70-IT-432-07, by Red de Trastornos Adictivos (RETICS), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación (MICINN), grant RD07/0001/2001 and MICINN grant SAF2009-07065. Nagore Puente is supported by a Basque Country University grant for PhD Researcher's Specialization. Leire Reguero is in receipt of a predoctoral fellowship from the Basque Country Government. Dr. Olivier J. Manzoni's laboratory is supported by INSERM, ANR Neurosciences “Neurologie et Psychiatrie ANR-06-NEURO-043-01” and Région Aquitaine. Dr. Giovanni Marsicano's laboratory is supported by AVENIR/INSERM (with the Fondation Bettencourt-Schueller), by ANR (ANR-06-NEURO-043-01), by European Foundation for the Study of Diabetes (EFSD), by the EU-FP7 (REPROBESITY, contract number HEALTH-F2-2008-223713) and European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0008869","2010-01-25T00:00:00Z",223713
"698",698,"
        The authors acknowledge the research infrastructure provided by the Norwegian Microarray Consortium (NMC; www.microarray.no), a national FUGE technology platform (Functional Genomics in Norway; www.fuge.no). The present study has been supported by grants from the Research Council of Norway (incl. the FUGE program and “PSYKISK HELSE” program), Norwegian Council for Mental Health, Extrastiftelsen Helse og Rehabilitering (JF), Helse Vest RHF, Dr. Einar Martens Fund, European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements n° 245009 and 223713 (CD, ML and RN) and n° 018734 (AVP), Xunta de Galicia (ML: 10PXIB208164PR; RN: 2010/14)), Fondo Investigationes Sanitarias (ML: PS09/01880), Ministerio de Educacion y Ciencia (CD: BFU2008-02001; ML: RyC-2007-00211; RN: RyC-2008-02219 and SAF2009-07049;), Medical Research Council (AVP) and Welcome Trust (AVP). CIBER de Fisiopatología de la Obesidad y Nutrición is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020571","2011-06-13T00:00:00Z",223713
"280",280,"This work was funded by the Bill & Melinda Gates Vaccine Modeling Initiative, the UK Medical Research Council, Microsoft Research, and the TransMalariaBloc European Commission FP7 Collaborative project (HEALTH-F3-2008-223736). TDH is funded by an Imperial College Junior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pmed.1000324","2010-08-10T00:00:00Z",223736
"324",324,"
        This work was funded by the Bill and Melinda Gates Vaccine Modeling Initiative, the UK Medical Research Council and the TransMalariaBloc European Commission FP7 Collaborative project (HEALTH-F3-2008-223736). TDH is funded by an Imperial College Junior Research Fellowship, and CJD by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020179","2011-05-24T00:00:00Z",223736
"379",379,"
        The research leading to these results has received funding from the French “Agence Nationale pour la Recherche” (ANR-06-MIME-001-01) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements N° 242095 and N°223736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030849","2012-01-26T00:00:00Z",223736
"663",663,"
        M-GB thanks the Wellcome Trust, http://www.wellcome.ac.uk (Grants 085133/Z/08/Z and 092677/Z/10/Z), and the Royal Society-Leverhulme Trust (http://royalsociety.org/) for a Capacity Building Africa Award. JSMC is funded by an NHMRC Practitioner Fellowship and by a Government of Queensland Health Research Fellowship. MDF is supported by the Schistosomiasis Control Initiative. MW is supported by the Wellcome Trust, MG by NIH–MIDAS, and TSC by the European Commission on an FP7-Health project (TransMalariaBloc, HEALTH-F3-2008-223736) and a Junior Fellowship at Imperial College London. The Special Programme for Research and Training in Tropical Diseases (TDR) provided both technical and financial support to the Disease Reference Group on Helminth Infections (DRG4), and the European Commission provided financial support under Agreement PP-AP/2008/160-163. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001548","2012-04-24T00:00:00Z",223736
"672",672,"
        This work was supported by the Bill & Melinda Gates Foundation 51991 to Teun Bousema. Roly Gosling is supported through grants from the Bill & Melinda Gates Foundation and ExxonMobil to the Global Health Group at the University of California, San Francisco. Chris Drakeley is supported by the Wellcome Trust (UK), Jamie Griffin by a fellowship from the UK Medical Research Council, Azra Ghani by the Bill & Melinda Gates Vaccine Modeling Initiative and the UK Medical Research Council, Tom Churcher by the European Commission FP7 Collaborative project TransMalariaBloc (HEALTH-F3-2008-223736), and David L. Smith by the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (http://www.fic.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pmed.1001165","2012-01-31T00:00:00Z",223736
"85",85,"Financial support for this work was provided by the Wellcome Trust, Engineering and Physical Sciences Research Council (EP/F059381/1), and the European commission project euHeart (FP7-224495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000371","2009-04-24T00:00:00Z",224495
"186",186,"
        The authors were supported by the European Projects VIACTORS (FP7-ICT-2007-3, contract N231554) and ITALK (ICT-214668) and by the Italian government through the IIT foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002183","2011-10-13T00:00:00Z",231554
"3",3,"
        This work was supported by the European Union (SENSOPAC, FP6-IST028056; CEREBNET FP7-ITN238686, REALNET FP7-ICT270434) to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021928","2011-07-19T00:00:00Z",270434
"372",372,"
        This work was supported by the Regional Council of Reunion Island, the French Ministry of Overseas, the ‘Run Sea Science’ (Theme - Capacity Building, contract 229968) and the ‘MADE: Mitigating adverse ecological impacts of open ocean fisheries’ (Theme 2 Food, Agriculture, Fisheries and Biotechnology, contract 210496) FP7 European projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028109","2011-12-12T00:00:00Z",210496
"612",612,"
        This work was supported by the Netherlands Organisation for Scientific Research (NWO)/WOTRO [W93-413, WAO93-441], UNICEF, Cornelis Visser Foundation and Wageningen University (Interdisciplinary Research and Education Fund). HV is currently supported by the INSTAPA project, which receives funding from the European Union's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 211484. QuikRead tests and trimagnesium dicitrate were donated by Orion Diagnostica, Espoo, Finland and Jungbunzlauer, Ladenburg, Germany, respectively; supplements were manufactured and donated by Laboratory Medisan, Heerenveen, The Netherlands. The funders had no role in the design or conduct of the study, in the collection, analysis and interpretation of data, or in the preparation or approval of the manuscript.
      ","10.1371/journal.pmed.1001125","2011-11-22T00:00:00Z",211484
"64",64,"This work was supported by the EC MacroSys project ref number FP7-KBBE-2007-1-1-2-211602, and partially by the Cariplo Foundation. Funding for GM and LB was provided by the EC MacroSys project ref number FP7-KBBE-2007-1-1-2-211602, and JLW and FS were funded by the Cariplo Foundation for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0011117","2010-06-15T00:00:00Z",211602
"73",73,"
        This work was supported by the EC MacroSys project ref number FP7-KBBE-2007-1-1-2-211602, and partially by the Cariplo Foundation for research support. Funding for GM was provided by the EC MacroSys project ref number FP7-KBBE-2007-1-1-2-211602 and JLW and FS were funded by the Cariplo Foundation for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032578","2012-03-02T00:00:00Z",211602
"591",591,"
        This work was funded by the following sources: Science Foundation Ireland (www.sfi.ie) Investigator grants (Nos: SFI/01/F.1/B028 and SFI/08/IN.1/B2038); Department of Agriculture, Fisheries and Food (www.agriculture.ie) Research Stimulus Grant (No: RSF 06 405); European Union Framework 7 (http://cordis.europa.eu/fp7) Project Grant (No: KBBE-211602-MACROSYS); Irish Research Council for Science, Engineering and Technology (IRCSET) funded Bioinformatics and Systems Biology PhD Programme (http://bioinfo-casl.ucd.ie/PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032034","2012-02-22T00:00:00Z",211602
"387",387,"
        This work was supported by grants from Ministry of Science and Innovation of Spain (BIO2007-60978, BIO2010-16705), U.S. National Institutes of Health (ARRA-W000151845), and the European Community’s Seventh Framework Programme (FP7/2007-2013) under the projects “EMPERIE” (EC Grant Agreement number 223498), and “PoRRSCon” (EC Grant Agreement number 245141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002090","2011-06-09T00:00:00Z",245141
"432",432,"
        This research was partly funded by PrevarTM (Contract no. 26015) and the New Zealand Foundation for Research Science and Technology (Contract no. C06X0812). The contribution of M. Bink was carried out as part of the COST Action TD0801 “StatSeq” and the EU-FruitBreedomics project funded by the Commission of the European Communities (Contract FP7-KBBE-2010-265582) and supported by USDA's National Institute of Food and Agriculture - Speciality Crop Research Initiative RosBREED (2009- 51181-05808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036674","2012-05-04T00:00:00Z",265582
"531",531,"
        This work was funded by: United States Department of Agriculture's National Institute of Food and Agriculture - Specialty Crop Research Initiative project (http://www.csrees.usda.gov/fo/specialtycropresearchinitiative.cfm), “RosBREED: Enabling marker-assisted breeding in Rosaceae"" (Grant # 2009-51181-05808); Ministero delle Politiche Agricole Alimentari e Forestali -Italy (MiPAAF, http://www.politicheagricole.it) through the project “DRUPOMICS: Sequenziamento del genoma del pesco ed utilizzo della sequenza in programmi di miglioramento della qualità del frutto del pesco e della resistenza alle malattie"" (Grant # DM14999/7303/08). European Union-funded project “FruitBreedomics: Integrated approach for increasing breeding efficiency in fruit tree crops"" (Grant #FP7-265582; http://fruitbreedomics.com/; http://ec.europa.eu/research/fp7/index_en.cfm). AGL2009-07305 project and Consolider-Ingenio 2010 Program project (grant # CSD2007-00036) both funded by the Spanish Ministry of Science and Innovation (http://www.micinn.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035668","2012-04-20T00:00:00Z",265582
"657",657,"
        The project was funded by the Fondo de Investigación Sanitaria (FIS) (CP09/00279). JGP holds a Miguel Servet contract funded by “Fondo de Investigación Sanitaria” FIS-ISCIII. This study was supported by the Spanish AIDS network “Red Temática Cooperativa de Investigación en SIDA” (RD06/0006), the European Community's Seventh Framework Program (FP7/2007-2013) under the project “Collaborative HIV-1 and Anti-HIV-1 Drug Resistance Network (CHAIN)” grant agreement number 223131, and the “HIV Vacine Catalonian Program” (HIVACAT Program). FMC was supported by the Marie Curie European Reintegration Grant number 238885, ‘HIV-1 Coevolution’, and by the European Commission Framework 7 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032714","2012-02-29T00:00:00Z",238885
"132",132,"
        This work was supported by the National Institute for Health Research and was in part funded by the EU Multibiodose project [FP7-241536]. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025113","2011-09-23T00:00:00Z",241536
"184",184,"
        Alexander-von-Humboldt Foundation supported E. A. Ahmed with a stipend. H. Scherthan acknowledges partial support from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 241536. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0039521","2012-06-27T00:00:00Z",241536
"695",695,"
        This work was supported by grants from the European Research Council (FP7/2007–2013 European Research Council Independent Researcher Starting Grant No. 243188 TUMETABO to P. Sonveaux), the NIH/NCI (CA40355-24 and CA40355-25 to M.W. Dewhirst), the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), an Action de Recherche Concertée from the Communauté Française de Belgique (to P. Sonveaux and O. Feron), the NEOANGIO research program from the Région Wallonne de Belgique (to O. Feron), the Fondation Belge contre le Cancer (200-2008 to P. Sonveaux and O. Feron), and the J. Maisin and St. Luc Foundations (to O. Feron). O. Feron is a Research Director, P. Sonveaux and B. F. Jordan are Research Associates, J. Verrax is a Postdoctoral Researcher, and P. Danhier is a Research Fellow of the F.R.S.-FNRS. C. De Saedeleer is a Télévie Research Fellow. For this study, P. Sonveaux was also supported by a fellowship from the Belgian American Educational Foundation (BAEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033418","2012-03-13T00:00:00Z",243188
"1",1,"
        This paper was written under partial support by the European Union project #FP7-237955 (FACETS-ITN), project #FP7-269921 (BrainScaleS), project #FP7-216593 (SECO), project #FP7-506778 (PASCAL2) and project #FP7-243914 (BRAIN-I-NETS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002211","2011-11-03T00:00:00Z",243914
"2",2,"
        This paper was written under partial support by the European Union project FP7-243914 (BRAIN-I-NETS), project 269921 (BrainScaleS), project FP7-248311 (AMARSI) and project FP7-506778 (PASCAL2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002294","2011-12-15T00:00:00Z",243914
"83",83,"
        This project was supported by the Austrian Science Fund (FWF P20882-B09) to HR, the Austrian Academy for Sciences and the Karl-Franzens-University of Graz to ABL. MP has been supported by a Forschungskredit grant of the University of Zurich. Written under partial support by the European Union project # FP7-506778 (PASCAL2), project #FP7-243914 (BRAIN-I-NETS), and project #269921 (BrainScaleS) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037354","2012-06-06T00:00:00Z",243914
"70",70,"The different parts of this work were funded by (i) The Food Standard Agency (UK) M03058, (ii) the FP7 EU project 'Priority' (243950 FP7-KBBE KBBE-2009-1-2-06), and (iii) Programme opérationnel de Coopération territoriale Espagne - France - Andorre 2007-2013 EFA85/08-COTSA. Lymphoid tissue collection in Portuguese sheep was supported by AGROS 558 (PO AGRO 8.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001285","2011-02-10T00:00:00Z",243950
"413",413,"
        This work was funded by grants from the Gyllenstierna Krapperup's Foundation, Ekhaga Foundation, the Swedish Board of Agriculture, The Swedish Research Council Formas, the EU FP7 project BeeDoc (244956), the Biotechnology and Biological Sciences Research Council's Insect Pollinators Initiative (grant BB/I000100/1), and the European Science Foundation COST (European Cooperation in Science and Technology) network COLOSS (FA0803).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033188","2012-03-12T00:00:00Z",244956
"317",317,"
        The research leading to these results was supported by the Spanish Government (grant AGL2009-11277) and the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement n° 244995 (BIOCLAIMS Project). The authors' Laboratory is a member of the European Research Network of Excellence NuGO (The European Nutrigenomics Organization, EU Contract: n° FP6-506360). The CIBER de Fisiopatología de la obesidad y nutrición is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017313","2011-02-18T00:00:00Z",244995
"359",359,"
        This work was supported by grant number AGL 2008-00387/ALI from the Spanish Government. The research leading to these results has received funding from the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement n° 244995 (BIOCLAIMS Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025982","2011-10-05T00:00:00Z",244995
"464",464,"
        The research leading to these results has received funding from the Internal Grant Agency of the Ministry of Health of the Czech Republic (NS/10528-3), the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement n° 244995 (BIOCLAIMS), EPAX AS (Norway), and the EFSD New Horizons research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027126","2011-11-03T00:00:00Z",244995
"134",134,"
        This research was supported by the German Research Foundation (DFG/HE5880) and the European ICT Programme Project FP7-247919 (http://cordis.europa.eu/fetch?CALLER=PROJ_ICT&ACTION=D&CAT=PROJ&RCN=93827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025574","2011-10-11T00:00:00Z",247919
"182",182,"
        Funding provided by EveryAware European project nr. 265432 under FP7-ICT-2009-C, National Science Foundation (BCS-1026943) and European Science Foundation, EuroUnderstanding Collaborative Research Projects, Digging for the roots of understanding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037744","2012-06-19T00:00:00Z",265432
"8",8,"
        This work was supported by grants from the German Ministry for Education and Research (BMBF, “German Competence Network Multiple Sclerosis” (KKNMS), 01GI0920), EU FP7 (NETSIM (215820-2) and VPHOP (FP7-223865)). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023080","2011-08-05T00:00:00Z",215820
"227",227,"
        This work was partly supported by grants from the German Ministry for Education and Research (BMBF, “German Competence Network Multiple Sclerosis” (KKNMS), 01GI0920), EU FP7 (NETSIM (215820-2) and VPHOP (FP7-223865)). The Cambridge CardioResource study was funded by the UK Medical Research Council/Wellcome Trust. Additional support was provided by NHS Blood and Transplant, National Institute for Health Research and British Heart Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michaela Schimpl and Martin Daumer are employees of Trium Analysis Online GmbH and contributed to all aspects of the study. No additional external funding was received for this study.
      ","10.1371/journal.pone.0023299","2011-08-10T00:00:00Z",215820
"96",96,"This work was supported by the Academy of Finland (projects 121946, 118637, and 205361), Maj and Tor Nessling Foundation, EU/Energy Network project SOLAR-H2 (FP7 contract 212508) and Kone foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0005331","2009-04-24T00:00:00Z",212508
"237",237,"
        This work was supported by EU projects HyVolution FP6-IP-SES6 019825 and FP7 Collaborative Project SOLAR-H2 FP7-Energy-212508, and by domestic funds (NAP-BIO Teller Ede Program OMFB-00441/2007, GOP-1.1.2.-07/1-2003+8-0007, Asbóth-DAMEC-2007/09, BAROSS-DA07-DA-TECH-07-2008-0012, KoBioCHG TECH_09_04 and TÁMOP-4.2.1/B-09/1/KONV-2010-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034666","2012-04-12T00:00:00Z",212508
"377",377,"
        The authors would like to thank the EU/Energy FP7 project SOLAR-H2 (contract 212508, OK), the German Federal Ministry of Science BMBF-ForSys-Partner project (contract 0315265A, OK), the Australian Research Council (DP0877147, BH) as well as the Engineering and Physical Sciences Research Council (EP/F00270X/1, PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029364","2011-12-29T00:00:00Z",212508
"714",714,"
        This research was supported through funds from The European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. SR was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680), Academy of Finland (251217), the Finnish foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. The ATFS cohort was funded by the Australian National Health and Medical Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498), the Australian Research Council (A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921), the EU 5th Framework Programme GenomEUtwin Project (QLG2-CT-2002-01254), and the U.S. National Institutes of Health (AA07535, AA10248, AA11998, AA13320, AA13321, AA13326, AA14041, AA17688, DA12854, MH66206). RPSM and GWM are supported by National Health and Medical Research Council (NHMRC) Fellowship Schemes. Special Population Research Network (EUROSPAN) was supported b' European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). In South Tyrol, the MICROS Study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Vis Study in the Croatian island of Vis was supported through the grants from the Medical research Council UK to HC and IR and from the Ministry of Science, Education, and Sport of the Republic of Croatia to IR (number 108-1080315-0302). Erasmus Ruchpen Family (ERF) was supported by grants from The Netherlands Organization for Scientific Research (NOW; Pionier Grant), Erasmus MC, and the Netherlands Genomics Initiative (NGI)–sponsored Center for Medical Systems Biology (CMSB). The Northern Swedish Population Health Study (NSPHS) was funded by the Swedish Medical Research Council (Project Number K2007-66X-20270-01-3) and the Foundation for Strategic Research (SSF). The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823) and by the “Genomics of Lipid-associated Disorders - GOLD” of the “Austrian Genome Research Programme GEN-AU.” The KORA research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The Northern Finland Birth Cohort 1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269 (SALVE), 114194, and Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland, NHLBI grant 5R01HL087679 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, the Medical Research Council (grant G0500539, centre grant G0600705, PrevMetSyn), and the Wellcome Trust (project grant GR069224), UK. The genotyping of NFBC1966 was funded by NHLBI grant 5R01HL087679, the Academy of Finland, and Biocentrum Helsinki. Helsinki Birth Cohort Study has been supported by grants from Academy of Finland (project numbers 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225, 216374), Finnish Diabetes Research Society, Samfundet Folkhälsan, Juho Vainio Foundation, Novo Nordisk Foundation, Finska Läkaresällskapet, Päivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, and Yrjö Jahnsson Foundation. The Young Finns Study has been financially supported by the Academy of Finland (grants 126925, 121584, and 124282), Finnish Cultural Foundation, Emil Aaltonen Foundation, the Social Institution of Finland, Kuopio, Tampere (grants for TL and MK) and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research (TL and OTR). The GenomEUtwin project is supported by the European Commission under the programme ‘Quality of Life and Management of the Living Resources’ of 5th Framework Programme (no. QLG2-CT-2002-01254). JK has been supported by the Academy of Finland Centre of Excellence in Complex Disease Genetics. The Swedish Twin Cohort has been financially supported by the Swedish Research Council and Swedish Foundation for Strategic Research. The Danish Twin Registry has been supported by the Danish Medical Research Council, the Danish Diabetes Foundation, the Danish Heart Association, and the Novo Nordic Foundation. The TWINSUK study was funded by the Wellcome Trust (Grant ref. 079771); European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-ENGAGE and Framework 6 Project EUroClot. The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. NS acknowledges financial support from the Wellcome Trust (Grant 091746/Z/10/Z). NTR, NTR2, and NLDTWIN funding was obtained from the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression (904-61-090); Genetics of individual differences in smoking initiation and persistence (NWO 985-10-002); Resolving cause and effect in the association between exercise and well-being (904-61-193); Twin family database for behavior genomics studies (480-04-004); Twin research focusing on behavior (400-05-717); Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder (Addiction-31160008); Genotype/phenotype database for behavior genetic and genetic epidemiological studies (911-09-032); Spinozapremie (SPI 56-464-14192); CMSB: Center for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/2008.024); BBMRI –NL: Biobanking and Biomolecular Resources Research Infrastructure; the VU University: Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Science Foundation (ESF): Genomewide analyses of European twin and population cohorts (EU/QLRT-2001-01254); European Community's Seventh Framework Program (FP7/2007-2013): ENGAGE (HEALTH-F4-2007-201413); the European Science Council (ERC) Genetics of Mental Illness (230374); Rutgers University Cell and DNA Repository cooperative agreement (NIMH U24 MH068457-06); Collaborative study of the genetics of DZ twinning (NIH R01D0042157-01A); the Genetic Association Information Network, a public–private partnership between the NIH and Pfizer, Affymetrix, and Abbott Laboratories. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The LifeLines Cohort Study, and generation and management of GWAS genotype data for the LifeLines Cohort Study is supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. PREVEND genetics is supported by the Dutch Kidney Foundation (Grant E033), the EU project grant GENECURE (FP-6 LSHM CT 2006 037697), the National Institutes of Health (grant LM010098), The Netherlands organisation for health research and development (NWO VENI grant 916.761.70), and the Dutch Inter UniversityCardiology Institute Netherlands (ICIN). EGCUT was supported by the Estonian Ministry of E&R (SF0180142s08), EU FP7 OPENGENE (#245536) and ENGAGE (201413), by EurRDF grant to the Centre of Excellence in Genomics, Estonian Biocentre and University of Tartu and by Estoinian Research Infrastructure's Roadmap. Genmets was supported through funds from The European Community's Seventh Framework Programme (FP7/2007-2013), BioSHaRE Consortium, grant agreement 261433. VS was supported by the Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular research, and the Finnish Academy (grant number 129494). The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). EPIC–Norfolk is supported by programme grants from the Medical Research Council UK (G9502233, G0300128) and Cancer Research UK (C865/A2883). Adipose Tissue eQTL dataset has been funded by Finnish Foundation for Cardiovascular Research, Helsinki University, Sigrid Juselius Foundation Central Hospital Research Foundation. Metabonomic datasets are supported by the Academy of Finland (grant number 137870 to PS) and the Responding to Public Health Challenges Research Programme of the Academy of Finland (grant number 129429 to MA-K), the Finnish Cardiovascular Research Foundation
(MA-K), and the Jenny and Antti Wihuri Foundation (AJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002333","2011-10-20T00:00:00Z",213506
"84",84,"
        Research was funded by EURO-BASIN (FP7 #264933) and Department of Environment, Fisheries and Rural Affairs (Defra) who funded the analysis of fish larvae samples from 1979 to 2005 through project MF1101. The long-term ECOSMO model simulation was funded by the projects EU-MEECE (FP7# 212085) and the Norwegian Research Council (MarinEra project ECODRIVE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038758","2012-06-21T00:00:00Z",212085
"116",116,"
        This work was funded by a grant from the European FP7 Integrated Project MEECE2
                    (contract n. 212085) and a grant from the Ministère de
                    l'Enseignement Supérieur et de la Recherche Scientifique, Republique
                    de Tunisia. The funders had no role in study design, data collection and
                    analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0018904","2011-05-05T00:00:00Z",212085
"221",221,"
        The study was supported by EU FP6 and FP7 research projects IMAGE (044227), MEECE
                    (212085) and VECTORS (266445), Estonian Ministry of Education and Research
                    (SF0180005s10), and Danish Network for Fisheries and Aquaculture Research
                    (FISHNET). The funders had no role in study design, data collection and
                    analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019231","2011-04-29T00:00:00Z",212085
"689",689,"The current paper is mostly based on research financed through various national as well as regional and European-wide research projects and programs. All these projects and programs are gratefully acknowledged, while stressing a few larger projects, such as European Union Sixth Framework Programme (EU FP6) projects Marine Biodiversity and Ecosystem Functioning (MarBEF), European Network of Excellence for Ocean Ecosystems Analysis (EUR-OCEANS), and EU Seventh Framework Programme (EU FP7) project Marine Ecosystem Evolution in a Changing Environment (MEECE) (contract 212085). The authors gratefully acknowledge the support given by the European Census of Marine Life, the Total Foundation, and the Alfred P. Sloan Foundation. The current work of HO was supported by the Estonian Government (grant no. SF0180005s10). IT was supported by the Program on ‘Leading Scientific Schools’ (grant 1993.2008.4) and the Russian Academy of Sciences Presidium Program on ‘Scientific Basics for Biodiversity Conservation in Russia’. SO and AZ would like to acknowledge the project on ‘Biological Invasions in Lithuanian Ecosystems under the Climate Change: Causes, Impacts and Projections’ (contract C-04/2008/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012467","2010-09-01T00:00:00Z",212085
"524",524,"
        The first phase of the Generation R Study is made possible by financial support from: Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw). The present study was conducted in commission of the European project CONTAMED with funding from the European Union's Seventh Framework Programme (FP7) for Research and Technology Development. EU grant agreement no. 212502. There are no commercial associations that may pose any conflict of interest. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0039263","2012-06-15T00:00:00Z",212502
"195",195,"
        The funders are EU-CARDIORISK (FP7-211403), DFG (SFB824/1), BMBDF-MOBITUM (01EZ0826), BMBF Kompetenzverbund Strahlenforschung (03NUK007E) and multimmune GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external sources for this study.
      ","10.1371/journal.pone.0015339","2010-12-16T00:00:00Z",211403
"589",589,"
        This work was supported by the Helmholtz Zentrum München (Clinical Cooperation Group - “Innate Immunity in Tumor Biology”), Deutsche Forschungsgemeinschaft (SFB 824/1; Cluster of Excellence 158: Munich-Centre of Advanced Photonics; INST 95/980-1 FUGG, Gulmay irradiation device), BMBF (Federal Ministry of Education and Research) (MOBITUM, 01EZ0826; Kompetenzverbund Strahlenforschung, 03NUK007E; Leading-Edge Cluster m4 - Personalized Medicine and Targeted Therapies, 01EX1021C), European Union (EU-CARDIORISK, FP7-211403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031110","2012-02-07T00:00:00Z",211403
"551",551,"This project was supported by Coordination Theme 1 (Health) of the European Community's FP7, Grant agreement number HEALTH-F2-2008-200515 (http://ec.europa.eu/research/health/medical-research/rare-diseases/projects/pemphigus_en.html)(to L.B.) and the Swiss National Foundation for Scientific Research (FNS/SNF 31003A-121966 and 31003A-09811, to L.B.)(http://www.projectdb.snf.ch/WebForms/Frameset.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012250","2010-08-18T00:00:00Z",200515
"138",138,"
        This work was supported by the Italian Space Agency (ASI) PR-DCMC-GO-1B1125-003, by the Italian MIUR 2006052343 and 2008J7YFNR002, by the Italian Institute of Technology program (Motor cognition), and by the European project FP7 270108 “Goal-Leaders”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027652","2011-11-28T00:00:00Z",200605
"251",251,"
         Our research, upon which this Primer is based, is supported by Human Frontier Science Program grant RG0043/2004-C, European Community FP7 grant BIOTACT (ICT-215910), Ministero per l'Istruzione, l'Università e la Ricerca grant 2006050482_003, Regione Friuli Venezia Giulia, and the Italian Institute of Technology. EA is the recipient of a Long-Term Fellowship from the Human Frontier Science Program.
      ","10.1371/journal.pbio.0060220","2008-08-26T00:00:00Z",200605
"546",546,"These studies were supported by Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante Et de la Recherche Medicale (Inserm), University of Lille 2, the European Community (APOPIS LSHM-CT-2003-503330, and cNEUPRO LSHM-CT-2007-037950 and MEMOSAD FP7 grant agreement 200611), Federation pour la Recherche sur le Cerveau (FRC), the Gis Longevite and the F.E.D.E.R.. A. Bretteville and K. Ando are recipients of a scholarship from Lille County Hospital (CHRU-Lille)/Region Nord/Pas-de-Calais and French Foreign Affairs Ministry respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0004843","2009-03-17T00:00:00Z",200611
"144",144,"
        This work was supported by a grant from the European Union FP7-HEALTH-200647, Fighting Aneurysmal Diseases, and grants from la Fondation de l'Avenir and la Fondation pour la Recherche Médicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028903","2011-12-14T00:00:00Z",200647
"417",417,"
        The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreements HEALTH F2 2008 200728 (Brainsync) and no. 269921 (BrainScaleS), from the Spanish Research Project SAF2010-16085 and from the CONSOLIDER-INGENIO 2010 Programme CSD2007-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002395","2012-03-29T00:00:00Z",200728
"50",50,"
        This work was supported by grant FP7 (HEALTH-F3-2008-200732) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032125","2012-02-29T00:00:00Z",200732
"82",82,"At Tampere University of Technology, this work was supported by the Academy of Finland, (http://www.aka.fi, application number 213462, Finnish Programme for Centres of Excellence in Research 2006–2011). Some of the work done at Medicel on data integration is supported by EU/FP7/HEALTH grant (http://cordis.europa.eu/fp7/health/, APO-SYS/200767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0010662","2010-05-14T00:00:00Z",200767
"567",567,"
        MB and SL are holders of a postdoc mandate from the FWO. PV holds a Methusalem grant from the Flemish Government (BOF09/01M00709) and is supported by Flanders Institute for Biotechnology (VIB), Interuniversity Poles of Attraction-Belgian Science Policy (IAP6/18), Fonds voor Wetenschappelijk Onderzoek – Vlaanderen (FWO, G.0226.09), and European Commission (EU Marie Curie Training and Mobility Program, ApopTrain, MRTN-CT-035624; FP6 Integrated Project Epistem LSHB-CT-2005-019067; COST action SKINBAD BM0903; EU FP7 Integrated Project, APO-SYS, HEALTH-F4-2007-200767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022356","2011-09-12T00:00:00Z",200767
"412",412,"
        Vincent Devictor received financial support from the Fondation pour la Recherche sur la Biodiversité (project FABIO and PHYBIO). Jean-Yves Barnagaud received financial support from the Région Centre (No. 200800033784), Isabelle Le Viol from Scales project (FP7-ENV-2008-1, No. 226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032819","2012-03-12T00:00:00Z",200800
"470",470,"
        This work was supported by Guy's and St Thomas' Charity project grant R070719. The TwinsUK resource is supported by the Wellcome Trust; T Andrew is supported by the Medical Research Council UK (New Investigator Award 91993) and the Central Research Fund, University of London (AR/CRF/B); AM Valdes is supported by the EU FP7 large collaborative project 200800 TREAT-OA and by NIH NIDDK R01 grant DK61722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022332","2011-08-03T00:00:00Z",200800
"597",597,"
        The work described herein was supported by Enterprise Ireland under Grant Number CC20080001. JFC and TGD are also supported in part by Science Foundation Ireland (SFI) in the form of a centre grant (Alimentary Pharmabiotic Centre) through the Irish Government's National Development Plan. The authors and their work were supported by SFI (grant no.s 02/CE/B124 and 07/CE/B1368). JFC is funded by European Community's Seventh Framework Programme; Grant Number: FP7/2007–2013, Grant Agreement 201714. GC is in receipt of research funding from the American Neurogastroenterology and Motility Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032266","2012-03-20T00:00:00Z",200800
"717",717,"
        This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Support for individual studies that participated in the effort is as follows: SBCS (Dr. Silverman) - Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics and intramural contract number NCI N02-CP-11015. FIS/Spain 98/1274, FIS/Spain 00/0745, PI061614, and G03/174, Fundació Marató TV3, Red Temática Investigación Cooperativa en Cáncer (RTICC), Consolíder ONCOBIO, EU-FP7-201663; and RO1- CA089715 and CA34627. NEBCS (Dr. Silverman) - Intramural research program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics and intramural contract number NCI N02-CP-01037 PLCO (Dr. Purdue) - The National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C), and study coordination at the GENEVA (Dr. Caporaso)- The NIH Genes, Environment and Health Initiative [GEI] partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C) and study coordination at the GENEVA Coordination Center (U01 HG004446) for EAGLE and part of PLCO studies. Genotyping for the remaining part of PLCO and all ATBC and CPS-II samples were supported by the Intramural Research Program of the National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics. The PLCO is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. ATBC (Dr. Albanes) - This research was supported in part by the Intramural Research Program of the NIH and the National Cancer Institute. Additionally, this research was supported by U.S. Public Health Service contracts N01-CN-45165, N01-RC-45035, and N01-RC-37004 from the National Cancer Institute, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029396","2012-01-04T00:00:00Z",200800
"475",475,"
        This work was supported by grant BFU2008-00995/BMC from Ministerio de Ciencia e Innovación (MCINN, Spain), grant RD06/0008/1012 from Instituto de Salud Carlos III, and grant 248919/FP7-ICT-2009-4 from the European VII Framework Program. CG was the recipient of fellowships from Fondation pour la Recherche Médicale (SPE20080512320) and European Molecular Biology Organization (157-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002073","2011-05-19T00:00:00Z",200805
"189",189,"This work was supported by grants from the French National Agency of Research (grant # ANR-05-MIME-009-01), the European Commission, FP7 work program (Grant # 200889), and the Copenhagen University Programme of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013105","2010-10-01T00:00:00Z",200889
"293",293,"This study received financial support from the Institut de Médecine et d'Epidémiologie Appliquée (grant IMEA-0801), from the European Commission, FP7 program (grant 200889), and from the French National Agency for Research (grant ANR-05-MIME-009-01). C. Badaut was supported by the National Agency of Research (ANR) and by the Institute of Research for Development (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0011276","2010-06-23T00:00:00Z",200889
"108",108,"This work was supported by the French Ministry of Health, the University Hospital of Montpellier, and the Coordination Theme 1 (Health) of the European Community's FP7, Grant Agreement Number HEALTH-F2-2008-200923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0014096","2010-11-23T00:00:00Z",200923
"348",348,"
        The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7) under grant agreement no 200931 (project IBDase). IC is a postdoctoral fellow and SV is a clinical researcher of the Fund for Scientific Research (FWO), Flanders, Belgium. CTU Bern is supported by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024106","2011-09-08T00:00:00Z",200931
"643",643,"
        The research leading to these results has received funding from the Ministère de la Recherche et de la Technologie (JE2526), by the INRA (USC 2018), by grants from the Association F. Aupetit (AFA) and from the European Community's Seventh Framework Programme (FP7) under agreement No 200931 (project IBDase). IBDase Partners are D. Lottaz (University of Bern, Switzerland), S. Vermeire  (Katholieke Universiteit Leuven, Leuven, Belgium), A. Darfeuille-Michaud (Université d'Auvergne, Clermont-Ferrand, France), C. Becker-Pauly (Johannes Gutenberg Universitaät Mainz, Germany), M. Artieda (Progenika Biopharma, S.A., Spain), M. Rescigno (Istituto Europeo di Oncologia, Italy), G. C. Hansson (University of Gothenburg, Sweden), S. L.F. Pender (University of Southampton, United Kingdom), G. Monteleone (University Tor Vergata of Rome, Italy), K. Leufgen (SCIPROM Sàrl, Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021199","2011-06-16T00:00:00Z",200931
"357",357,"
        MB's laboratory is funded by the Spanish Ministry of Science and Innovation Projects SAF2008-05384 and CSD2007-00017, European Union FP7 Projects 2007-A-201630 (GENICA) and 2007-A-200950 (TELOMARKER), European Research Council Advanced Grant GA#232854, Körber Foundation, Fundación Botín and Fundación Lilly (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025680","2011-10-12T00:00:00Z",200950
"565",565,"
        This study was supported by grants from the Swedish Cancer Society (GR), the Lion’s Cancer Research Foundation, Umeå (GR), the Swedish Research Council (GR), the County Council of VÃ¤sterbotten (GR), Cancer Research UK (DB), the Swedish National Institute of Public Health (M-LH), The Swedish Heart and Lung Foundation (M-LH), Tornspiran Foundation (M-LH) and The Albert and Gerda Svensson Foundation (M-LH). The research leading to these results has received funding from the European Community’s Seventh Framework Program FP7/2007-2011 under grant agreement no. 200950 (GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021485","2011-06-24T00:00:00Z",200950
"427",427,"
        This work was supported by grants from the EU (FP6-518230, FP7-200970, TÁMOP-4.2.2/B-10/1-2010-0013), a joint grant of the Hungarian Science Foundation and Norway Grants (NNF-78794), the Hungarian Science Foundation (OTKA K69105 and OTKA-K83314). C.S. is a Bolyai Research Scholar of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002673","2012-04-26T00:00:00Z",200970
"135",135,"
        This work was supported by the Bill & Melinda Gates Foundation Grand Challenges Explorations, Phase I (ID: 52226), Key Project of the Chinese National Program (2012ZX10003-004) and European Community (FP7 project TB-VIR, 200973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025832","2011-10-07T00:00:00Z",200973
"288",288,"This work was supported in part by the Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R-19, KSCX1-YW-22-01), Ministry of Science and Technology of China Grants (2006CB910405, 2006CB910700, 2007AA02Z335 and 2009CB825607), National Natural Science Foundation Grants (30730033, 30670436 and 30600260), Shanghai Postdoctoral Scientific Program (09R21414900). LTR is part of the TB-VIR network (European Community Grants of FP7, 200973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0007538","2009-10-21T00:00:00Z",200973
"302",302,"This work was supported by the Centre de la Recherche Scientifique (CNRS), the Institut Pasteur, and the European Community (FP7 project TB-VIR, Grant no 200973, and FP6 project TB-ADAPT, Grant no LSHP-CT-2006-037919). ON is a fellow of a CNRS-ATIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013594","2010-10-25T00:00:00Z",200973
"582",582,"This work was supported by INSERM, CNRS, Fondation pour la Recherche Medicale, Institut Pasteur Paris (incl. Programme Transversal de Recherche nr 253), Institut Pasteur Korea, and the European Community (TB-MACS, Grant nr LSHP-CT-2006-037732; TB-VIR, Grant nr 200973; and EU-FP7 NEWTBVAC project, Grant nr 241745) and the Korea Research Foundation Grant (K20802001409-09B1300-03700). P.B. is a fellow of an INSERM-Avenir fellowship; O.N. is a fellow of a CNRS-ATIP fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001100","2010-09-09T00:00:00Z",200973
"623",623,"
        This work was supported in part by the European Community (FP7 project TB-VIR, grant no. 200973, and FP6 project TB-ADAPT, grant no. LSHP-CT-2006-037919). Also, this work was supported in part by National Natural Science Foundation Grants of China (90919059, 30730033, 31171257, 30971623, and 81170503), Chinese Academy of Sciences (KSCX1-YW-22-01, and KSCX2-EW-Q-1-08), Ministry of Science and Technology of China (2009CB825607), and the Shanghai Commission of Science and Technology (09410706500), the Centre de la Recherche Scientifique (CNRS) and the Institut Pasteur. ON is a fellow of a CNRS-ATIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038367","2012-06-04T00:00:00Z",200973
"145",145,"
        The research leading to these results has received funding from the European Community's 7th Framework Programme HEALTH-2007-2.3.2-2 (FP7/2007–2013: TOPLATENT-TB project under grant agreement 200999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029010","2012-01-03T00:00:00Z",200999
"294",294,"This work has been funded in part by the Centro de Estudios de America Latina (CEAL) of the Autonoma University of Madrid (http://www.uam.es). This work is also part of the StopLATENT-TB network (Collaborative Project) supported by the EC under the Health Cooperation Work Programme of the 7th Framework Programme (G.A. no. 200999) (http://cordis.europa.eu/fp7/dc/index.cfm). The financial supporters had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0011575","2010-07-14T00:00:00Z",200999
"616",616,"Archivel Farma S.L. supported the study by providing the vaccine RUTI®. The Spanish Ministry of Health (FIS PI080785; National Plan I+D+I FIS CM06/00123); the Spanish Ministry of Science and Innovation (BIO2005-07949-C02-02; CIBER Enfermedades Respiratorias, programa CRP-TB); the Bill and Melinda Gates Foundation (Grand Challenges GC12) and the European Community's 7th Framework Programme (FP7/2007-2013: STOPLATENT-TB project under grant agreement 200999) collaborated in funding the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0010030","2010-04-06T00:00:00Z",200999
"290",290,"Financed in part by the European Community (FP7/2007-2013; grant agreement n° 201024), the Spanish Ministry of Education and Science (SAF2008-04515-CO2-01 to AMP), the non-profitable foundation ‘Fundación Melchor Colet’ to A.Ch., and the Spanish Network for the Research in Infectious Diseases (REIPI, RD06/0008/1013) to F.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. Cervera and X. Urra are recipients of grants from the Spanish Institute of Health Carlos III.","10.1371/journal.pone.0008433","2010-02-03T00:00:00Z",201024
"11",11,"
        This study was supported by the European Community (http://cordis.europa.eu/fp7/) Seventh Framework Programme (FP7/2002-2013) under grant agreement 201038, “EuroNeut-41”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033736","2012-03-16T00:00:00Z",201038
"14",14,"This work was supported by the EU FP7 programme (HEALTH-F4-2007-201052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0003976","2008-12-19T00:00:00Z",201052
"552",552,"This work was supported by L'Institut National de la Recherche Agronomique and in part by the European Community's Seventh Framework Programme (FP7/2007-2013): Metagenomics of the Human Intestinal Tract (MetaHIT), grant agreement HEALTH-F4-2007-201052. OL is supported by a Conventions Industrielles de Formation par la Recherche (CIFRE) grant from the Ministere de l'Enseignement Superieur et de la Recherche and LibraGen. AC is supported by the European Community-funded project MetaHIT. LibraGen participated in study design, data analysis and decision to publish. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013092","2010-09-30T00:00:00Z",201052
"433",433,"
        This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) UK through a studentship award (MP) and Institute Strategic Programme Grant Funding from the BBSRC (CF). NL acknowledges the support of the EU FP7 (TALOS: Health-F2-2008-201099). AP acknowledges continued funding to his group from Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036786","2012-05-07T00:00:00Z",201099
"722",722,"
        JRB Perry is supported by the Wellcome Trust as a Sir Henry Wellcome Postdoctoral Research Fellow (092447/Z/10/Z). This work was partially funded by grants from the Wellcome Trust 083270/Z/07/Z and MRC G0601261. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; National Institutes of Health contract HHSN268200625226C; and grants DK062370 and DK072193. ARIC: Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. Work at Lund University diabetes centre was funded by several grants from the Swedish Research Council (LG prject grant, Linné, Exodiab). Norfolk Diabetes Case-Control and ADDITION-Ely Studies: The work on Ely, ADDITION, and EPIC-Norfolk studies was funded by support from the Wellcome Trust and MRC. The Norfolk Diabetes study is funded by the MRC with support from NHS Research and Development and the Wellcome Trust. This research was conducted in part using data and resources from the Framingham Heart Study of the National Heart, Lung, and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II), funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Also supported by National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK078616 to JB Meigs and J Dupuis, and NIDDK K24 DK080140 to JB Meigs. The research performed at deCODE Genetics was part funded through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The DGDG study was supported by the French Government (Agence Nationale de la Recherche), the French Region of Nord Pas De Calais (Contrat de Projets État-Région), Programme Hospitalier de Recherche Clinique (French Ministry of Health), and the following charities: Association Française des Diabétiques, Programme National de Recherche sur le Diabète, Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques, Association Diabète Risque Vasculaire (Paris, France), and Groupe d'Etude des Maladies Métaboliques et Systémiques. This study was also supported in part by a grant from the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European Community). The D.E.S.I.R. study was supported by the Caisse Nationale d'Assurance Maladie des Travailleurs Salariés, Lilly, Novartis Pharma and Sanofi-Aventis, Institut National de la Santé et de la Recherche Médicale (INSERM) (Réseaux en Santé Publique, Interactions entre les déterminants de la santé, Cohortes Santé TGIR 2008), Association Diabète Risque Vasculaire, Fédération Française de Cardiologie, Fondation de France, Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques, Office National Interprofessionnel des Vins, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Santé, Novo Nordisk, Pierre Fabre, Roche and Topcon. The D.E.S.I.R. Study Group: INSERM 1018: B Balkau, P Ducimetière, E Eschwège; INSERM U367: F Alhenc-Gelas; Centre Hospitalier Universitaire D'Angers: Y Gallois, A Girault; Bichat Hospital: F Fumeron, M Marre, R Roussel; CHU de Rennes: F Bonnet; CNRS UMR8199, Lille: P Froguel; Medical Examination Services: Alençon, Angers, Blois, Caen, Chartres, Chateauroux, Cholet, Le Mans, Orléans and Tours; Research Institute for General Medicine: J Cogneau; General practitioners of the region; Cross-Regional Institute for Health: C Born, E Caces, M Cailleau, JG Moreau, F Rakotozafy, J Tichet, S. Vol. We are grateful to all patients for participation in the genetic study. We also thank Marianne Deweirder, Frédéric Allegaert (UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France) for their technical assistance and their precious management of DNA samples. This work was partially funded by grants from the Wellcome Trust 083270/Z/07/Z and MRC G0601261. This work was presented as a poster at the American Diabetes Association's scientific sessions June 2011. The NHS/HPFS T2D GWA study (U01HG004399) is a component of a collaborative project that includes 13 other GWA studies funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI) (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033) with additional support from individual NIH (NIDCR:U01DE018993, U01DE018903; NIAAA: U10AA008401, NIDA: P01CA089392,R01DA013423; NCI: CA63464, CA54281, CA136792, Z01CP010200). EUROSPAN cohorts were supported by the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The ERF study was supported by grants from the NWO, Erasmus MC and the Centre for Medical Systems Biology (CMSB). We are grateful to all patients and their relatives, general practitioners and neurologists for their contributions and to P Veraart for her help in genealogy, Jeannette Vergeer for the supervision of the laboratory work and P Snijders for his help in data collection. MICROS: The MICROS study is part of the genomic health care program ‘GenNova’ and was carried out in three villages of the Val Venosta on the populations of Stelvio, Vallelunga and Martello. In South Tyrol, the study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The VIS study in the Croatian island of Vis was supported through the grants from the Medical Research Council UK and Ministry of Science, Education and Sport of the Republic of Croatia (number 108-1080315-0302). The research within the KORA study was partially funded by the German Center for Diabetes Research (DZD), the Helmholtz Zentrum München, Neuherberg, Germany, and supported by grants from the German Federal Ministry of Education and Research the Federal Ministry of Health, the Ministry of Innovation, Science, Research, and Technology of the state North Rhine-Westphalia, the German National Genome Research Network (NGFN), and the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The research of I Prokopenko is funded in part through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002741","2012-05-31T00:00:00Z",201100
"725",725,"
        The AGES study has been funded by NIH contract N01-AG-1-2100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Amish study was supported by grants and contracts from the NIH including R01 AG18728 (Amish Longevity Study), R01 HL088119 (Amish Calcification Study), U01 GM074518-04 (PAPI Study), U01 HL072515-06 (HAPI Study), U01 HL084756 and NIH K12RR023250 (University of Maryland MCRDP), the University of Maryland General Clinical Research Center, grant M01 RR 16500, the Baltimore Veterans Administration Medical Center Geriatrics Research and Education Clinical Center, and the Paul Beeson Physician Faculty Scholars in Aging Program. The ASPS research reported in this article was funded by the Austrian Science Fund (FWF) grant number P20545-P05 and P13180. The Medical University of Graz supported the databank of the ASPS. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. A Köttgen and C Hundertmark were supported by the grant KO3598/2-1 (Emmy Noether Programme) of the German Research Foundation. The BLSA was supported in part by the Intramural Research Program of the NIH (National Institute on Aging). The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The ERF study was supported by grants from the Netherlands Organization for Scientific Research (NWO; Pioneergrant), Erasmus Medical Center, the Centre for Medical Systems Biology (CMSB), and the Netherlands Kidney Foundation. The Family Heart Study (FHS) work was supported in part by NIH grants 5R01HL08770003, 5R01HL08821502 (M Province) from the NHLBI and 5R01DK07568102, 5R01DK06833603 from the NIDDK (I Borecki). The Framingham Heart Study research reported in this paper was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The GENOA research was partially supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health R01 HL-87660. The Health Aging and Body Composition Study (Health ABC) was funded by the National Institutes of Aging. This research was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. The GWAS was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. For the KORA F3 and F4 studies, the genetic epidemiological work was funded by the NIH subcontract from the Children's Hospital, Boston, US, (HE Wichmann, IM Heid, prime grant 1 R01 DK075787-01A1), the German National Genome Research Net NGFN2 and NGFNplus (H.E.Wichmann 01GS0823; WK project A3, number 01GS0834), the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ, and by the Else Kröner-Fresenius-Stiftung (P48/08//A11/08; CA Böger, BK Krämer). The kidney parameter measurements in F3 were funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer) and the Regensburg University Medical Center, Germany; in F4 by the University of Ulm, Germany (W Koenig). Genome-wide genotyping costs in F3 and F4 was in part funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). De novo genotyping in F3 and F4 was funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). The KORA research platform and the MONICA Augsburg studies were initiated and financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, by the German Federal Ministry of Education and Research, and by the State of Bavaria. Genotyping was performed in the Genome Analysis Center (GAC) of the Helmholtz Zentrum München. The LINUX platform for computation was funded by the University of Regensburg for the Department of Epidemiology and Preventive Medicine at the Regensburg University Medical Center. The NHS/HPFS type 2 diabetes GWAS (U01HG004399) is a component of a collaborative project that includes 13 other GWAS (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033; National Institute of Dental and Craniofacial Research: U01DE018993, U01DE018903) funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI). Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Genotyping was performed at the Broad Institute of MIT and Harvard, with funding support from the NIH GEI (U01HG04424), and Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438) and the NIH contract “High-throughput genotyping for studying the genetic contributions to human disease” (HHSN268200782096C). Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). We thank the staff and participants of the NHS and HPFS for their dedication and commitment. The Korcula study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan and by Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302). The MICROS study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, the South Tyrolean Sparkasse Foundation, and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The Northern Swedish Population Health Study was supported by grants from the Swedish Natural Sciences Research Council, the European Union through the EUROSPAN project (contract no. LSHG-CT-2006-018947), the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). The NHS renal function and albuminuria work was supported by DK66574. Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). ORCADES was supported by the Chief Scientist Office of the Scottish Government, the Royal Society and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). DNA extractions were performed at the Wellcome Trust Clinical Research Facility in Edinburgh. The popgen study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the Ministry of Science, Commerce, and Transportation of the State of Schleswig-Holstein. The project has also received infrastructure support through the DFG excellence cluster “Inflammation  at Interfaces.” The Sorbs study was funded by grants from the German Research Council KFO-152 (to M Stumvoll) and the IFB (Integrated Research and Treatment Center) AdiposityDiseases (K7-37 to M Stumvoll and A Tönjes). We also thank Dr. Knut Krohn (Microarray Core Facility of the Interdisciplinary Centre for Clinical Research, University of Leipzig, Germany) for providing the genotyping platform. The research of Inga Prokopenko is funded in part through the European Community's
Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. R Mägi acknowledges financial support from the European Commission under a Marie Curie Intra-European Fellowship. For the Rotterdam Study-I and Rotterdam Study-II, the GWAS was funded by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The Erasmus Computing Grid, Rotterdam (The Netherlands) and the national German MediGRID and Services@MediGRID part of the German D-Grid were both funded by the German Bundesministerium fuer Forschung und Technology under grants #01 AK 803 A-H and # 01 IG 07015 G, for access to their grid resources. A Dehghan is supported by NWO grant (vici, 918-76-619). The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research net of the University of Greifswald, Germany, funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the ‘Center of Knowledge Interchange’ program of the Siemens AG. The Vis study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan; and Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302) and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The 3 City Study was supported by the National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Génotypage. The 3 City Study was performed as part of a collaboration between the Institut National de la Santé et de la Recherche Médicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthélabo. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM “Cohortes et collections de données biologiques” programme. Lille Génopôle received an unconditional grant from Eisai. The Blue Mountains Eye Study (BMES) has been supported by the Australian RADGAC grant (1992–94) and Australian National Health and Medical Research Council, Canberra Australia (Grant Nos: 974159, 211069, 991407, 457349). The GWAS studies of BMES population are supported by the Australian National Health and Medical Research Council (Grant Nos: 512423, 475604, 529912) and the Wellcome Trust, UK (2008), as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster, grant numbers 085475/B/08/Z and 085475/08/Z). EG Holliday and JJ Wang are funded by the Australian National Health and Medical Research Council Fellowship Schemes. The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). M Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The Cardiovascular Risk in Young Finns study (YFS) is supported by the Academy of Finland (grant no. 117797, 121584, and 126925), the Social Insurance Institution of Finland, University Hospital Medical funds to Tampere and Turku University Hospitals, and the Finnish Foundation of Cardiovascular Research. The Emil Aaaltonen Foundation (T Lehtimäki). EGCUT received support from FP7 grants ((201413 ENGAGE, 212111 BBMRI, 205419 ECOGENE, 245536 OPENGENE) and also received targeted financing from Estonian Government SF0180142s08 and from the European Union through the European Regional Development Fund, in the frame of Centre of Excellence in Genomics. The research of the FamHS-II was conducted in part using data and resources from the NHLBI Family Heart Study supported in part by NIH grant 5R01HL08770002. For the GoDARTs study, the Wellcome Trust provides support for Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection and the informatics support is provided by the Chief Scientist Office, and the Wellcome Trust funded Scottish Health Informatics Programme (SHIP). The INGI-Carlantino and INGI-FVG studies were supported by grants from Telethon, FVG region, and Fondo Trieste. The INGI-Cilento study was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano, and the Fondazione Banco di Napoli to M Ciullo. The INGI – Val Borbera Study was supported from Compagnia di San Paolo, Torino, Italy, the Cariplo Fundation, Milano, Italy, and Italian Ministry of Health Progetto Finalizzato 2007 and 2009. The JUPITER trial and the genotyping were supported by AstraZeneca. The Ogliastra Genetic Park (OGP) - Replication Study and OGP - Talana study were supported by grants from the Italian Ministry of Education, University, and Research (MIUR) no. 5571/DSPAR/2002 and (FIRB) D. M. no. 718/Ric/2005. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) trial was supported by an investigator initiated grant from Bristol-Myers Squibb, USA. The study was conducted, analyzed, and reported independently of the company. The SAPALDIA study was supported by the Swiss National Science Foundation (grants no 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the Federal Office for Forest, Environment, and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, and Zurich. The SAPHIR-study was partially supported by a grant from the Kamillo Eisner Stiftung to B Paulweber and by grants from the “Genomics of Lipid-associated Disorders – GOLD” of the “Austrian Genome Research Programme GEN-AU” to F Kronenberg. eQTL analysis: HJ Gierman received support from the AFAR/EMF postdoctoral fellowship and the Stanford Dean's postdoctoral fellowship. HE Wheeler and SK Kim were supported by grants from the NIA, NHGRI and NIGMS.
      ","10.1371/journal.pgen.1002584","2012-03-29T00:00:00Z",201100
"291",291,"Work in the authors' laboratory is supported by European Commission (EC) FP7 funding (ONCOMIRS, grant agreement number 201102. This publication reflects only authors' views. The commission is not liable for any use that may be made of the information herein), The Novo Nordisk Foundation, The Lundbeck Foundation, The Danish National Research Foundation, The Danish Medical Research Council, The Danish Cancer Society and the Danish National Advanced Technology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0008836","2010-01-21T00:00:00Z",201102
"665",665,"
        Work in the authors' laboratory was supported by the Danish National Research Foundation, the Danish National Advanced Technology Foundation, the Novo Nordisk Foundation, the EC FP7 programs (ONCOMIRS, grant agreement number 201102, and APO-SYS: This publication reflects only the authors' views. The commission is not liable for any use that may be made of the information herein.), the Lundbeck Foundation, and the Danish Cancer Society. This work has also been funded by the German Federal Ministry of Education and Research to the German Mouse Clinic (NGFNplus grant No. 01GS0850), Infrafrontier grant No. 01KX1012), and by an EU grant (EUMODIC, LSHG-2006-037188, German Mouse Clinic) and the Wellcome Trust (senior research fellowship to JR 084229, centre core grants 077707 and 092076, and instrument grant 091020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002711","2012-05-10T00:00:00Z",201102
"459",459,"
        The research leading to these results has received funding from the Italian Association for Cancer Research (AIRC) to I.S. (IG grant n° 5118) and to A.V. (IG grant n°5629 and RG 6278), the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement n°201106 and EMBO YIP to A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022482","2011-08-10T00:00:00Z",201106
"364",364,"
        This work was supported by the Swedish Research Council, the Science Faculty at the University of Gothenburg Platform program, the European Commission funded projects FP6 CELLCOMPUT (Contract No. 043310) and FP7 UNICELLSYS (Contract No. 201142). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026584","2011-10-21T00:00:00Z",201142
"490",490,"
        This work was financed by the European Commission (QUASI, contract LSHG-CT2003-503230 and CellComput, contract 043310). CN is supported by a grant from the Canadian Institutes for Health Research (#84305) and from the Canadian Cancer Society (grant # 020380) to GG. FP's laboratory is also supported by the FP7 UNICELLSYS grant (#201142) and the Fundación Marcelino Botín (FMB). FP is the recipient of an ICREA Acadèmia (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020789","2011-06-17T00:00:00Z",201142
"248",248,"
        This work was supported by: European Union grants (IMECS n. 201169, FP7-Health-2007-A and SPHYNX n. 261365, FP7-Health-2010); Ministero della Sanità (Ricerca finalizzata [RFPS-2006-3-337923 and RFPS-2007-1-636647]; Istituto Superiore di Sanità [Progetti AIDS-2006 and -2008]); Ministero dell'Istruzione, dell'Università e della Ricerca (MIUR) (Programmi di ricerca di interesse nazionale [PRIN]-2008/10 n. 7245/1; Fondo per gli investimenti di ricerca di base [FIRB]-2011/13 n. RBAP10TPXK); Fondazione Cariplo (progetti n. 13535 and 3603 2010/12); Associazione Italiana per la Ricerca sul Cancro (AIRC) (progetto “Investigator Grant” [IG]-2010/13 n. 10756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002759","2012-06-21T00:00:00Z",201169
"325",325,"
        This work was supported by an ATIP-AVENIR grant from the Institut National de la Santé et de la Recherche Médicale and Sanofi-Aventis (BG). The research leading to these results has received funding from the European Community's Seventh Framework Programme Grant ([FP7/2007–2013]) (to GAB and BG) under Grant agreement 201222. AS was supported by a grant from the Fondation pour la Recherche Médicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020270","2011-05-19T00:00:00Z",201222
"381",381,"The work on P. berghei sequestration was supported by grants of The Netherlands Organization for Scientific Research (ZonMw TOP grant number 9120_6135), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements N°201222 and N° 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001032","2010-09-30T00:00:00Z",201222
"557",557,"
        This work was supported by a grant from the Bill and Melinda Gates Foundation (JDS) and an ATIP-AVENIR grant from the Institut National de la Santé et de la Recherche Médicale and Sanofi-Aventis (BG). JGB and MH are supported by the National Health and Medical Research Council of Australia, and the Australian Research Council. The research leading to these results has received funding from the European Community's Seventh Framework Programme Grant ([FP7/2007-2013]) (BG) under Grant agreement 201222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016622","2011-02-07T00:00:00Z",201222
"624",624,"
        This study received funding primarily from the PMI2 (#47029) Gates Malaria Programme grant from the Bill and Melinda Gates Foundation. The work was also supported by the Danish Research Council (SSVF) (grant 22-03-0333), The Novo Nordisk Foundation (grant 10335), the Danish Research Council for Development Research (RUF) (grant 104.Dan.8.L.306 and 8.L.306), The PreMalStruct FP7-HEALTH-2007-A ID 201222 and The University of Copenhagen Program of Excellence (Membrane topology and quaternary structure of key parasite proteins involved in Plasmodium falciparum malaria pathogenesis and immunity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017942","2011-03-25T00:00:00Z",201222
"199",199,"This work was supported by the Canceropole PACA, the INCa (PL0079), the European Community (MICROENVIMET, FP7-HEALTH-F2-2008-201279), “Vaincre la Mucoviscidose” and the “Institut de Recherche en Environnement Industriel (IRENI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0006718","2009-08-24T00:00:00Z",201279
"368",368,"
        This work was supported by the “Fonds National de la Recherche Scientifique”, FP7-HEALTH-2007-A, proposal No. 201279 “MICROENVIMET”, the Interuniversity Attraction Poles Programme-Belgian Science Policy (Brussels, Belgium) and the Neoangio program #616476 of the “Service Public de Wallonie”, the Belgian Foundation against Cancer. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027318","2011-11-07T00:00:00Z",201279
"480",480,"
        This study was supported by the FRIA (Fonds pour la Recherche industrielle et agricole), FNRS (Fond national de la recherche scientifique), Télévie, le Fonds Leon Fredericq, ULg (Mirage program), FP7-HEALTH-2007-A, proposal No. 201279 ""MICROENVIMET"", the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium) and by the Neoangio Program of the Walloon Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016979","2011-02-10T00:00:00Z",201279
"548",548,"This work was supported by grants from the European Union Framework Program projects (FP7-2007-2011 “MICROENVIMET” No 201279), the Fonds de la Recherche Scientifique Médicale, the Fonds National de la Recherche Scientifique (F.N.R.S., Belgium), the Fondation contre le Cancer, the Fonds spéciaux de la Recherche (University of Liège), the Centre Anticancéreux près l'Université de Liège, the Fonds Léon Fredericq (University of Liège), the D.G.T.R.E. from the «Région Wallonne», the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium). FB, BD, AM and JL are recipients of a Televie-FNRS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0009653","2010-03-11T00:00:00Z",201279
"415",415,"
        This study was supported by the European Commission (FP7-LUPA, GA-201370), the Academy of Finland, the Sigrid Juselius Foundation, the Morris Animal Foundation, the Canine Health Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation, the University of Helsinki Research Funds, The Finnish Belgian Shepherd Breed Club, Folkhälsan Research Foundation, and the Danish Kennel Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033549","2012-03-23T00:00:00Z",201370
"446",446,"
        This study was supported partly by the European Commission (FP7-LUPA, GA-201370), the Academy of Finland, the Sigrid Juselius Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation, the University of Helsinki Research Funds, and the Finnish Foundation of Veterinary Research. HL is a member of Biocentrum Helsinki and Nordic Center of Excellence in Disease Genetics, and KK is a student in Helsinki Graduate Program in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002759","2012-06-14T00:00:00Z",201370
"513",513,"
        Supported by funding from the Kennel Club Charitable Trust, the European Commission (FP7-LUPA, GA-201370), the Research Fund of the Swedish Kennel Club, the European Science Foundation, the Guide Dogs for the Blind Association and donations from dog owners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021452","2011-06-27T00:00:00Z",201370
"540",540,"This work was supported by the Swedish Research Council; FORMAS; the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning; the Swedish Foundation for Strategic Research; in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Human Genome Research Institute of the National Institutes of Health; the Chinese Shar-Pei Charitable Trust and the European Commission (FP7-LUPA, GA-201370). KL-T is the recipient of a EURYI award from the European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1001332","2011-03-17T00:00:00Z",201370
"541",541,"
        This study was supported in part by the Academy of Finland, the Sigrid Juselius Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation, the University of Helsinki Research Funds, the Albert-Heim-Foundation, a Vanier Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada, the Canadian Institutes of Health Research, and the European Commission (FP7-LUPA, GA-201370). KL-T is the recipient of a EURYI award from the European Science Foundation. BAM holds the Canada Research Chair in Paediatric Neurogenetics. HL is a member of Biocentrum Helsinki and the Nordic Center of Excellence in Disease Genetics, and is the recipient of a ERCStG award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002194","2011-07-28T00:00:00Z",201370
"528",528,"
        This work was supported by IOP Genomics grant IGE05012A, the Netherlands Organisation for Scientific Research (NWO) VICI grant 918.66.620 (CW), a European Union FP7 COPACETIC grant 201379 (CW), the Dutch Diabetes Foundation (2006.00.007), the Wellcome Trust (084743 to DvH), the Medical Research Council UK (G1001158 to DvH), Juvenile Diabetes Research Foundation (33-2008-402 to DvH), a NWO VENI grant 863.09.007 (JF), a NWO VENI grant 916.10.135, a Horizon Breakthrough grant 92519031 from the Netherlands Genomics Initiative (LF), a NWO clinical fellowship grant 90.700.281 (RKW), the Netherlands ALS foundation and the Adessium Foundation (LHvdB), the Thierry Latran Foundation (JV), and a Transnational University Limburg (TUL) grant (SSMR). The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007–2013) under grant agreement n° 259867. This study was financed in part by the SIA-raakPRO subsidy for project BioCOMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002431","2012-01-19T00:00:00Z",201379
"707",707,"
        The genotype and gene expression generation was funded in part by COPACETIC (EU grant 201379), the Wellcome Trust (084743 to DAvH), and the Coeliac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative, as well as partially funded by the Dutch Government (BSIK03009 to CW) and by the Netherlands Organization for Scientific Research (NWO, VICI grant 918.66.620 to CW). LHvdB acknowledges funding from the Prinses Beatrix Fonds, the Adessium Foundation, and the Amyotrophic Lateral Sclerosis Association. JHV was supported by the Brain Foundation of the Netherlands. MHH received a grant from the Dutch Diabetes Foundation (2006.00.007) and IOP genomics (IGE05012A). LF received a Horizon Breakthrough grant from the Netherlands Genomics Initiative (93519031) and a VENI grant from NWO (ZonMW grant 916.10.135). GT received a Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences (KNAW). JF received a VENI grant from NWO (ALW 863.09.007). RKW is supported by a clinical fellowship grant (90.700.281) from the Netherlands Organization for Scientific Research (NWO). We acknowledge funding from the NIH: NS058980 (to RAO). The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007–2013) under grant agreement 259867. This study was financed in part by the SIA-raakPRO subsidy for project BioCOMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002197","2011-08-04T00:00:00Z",201379
"518",518,"This work was supported by grants from the Agence Nationale de Recherche sur le SIDA (ANRS), the Agence Nationale de Recherche (ANR), SIDACTION, the CNRS, the European Community, the Fondation pour la Recherche Medicale (FRM), and Institut Pasteur. MS and SL are supported by an EC contract (FP7 contract 201412). We thank the ANRS HIV Vaccine Network for supporting this work. The authors have no conflicting financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001284","2011-02-17T00:00:00Z",201412
"271",271,"
        This work was funded in part by the European Commission (PolyALA LSHM-CT-2005018675) and Muscular Dystrophy Association (68016) to SMvdM and MDA, European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413, and the Centre for Medical Systems Biology within the framework of the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002258","2011-11-03T00:00:00Z",201413
"278",278,"
        This study was supported by the national Functional Genomics Programme (FUGE) of the Research Council of Norway. This research was also partly funded through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project (grant agreement HEALTH-F4-2007-201413), and Southern and Eastern Norway Regional Health Authority (grant number 51932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002454","2012-01-19T00:00:00Z",201413
"426",426,"
        This research was supported by the Russian Foundation for Basic Research (grant RFBR-10-04-01385-a). Dr. 't Hoen was funded through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413, and the Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035618","2012-04-25T00:00:00Z",201413
"527",527,"The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2, NGFNPlus 01GS0823, and NGFNPlus 01GS0834) and through additional funds from the University of Ulm. Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ and by a grant from the BMBF to the German Center for Diabetes Research (DZD e.V.), as well as from the BMBF funded German Network for Mitochondrial Disorders (mitoNET 01GM0862) and Systems Biology of Metabotypes (SysMBo 0315494A). Furthermore, the study received funding from the European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. The LURIC part of this study has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 201668; AtheroRemo. It was further supported by the Centre of Excellence “Metabolic disorder” Baden-Württemberg, Ulm, University Ulm, Germany. The Sorbs part of this study was supported by grants from the Interdisciplinary Centre for Clinical Research at the University of Leipzig (B27; N06) and from the German Diabetes Association as well as by a grant from the DFG (KFO 152). Furthermore, the authors received funding through the European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The TwinsUK study was funded by the Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, the European Community's Seventh Framework Programme (FP7/2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also received support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and by the WT Grant n. 091746/Z/10/Z. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). Genotyping was in part performed by CIDR as part of an NEI/NIH project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1001213","2010-11-18T00:00:00Z",201413
"556",556,"
        This research was supported through funds from The European Community's Seventh Framework Programme [FP7/2007-2013, ENGAGE Consortium, grant agreement HEALTH-F4-2007- 201413] (AK, A-CS); the Nordic Centre of Excellence in Disease Genetics (AK); The Nordic Sequencing Infrastructure (KL-T, A-CS); The Swedish Research Council for Science and Technology [2009-5594] (A-CS); the Knut and Alice Wallenberg Foundation (A-CS); and the Swedish Cancer Foundation (A-CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016486","2011-02-09T00:00:00Z",201413
"700",700,"The Australian Twin Registry is supported by an Australian National Health and Medical Research Council (NHMRC) Enabling Grant (2004–2009). The Blue Mountains Eye Study has also been supported by NHMRC grants (974159, 211069, 457349), a Capacity Building grant (262120), and a Centre for Clinical Research Excellence grant (529923). We also thank the following organisations for their financial support: Clifford Craig Medical Research Trust, Ophthalmic Research Institute of Australia (ORIA), Glaucoma Australia, American Health Assistance Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Foundation for Children, NHMRC project grant (2005–2007), Jack Brockhoff Foundation, National Eye Institute (NEI) Project Grant (2007–2010). Genotyping for part of the Australian sample was funded by an NHMRC Medical Genomics Grant. Genotyping for the remainder was performed by the National Institutes of Health (NIH) and CIDR as part of an NIH/NEI grant 1RO1EY018246, and we are grateful to Dr Camilla Day and staff. Australian sample imputation analyses were carried out on the Genetic Cluster Computer which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). YL is supported by Australian NHMRC grant 496675. DAM is a recipient of the Pfizer Australia Senior Research Fellowship. SM is supported by an Australian NHMRC Career Development Award. The KCL authors acknowledge funding from the Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, Guide Dogs for the Blind Association the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413 and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator and CJH an NIHR Senior Research Fellow. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant. (G20234). The authors acknowledge the funding and support of the NIH/NEI grant 1RO1EY018246, an NIH/Center for Inherited Diseases Research genotyping project grant (PI: Terri Young). Genotyping of the BMES and Adelaide cohorts was funded by the Ophthalmic Research Institute of Australia and NHMRC Project Grant #535044. DPD is supported by NHMRC Dora Lush Scholarship and KPB by NHRMC Peter Foherty Fellowship. JEC is an NHMRC Practioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000947","2010-05-13T00:00:00Z",201413
"701",701,"This research was supported by the EU European Regional Development Fund through the Centre of Excellence in Genomics, Estonian Biocentre and University of Tartu. MN, TE and AM were supported by Enterprise Estonia project EU19955 and by the Estonian Ministry of Education and Research grant 0180142s08. RM was financed through European Commission grant 205419 (ECOGENE) to Estonian Biocentre and EU FP6 project “LifeSpan”. RM and MR were also supported by the Estonian Ministry of Education and Research grant 0182649s04. Part of the financing came from the EU funded ENGAGE project (grant 201413) of the FP7. DToncheva and SK were supported by the “Characterization of the anthropo-genetic identity of Bulgarians” Project of the Bulgarian Ministry of Education and Science, reference No. TK01-487/16.06.2008. LP was funded by the Center of Excellence in Common Disease Genetics of the Academy of Finland. RR is a “Ramon y Cajal” postdoctoral fellow supported by the Spanish Ministry of Science and Innovation. MM was supported by grants VZFNM00064203 and NS NS9488/3 provided by the Ministry of Health of the Czech Republic. Research on the French sample has been supported by the French Ministry of Higher Education and Research. Research on samples from Northern Italy has been supported by the Compagnia di San Paolo Foundation and Health Ministry grant PS-CARDIO ex 56//05/7. Research on the Spanish sample has been supported by grants from the Spanish Ministry of Science and Innovation (SAF2008-00357 to XE and PSE-01000-2006-6 to SM), ENGAGE (FP7/2007-201413) and AnEUploidy (FP6/2006-037627) EU grants to XE. The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The work of KORA is supported by the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). Swiss sample provision has been supported by grants from the National Science Foundation, Infectigen Foundation, and AnEUploidy EU IP (037627) grants to SEA. Research on the Latvian sample has been supported by Ministry of Health, Republic of Latvia (agreement No. 3308/IGDB-1/2008). This research was also supported by the Russian Academy of Sciences, Program “Molecular and Cell Biology”, and the Russian Basic Research Foundation. The study has also been supported by a research grant of the Italian Ministry of Health (Ricerca Corrente 2007 and Ricerca Finalizzata Cardiovascolare).","10.1371/journal.pone.0005472","2009-05-08T00:00:00Z",201413
"702",702,"The Rotterdam Study authors acknowledge funding from the Netherlands Genomics Initiative (NGI) and Netherlands Organization for Scientific Research (NWO) (nr. 050-060-810) within the framework of the Forensic Genomics Consortium Netherlands (FGCN), the Netherlands Forensic Institute and the Research Institute for Diseases in the Elderly (RIDE) (nr. 014-93-015). The generation and management of GWAS genotype data for the Rotterdam Study (RS-I, RS-II) was supported by a NWO investments grant (nr. 175.010.2005.011, 911-03-012). The Rotterdam Study is funded by the Erasmus University Medical Center, Erasmus University Rotterdam; the Netherlands Organization for the Health Research and Development (ZonMw); the RIDE; the Ministry of Education, Culture, and Science; the Ministry for Health, Welfare, and Sports of the Netherlands; the European Commission (DG XII); and the Municipality of Rotterdam. The ophthalmic part of the Rotterdam Study was supported by Lijf en Leven, Krimpen, and Lek; MD Fonds, Utrecht. Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, Rotterdam; Swart van Essen, Rotterdam; NWO; Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen (all in the Netherlands); as well as Heidelberg Engineering, Dossenheim, Germany. The TwinsUK authors acknowledge funding from the Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, Guide Dogs for the Blind Association the European Community's Seventh Framework Programme (FP7 2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7 2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guys St Thomas NHS Foundation Trust in partnership with Kings College London. TDS is an NIHR senior Investigator and CJH an NIHR Senior Research Fellow. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). The authors acknowledge the funding and support of the National Institutes of Health(NIH) National Eye Institute grant 1RO1EY018246, and the NIH Center for Inherited Diseases Research (CIDR) (PI: Terri Young). The BTNS authors acknowledge funding from the Australian National Health and Medical Research Council (NHMRC, grants 241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496739, 552485, 552498), Australian Research Council (A7960034, A79906588, A79801419, DP0212016, DP0343921); National Institutes of Health National Cancer Institute (CA88363). DLD and GWM were supported by the NHMRC Fellowships scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000934","2010-05-06T00:00:00Z",201413
"703",703,"Major funding for the work described in this manuscript comes from the Medical Research Council of Great Britain (G9521010D), the British Heart Foundation (PG02/128, FS/05/061/19501), the Wellcome Trust (076113/B/04/Z), The Barts and The London Charity, GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, the Swiss National Science Foundation (33CSCO-122661, 3200BO-111361/2, 3100AO-116323/1), the Giorgi-Cavaglieri Foundation, the European Framework Project 6 (EuroDia, AnEuploidy and Hypergenes projects), the EUROSPAN (European Special Populations Research Network) project funded by the European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947), the Medical Research Council UK, the Ministry of Science, Education and Sport of the Republic of Croatia (108-1080315-0302, 196-1962766-2751, 196-1962766-2763, 196-1962766-2747), the Helmholtz Zentrum München, the German Federal Ministry of Education and Research, the German National Genome Research Network (NGFN), LMUinnovativ, the Ministry of Health of the Autonomous Province of Bolzano, the South Tyrolean Sparkasse Foundation, The Swedish Natural Sciences Research Council, The Foundation for Strategic Research, the Scottish Executive Health Department, the Royal Society, the EC Sixth Framework Programme (LSHM-CT-2007-037273), AstraZeneca AB, the Knut and Alice Wallenberg Foundation, the National Institute on Aging (NO1-AG-1-2109 to the “SardiNIA-ProgeNIA” team), the Intramural research funding at the National Institute on Aging (NIH), the Ministry of Cultural Affairs (Germany), the Social Ministry of the Federal State of Mecklenburg-Western Pomerania, Siemens Healthcare, the Federal State of Mecklenburg- West Pomerania, the Australian National Health and Medical Research Council (NHMRC), the US National Institutes of Health (AA007535), the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254), the Arthritis Research Campaign, the Chronic Disease Research Foundation, the National Institute for Health Research (NIHR) and the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000504","2009-06-05T00:00:00Z",201413
"705",705,"The NFBC1966 received financial support from the Academy of Finland (project grants 104781, 120315, 132797, and Center of Excellence in Complex Disease Genetics); University Hospital Oulu, Biocenter, University of Oulu, Finland; the European Community's Fifth/Seventh Framework Programme (EURO-BLCS, QLG1-CT-2000-01643, FP7/2007-2013); NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01); ENGAGE project (HEALTH-F4-2007-201413); the Medical Research Council (studentship grant G0500539, centre grant G0600705); the Wellcome Trust (project grant GR069224), UK; the Research Council UK fellowship; the National Institute of Health Research (NIHR) Biomedical Research Centre Programme at Imperial College; and the Division of Epidemiology, Public Health and Primary Care (studentship grant DFHM G24038). The DNA extractions, sample quality controls, biobank up-keeping, and aliquotting were performed in the National Public Health Institute, Biomedicum Helsinki, Finland, and supported financially by the Academy of Finland and Biocentrum Helsinki. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC. CJH is funded by a European Union grant HEALTH-2007-201550 HyperGenes. DME is supported by a Medical Research Council New Investigator Award (MRC G0800582). The ICLS (International Centre for Life Course Studies in Society and Health) is funded by an ESRC award: RES-596-28-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000856","2010-02-26T00:00:00Z",201413
"7141",714,"
        This research was supported through funds from The European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. SR was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680), Academy of Finland (251217), the Finnish foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. The ATFS cohort was funded by the Australian National Health and Medical Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498), the Australian Research Council (A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921), the EU 5th Framework Programme GenomEUtwin Project (QLG2-CT-2002-01254), and the U.S. National Institutes of Health (AA07535, AA10248, AA11998, AA13320, AA13321, AA13326, AA14041, AA17688, DA12854, MH66206). RPSM and GWM are supported by National Health and Medical Research Council (NHMRC) Fellowship Schemes. Special Population Research Network (EUROSPAN) was supported b' European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). In South Tyrol, the MICROS Study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Vis Study in the Croatian island of Vis was supported through the grants from the Medical research Council UK to HC and IR and from the Ministry of Science, Education, and Sport of the Republic of Croatia to IR (number 108-1080315-0302). Erasmus Ruchpen Family (ERF) was supported by grants from The Netherlands Organization for Scientific Research (NOW; Pionier Grant), Erasmus MC, and the Netherlands Genomics Initiative (NGI)–sponsored Center for Medical Systems Biology (CMSB). The Northern Swedish Population Health Study (NSPHS) was funded by the Swedish Medical Research Council (Project Number K2007-66X-20270-01-3) and the Foundation for Strategic Research (SSF). The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823) and by the “Genomics of Lipid-associated Disorders - GOLD” of the “Austrian Genome Research Programme GEN-AU.” The KORA research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The Northern Finland Birth Cohort 1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269 (SALVE), 114194, and Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland, NHLBI grant 5R01HL087679 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, the Medical Research Council (grant G0500539, centre grant G0600705, PrevMetSyn), and the Wellcome Trust (project grant GR069224), UK. The genotyping of NFBC1966 was funded by NHLBI grant 5R01HL087679, the Academy of Finland, and Biocentrum Helsinki. Helsinki Birth Cohort Study has been supported by grants from Academy of Finland (project numbers 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225, 216374), Finnish Diabetes Research Society, Samfundet Folkhälsan, Juho Vainio Foundation, Novo Nordisk Foundation, Finska Läkaresällskapet, Päivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, and Yrjö Jahnsson Foundation. The Young Finns Study has been financially supported by the Academy of Finland (grants 126925, 121584, and 124282), Finnish Cultural Foundation, Emil Aaltonen Foundation, the Social Institution of Finland, Kuopio, Tampere (grants for TL and MK) and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research (TL and OTR). The GenomEUtwin project is supported by the European Commission under the programme ‘Quality of Life and Management of the Living Resources’ of 5th Framework Programme (no. QLG2-CT-2002-01254). JK has been supported by the Academy of Finland Centre of Excellence in Complex Disease Genetics. The Swedish Twin Cohort has been financially supported by the Swedish Research Council and Swedish Foundation for Strategic Research. The Danish Twin Registry has been supported by the Danish Medical Research Council, the Danish Diabetes Foundation, the Danish Heart Association, and the Novo Nordic Foundation. The TWINSUK study was funded by the Wellcome Trust (Grant ref. 079771); European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-ENGAGE and Framework 6 Project EUroClot. The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. NS acknowledges financial support from the Wellcome Trust (Grant 091746/Z/10/Z). NTR, NTR2, and NLDTWIN funding was obtained from the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression (904-61-090); Genetics of individual differences in smoking initiation and persistence (NWO 985-10-002); Resolving cause and effect in the association between exercise and well-being (904-61-193); Twin family database for behavior genomics studies (480-04-004); Twin research focusing on behavior (400-05-717); Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder (Addiction-31160008); Genotype/phenotype database for behavior genetic and genetic epidemiological studies (911-09-032); Spinozapremie (SPI 56-464-14192); CMSB: Center for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/2008.024); BBMRI –NL: Biobanking and Biomolecular Resources Research Infrastructure; the VU University: Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Science Foundation (ESF): Genomewide analyses of European twin and population cohorts (EU/QLRT-2001-01254); European Community's Seventh Framework Program (FP7/2007-2013): ENGAGE (HEALTH-F4-2007-201413); the European Science Council (ERC) Genetics of Mental Illness (230374); Rutgers University Cell and DNA Repository cooperative agreement (NIMH U24 MH068457-06); Collaborative study of the genetics of DZ twinning (NIH R01D0042157-01A); the Genetic Association Information Network, a public–private partnership between the NIH and Pfizer, Affymetrix, and Abbott Laboratories. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The LifeLines Cohort Study, and generation and management of GWAS genotype data for the LifeLines Cohort Study is supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. PREVEND genetics is supported by the Dutch Kidney Foundation (Grant E033), the EU project grant GENECURE (FP-6 LSHM CT 2006 037697), the National Institutes of Health (grant LM010098), The Netherlands organisation for health research and development (NWO VENI grant 916.761.70), and the Dutch Inter UniversityCardiology Institute Netherlands (ICIN). EGCUT was supported by the Estonian Ministry of E&R (SF0180142s08), EU FP7 OPENGENE (#245536) and ENGAGE (201413), by EurRDF grant to the Centre of Excellence in Genomics, Estonian Biocentre and University of Tartu and by Estoinian Research Infrastructure's Roadmap. Genmets was supported through funds from The European Community's Seventh Framework Programme (FP7/2007-2013), BioSHaRE Consortium, grant agreement 261433. VS was supported by the Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular research, and the Finnish Academy (grant number 129494). The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). EPIC–Norfolk is supported by programme grants from the Medical Research Council UK (G9502233, G0300128) and Cancer Research UK (C865/A2883). Adipose Tissue eQTL dataset has been funded by Finnish Foundation for Cardiovascular Research, Helsinki University, Sigrid Juselius Foundation Central Hospital Research Foundation. Metabonomic datasets are supported by the Academy of Finland (grant number 137870 to PS) and the Responding to Public Health Challenges Research Programme of the Academy of Finland (grant number 129429 to MA-K), the Finnish Cardiovascular Research Foundation
(MA-K), and the Jenny and Antti Wihuri Foundation (AJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002333","2011-10-20T00:00:00Z",201413
"715",715,"This work was supported, in part, by grants from the Wellcome Trust (to RKS: Intermediate Clinical Fellowship 080952/Z/06/Z; to SOR: Programme Grant 078986/Z/06/Z), the United Kingdom Medical Research Council Centre for Obesity and Related Metabolic Diseases. The Canadian Institutes of Health Research (CIHR) provided support to this project to JBR, MFH, and TP). DELFIA Adiponectin Assays were performed by the NIHR Cambridge Biomedical Research Centre, Core Biochemical Assay Laboratory. Recruitment of the PennCATH cohort was supported by the Cardiovascular Institute of the University of Pennsylvania. Recruitment of the MedStar cohort was supported by a research grant from GlaxoSmithKline. Genotyping was performed at the Center for Applied Genomics at the Children's Hospital of Philadelphia and supported by GlaxoSmithKline through an Alternate Drug Discovery Initiative research alliance award (to MPR and DJR) with the University of Pennsylvania School of Medicine. The German Study was supported by the Deutsche Forschungsgemeinschaft and the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus) and the EU-funded integrated project Cardiogenics (LSHM-CT-2006-037593). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the GSF National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and the State of Bavaria. The EPIC Norfolk Study is funded by Cancer Research United Kingdom and the Medical Research Council. The WTCCC Study was funded by the Wellcome Trust. Recruitment of cases for the WTCCC Study was carried out by the British Heart Foundation (BHF) Family Heart Study Research Group and supported by the BHF and the UK Medical Research Council. NJS holds a Chair funded by the BHF. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC; and this ALSPAC study was specifically funded by the British Heart Foundation # MRC PG/07/002. The gene expression work was supported by Genome Quebec, Genome Canada, and the CIHR. TP holds a Canada Research Chair, and Drs. O. Nilsson, Ljunggren, and H. Mallmin (Uppsala University, Sweden) are acknowledged for collection of the osteoblasts. The Framingham Heart Study component of this work was supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195), its contract with Affymetrix for genotyping services (Contract No.N02-HL-6-4278), and the resources of the Framingham Heart Study SNP Health Association Resource (SHARe) project, the National Institutes of Health, National Center for Research Resources, General Clinical Research Centers Program (Grant Number M01-RR-01066), an American Diabetes Association Career Development Award (JBM), a research grant from sanofi-aventis (JBM), the Boston University Linux Cluster for Genetic Analysis (LinGA) funded by the NIH NCRR Shared Instrumentation grant (1S10RR163736-01A1), and the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center, by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195), National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK078616 to JBM, JD, and JCF, NIDDK K24 DK080140 to JBM, NIDDK Research Career Award K23 DK65978, a Massachusetts General Hospital Physician Scientist Development Award and a Doris Duke Charitable Foundation Clinical Scientist Development Award to JCF, and the Boston University Linux Cluster for Genetic Analysis (LinGA) funded by the NIH NCRR Shared Instrumentation grant (1S10RR163736-01A1). MFH was supported by the Centre de Recherche Medicale de l'Universite de Sherbrooke (CRMUS) and the CIHR. TwinsUK: The study was funded by the Wellcome Trust, European Community’s Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. TDS is an NIHR senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). The authors acknowledge the funding and support of the National Eye Institute via an NIH/CIDR genotyping project (PI: Terri Young). We thank the staff from the Genotyping Facilities at the Wellcome Trust Sanger Institute for sample preparation, quality control, and genotyping led by Leena Peltonen and Panos Deloukas; Le Centre National de Genotypage, France, led by Mark Lathrop, for genotyping; Duke University, North Carolina, USA, led by David Goldstein, for genotyping; and the Finnish Institute of Molecular Medicine, Finnish Genome Center, University of Helsinki, led by Aarno Palotie. Genotyping was also performed by CIDR as part of an NEI/NIH project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000768","2009-12-11T00:00:00Z",201413
"718",718,"
        This research was made possible by NIA/NIH contract AG000932-02 (2009) Characterization of Normal Genomic Variability. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD [http://biowulf.nih.gov]. The Age, Gene/Environment Susceptibility Reykjavik Study is funded by NIH contract N01-AG-12100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, and grants R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The National Heart, Lung, and Blood Institute's Framingham Heart Study is a joint project of the National Institutes of Health and Boston University School of Medicine and was supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (contract No. N02-HL-6-4278). Analyses reflect the efforts and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The Health ABC Study was supported in part by the Intramural Research Program of the NIH, National Institute on Aging, NIA contracts N01AG62101, N01AG62103, and N01AG62106. The genome-wide association study was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. The InChianti Study was supported as a “targeted project” (ICS 110.1RS97.71) by the Italian Ministry of Health, by the U.S. National Institute on Aging (Contracts N01-AG-916413, N01-AG-821336, 263 MD 9164 13, and 263 MD 821336), and in part by the Intramural Research Program, National Institute on Aging, National Institutes of Health, USA. David Melzer's participation was supported in part by NIH grant R01 AG24233-01. The Heart and Vascular Health (HVH) Study was funded by grants HL085251 and HL087652 from the National Heart, Lung and Blood Institute. The INGI cohorts and their investigators would like to acknowledge the regions of Friuli Venezia Giulia region and Fondo Trieste, and funding from Health Ministry project RF-FSR-2007-647201, Fondazione Compagnia di San Paolo and Fondazione Cassa di Risparmio di Alessandria. The KORA Augsburg studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany, and supported by grants from the German Federal Ministry of Education and Research (BMBF). Part of this work was financed by the German National Genome Research Network (NGFN). This research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The GWAS database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011, 911.03.012) and the Research Institute for Diseases in the Elderly (RIDE). This study was supported by the Netherlands Genomics Initiative (NGI)/NWO project number 050 060 810 (Netherlands Consortium for Healthy Ageing). The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands organization for scientific research (NWO); the Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Heart Foundation; the Ministry of Education, Culture, and Science; the Ministry of Health, Welfare, and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. Janine F. Felix and Abbas Dehghan are supported by the Netherlands Organization for Scientific Research (NWO, VICI no. 918-76-619). The Twins UK study was funded by the Wellcome Trust, European Community's Seventh Framework Programme (FP7/2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London. Tim D. Spector is an NIHR senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). Additional support includes the Wellcome Trust grant 076113/C/04/Z, the Juvenile Diabetes Research Foundation grant WT061858, and by the National Institute of Health Research of England. Nicole Soranzo is supported by Wellcome Trust (Core Grant Number 091746/Z/10/Z). The participation of Alex P. Reiner is supported by National Heart, Lung, and Blood Institute grant R01 HL-071862. Holger Prokisch's participation was supported by the German Federal Ministry of Education and Research (BMBF) funded German Center for Diabetes Research (DZD e.V.) and Systems Biology of Metabotypes (SysMBo #0315494A). Financial support was received from the German Research Council (KFO-152), IZKF (B27), and the German Diabetes Association. Inga Prokopenko and Vasiliki Lagou were partial funded through the European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. Acknowledgments from COGENT collaborators: COGENT and CARe: The authors acknowledge the essential role of the Continental Origins and Genetic Epidemiology Network (COGENT) Consortium in development and support of this manuscript. COGENT members participating in support of this manuscript include the WHI, ARIC, CARDIA, JHS, HANDLS, Health ABC, and GeneSTAR. CARe: The authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute and the contributions of the research institutions, study investigators, field staff and study participants in creating this resource for biomedical research. The following parent studies contributed study data, ancillary study data, and DNA samples through the Broad Institute (N01-HC-65226) to create this genotype/phenotype data base for wide dissemination to the biomedical research community: Atherosclerosis Risk in Communities (ARIC): University of North Carolina at Chapel Hill (N01-HC-55015), Baylor Medical College (N01-HC-55016), University of Mississippi Medical Center (N01-HC-55021),University of Minnesota (N01-HC-55019), Johns Hopkins University (N01-HC-55020), University of Texas, Houston (N01-HC-55017), University of North Carolina (N01-HC-55018). Other NIH support contributing to the GWAS in ARIC are: R01HL087641, R01HL59367, R01HL86694, U01HG004402, and HHSN268200625226C. Coronary Artery Risk in Young Adults (CARDIA): University of Alabama at Birmingham (N01-HC-48047), University of Minnesota (N01-HC-48048), Northwestern University (N01-HC-48049), Kaiser Foundation Research Institute (N01-HC-48050), University of Alabama at Birmingham (N01-HC-95095), Tufts-New England Medical Center (N01-HC-45204), Wake Forest University (N01-HC-45205), Harbor-UCLA Research and Education Institute (N01-HC-05187), University of California, Irvine (N01-HC-45134, N01-HC-95100). Jackson Heart Study (JHS): Jackson State University (N01-HC-95170), University of Mississippi (N01-HC-95171), Tougaloo College (N01-HC-95172). Healthy Aging in Neighborhoods of Diversity across the Life Span Study (HANDLS): This research was supported by the Intramural Research Program of the NIH, National Institute on Aging and the National Center on Minority Health and Health Disparities (intramural project # Z01-AG000513 and human subjects protocol # 2009-149). Data analyses for the HANDLS study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Maryland (http://biowulf.nih.gov). GeneSTAR: This research was supported by the National Heart, Lung, and Blood Institute (NHLBI) through the PROGENI (U01 HL72518) and STAMPEED (R01 HL087698-01) consortia. Additional support was provided by grants from the NIH/National Institute of Nursing Research (R01 NR08153), and the NIH/National Center for Research Resources (M01-RR000052) to the Johns Hopkins General Clinical Research Center. WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. RIKEN collaborators: We would like to thank all the staff of the Laboratory for Statistical Analysis at RIKEN for
their technical assistance. This study was supported by Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002113","2011-06-30T00:00:00Z",201413
"719",719,"For TwinsUK: This study was funded by the British Heart Foundation, Project grant No. 06/094. The study was also funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413 and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant(G20234). The authors acknowledge the funding and support of the National Eye Institute via an NIH/CIDR genotyping project (PI: Terri Young). CD is supported by a British Heart Foundation grant: SP/02/001. For the BRIGHT study: The BRIGHT study is supported by the Medical Research Council of Great Britain (grant number; G9521010D) and the British Heart Foundation (grant number PG02/128). CW was funded by the British Heart Foundation (grant number: FS/05/061/19501). SJN is funded by the Medical Research Council and The William Harvey Research Foundation. Profs Dominiczak and Samani are British Heart Foundation Chairholders. EZ is funded by the Wellcome Trust (WT088885/Z/09/Z). For the DCCT/EDIC study: The DCCT/EDIC Research Group is sponsored through research contracts from the National Institute of Diabetes, Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institutes of Health. The authors are grateful to the subjects in the DCCT/EDIC cohort for their long-term participation. A.D.P. holds a Canada Research Chair in the Genetics of Complex Diseases. This work has received support from National Institute of Diabetes and Digestive and Kidney Diseases Contract N01-DK-6-2204, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK-077510 and support from the Canadian Network of Centres of Excellence in Mathematics and Genome Canada through the Ontario Genomics Institute. For QTSCD: ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. In addition, we acknowledge support from NHLBI grants HL86694 and HL054512, and the Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University for genotyping and data analysis relevant to this study. AK is supported by a German Research Foundation Fellowship. The KORA study was funded by the State of Bavaria and by grants from the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN), the German National Competence network on atrial fibrillation (AFNET) and the Bioinformatics for the Functional Analysis of Mammalian Genomes program (BFAM) by grants to Stefan Kaab (NGFN 01GS0499, 01GS0838 and AF-Net 01GI0204/N), Arne Pfeufer (NGFN 01GR0803, 01EZ0874), H. -Erich Wichmann (NGFN 01GI0204) and to Thomas Meitinger (NGFN 01GR0103). Stefan Kaab is also supported by a grant from the Fondation Leducq. The SardiNIA team was supported by Contract NO1-AG-1-2109 from the National Institute on Aging contract NO1-AG-1-2109 to the SardiNIA (“ProgeNIA”) team and in part by the Intramural Research Program of the US National Institute on Aging, NIH. The efforts of G.R.A. were supported in part by contract 263-MA-410953 from the National Institute on Aging to the University of Michigan and by research grants from the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute (to G.R.A.). The GenNOVA study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Heinz Nixdorf Recall Study was funded by a grant of the Heinz Nixdorf Foundation (Chairman: Dr. jur. G. Schmidt). For QTGEN: The Framingham Heart Study work was supported by the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine (Contract No. N01-HC-25195), its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278), and the Doris Duke Charitable Foundation (C.N.-C.) and Burroughs Wellcome Fund (C.N.-C.), based on analyses by Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. The measurement of ECG intervals in Framingham Heart Study generation 1 and 2 samples was performed by eResearchTechnology and was supported by an unrestricted grant from Pfizer. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (#175.010.2005.011, 911- 03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project #050-060-810. The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. C.N.-C. is supported by NIH K23-HL-080025, a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists. M.E is funded by the Netherlands Heart Foundation 2007B221. J.I.R. is supported by the Cedars-Sinai Board of Governors' Chair in Medical Genetics. The measurement of ECG intervals in the Framingham Heart Study generation 3 sample was completed by Alim Hirji and Sirisha Kovvali using AMPS software provided through an unrestricted academic license by AMPS, LLC (New York, NY,) USAA full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The authors acknowledge the essential role of the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium in development and support of this manuscript. CHARGE members include the Netherland's Rotterdam Study, the NHLBI's Atherosclerosis Risk in Communities (ARIC) Study, Cardiovascular Health Study (CHS) and Framingham Heart Study (FHS), and the NIA's Iceland Age, Gene/Environment Susceptibility (AGES) Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0006138","2009-07-09T00:00:00Z",201413
"720",720,"
        Cohort funding: ALSPAC: The UK Medical Research Council (Grant number: G990146), the Wellcome Trust and the University of Bristol provide core support for ALSPAC. B58C - WTCCC: The British 1958 Birth Cohort DNA collection was funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Genotyping for the Wellcome Trust Case Control Consortium was funded by the Wellcome Trust grant 076113/B/04/Z. B58C - T1DGC: This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. T1DGC GWAS data were deposited by the Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research (CIMR), University of Cambridge (John Todd, Helen Stevens and Neil Walker), which is funded by Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Research Centre; the CIMR is in receipt of a Wellcome Trust Strategic Award (079895). EPIC: The EPIC Norfolk Study is funded by Cancer Research United Kingdom and the Medical Research Council.. I.B. received funding from the Wellcome Trust (077016/Z/05/Z) and from the United Kingdom NIHR Cambridge Biomedical Research Centre. FTC: Academy of Finland Centre of Excellence in Complex Disease Genetics. Finnish Twin Study on Aging was funded by Academy of Finland and Finnish Ministry of Education. ENGAGE project grant agreement HEALTH-F4-2007-201413 and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). KORA S3: The KORA Augsburg studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). The authors research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. Genotyping for the KORA F3/500K Study which included the lung function characterized KORA C sample was partly funded by UBS Wealth Foundation Grant BA29s8Q7-DZZ. Korcula: The Korcula study (Croatia) was funded by grants from the Medical Research Council (UK) and Republic of Croatia Ministry of Science, Education and Sports research grants to I.R. (Vis) (108-1080315-0302). NFBC1966: Financial support was received from the Academy of Finland (project grants 104781, 1114194, 120315 and Center of Excellence in Complex Disease Genetics), Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland, the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the Medical Research Council (studentship grant G0500539). The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Institute for Health and Welfare, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. A.R. was supported by the European Commission as part of GABRIEL (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) contract number 018996 under the Integrated Program LSH-2004-1.2.5-1 Post genomic approaches to understand the molecular basis of asthma aiming at a preventive or therapeutic control. NSPHS: EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 01947 (LSHG-CT-2006-01947). The Northern Swedish Population Health Study (NSPHS) was funded by the Swedish Medical Research Council (project number K2007-66X-20270-01-3). The computations were performed on UPPMAX (http://www.uppmax.uu.se) resources under Project p2008027. ORCADES: The ORCADES study was funded by the Chief Scientist Office of the Scottish Government, the Royal Society and the MRC Human Genetics Unit. DNA extraction was performed at the Wellcome Trust Clinical Research Facility in Edinburgh. Genotyping was funded by the European Union Framework Programme 6 EUROSPAN project. SHIP: SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the German Asthma and COPD Network (COSYCONET; BMBF grant 01GI0883), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg- West Pomerania. The University of Greifswald is a member of the ‘Center of Knowledge Interchange’ program of the Siemens AG. TwinsUK: TwinsUK is funded by the Wellcome Trust; the Arthritis Research Campaign; European Community's Seventh Framework Programme (FP7/2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and Seventh Framework Programme (FP7/2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413 and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator. The project also received support from a Biotechnology and biological Sciences Research Council (BBSRC) project grant. Vis: The Vis study (Croatia) was funded by grants from the Medical Research Council (UK), European Commission Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) and Republic of Croatia Ministry of Science, Education and Sports research grants to I.R. (108-1080315-0302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019382","2011-05-20T00:00:00Z",201413
"721",721,"
        Vesna Boraska is supported by Unity Through Knowledge Fund CONNECTIVITY PROGRAM (“Gaining Experience” Grant 2A), The National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia (BRAIN GAIN- Postdoc fellowship) and the Wellcome Trust (098051). Eleftheria Zeggini is supported by the Wellcome Trust (098051). ALSPAC: ALSPAC is jointly funded by the University of Bristol, Wellcome Trust and MRC. Current renewal grant numbers: WT092731 and G9815508. BUSSELTON: The Busselton Health Study acknowledges the generous support for the 1994/5 follow-up study from Healthway, Western Australia. The Busselton Health Study is supported by The Great Wine Estates of the Margaret River region of Western Australia. The study gratefully acknowledges the assistance of the Western Australian DNA Bank (National Health and Medical Research Council (NHMRC) Enabling Facility) with DNA samples and the support provided by the The Ark at UWA for this study. CoLaus-Hercules: The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). Murielle Bochud is supported by the Swiss School of Public Health Plus. CROATIA-Korcula: The CROATIA-Korcula study was funded by grants from the Medical Research Council (UK), and Republic of Croatia Ministry of Science, Education and Sports research (108-1080315-0302). The SNP genotyping for the CROATIA-Korcula cohort was performed in Helmholtz Zentrum München, Neuherberg, Germany. CROATIA-Split: The CROATIA-Split study is funded by grants from the Medical Research Council (UK) and Republic of Croatia Ministry of Science, Education and Sports research grants to I.R. (108-1080315-0302). The SNP genotyping for the CROATIA-Split cohort was performed by AROS Applied Biotechnology, Aarhus, Denmark. CROATIA-Vis: The CROATIA-Vis study was funded by grants from the Medical Research Council (UK), European Commission Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) and Republic of Croatia Ministry of Science, Education and Sports research grants (108-1080315-0302). The SNP genotyping for the CROATIA-Vis cohort was performed in the core genotyping laboratory of the Wellcome Trust Clinical Research Facility at the Western General Hospital, Edinburgh, Scotland, UK. FamHS: The Family Heart Study (FamHS) was supported by NIH grants R01-HL-087700, R01-HL-088215 (Michael A. Province) from the National Heart, Lung, and Blood Institute (NHLBI), and R01-DK-8925601, R01-DK-075681 (Ingrid B. Borecki) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). HUNT: Bendik S. Winsvold is funded from the South-Eastern Norway Regional Health Authority, Norway. Verneri Anttila is funded from the Wellcome Trust (grant number WT089062; www.wellcome.ac.uk) and the Finnish Cultural Foundation (www.skr.fi). HYPERGENES: HYPERGENES (European Network for Genetic-Epidemiological Studies: Building a method to dissect complex genetic traits, using essential hypertension as a disease model) is a Large Cooperative Project funded by EU within the FP7 (HEALTH-F4-2007-201550). InCHIANTI: The InCHIANTI study baseline (1998-2000) was supported as a “targeted project” (ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336); the InCHIANTI Follow-up 1 (2001-2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1-1 and N.1-AG-1-2111); the InCHIANTI Follow-ups 2 and 3 studies (2004-2010) were financed by the U.S. National Institute on Aging (Contract: N01-AG-5-0002); supported in part by the Intramural research program of the National Institute on Aging, National Institutes of Health, Baltimore, Maryland. JRBP is funded by a Sir Henry Wellcome Postdoctoral Fellowship (092447/Z/10/Z). KORA: The KORA Augsburg studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (http://www.helmholtz-muenchen.de) and supported by grants from the German Federal Ministry of Education and Research (BMBF) (http://www.bmbf.de). Part of this work was financed by the German National Genome Research Network (NGFN-2, NGFNPlus 01GS0823 and 01GS0834) (http://www.ngfn.de). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ (http://www.mc-health.uni-muenchen.de). Cornelia Huth was supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). MICROS: In South Tyrol, the study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. RAINE: The National Health and Medical Research Council of Australia (Grant ID 572613, ID 403981 and ID 353514; URL: http://www.nhmrc.gov.au/), The Western Australian Health Promotion Foundation (URL: http://www.healthway.wa.gov.au/) and the Canadian Institutes of Health Research (MOP-82893; URL: http://www.cihr-irsc.gc.ca/e/193.html). The authors gratefully acknowledge the NH&MRC for their long term contribution to funding the study over the last 20 years and also the Telethon Institute for Child Health Research for long term support of the study. The following Institutions are acknowledged for providing funding for Core Management of the Raine Study: The University of Western Australia (UWA), Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, The Telethon Institute for Child Health Research, Women and Infants Research Foundation and Curtin University. SHIP: SHIP (BMBF), Henry Völzke (public funding from Federal Ministry of Education and Research). SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the “Center of Knowledge Interchange” program of the Siemens AG. TEENAGE: This research has been co-financed by the European Union (European Social Fund – ESF) and Greek national funds through the Operational Program “Education and Lifelong Learning” of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. TwinFat: Helsinki University Hospital Research Funds, grants from Novo Nordisk, Gyllenberg, Biomedicum Helsinki, Jalmari and Rauha Ahokas Foundation, and Finnish Foundation for Cardiovascular Research. Academy of Finland Centre of Excellence in Complex Disease Genetics. The European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007- 201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031369","2012-03-29T00:00:00Z",201413
"7221",722,"
        JRB Perry is supported by the Wellcome Trust as a Sir Henry Wellcome Postdoctoral Research Fellow (092447/Z/10/Z). This work was partially funded by grants from the Wellcome Trust 083270/Z/07/Z and MRC G0601261. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; National Institutes of Health contract HHSN268200625226C; and grants DK062370 and DK072193. ARIC: Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. Work at Lund University diabetes centre was funded by several grants from the Swedish Research Council (LG prject grant, Linné, Exodiab). Norfolk Diabetes Case-Control and ADDITION-Ely Studies: The work on Ely, ADDITION, and EPIC-Norfolk studies was funded by support from the Wellcome Trust and MRC. The Norfolk Diabetes study is funded by the MRC with support from NHS Research and Development and the Wellcome Trust. This research was conducted in part using data and resources from the Framingham Heart Study of the National Heart, Lung, and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II), funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Also supported by National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK078616 to JB Meigs and J Dupuis, and NIDDK K24 DK080140 to JB Meigs. The research performed at deCODE Genetics was part funded through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The DGDG study was supported by the French Government (Agence Nationale de la Recherche), the French Region of Nord Pas De Calais (Contrat de Projets État-Région), Programme Hospitalier de Recherche Clinique (French Ministry of Health), and the following charities: Association Française des Diabétiques, Programme National de Recherche sur le Diabète, Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques, Association Diabète Risque Vasculaire (Paris, France), and Groupe d'Etude des Maladies Métaboliques et Systémiques. This study was also supported in part by a grant from the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European Community). The D.E.S.I.R. study was supported by the Caisse Nationale d'Assurance Maladie des Travailleurs Salariés, Lilly, Novartis Pharma and Sanofi-Aventis, Institut National de la Santé et de la Recherche Médicale (INSERM) (Réseaux en Santé Publique, Interactions entre les déterminants de la santé, Cohortes Santé TGIR 2008), Association Diabète Risque Vasculaire, Fédération Française de Cardiologie, Fondation de France, Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques, Office National Interprofessionnel des Vins, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Santé, Novo Nordisk, Pierre Fabre, Roche and Topcon. The D.E.S.I.R. Study Group: INSERM 1018: B Balkau, P Ducimetière, E Eschwège; INSERM U367: F Alhenc-Gelas; Centre Hospitalier Universitaire D'Angers: Y Gallois, A Girault; Bichat Hospital: F Fumeron, M Marre, R Roussel; CHU de Rennes: F Bonnet; CNRS UMR8199, Lille: P Froguel; Medical Examination Services: Alençon, Angers, Blois, Caen, Chartres, Chateauroux, Cholet, Le Mans, Orléans and Tours; Research Institute for General Medicine: J Cogneau; General practitioners of the region; Cross-Regional Institute for Health: C Born, E Caces, M Cailleau, JG Moreau, F Rakotozafy, J Tichet, S. Vol. We are grateful to all patients for participation in the genetic study. We also thank Marianne Deweirder, Frédéric Allegaert (UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France) for their technical assistance and their precious management of DNA samples. This work was partially funded by grants from the Wellcome Trust 083270/Z/07/Z and MRC G0601261. This work was presented as a poster at the American Diabetes Association's scientific sessions June 2011. The NHS/HPFS T2D GWA study (U01HG004399) is a component of a collaborative project that includes 13 other GWA studies funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI) (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033) with additional support from individual NIH (NIDCR:U01DE018993, U01DE018903; NIAAA: U10AA008401, NIDA: P01CA089392,R01DA013423; NCI: CA63464, CA54281, CA136792, Z01CP010200). EUROSPAN cohorts were supported by the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The ERF study was supported by grants from the NWO, Erasmus MC and the Centre for Medical Systems Biology (CMSB). We are grateful to all patients and their relatives, general practitioners and neurologists for their contributions and to P Veraart for her help in genealogy, Jeannette Vergeer for the supervision of the laboratory work and P Snijders for his help in data collection. MICROS: The MICROS study is part of the genomic health care program ‘GenNova’ and was carried out in three villages of the Val Venosta on the populations of Stelvio, Vallelunga and Martello. In South Tyrol, the study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The VIS study in the Croatian island of Vis was supported through the grants from the Medical Research Council UK and Ministry of Science, Education and Sport of the Republic of Croatia (number 108-1080315-0302). The research within the KORA study was partially funded by the German Center for Diabetes Research (DZD), the Helmholtz Zentrum München, Neuherberg, Germany, and supported by grants from the German Federal Ministry of Education and Research the Federal Ministry of Health, the Ministry of Innovation, Science, Research, and Technology of the state North Rhine-Westphalia, the German National Genome Research Network (NGFN), and the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The research of I Prokopenko is funded in part through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002741","2012-05-31T00:00:00Z",201413
"723",723,"JN, AR, and M-RT have received support from EVO, from a grant from the special governmental subsidy for health sciences research (Helsinki University Central Hospital), and from the Finnish heart Association. KHP was supported by Helsinki University Central Hospital Grants, Yrjö Jahnsson, the Jalmari and Rauha Ahokas Foundation, the Biomedicum Helsinki Foundation, and Novo Nordisk Foundations. JK and LP were supported by by the Academy of Finland Center of Excellence in Complex Disease Genetics. VS was supported by the Finnish Academy (grant number 129494), Finnish Foundation for Cardiovascular Research, and Sigrid Juselius Foundation. This research was supported through funds from The European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NFBC genotyping was supported on NHLBI grant 5R01HL087679-02 through the STAMPEED program. EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). For the MICROS study in South Tyrol, we thank the primary care practitioners R. Stocker, S. Waldner, T. Pizzecco, J. Plangger, U. Marcadent and the personnel of the Hospital of Silandro (Department of Laboratory Medicine) for their participation and collaboration in the research project. In South Tyrol, the study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. NTR/NESDA was supported by 'Genetic basis of anxiety and depression' program (NWO 904-61-090); Twin-family database for behavior genomics studies (NWO 480-04-004); Center for Medical Systems Biology (NWO Genomics); Spinozapremie (SPI 56-464-14192); Centre for Neurogenomics and Cognitive Research (CNCR-VU); Genome-wide analyses of European twin and population cohorts (EU/QLRT-2001-01254); Geestkracht program of ZonMW (10-000-1002); and matching funds from universities and mental health care institutes involved in NESDA (GGZ Buitenamstel-Geestgronden, Rivierduinen, University Medical Center Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe). Major funding for this project is from the Genetic Association Information Network of the Foundation for the US National Institutes of Health, a public-private partnership between the NIH and Pfizer, Affymetrix and Abbott Laboratories. The MONICA/KORA Augsburg studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the German Federal Ministry of Education and Research (BMBF). Part of this work was financed by the German National Genome Research Network (NGFN) and by the 'Genomics of Lipid-associated Disorders - GOLD' of the 'Austrian Genome Research Programme GEN-AU'. The KORA research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. We gratefully acknowledge the contribution of P. Lichtner, G. Eckstein and T. Strom and all other members of the Helmholtz Zentrum München genotyping staff in generating and analyzing the SNP dataset. We thank all members of field staffs who were involved in the planning and conduct of the MONICA/KORA Augsburg studies. Finally, we express our appreciation to all study participants. Genome-wide genotyping of the Rotterdam Study was supported by NWO (175.010.2005.011). The Vis study in the Croatian island of Vis was supported through the grants from the Medical Research Council UK to HC, AW and IR; and Ministry of Science, Education and Sport of the Republic of Croatia to IR (number 108-1080315-0302). The ERF study was supported by grants from The Netherlands Organisation for Scientific Research, Erasmus MC and the Centre for Medical Systems Biology (CMSB). We are grateful to all study participants and their relatives, general practitioners and neurologists for their contributions and to P. Veraart for her help in genealogy, J. Vergeer for the supervision of the laboratory work and P. Snijders for his help in data collection. The Northern Swedish Population Health Study was funded by the Swedish Medical Research Council and the European Commission through the EUROSPAN project. We are greatly indebted to the participants in the study. The ORCADES study was supported by the Scottish Executive Health Department, the Royal Society, and the Wellcome Trust Clinical Research Facility.","10.1371/journal.pgen.1000976","2010-06-03T00:00:00Z",201413
"724",724,"
        The Rotterdam Study is funded by the Erasmus Medical Center and the Erasmus University Rotterdam, The Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of genome-wide association studies (GWAS) genotype data for the Rotterdam Study is supported by The Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. The Erasmus Rucphen Family (ERF) Study is supported by the Center for Medical Systems Biology (CMSB) of NGI, the Internationale Stichting voor Alzheimer Onderzoek (ISAO, 04516), Hersenstichting Nederland (HSN, 150207), and the Alzheimer Association (IRRG0514359). The ophthalmic part of the Rotterdam and ERF Studies is supported by The Netherlands Organization for Health Research and Development (ZonMw) grant 2200.0035; Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht; Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research (NWO); Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Blindenpenning, Amsterdam; Stichting Winckel-Sweep, Utrecht; Landelijke Stichting voor Blinden en Slechtzienden (LSBS), Utrecht; Rotterdamse Vereniging voor Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB), Doorn; The Rotterdam Eye Hospital Research Foundation (Stichting Wetenschappelijk Onderzoek Het Oogziekenhuis [SWOO] Prof. Dr. H. J. Flieringa, Rotterdam); Laméris Ootech BV, Nieuwegein; Topcon Europe BV, Capelle aan de IJssel, all in The Netherlands; and Heidelberg Engineering, Dossenheim, Germany. The King's College London authors acknowledge funding from the Guide Dogs for the Blind Association, Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, the European Community's FP7 (HEALTH-F2-2008-201865-GEFOS), ENGAGE (HEALTH-F4-2007-201413), FP-5 GenomEUtwin Project (QLG2-CT-2002-01254), National Institutes of Health (NIH)/National Eye Institute (NEI) grant 1RO1EY018246 (PI TLY), and genotyping by the NIH Center for Inherited Disease Research (CIDR) (PI TLY). The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust partnering KCL. CJH is an NIHR Senior Research Fellow. The Australian Twin Registry is supported by an Australian National Health and Medical Research Council (NHMRC) Enabling Grant (2004–2009). We also thank the following organisations for their financial support: Clifford Craig Medical Research Trust, Ophthalmic Research Institute of Australia (ORIA), American Health Assistance Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Foundation for Children, NHMRC project grant 350415 (2005–2007), Jack Brockhoff Foundation, NEI Project Grant RO1 EY 018246-01 (2007–2010) (PI TLY). Genotyping for part of the Australian sample was funded by an NHMRC Medical Genomics Grant. Genotyping for the remainder was performed by CIDR as part of an NEI/NIH project grant. Australian sample imputation analyses were carried out on the Genetic Cluster Computer which is financially supported by The Netherlands Scientific Organization (NWO 480-05-003). DAM is a recipient of the Pfizer Australia Senior Research Fellowship. SM is supported by an Australian NHMRC Career Development Award. The Wellcome Trust Case-Control Consortium 2 project was funded by the Wellcome Trust (085475/B/08/Z and 085475/Z/08/Z), the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHSFT, and UCL Institute of Ophthalmology. This project included genotyping of the Blue Mountains Eye Study, which was also supported in part by the Australian National Health and Medical Research Council (512423). We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02, and of the UK National Blood Service controls funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002611","2012-05-03T00:00:00Z",201413
"7251",725,"
        The AGES study has been funded by NIH contract N01-AG-1-2100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Amish study was supported by grants and contracts from the NIH including R01 AG18728 (Amish Longevity Study), R01 HL088119 (Amish Calcification Study), U01 GM074518-04 (PAPI Study), U01 HL072515-06 (HAPI Study), U01 HL084756 and NIH K12RR023250 (University of Maryland MCRDP), the University of Maryland General Clinical Research Center, grant M01 RR 16500, the Baltimore Veterans Administration Medical Center Geriatrics Research and Education Clinical Center, and the Paul Beeson Physician Faculty Scholars in Aging Program. The ASPS research reported in this article was funded by the Austrian Science Fund (FWF) grant number P20545-P05 and P13180. The Medical University of Graz supported the databank of the ASPS. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. A Köttgen and C Hundertmark were supported by the grant KO3598/2-1 (Emmy Noether Programme) of the German Research Foundation. The BLSA was supported in part by the Intramural Research Program of the NIH (National Institute on Aging). The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The ERF study was supported by grants from the Netherlands Organization for Scientific Research (NWO; Pioneergrant), Erasmus Medical Center, the Centre for Medical Systems Biology (CMSB), and the Netherlands Kidney Foundation. The Family Heart Study (FHS) work was supported in part by NIH grants 5R01HL08770003, 5R01HL08821502 (M Province) from the NHLBI and 5R01DK07568102, 5R01DK06833603 from the NIDDK (I Borecki). The Framingham Heart Study research reported in this paper was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The GENOA research was partially supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health R01 HL-87660. The Health Aging and Body Composition Study (Health ABC) was funded by the National Institutes of Aging. This research was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. The GWAS was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. For the KORA F3 and F4 studies, the genetic epidemiological work was funded by the NIH subcontract from the Children's Hospital, Boston, US, (HE Wichmann, IM Heid, prime grant 1 R01 DK075787-01A1), the German National Genome Research Net NGFN2 and NGFNplus (H.E.Wichmann 01GS0823; WK project A3, number 01GS0834), the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ, and by the Else Kröner-Fresenius-Stiftung (P48/08//A11/08; CA Böger, BK Krämer). The kidney parameter measurements in F3 were funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer) and the Regensburg University Medical Center, Germany; in F4 by the University of Ulm, Germany (W Koenig). Genome-wide genotyping costs in F3 and F4 was in part funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). De novo genotyping in F3 and F4 was funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). The KORA research platform and the MONICA Augsburg studies were initiated and financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, by the German Federal Ministry of Education and Research, and by the State of Bavaria. Genotyping was performed in the Genome Analysis Center (GAC) of the Helmholtz Zentrum München. The LINUX platform for computation was funded by the University of Regensburg for the Department of Epidemiology and Preventive Medicine at the Regensburg University Medical Center. The NHS/HPFS type 2 diabetes GWAS (U01HG004399) is a component of a collaborative project that includes 13 other GWAS (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033; National Institute of Dental and Craniofacial Research: U01DE018993, U01DE018903) funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI). Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Genotyping was performed at the Broad Institute of MIT and Harvard, with funding support from the NIH GEI (U01HG04424), and Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438) and the NIH contract “High-throughput genotyping for studying the genetic contributions to human disease” (HHSN268200782096C). Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). We thank the staff and participants of the NHS and HPFS for their dedication and commitment. The Korcula study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan and by Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302). The MICROS study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, the South Tyrolean Sparkasse Foundation, and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The Northern Swedish Population Health Study was supported by grants from the Swedish Natural Sciences Research Council, the European Union through the EUROSPAN project (contract no. LSHG-CT-2006-018947), the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). The NHS renal function and albuminuria work was supported by DK66574. Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). ORCADES was supported by the Chief Scientist Office of the Scottish Government, the Royal Society and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). DNA extractions were performed at the Wellcome Trust Clinical Research Facility in Edinburgh. The popgen study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the Ministry of Science, Commerce, and Transportation of the State of Schleswig-Holstein. The project has also received infrastructure support through the DFG excellence cluster “Inflammation  at Interfaces.” The Sorbs study was funded by grants from the German Research Council KFO-152 (to M Stumvoll) and the IFB (Integrated Research and Treatment Center) AdiposityDiseases (K7-37 to M Stumvoll and A Tönjes). We also thank Dr. Knut Krohn (Microarray Core Facility of the Interdisciplinary Centre for Clinical Research, University of Leipzig, Germany) for providing the genotyping platform. The research of Inga Prokopenko is funded in part through the European Community's
Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. R Mägi acknowledges financial support from the European Commission under a Marie Curie Intra-European Fellowship. For the Rotterdam Study-I and Rotterdam Study-II, the GWAS was funded by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The Erasmus Computing Grid, Rotterdam (The Netherlands) and the national German MediGRID and Services@MediGRID part of the German D-Grid were both funded by the German Bundesministerium fuer Forschung und Technology under grants #01 AK 803 A-H and # 01 IG 07015 G, for access to their grid resources. A Dehghan is supported by NWO grant (vici, 918-76-619). The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research net of the University of Greifswald, Germany, funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the ‘Center of Knowledge Interchange’ program of the Siemens AG. The Vis study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan; and Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302) and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The 3 City Study was supported by the National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Génotypage. The 3 City Study was performed as part of a collaboration between the Institut National de la Santé et de la Recherche Médicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthélabo. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM “Cohortes et collections de données biologiques” programme. Lille Génopôle received an unconditional grant from Eisai. The Blue Mountains Eye Study (BMES) has been supported by the Australian RADGAC grant (1992–94) and Australian National Health and Medical Research Council, Canberra Australia (Grant Nos: 974159, 211069, 991407, 457349). The GWAS studies of BMES population are supported by the Australian National Health and Medical Research Council (Grant Nos: 512423, 475604, 529912) and the Wellcome Trust, UK (2008), as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster, grant numbers 085475/B/08/Z and 085475/08/Z). EG Holliday and JJ Wang are funded by the Australian National Health and Medical Research Council Fellowship Schemes. The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). M Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The Cardiovascular Risk in Young Finns study (YFS) is supported by the Academy of Finland (grant no. 117797, 121584, and 126925), the Social Insurance Institution of Finland, University Hospital Medical funds to Tampere and Turku University Hospitals, and the Finnish Foundation of Cardiovascular Research. The Emil Aaaltonen Foundation (T Lehtimäki). EGCUT received support from FP7 grants ((201413 ENGAGE, 212111 BBMRI, 205419 ECOGENE, 245536 OPENGENE) and also received targeted financing from Estonian Government SF0180142s08 and from the European Union through the European Regional Development Fund, in the frame of Centre of Excellence in Genomics. The research of the FamHS-II was conducted in part using data and resources from the NHLBI Family Heart Study supported in part by NIH grant 5R01HL08770002. For the GoDARTs study, the Wellcome Trust provides support for Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection and the informatics support is provided by the Chief Scientist Office, and the Wellcome Trust funded Scottish Health Informatics Programme (SHIP). The INGI-Carlantino and INGI-FVG studies were supported by grants from Telethon, FVG region, and Fondo Trieste. The INGI-Cilento study was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano, and the Fondazione Banco di Napoli to M Ciullo. The INGI – Val Borbera Study was supported from Compagnia di San Paolo, Torino, Italy, the Cariplo Fundation, Milano, Italy, and Italian Ministry of Health Progetto Finalizzato 2007 and 2009. The JUPITER trial and the genotyping were supported by AstraZeneca. The Ogliastra Genetic Park (OGP) - Replication Study and OGP - Talana study were supported by grants from the Italian Ministry of Education, University, and Research (MIUR) no. 5571/DSPAR/2002 and (FIRB) D. M. no. 718/Ric/2005. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) trial was supported by an investigator initiated grant from Bristol-Myers Squibb, USA. The study was conducted, analyzed, and reported independently of the company. The SAPALDIA study was supported by the Swiss National Science Foundation (grants no 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the Federal Office for Forest, Environment, and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, and Zurich. The SAPHIR-study was partially supported by a grant from the Kamillo Eisner Stiftung to B Paulweber and by grants from the “Genomics of Lipid-associated Disorders – GOLD” of the “Austrian Genome Research Programme GEN-AU” to F Kronenberg. eQTL analysis: HJ Gierman received support from the AFAR/EMF postdoctoral fellowship and the Stanford Dean's postdoctoral fellowship. HE Wheeler and SK Kim were supported by grants from the NIA, NHGRI and NIGMS.
      ","10.1371/journal.pgen.1002584","2012-03-29T00:00:00Z",201413
"726",726,"
        Baltimore Longitudinal Study of Aging (BLSA): The BLSA was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. A portion of that support was through an R&D contract with MedStar Research Institute. Erasmus Rucphen Family (ERF). The ERF study was supported by grants from The Netherlands Organisation for Scientific Research, Erasmus MC and the Centre for Medical Systems Biology (CMSB), and the European Network for Genetic and Genomic Epidemiology (ENGAGE) consortium. Invecchaire in Chianti (InCHIANTI). JRB Perry is a Sir Henry Wellcome Postdoctoral Research Fellow (092447/Z/10/Z). Framingham Heart Study (FHS): This research was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The Collaborative Health Research in the Region of Augsburg (KORA F3): This study was partially funded by the “Tiroler Wissenschaftsfonds” (Project UNI-0407/29) and by the “Genomics of Lipid-associated Disorders – GOLD” of the “Austrian Genome Research Programme GEN-AU” to F Kronenberg. The MONICA/KORA Augsburg cohort study was financed by the Helmholtz Zentrum München. It was further funded by the NIH subcontract from the Children's Hospital, Boston, US, (H-E Wichmann and IM Heid, prime grant 1 R01 DK075787-01A1 to JN Hirschhorn) and the German National Genome Research Net NGFN2 and NGFNplus (H-E Wichmann 01GS0823). TwinsUK: Study was funded by the Wellcome Trust, European Commission Framework (FP7/2007–2013), ENGAGE project HEALTH-F4-2007-201413, and the FP5 GenomEUtwin Project (QLG2-CT-2002-01254). It also receives support from the Arthritis Research Campaign, Chronic Disease Research Foundation, the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London, and a Biotechnology and Biological Sciences Research Council project grant (G20234). Cardiovascular Health Study (CHS): The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652, HL105756, and HL094555 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01-RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center, NHLBI R01-HL085251. Helsinki Birth Cohort Study (HBCS): HBCS has been supported by grants from Academy of Finland (project numbers 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225, 216374), Finnish Diabetes Research Society, Finnish Foundation for Pediatric Research, Samfundet Folkhälsan, Juho Vainio Foundation, Novo Nordisk Foundation, Finska Läkaresällskapet, Päivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, and Yrjö Jahnsson Foundation. DILGOM survey was funded by the Finnish Academy, grant number 118065. Cardiovascular Risk in Young Finns (YFS): The Young Finns Study has been financially supported by the Academy of Finland: grants 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi), the Social Insurance Institution of Finland, Kuopio, Tampere and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research (T.L., OT.R), Tampere Tuberculosis Foundation (Te.Le., Mik, Kä), the Emil Aaltonen Foundation (T.L.) and Finnish Cultural Foundation. The expert technical assistance in the statistical analyses by Irina Lisinen and Ville Aalto are gratefully acknowledged. Dietary, Lifestyle, and Genetic determinants of Obesity and Metabolic syndrome (DILGOM): K Kristiansson was supported by the Orion-Farmos Research Foundation and the Academy of Finland (grant no. 125973). M Perola and V Salomaa were supported by the Finnish Foundation for Cardiovascular Research, the Sigrid Jusélius Foundation, and the Academy of Finland (grants 129322, 129494 and 139635). JG Eriksson was supported by the Academy of Finland (grants 126775, 129255, 129907, and 135072). Fenland study: The Fenland Study is funded by the Wellcome Trust and the Medical Research Council, as well as by the Support for Science Funding programme and CamStrad. We are grateful to all the volunteers for their time and help, and to the General Practitioners and practice staff for help with recruitment. We thank the Fenland Study co-ordination team and the Field Epidemiology team of the MRC Epidemiology Unit for recruitment and clinical testing. Multiethnic Study of Atherosclerosis (MESA): The MESA project is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support is provided by grants and contracts N01 HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, and RR-024156. Funding for CARe genotyping was provided by NHLBI Contract N01-HC-65226. Jackson Heart Study (JHS): The Jackson Heart Study is supported by the National Heart, Lung, and Blood Institute, through contracts with Jackson State University (N01-HC-95170), the University of Mississippi Medical Center (N01-HC-95171), and Tougaloo College (N01-HC-95172). Adiponectin measurements used in the current study were funded by PHS Award UL1 RR025008 from the Clinical and Translational Science Award program, National Institutes of Health, National Center for Research Resources (NCRR). Health ABC: This research was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. The genome-wide association study was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. Genetics, Arthrosis , and Progression) study (GARP): This study was supported the Leiden University Medical Centre and the Dutch Arthritis Association. Pfizer, Groton, CT, USA supported the inclusion of the GARP study. The genotypic work was supported by the Netherlands Organization of Scientific Research (MW 904-61-095, 911-03-016, 917 66344 and 911-03-012), Leiden University Medical Centre and the Centre of Medical System Biology and Netherlands Consortium for Healthy Aging both in the framework of the Netherlands Genomics Initiative (NGI). The adiponectin measurements were supported by TI-Pharma. Atherosclerosis Risk in Communities (ARIC): The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694, and RC2 HL102419; National Human Genome Research Institute contract U01HG004402; National Institutes of Health contract HHSN268200625226C; and National Institute of Diabetes and Digestive and Kidney Diseases R01DK056918. Infrastructure was partly supported by Grant Number UL1RR025005,a component of the National Institutes of Health and NIH Roadmap for Medical Research. Salzburg Atherosclerosis Prevention Program in subjects at High Individual Risk (SHAPIR): Part of this work was funded by the “Genomics of Lipid-associated Disorders” (GOLD) of the “Austrian Genome Research Programme” (GEN-AU) to Florian Kronenberg, and grants from the “Medizinische Forschungsgesellschaft Salzburg” and the “Kamillo Eisner Stiftung” (Switzerland) to Bernhard Paulweber. THISEAS: The genotyping of the THISEAS study was funded by the Wellcome Trust. The recruitment was partially supported by the General Secretary of Research and Technology (PENED 03<EPSILON><DELTA>474). We are grateful to all the volunteers for their time and help, the medical staff of the hospitals and the field investigators, Eirini Theodoraki, Maria Dimitriou and Kathy Stirrups for her assistance in the genotyping. Cebu Longitudinal Health and Nutrition Survey (CLHNS): We thank the Office of Population Studies Foundation research and data collection teams and the study participants who generously provided their time for this study. This work was supported by National Institutes of Health grants DK078150,
TW05596, HL085144, RR20649, ES10126, and DK56350. Coordinating Centre: McGill University. This work was supported by grants from the Canadian Foundation for Innovation, the Canadian Institutes of Health Research (CIHR), Fonds de la recherche en santé du Québec, the Lady Davis Institute, the Ministère du Développement économique, de l'Innovation et de l'Exportation du Québec and the Jewish General Hospital. JB Richards and Z Dastani are supported by the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002607","2012-03-29T00:00:00Z",201413
"245",245,"
        This project was supported by funding from the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/), as well as by the Swedish Research Council (http://www.vr.se/), Vinnova/Uppsala Bio (http://www.vinnova.se/), Uppsala Berzelii Center (http://www.berzelii.uu.se/), the European Community's 6th and 7th Framework Programs and European Community's Seventh Framework Program (http://cordis.europa.eu/fp7/home_en.html) (FP7/2007-2013) under grant agreement n° Health-F4-2008-201418 – READNA (REvolutionary Approaches and Devices for Nucleic Acid analysis) and grant agreement n 259796 (DiaTools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025583","2011-09-29T00:00:00Z",201418
"383",383,"
         The work of the authors is supported through grants from the Swedish MRC, the Swedish International Development Agency (SIDA-SAREC), the Karolinska Institutet, the Fp6 EU Europrise network of excellence, the Fp7 EU NGIN Collaborative project Health-F3-2007-201433, and the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1001241","2011-02-10T00:00:00Z",201433
"562",562,"
        The work was supported by grants provided to MJ and AA from the Swedish Research Council, to MJ from the Swedish International Development Agency/Department for Research Cooperation, to EMF and JA from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 2014332. Grants were also provided by the Physicians Against AIDS Research Foundation, Clas Groschinskys Foundation, The Royal Physiographic Society in Lund and Crafoords Foundation. MB and HU are supported by the EC FP6 grant 037611 (EUROPRISE), PRG was supported in part by a grant from the Australian National Health and Medical Research Council (433915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020135","2011-06-16T00:00:00Z",201433
"477",477,"
        This work was supported by a GSK Clinician Scientist fellowship to JC and project grants to JC from Yorkshire Cancer Research, Sheffield Hospitals Charitable Trust and from the European Union (European Community's Seventh Framework Programme. Grant Numbers: FP7/2007–2013, HEALTH-F2-2007-201438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032750","2012-03-07T00:00:00Z",201438
"61",61,"
        This work was supported by the Dutch Cancer Society (UL-2010-4670) and EU FP7 ZF Cancer project (HEALTH-F2-2008-201439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031281","2012-02-08T00:00:00Z",201439
"708",708,"
        The authors gratefully acknowledge the financial support of the Smart Mix Program (http://www.nwo.nl/nwohome.nsf/pages/NWOA_6QY9BM_Eng) of The Netherlands Ministry of Economic Affairs and of The Netherlands Ministry of Education, Culture and Science awarded to Leiden University and to ZF-screens B.V. The COPAS system acquisition was in part supported by the Division for Earth and Life Sciences (ALW; http://www.nwo.nl/NWOHOME.nsf/pages/ACPP_4WMJGH_Eng) with financial aid from the Netherlands Organization for Scientific Research (NWO, 834.10.004; http://www.nwo.nl/). Additionally, A.H.M. and H.P.S were supported by the European community ZF-TOOLS project (contract LSHG-CT-2006-037220; http://ec.europa.eu/research/fp6/index_en.cfm), and H.P.S. and R.C. were supported by the European community ZF-Cancer project (contract Health-F2-2008-201439; http://cordis.europa.eu/fp7/home_en.html). The authors acknowledge financial support from Cyttron, in the Besluit Subsidies Investeringen Kennisinfrastructuur program (J.S.), which in turn is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek. Finally, T.H.M.O. and N.D.L.S. received support from the Netherlands Leprosy Relief Foundation (http://www.leprastichting.nl/), the European Commission and the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/Pages/home.aspx). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016779","2011-02-16T00:00:00Z",201439
"349",349,"
        This work was supported by research grants rewarded to KM from the Agence Nationale de la Recherche-GIS Institut des Maladies Rares and a grant (1-FY07-490) from the March of Dimes Foundation. Authors KM and AB received support from the EuroDSD in the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement n° 201444 (www.euroDSD.eu). Author DL was supported by a research grant from the Portuguese Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024117","2011-10-20T00:00:00Z",201444
"686",686,"
        This project was funded by Agence Nationale pour la Recherche (Project ANR-08-GENO-016-1) and supported by research grants from SERVIER research group, SANOFI-AVENTIS, Association des Sclérodermies de France, and Groupe Français de Recherche sur la Sclérodermie. The KORA (Cooperative health research in the Region of Augsburg) studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany, and supported by grants from the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN). This research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. HYPERGENES (European Network for Genetic-Epidemiological Studies) is funded by EU within the FP7: HEALTH-F4-2007-201550. The sample considered in the present study has been collected by the Milano group in collaboration with the Center of Transfusion Medicine, Cellular Therapy, and Cryobiology, Foundation Ca' Granda Ospedale Maggiore Policlinico, and Fondazione Filarete. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002091","2011-07-07T00:00:00Z",201550
"7051",705,"The NFBC1966 received financial support from the Academy of Finland (project grants 104781, 120315, 132797, and Center of Excellence in Complex Disease Genetics); University Hospital Oulu, Biocenter, University of Oulu, Finland; the European Community's Fifth/Seventh Framework Programme (EURO-BLCS, QLG1-CT-2000-01643, FP7/2007-2013); NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01); ENGAGE project (HEALTH-F4-2007-201413); the Medical Research Council (studentship grant G0500539, centre grant G0600705); the Wellcome Trust (project grant GR069224), UK; the Research Council UK fellowship; the National Institute of Health Research (NIHR) Biomedical Research Centre Programme at Imperial College; and the Division of Epidemiology, Public Health and Primary Care (studentship grant DFHM G24038). The DNA extractions, sample quality controls, biobank up-keeping, and aliquotting were performed in the National Public Health Institute, Biomedicum Helsinki, Finland, and supported financially by the Academy of Finland and Biocentrum Helsinki. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC. CJH is funded by a European Union grant HEALTH-2007-201550 HyperGenes. DME is supported by a Medical Research Council New Investigator Award (MRC G0800582). The ICLS (International Centre for Life Course Studies in Society and Health) is funded by an ESRC award: RES-596-28-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000856","2010-02-26T00:00:00Z",201550
"7211",721,"
        Vesna Boraska is supported by Unity Through Knowledge Fund CONNECTIVITY PROGRAM (“Gaining Experience” Grant 2A), The National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia (BRAIN GAIN- Postdoc fellowship) and the Wellcome Trust (098051). Eleftheria Zeggini is supported by the Wellcome Trust (098051). ALSPAC: ALSPAC is jointly funded by the University of Bristol, Wellcome Trust and MRC. Current renewal grant numbers: WT092731 and G9815508. BUSSELTON: The Busselton Health Study acknowledges the generous support for the 1994/5 follow-up study from Healthway, Western Australia. The Busselton Health Study is supported by The Great Wine Estates of the Margaret River region of Western Australia. The study gratefully acknowledges the assistance of the Western Australian DNA Bank (National Health and Medical Research Council (NHMRC) Enabling Facility) with DNA samples and the support provided by the The Ark at UWA for this study. CoLaus-Hercules: The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). Murielle Bochud is supported by the Swiss School of Public Health Plus. CROATIA-Korcula: The CROATIA-Korcula study was funded by grants from the Medical Research Council (UK), and Republic of Croatia Ministry of Science, Education and Sports research (108-1080315-0302). The SNP genotyping for the CROATIA-Korcula cohort was performed in Helmholtz Zentrum München, Neuherberg, Germany. CROATIA-Split: The CROATIA-Split study is funded by grants from the Medical Research Council (UK) and Republic of Croatia Ministry of Science, Education and Sports research grants to I.R. (108-1080315-0302). The SNP genotyping for the CROATIA-Split cohort was performed by AROS Applied Biotechnology, Aarhus, Denmark. CROATIA-Vis: The CROATIA-Vis study was funded by grants from the Medical Research Council (UK), European Commission Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) and Republic of Croatia Ministry of Science, Education and Sports research grants (108-1080315-0302). The SNP genotyping for the CROATIA-Vis cohort was performed in the core genotyping laboratory of the Wellcome Trust Clinical Research Facility at the Western General Hospital, Edinburgh, Scotland, UK. FamHS: The Family Heart Study (FamHS) was supported by NIH grants R01-HL-087700, R01-HL-088215 (Michael A. Province) from the National Heart, Lung, and Blood Institute (NHLBI), and R01-DK-8925601, R01-DK-075681 (Ingrid B. Borecki) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). HUNT: Bendik S. Winsvold is funded from the South-Eastern Norway Regional Health Authority, Norway. Verneri Anttila is funded from the Wellcome Trust (grant number WT089062; www.wellcome.ac.uk) and the Finnish Cultural Foundation (www.skr.fi). HYPERGENES: HYPERGENES (European Network for Genetic-Epidemiological Studies: Building a method to dissect complex genetic traits, using essential hypertension as a disease model) is a Large Cooperative Project funded by EU within the FP7 (HEALTH-F4-2007-201550). InCHIANTI: The InCHIANTI study baseline (1998-2000) was supported as a “targeted project” (ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336); the InCHIANTI Follow-up 1 (2001-2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1-1 and N.1-AG-1-2111); the InCHIANTI Follow-ups 2 and 3 studies (2004-2010) were financed by the U.S. National Institute on Aging (Contract: N01-AG-5-0002); supported in part by the Intramural research program of the National Institute on Aging, National Institutes of Health, Baltimore, Maryland. JRBP is funded by a Sir Henry Wellcome Postdoctoral Fellowship (092447/Z/10/Z). KORA: The KORA Augsburg studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany (http://www.helmholtz-muenchen.de) and supported by grants from the German Federal Ministry of Education and Research (BMBF) (http://www.bmbf.de). Part of this work was financed by the German National Genome Research Network (NGFN-2, NGFNPlus 01GS0823 and 01GS0834) (http://www.ngfn.de). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ (http://www.mc-health.uni-muenchen.de). Cornelia Huth was supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). MICROS: In South Tyrol, the study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. RAINE: The National Health and Medical Research Council of Australia (Grant ID 572613, ID 403981 and ID 353514; URL: http://www.nhmrc.gov.au/), The Western Australian Health Promotion Foundation (URL: http://www.healthway.wa.gov.au/) and the Canadian Institutes of Health Research (MOP-82893; URL: http://www.cihr-irsc.gc.ca/e/193.html). The authors gratefully acknowledge the NH&MRC for their long term contribution to funding the study over the last 20 years and also the Telethon Institute for Child Health Research for long term support of the study. The following Institutions are acknowledged for providing funding for Core Management of the Raine Study: The University of Western Australia (UWA), Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, The Telethon Institute for Child Health Research, Women and Infants Research Foundation and Curtin University. SHIP: SHIP (BMBF), Henry Völzke (public funding from Federal Ministry of Education and Research). SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the “Center of Knowledge Interchange” program of the Siemens AG. TEENAGE: This research has been co-financed by the European Union (European Social Fund – ESF) and Greek national funds through the Operational Program “Education and Lifelong Learning” of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. TwinFat: Helsinki University Hospital Research Funds, grants from Novo Nordisk, Gyllenberg, Biomedicum Helsinki, Jalmari and Rauha Ahokas Foundation, and Finnish Foundation for Cardiovascular Research. Academy of Finland Centre of Excellence in Complex Disease Genetics. The European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007- 201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031369","2012-03-29T00:00:00Z",201550
"131",131,"
        The work was supported in part by the Danish Medical Research Council, Novo Nordisk Foundation and Arvid Nilsson's Foundation, the European Commission EUNEFRON (FP7, GA#201590), Aarhus University, and Genzyme Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025065","2011-09-19T00:00:00Z",201590
"77",77,"
        This work was supported by a FP7 EU grant (MemStick, N° 201600; http://cordis.europa.eu/fp7/home_en.html) to CS and LMP. MI was a PhD student fellow from CONICYT (Comisión Nacional de Investigación Científica y Tecnológica; www.conicyt.cl), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038959","2012-06-15T00:00:00Z",201600
"124",124,"
        This work was supported by grants from the Spanish Ministry MICINN (BFU2009-07989) to LMdlP and by the European Commission under FP7 (MemStick Grant Agreement N° 201600) to LMdlP and CS. MI was a PhD student fellow from CONICYT, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022372","2011-07-26T00:00:00Z",201600
"194",194,"This work was supported by grants from the European Union 7th Framework Programme (FP7-HEALTH-F2M-2007-201600; MemStick) and the Swiss National Science Foundation (310000-120791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0008618","2010-01-08T00:00:00Z",201600
"694",694,"
        This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF-2008-04616, SAF-2009-05558-E, CSD-2010-00045, and SAF-2011-24730 to J.A.E; SAF2010-15676 to S.K.; SAF-2009-09129 to C.V.; PI-08/1067 to J.M.S.; SAF-2009-09394 to J.D.F.). In addition, the laboratory of J.A.E. is funded from Fundación Ramón Areces and Institut de France-NRJ; the laboratory of J.D.F. from Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, CB06/05/0066) and Fundación CIEN; the laboratory of C.S. from the EU (FP7-HEALTH-F2M-2008-201600, MemStick) and the Swiss National Science Foundation (310000-120791). S.K. is the recipient of a “Ramón y Cajal” contract from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pbio.1001262","2012-02-21T00:00:00Z",201600
"216",216,"
        This work was supported by the German Research Foundation (DFG, GRK1331/2), the Doerenkamp-Zbinden Foundation, Konstanz Research School Chemical Biology (KoRS-CB), graduate school for computer and information science at Konstanz University and the ESNATS project of the European Union (FP7 – 201619). The funders had no role in study design, data collection and analysis.
      ","10.1371/journal.pone.0036708","2012-05-09T00:00:00Z",201619
"3571",357,"
        MB's laboratory is funded by the Spanish Ministry of Science and Innovation Projects SAF2008-05384 and CSD2007-00017, European Union FP7 Projects 2007-A-201630 (GENICA) and 2007-A-200950 (TELOMARKER), European Research Council Advanced Grant GA#232854, Körber Foundation, Fundación Botín and Fundación Lilly (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025680","2011-10-12T00:00:00Z",201630
"351",351,"
        This work was supported by the European School of Molecular Medicine (SEMM) “Federico II” University of Naples, Naples, Italy, FP6-E.E.T pipeline LSH-CT-2006-037260 and FP7-Tumic HEALTH-F2-2008-201662 grants (MZ), an Associazione Italiana per la Ricerca sul Cancro AIRC 2007-2009 grant (MZ), a 2006/08 Associazione Italiana della Lotta al Neuroblastoma “Progetto Pensiero” grant (MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024584","2011-09-12T00:00:00Z",201662
"547",547,"This study was supported by FP6-E.E.T pipeline LSH-CT-2006-037260 (MZ), FP7-Tumic HEALTH-F2-2008-201662 (MZ), Associazione contro la lotta al Neuroblastoma Italiana “Progetto Pensiero” (AI,MZ), AIRC grant 2007 (MZ), Progetto AIRC Tumori Pediatrici 2008 (MZ). Associazione Open Neuroblastoma (AI), a Scuola Europea di Medicina Molecolare (SEMM-CEINGE) Fellowship (EC), and AIRC-FIRC Fellowships (LG, NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0004998","2009-03-24T00:00:00Z",201662
"7171",717,"
        This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Support for individual studies that participated in the effort is as follows: SBCS (Dr. Silverman) - Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics and intramural contract number NCI N02-CP-11015. FIS/Spain 98/1274, FIS/Spain 00/0745, PI061614, and G03/174, Fundació Marató TV3, Red Temática Investigación Cooperativa en Cáncer (RTICC), Consolíder ONCOBIO, EU-FP7-201663; and RO1- CA089715 and CA34627. NEBCS (Dr. Silverman) - Intramural research program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics and intramural contract number NCI N02-CP-01037 PLCO (Dr. Purdue) - The National Institutes of Health (NIH) Genes, Environment and Health Initiative (GEI) partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C), and study coordination at the GENEVA (Dr. Caporaso)- The NIH Genes, Environment and Health Initiative [GEI] partly funded DNA extraction and statistical analyses (HG-06-033-NCI-01 and RO1HL091172-01), genotyping at the Johns Hopkins University Center for Inherited Disease Research (U01HG004438 and NIH HHSN268200782096C) and study coordination at the GENEVA Coordination Center (U01 HG004446) for EAGLE and part of PLCO studies. Genotyping for the remaining part of PLCO and all ATBC and CPS-II samples were supported by the Intramural Research Program of the National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics. The PLCO is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, National Institutes of Health. ATBC (Dr. Albanes) - This research was supported in part by the Intramural Research Program of the NIH and the National Cancer Institute. Additionally, this research was supported by U.S. Public Health Service contracts N01-CN-45165, N01-RC-45035, and N01-RC-37004 from the National Cancer Institute, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029396","2012-01-04T00:00:00Z",201663
"310",310,"
        The authors were supported by grants from the Finnish Foundation for Cardiovascular Research (TH), Finnish Medical Foundation (TH), the special governmental subsidy for health sciences research TYH 7106 and TYH2009121 (TH), and the European Commission (ATHEROREMO project, FP7-HEALTH-2007-A contract number 201668) to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015744","2011-01-20T00:00:00Z",201668
"5271",527,"The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2, NGFNPlus 01GS0823, and NGFNPlus 01GS0834) and through additional funds from the University of Ulm. Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ and by a grant from the BMBF to the German Center for Diabetes Research (DZD e.V.), as well as from the BMBF funded German Network for Mitochondrial Disorders (mitoNET 01GM0862) and Systems Biology of Metabotypes (SysMBo 0315494A). Furthermore, the study received funding from the European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. The LURIC part of this study has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 201668; AtheroRemo. It was further supported by the Centre of Excellence “Metabolic disorder” Baden-Württemberg, Ulm, University Ulm, Germany. The Sorbs part of this study was supported by grants from the Interdisciplinary Centre for Clinical Research at the University of Leipzig (B27; N06) and from the German Diabetes Association as well as by a grant from the DFG (KFO 152). Furthermore, the authors received funding through the European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The TwinsUK study was funded by the Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, the European Community's Seventh Framework Programme (FP7/2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also received support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and by the WT Grant n. 091746/Z/10/Z. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). Genotyping was in part performed by CIDR as part of an NEI/NIH project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1001213","2010-11-18T00:00:00Z",201668
"467",467,"The research leading to these results has received funding from the European Community Seventh Framework Program (FP7/2007-201714, DEVANX Project), the Spanish Ministry of Science and Innovation (BFU2008-00899 and BFU2008-03390), the Junta de Andalucia (Spain, BIO-122 and CVI-02487), and the Fundacion Conocimiento y Cultura of the Pablo de Olavide University (Seville, Spain). Dr. Sacktor is supported by National Institutes of Health (NIH) MH53576 and MH57068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0010400","2010-04-29T00:00:00Z",201714
"5971",597,"
        The work described herein was supported by Enterprise Ireland under Grant Number CC20080001. JFC and TGD are also supported in part by Science Foundation Ireland (SFI) in the form of a centre grant (Alimentary Pharmabiotic Centre) through the Irish Government's National Development Plan. The authors and their work were supported by SFI (grant no.s 02/CE/B124 and 07/CE/B1368). JFC is funded by European Community's Seventh Framework Programme; Grant Number: FP7/2007–2013, Grant Agreement 201714. GC is in receipt of research funding from the American Neurogastroenterology and Motility Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032266","2012-03-20T00:00:00Z",201714
"234",234,"
        This work was supported by EU FP5 ‘Neurobotics’ 001917 (to Dr. Grillner), EU FP7 ‘Lampetra’ 21610 (to Dr. Grillner), Swedish research council, VR-M -3026, VR-NT 621-2007-6049 (to Dr. Grillner), Karolinska Institutet's Research funds (to Dr. Robertson), FP7 Select-and-Act 201716 (to Dr. Grillner and Dr. Bolam) and Karolinska Institutet Doctoral funds (to Dr. Ericsson), Stockholm Brain Institute (to Dr. Grillner and Dr. Diaz-Heijtz), Spanish MICINN-FEDER BFU2009-13369 (to Dr. Pérez-Fernández). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035642","2012-04-26T00:00:00Z",201716
"207",207,"This work has received funding from the European Community's Seventh Framework Programme ([FP7/2007–2013]) under grant agreement n°201762. In addition, the authors acknowledge their individual external funding for T7S/ESX related research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1000507","2009-10-30T00:00:00Z",201762
"499",499,"
        This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n°201762 and by Ministero dell'Università e della Ricerca Scientifica (MIUR), Progetti di Interesse Nazionale (PRIN) 2008 (code number 2008Y8RZTF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027713","2011-11-16T00:00:00Z",201762
"599",599,"
        The research leading to these results has received funding from the European Community's Seventh Framework Programme ([FP7/2007-2013]) under grant agreement n°201762, SystemsX.ch and the Swiss National Science Foundation under grant n°31003A-125061. F.P. is a Swiss National Science Foundation MHV Post-doctoral Fellow. J.M.C. is a recipient of Canadian Thoracic Society and Canadian Institutes of Health Research Post-doctoral Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002621","2012-03-29T00:00:00Z",201762
"401",401,"
        This work was conducted as part of “AsiaFluCap: Heath system analysis to support capacity development in response to the threat of pandemic influenza in Asia”, a project funded within the European Commission Seventh Framework Programme (FP7/2007-2013), grant agreement number: Health-F3-2008-201823; and the Rockefeller Foundation Grant 2008 DSN 2001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031800","2012-02-21T00:00:00Z",201823
"5272",527,"The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2, NGFNPlus 01GS0823, and NGFNPlus 01GS0834) and through additional funds from the University of Ulm. Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ and by a grant from the BMBF to the German Center for Diabetes Research (DZD e.V.), as well as from the BMBF funded German Network for Mitochondrial Disorders (mitoNET 01GM0862) and Systems Biology of Metabotypes (SysMBo 0315494A). Furthermore, the study received funding from the European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. The LURIC part of this study has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 201668; AtheroRemo. It was further supported by the Centre of Excellence “Metabolic disorder” Baden-Württemberg, Ulm, University Ulm, Germany. The Sorbs part of this study was supported by grants from the Interdisciplinary Centre for Clinical Research at the University of Leipzig (B27; N06) and from the German Diabetes Association as well as by a grant from the DFG (KFO 152). Furthermore, the authors received funding through the European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The TwinsUK study was funded by the Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, the European Community's Seventh Framework Programme (FP7/2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also received support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and by the WT Grant n. 091746/Z/10/Z. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). Genotyping was in part performed by CIDR as part of an NEI/NIH project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1001213","2010-11-18T00:00:00Z",201865
"690",690,"This work was supported by deCODE Genetics and funded in part by the European Community's Seventh Framework Programme (FP7/2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS. The Korean study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Project No.: A010252). The Chinese Hong Kong-I study was supported in part by grants from Research Grants Council of Hong Kong, (CUHK 4101/02M), Direct Grant from the Chinese University of Hong Kong, the Centre for Nutritional Studies, School of Public Health and Primary Care, and the Hong Kong Jockey Club Charities Foundation. The Hong Kong-II study was supported by Hong Kong Research Grant Council; The Bone Health fund of HKU Foundation; Matching Grant, CRCG Grant and The Osteoporosis Research Fund of The University of Hong Kong. The study design, data generation (in part), overall analysis of data, decision to publish and preparation of the manuscript was lead by employees of deCODE Genetics, a funder of this study.","10.1371/journal.pone.0013217","2010-10-07T00:00:00Z",201865
"7001",700,"The Australian Twin Registry is supported by an Australian National Health and Medical Research Council (NHMRC) Enabling Grant (2004–2009). The Blue Mountains Eye Study has also been supported by NHMRC grants (974159, 211069, 457349), a Capacity Building grant (262120), and a Centre for Clinical Research Excellence grant (529923). We also thank the following organisations for their financial support: Clifford Craig Medical Research Trust, Ophthalmic Research Institute of Australia (ORIA), Glaucoma Australia, American Health Assistance Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Foundation for Children, NHMRC project grant (2005–2007), Jack Brockhoff Foundation, National Eye Institute (NEI) Project Grant (2007–2010). Genotyping for part of the Australian sample was funded by an NHMRC Medical Genomics Grant. Genotyping for the remainder was performed by the National Institutes of Health (NIH) and CIDR as part of an NIH/NEI grant 1RO1EY018246, and we are grateful to Dr Camilla Day and staff. Australian sample imputation analyses were carried out on the Genetic Cluster Computer which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). YL is supported by Australian NHMRC grant 496675. DAM is a recipient of the Pfizer Australia Senior Research Fellowship. SM is supported by an Australian NHMRC Career Development Award. The KCL authors acknowledge funding from the Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, Guide Dogs for the Blind Association the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413 and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator and CJH an NIHR Senior Research Fellow. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant. (G20234). The authors acknowledge the funding and support of the NIH/NEI grant 1RO1EY018246, an NIH/Center for Inherited Diseases Research genotyping project grant (PI: Terri Young). Genotyping of the BMES and Adelaide cohorts was funded by the Ophthalmic Research Institute of Australia and NHMRC Project Grant #535044. DPD is supported by NHMRC Dora Lush Scholarship and KPB by NHRMC Peter Foherty Fellowship. JEC is an NHMRC Practioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000947","2010-05-13T00:00:00Z",201865
"7021",702,"The Rotterdam Study authors acknowledge funding from the Netherlands Genomics Initiative (NGI) and Netherlands Organization for Scientific Research (NWO) (nr. 050-060-810) within the framework of the Forensic Genomics Consortium Netherlands (FGCN), the Netherlands Forensic Institute and the Research Institute for Diseases in the Elderly (RIDE) (nr. 014-93-015). The generation and management of GWAS genotype data for the Rotterdam Study (RS-I, RS-II) was supported by a NWO investments grant (nr. 175.010.2005.011, 911-03-012). The Rotterdam Study is funded by the Erasmus University Medical Center, Erasmus University Rotterdam; the Netherlands Organization for the Health Research and Development (ZonMw); the RIDE; the Ministry of Education, Culture, and Science; the Ministry for Health, Welfare, and Sports of the Netherlands; the European Commission (DG XII); and the Municipality of Rotterdam. The ophthalmic part of the Rotterdam Study was supported by Lijf en Leven, Krimpen, and Lek; MD Fonds, Utrecht. Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, Rotterdam; Swart van Essen, Rotterdam; NWO; Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen (all in the Netherlands); as well as Heidelberg Engineering, Dossenheim, Germany. The TwinsUK authors acknowledge funding from the Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, Guide Dogs for the Blind Association the European Community's Seventh Framework Programme (FP7 2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7 2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guys St Thomas NHS Foundation Trust in partnership with Kings College London. TDS is an NIHR senior Investigator and CJH an NIHR Senior Research Fellow. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). The authors acknowledge the funding and support of the National Institutes of Health(NIH) National Eye Institute grant 1RO1EY018246, and the NIH Center for Inherited Diseases Research (CIDR) (PI: Terri Young). The BTNS authors acknowledge funding from the Australian National Health and Medical Research Council (NHMRC, grants 241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496739, 552485, 552498), Australian Research Council (A7960034, A79906588, A79801419, DP0212016, DP0343921); National Institutes of Health National Cancer Institute (CA88363). DLD and GWM were supported by the NHMRC Fellowships scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000934","2010-05-06T00:00:00Z",201865
"7151",715,"This work was supported, in part, by grants from the Wellcome Trust (to RKS: Intermediate Clinical Fellowship 080952/Z/06/Z; to SOR: Programme Grant 078986/Z/06/Z), the United Kingdom Medical Research Council Centre for Obesity and Related Metabolic Diseases. The Canadian Institutes of Health Research (CIHR) provided support to this project to JBR, MFH, and TP). DELFIA Adiponectin Assays were performed by the NIHR Cambridge Biomedical Research Centre, Core Biochemical Assay Laboratory. Recruitment of the PennCATH cohort was supported by the Cardiovascular Institute of the University of Pennsylvania. Recruitment of the MedStar cohort was supported by a research grant from GlaxoSmithKline. Genotyping was performed at the Center for Applied Genomics at the Children's Hospital of Philadelphia and supported by GlaxoSmithKline through an Alternate Drug Discovery Initiative research alliance award (to MPR and DJR) with the University of Pennsylvania School of Medicine. The German Study was supported by the Deutsche Forschungsgemeinschaft and the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus) and the EU-funded integrated project Cardiogenics (LSHM-CT-2006-037593). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the GSF National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and the State of Bavaria. The EPIC Norfolk Study is funded by Cancer Research United Kingdom and the Medical Research Council. The WTCCC Study was funded by the Wellcome Trust. Recruitment of cases for the WTCCC Study was carried out by the British Heart Foundation (BHF) Family Heart Study Research Group and supported by the BHF and the UK Medical Research Council. NJS holds a Chair funded by the BHF. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC; and this ALSPAC study was specifically funded by the British Heart Foundation # MRC PG/07/002. The gene expression work was supported by Genome Quebec, Genome Canada, and the CIHR. TP holds a Canada Research Chair, and Drs. O. Nilsson, Ljunggren, and H. Mallmin (Uppsala University, Sweden) are acknowledged for collection of the osteoblasts. The Framingham Heart Study component of this work was supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195), its contract with Affymetrix for genotyping services (Contract No.N02-HL-6-4278), and the resources of the Framingham Heart Study SNP Health Association Resource (SHARe) project, the National Institutes of Health, National Center for Research Resources, General Clinical Research Centers Program (Grant Number M01-RR-01066), an American Diabetes Association Career Development Award (JBM), a research grant from sanofi-aventis (JBM), the Boston University Linux Cluster for Genetic Analysis (LinGA) funded by the NIH NCRR Shared Instrumentation grant (1S10RR163736-01A1), and the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center, by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195), National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK078616 to JBM, JD, and JCF, NIDDK K24 DK080140 to JBM, NIDDK Research Career Award K23 DK65978, a Massachusetts General Hospital Physician Scientist Development Award and a Doris Duke Charitable Foundation Clinical Scientist Development Award to JCF, and the Boston University Linux Cluster for Genetic Analysis (LinGA) funded by the NIH NCRR Shared Instrumentation grant (1S10RR163736-01A1). MFH was supported by the Centre de Recherche Medicale de l'Universite de Sherbrooke (CRMUS) and the CIHR. TwinsUK: The study was funded by the Wellcome Trust, European Community’s Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. TDS is an NIHR senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). The authors acknowledge the funding and support of the National Eye Institute via an NIH/CIDR genotyping project (PI: Terri Young). We thank the staff from the Genotyping Facilities at the Wellcome Trust Sanger Institute for sample preparation, quality control, and genotyping led by Leena Peltonen and Panos Deloukas; Le Centre National de Genotypage, France, led by Mark Lathrop, for genotyping; Duke University, North Carolina, USA, led by David Goldstein, for genotyping; and the Finnish Institute of Molecular Medicine, Finnish Genome Center, University of Helsinki, led by Aarno Palotie. Genotyping was also performed by CIDR as part of an NEI/NIH project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000768","2009-12-11T00:00:00Z",201865
"7181",718,"
        This research was made possible by NIA/NIH contract AG000932-02 (2009) Characterization of Normal Genomic Variability. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD [http://biowulf.nih.gov]. The Age, Gene/Environment Susceptibility Reykjavik Study is funded by NIH contract N01-AG-12100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, and grants R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The National Heart, Lung, and Blood Institute's Framingham Heart Study is a joint project of the National Institutes of Health and Boston University School of Medicine and was supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (contract No. N02-HL-6-4278). Analyses reflect the efforts and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The Health ABC Study was supported in part by the Intramural Research Program of the NIH, National Institute on Aging, NIA contracts N01AG62101, N01AG62103, and N01AG62106. The genome-wide association study was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. The InChianti Study was supported as a “targeted project” (ICS 110.1RS97.71) by the Italian Ministry of Health, by the U.S. National Institute on Aging (Contracts N01-AG-916413, N01-AG-821336, 263 MD 9164 13, and 263 MD 821336), and in part by the Intramural Research Program, National Institute on Aging, National Institutes of Health, USA. David Melzer's participation was supported in part by NIH grant R01 AG24233-01. The Heart and Vascular Health (HVH) Study was funded by grants HL085251 and HL087652 from the National Heart, Lung and Blood Institute. The INGI cohorts and their investigators would like to acknowledge the regions of Friuli Venezia Giulia region and Fondo Trieste, and funding from Health Ministry project RF-FSR-2007-647201, Fondazione Compagnia di San Paolo and Fondazione Cassa di Risparmio di Alessandria. The KORA Augsburg studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany, and supported by grants from the German Federal Ministry of Education and Research (BMBF). Part of this work was financed by the German National Genome Research Network (NGFN). This research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The GWAS database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011, 911.03.012) and the Research Institute for Diseases in the Elderly (RIDE). This study was supported by the Netherlands Genomics Initiative (NGI)/NWO project number 050 060 810 (Netherlands Consortium for Healthy Ageing). The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands organization for scientific research (NWO); the Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Heart Foundation; the Ministry of Education, Culture, and Science; the Ministry of Health, Welfare, and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. Janine F. Felix and Abbas Dehghan are supported by the Netherlands Organization for Scientific Research (NWO, VICI no. 918-76-619). The Twins UK study was funded by the Wellcome Trust, European Community's Seventh Framework Programme (FP7/2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413, and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London. Tim D. Spector is an NIHR senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant (G20234). Additional support includes the Wellcome Trust grant 076113/C/04/Z, the Juvenile Diabetes Research Foundation grant WT061858, and by the National Institute of Health Research of England. Nicole Soranzo is supported by Wellcome Trust (Core Grant Number 091746/Z/10/Z). The participation of Alex P. Reiner is supported by National Heart, Lung, and Blood Institute grant R01 HL-071862. Holger Prokisch's participation was supported by the German Federal Ministry of Education and Research (BMBF) funded German Center for Diabetes Research (DZD e.V.) and Systems Biology of Metabotypes (SysMBo #0315494A). Financial support was received from the German Research Council (KFO-152), IZKF (B27), and the German Diabetes Association. Inga Prokopenko and Vasiliki Lagou were partial funded through the European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. Acknowledgments from COGENT collaborators: COGENT and CARe: The authors acknowledge the essential role of the Continental Origins and Genetic Epidemiology Network (COGENT) Consortium in development and support of this manuscript. COGENT members participating in support of this manuscript include the WHI, ARIC, CARDIA, JHS, HANDLS, Health ABC, and GeneSTAR. CARe: The authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute and the contributions of the research institutions, study investigators, field staff and study participants in creating this resource for biomedical research. The following parent studies contributed study data, ancillary study data, and DNA samples through the Broad Institute (N01-HC-65226) to create this genotype/phenotype data base for wide dissemination to the biomedical research community: Atherosclerosis Risk in Communities (ARIC): University of North Carolina at Chapel Hill (N01-HC-55015), Baylor Medical College (N01-HC-55016), University of Mississippi Medical Center (N01-HC-55021),University of Minnesota (N01-HC-55019), Johns Hopkins University (N01-HC-55020), University of Texas, Houston (N01-HC-55017), University of North Carolina (N01-HC-55018). Other NIH support contributing to the GWAS in ARIC are: R01HL087641, R01HL59367, R01HL86694, U01HG004402, and HHSN268200625226C. Coronary Artery Risk in Young Adults (CARDIA): University of Alabama at Birmingham (N01-HC-48047), University of Minnesota (N01-HC-48048), Northwestern University (N01-HC-48049), Kaiser Foundation Research Institute (N01-HC-48050), University of Alabama at Birmingham (N01-HC-95095), Tufts-New England Medical Center (N01-HC-45204), Wake Forest University (N01-HC-45205), Harbor-UCLA Research and Education Institute (N01-HC-05187), University of California, Irvine (N01-HC-45134, N01-HC-95100). Jackson Heart Study (JHS): Jackson State University (N01-HC-95170), University of Mississippi (N01-HC-95171), Tougaloo College (N01-HC-95172). Healthy Aging in Neighborhoods of Diversity across the Life Span Study (HANDLS): This research was supported by the Intramural Research Program of the NIH, National Institute on Aging and the National Center on Minority Health and Health Disparities (intramural project # Z01-AG000513 and human subjects protocol # 2009-149). Data analyses for the HANDLS study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Maryland (http://biowulf.nih.gov). GeneSTAR: This research was supported by the National Heart, Lung, and Blood Institute (NHLBI) through the PROGENI (U01 HL72518) and STAMPEED (R01 HL087698-01) consortia. Additional support was provided by grants from the NIH/National Institute of Nursing Research (R01 NR08153), and the NIH/National Center for Research Resources (M01-RR000052) to the Johns Hopkins General Clinical Research Center. WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. RIKEN collaborators: We would like to thank all the staff of the Laboratory for Statistical Analysis at RIKEN for
their technical assistance. This study was supported by Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002113","2011-06-30T00:00:00Z",201865
"7191",719,"For TwinsUK: This study was funded by the British Heart Foundation, Project grant No. 06/094. The study was also funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and (FP7/2007-2013), ENGAGE project grant agreement HEALTH-F4-2007-201413 and the FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the Dept of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator. The project also received support from a Biotechnology and Biological Sciences Research Council (BBSRC) project grant(G20234). The authors acknowledge the funding and support of the National Eye Institute via an NIH/CIDR genotyping project (PI: Terri Young). CD is supported by a British Heart Foundation grant: SP/02/001. For the BRIGHT study: The BRIGHT study is supported by the Medical Research Council of Great Britain (grant number; G9521010D) and the British Heart Foundation (grant number PG02/128). CW was funded by the British Heart Foundation (grant number: FS/05/061/19501). SJN is funded by the Medical Research Council and The William Harvey Research Foundation. Profs Dominiczak and Samani are British Heart Foundation Chairholders. EZ is funded by the Wellcome Trust (WT088885/Z/09/Z). For the DCCT/EDIC study: The DCCT/EDIC Research Group is sponsored through research contracts from the National Institute of Diabetes, Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institutes of Health. The authors are grateful to the subjects in the DCCT/EDIC cohort for their long-term participation. A.D.P. holds a Canada Research Chair in the Genetics of Complex Diseases. This work has received support from National Institute of Diabetes and Digestive and Kidney Diseases Contract N01-DK-6-2204, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK-077510 and support from the Canadian Network of Centres of Excellence in Mathematics and Genome Canada through the Ontario Genomics Institute. For QTSCD: ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. In addition, we acknowledge support from NHLBI grants HL86694 and HL054512, and the Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University for genotyping and data analysis relevant to this study. AK is supported by a German Research Foundation Fellowship. The KORA study was funded by the State of Bavaria and by grants from the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN), the German National Competence network on atrial fibrillation (AFNET) and the Bioinformatics for the Functional Analysis of Mammalian Genomes program (BFAM) by grants to Stefan Kaab (NGFN 01GS0499, 01GS0838 and AF-Net 01GI0204/N), Arne Pfeufer (NGFN 01GR0803, 01EZ0874), H. -Erich Wichmann (NGFN 01GI0204) and to Thomas Meitinger (NGFN 01GR0103). Stefan Kaab is also supported by a grant from the Fondation Leducq. The SardiNIA team was supported by Contract NO1-AG-1-2109 from the National Institute on Aging contract NO1-AG-1-2109 to the SardiNIA (“ProgeNIA”) team and in part by the Intramural Research Program of the US National Institute on Aging, NIH. The efforts of G.R.A. were supported in part by contract 263-MA-410953 from the National Institute on Aging to the University of Michigan and by research grants from the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute (to G.R.A.). The GenNOVA study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Heinz Nixdorf Recall Study was funded by a grant of the Heinz Nixdorf Foundation (Chairman: Dr. jur. G. Schmidt). For QTGEN: The Framingham Heart Study work was supported by the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine (Contract No. N01-HC-25195), its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278), and the Doris Duke Charitable Foundation (C.N.-C.) and Burroughs Wellcome Fund (C.N.-C.), based on analyses by Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. The measurement of ECG intervals in Framingham Heart Study generation 1 and 2 samples was performed by eResearchTechnology and was supported by an unrestricted grant from Pfizer. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (#175.010.2005.011, 911- 03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project #050-060-810. The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. C.N.-C. is supported by NIH K23-HL-080025, a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists. M.E is funded by the Netherlands Heart Foundation 2007B221. J.I.R. is supported by the Cedars-Sinai Board of Governors' Chair in Medical Genetics. The measurement of ECG intervals in the Framingham Heart Study generation 3 sample was completed by Alim Hirji and Sirisha Kovvali using AMPS software provided through an unrestricted academic license by AMPS, LLC (New York, NY,) USAA full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The authors acknowledge the essential role of the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium in development and support of this manuscript. CHARGE members include the Netherland's Rotterdam Study, the NHLBI's Atherosclerosis Risk in Communities (ARIC) Study, Cardiovascular Health Study (CHS) and Framingham Heart Study (FHS), and the NIA's Iceland Age, Gene/Environment Susceptibility (AGES) Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0006138","2009-07-09T00:00:00Z",201865
"7201",720,"
        Cohort funding: ALSPAC: The UK Medical Research Council (Grant number: G990146), the Wellcome Trust and the University of Bristol provide core support for ALSPAC. B58C - WTCCC: The British 1958 Birth Cohort DNA collection was funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. Genotyping for the Wellcome Trust Case Control Consortium was funded by the Wellcome Trust grant 076113/B/04/Z. B58C - T1DGC: This research utilizes resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. T1DGC GWAS data were deposited by the Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research (CIMR), University of Cambridge (John Todd, Helen Stevens and Neil Walker), which is funded by Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Research Centre; the CIMR is in receipt of a Wellcome Trust Strategic Award (079895). EPIC: The EPIC Norfolk Study is funded by Cancer Research United Kingdom and the Medical Research Council.. I.B. received funding from the Wellcome Trust (077016/Z/05/Z) and from the United Kingdom NIHR Cambridge Biomedical Research Centre. FTC: Academy of Finland Centre of Excellence in Complex Disease Genetics. Finnish Twin Study on Aging was funded by Academy of Finland and Finnish Ministry of Education. ENGAGE project grant agreement HEALTH-F4-2007-201413 and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). KORA S3: The KORA Augsburg studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). The authors research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. Genotyping for the KORA F3/500K Study which included the lung function characterized KORA C sample was partly funded by UBS Wealth Foundation Grant BA29s8Q7-DZZ. Korcula: The Korcula study (Croatia) was funded by grants from the Medical Research Council (UK) and Republic of Croatia Ministry of Science, Education and Sports research grants to I.R. (Vis) (108-1080315-0302). NFBC1966: Financial support was received from the Academy of Finland (project grants 104781, 1114194, 120315 and Center of Excellence in Complex Disease Genetics), Oulu University Hospital, Biocenter Oulu, University of Oulu, Finland, the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the Medical Research Council (studentship grant G0500539). The DNA extractions, sample quality controls, biobank up-keeping and aliquotting was performed in the National Institute for Health and Welfare, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. A.R. was supported by the European Commission as part of GABRIEL (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) contract number 018996 under the Integrated Program LSH-2004-1.2.5-1 Post genomic approaches to understand the molecular basis of asthma aiming at a preventive or therapeutic control. NSPHS: EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 01947 (LSHG-CT-2006-01947). The Northern Swedish Population Health Study (NSPHS) was funded by the Swedish Medical Research Council (project number K2007-66X-20270-01-3). The computations were performed on UPPMAX (http://www.uppmax.uu.se) resources under Project p2008027. ORCADES: The ORCADES study was funded by the Chief Scientist Office of the Scottish Government, the Royal Society and the MRC Human Genetics Unit. DNA extraction was performed at the Wellcome Trust Clinical Research Facility in Edinburgh. Genotyping was funded by the European Union Framework Programme 6 EUROSPAN project. SHIP: SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the German Asthma and COPD Network (COSYCONET; BMBF grant 01GI0883), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg- West Pomerania. The University of Greifswald is a member of the ‘Center of Knowledge Interchange’ program of the Siemens AG. TwinsUK: TwinsUK is funded by the Wellcome Trust; the Arthritis Research Campaign; European Community's Seventh Framework Programme (FP7/2007–2013)/grant agreement HEALTH-F2-2008-201865-GEFOS and Seventh Framework Programme (FP7/2007–2013), ENGAGE project grant agreement HEALTH-F4-2007-201413 and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. TDS is an NIHR senior Investigator. The project also received support from a Biotechnology and biological Sciences Research Council (BBSRC) project grant. Vis: The Vis study (Croatia) was funded by grants from the Medical Research Council (UK), European Commission Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) and Republic of Croatia Ministry of Science, Education and Sports research grants to I.R. (108-1080315-0302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019382","2011-05-20T00:00:00Z",201865
"7241",724,"
        The Rotterdam Study is funded by the Erasmus Medical Center and the Erasmus University Rotterdam, The Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of genome-wide association studies (GWAS) genotype data for the Rotterdam Study is supported by The Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. The Erasmus Rucphen Family (ERF) Study is supported by the Center for Medical Systems Biology (CMSB) of NGI, the Internationale Stichting voor Alzheimer Onderzoek (ISAO, 04516), Hersenstichting Nederland (HSN, 150207), and the Alzheimer Association (IRRG0514359). The ophthalmic part of the Rotterdam and ERF Studies is supported by The Netherlands Organization for Health Research and Development (ZonMw) grant 2200.0035; Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht; Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research (NWO); Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Blindenpenning, Amsterdam; Stichting Winckel-Sweep, Utrecht; Landelijke Stichting voor Blinden en Slechtzienden (LSBS), Utrecht; Rotterdamse Vereniging voor Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (ANVVB), Doorn; The Rotterdam Eye Hospital Research Foundation (Stichting Wetenschappelijk Onderzoek Het Oogziekenhuis [SWOO] Prof. Dr. H. J. Flieringa, Rotterdam); Laméris Ootech BV, Nieuwegein; Topcon Europe BV, Capelle aan de IJssel, all in The Netherlands; and Heidelberg Engineering, Dossenheim, Germany. The King's College London authors acknowledge funding from the Guide Dogs for the Blind Association, Wellcome Trust, the EU MyEuropia Marie Curie Research Training Network, the European Community's FP7 (HEALTH-F2-2008-201865-GEFOS), ENGAGE (HEALTH-F4-2007-201413), FP-5 GenomEUtwin Project (QLG2-CT-2002-01254), National Institutes of Health (NIH)/National Eye Institute (NEI) grant 1RO1EY018246 (PI TLY), and genotyping by the NIH Center for Inherited Disease Research (CIDR) (PI TLY). The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust partnering KCL. CJH is an NIHR Senior Research Fellow. The Australian Twin Registry is supported by an Australian National Health and Medical Research Council (NHMRC) Enabling Grant (2004–2009). We also thank the following organisations for their financial support: Clifford Craig Medical Research Trust, Ophthalmic Research Institute of Australia (ORIA), American Health Assistance Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Foundation for Children, NHMRC project grant 350415 (2005–2007), Jack Brockhoff Foundation, NEI Project Grant RO1 EY 018246-01 (2007–2010) (PI TLY). Genotyping for part of the Australian sample was funded by an NHMRC Medical Genomics Grant. Genotyping for the remainder was performed by CIDR as part of an NEI/NIH project grant. Australian sample imputation analyses were carried out on the Genetic Cluster Computer which is financially supported by The Netherlands Scientific Organization (NWO 480-05-003). DAM is a recipient of the Pfizer Australia Senior Research Fellowship. SM is supported by an Australian NHMRC Career Development Award. The Wellcome Trust Case-Control Consortium 2 project was funded by the Wellcome Trust (085475/B/08/Z and 085475/Z/08/Z), the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHSFT, and UCL Institute of Ophthalmology. This project included genotyping of the Blue Mountains Eye Study, which was also supported in part by the Australian National Health and Medical Research Council (512423). We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02, and of the UK National Blood Service controls funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002611","2012-05-03T00:00:00Z",201865
"218",218,"EU FP7 project EDICT European Drug Initiative on Channels and Transporters Grant number 201924(AM), Deutsche Forschungsgemeinschaft Th558/19-1 (GT), NIH-NINDS (DLM), McKnight Foundation for Neuroscience (DLM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0007496","2009-10-16T00:00:00Z",201924
"444",444,"
        Study was supported by: 1) Deutsche Forschungsgemeinschaft (DFG GrK-1657: GT, and KH), 2)Public Health Service Grant GM32441 (JLVE), 3)Fonds der Chemischen Industrie (KH), 4) National Institutes of Health grant P20RR15635 from the COBRE program of the National Center for Research Resources (JLVE) 5)European Drug Initiative on Channels and Transporters (EDICT) project EU FP7 (201924) (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
      ","10.1371/journal.pone.0038826","2012-06-07T00:00:00Z",201924
"239",239,"This work was supported by the European Commission (FP6, http://cordis.europa.eu/fp6/) BioBridge LSHG-CT-2006-037939, (FP7, http://cordis.europa.eu/fp7/) Diaprepp Health-F2-2008-202013, Etherpath KBBE-grant agreement n°222639; the Spanish Government and the European Union FEDER funds (http://ec.europa.eu/regional_policy/funds/feder/index_es.htm) SAF2008-00164 and ISCIII-RTICC (RD06/0020/0046); Generalitat de Catalunya, http://www.gencat.cat/ (2005SGR00204; 2006ITT-10007); Foundation Marato TV3-042010 (http://www.tv3.cat/marato/missio) and the National Institutes of Health (http://www.nih.gov/), AG 20899 and U01 DK61058-01; and the Department of Defense W81XWH-06-1-0317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000619","2009-12-24T00:00:00Z",202013
"684",684,"This work was supported by the European Commission (http://cordis.europa.eu/fp7) Diaprepp Health-F2-2008-202013, Etherpaths KBBE-grant n°222639, Synergy, FP7grant n° 270086; the Spanish Government and the European Union FEDER funds (http://ec.europa.eu/regional_policy/funds/feder/index_es.htm) SAF2008-00164 and Instituto de Salud Carlos III; Spanish Ministry of Science and Innovation & European Regional Development Fund (ERDF) “Una manera de hacer Europa” ISCIII-RTICC (RD06/0020/0046); Generalitat de Catalunya-AGAUR, (http://www.gencat.cat/) 2009SGR1308 and 2009 CTP 00026; Foundation Marato TV3-042010 (http://www.tv3.cat/marato/missio); the National Institutes of Health (http://www.nih.gov/)AG 20899 and U01 DK61058-01; and the Department of Defense W81XWH-06-1-0317. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1001115","2011-03-31T00:00:00Z",202013
"367",367,"
        This study was supported by the Norwegian Research Counsil Globvac (185441, http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1253954270899&pagename=globvac%2FHovedsidemal) the EU FP6 and FP7 funded projects NASPANVAC (202083, http://www.naspanvac.com/introduction.asp) and PANFLUVAC (044115, http://www.panfluvac.org/)) and intramurally by the Influenza Centre, University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026973","2011-11-01T00:00:00Z",202083
"95",95,"This work was supported by grants of the Dutch Arthritis Association, “Reumafonds” and SenterNovem, IOP Genomics project nr IGE03018, the European Union FP7 TOLERAGE: HEALTH-F4-2008-202156. Funders were not involved in design and conduct of the study, collection analysis and interpretation of the data or in the preperation, review or approval of the manuscript.","10.1371/journal.pone.0004186","2009-01-14T00:00:00Z",202156
"197",197,"
        This work was supported by grants from the European Union FP7 TOLERAGE: HEALTH-F4-2008-202156, TI Pharma Project D5-106, BSIK VIRGO consortium grant no. 03012, and the Dutch Arthritis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026684","2011-11-02T00:00:00Z",202156
"115",115,"
        This work was supported by DFG (SFB/TR3 to CS, AD and MF; SPP1172 to CS, GS and
                    JT), EC (FP7-202167 NeuroGLIA to CS) and Land NRW (Graduate School
                    Biotech-Pharma to CH). The funders had no role in study design, data collection
                    and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017575","2011-03-24T00:00:00Z",202167
"289",289,"Internationale Stichting Alzheimer Onderzoek (ISAO; 04511; EH) - www.alzheimer.nl/ Hersenstichting Nederland (HsN; 13F05.08; EH) - www.hersenstichting.nl Internationaal Parkinson Fonds (EH) - www.parkinsonfonds.nl Dorpmans-Wigmans-Stichting (EH) EU FP7 project NeuroGlia (Grant Agreement N° 202167; EA) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0007663","2009-11-04T00:00:00Z",202167
"396",396,"
        Supported by grants from Ministerio de Ciencia e Innovación (BFU2010-15832, BFU2008-03488, BFU2008-04196, CSD2010-00045), Spain, European Union (HEALTH-F2-2007-202167) and Cajal Blue Brain. G.P. is supported by a Marie Curie Fellowship (FP7-253635). E.D.M. is supported by INCRECyT project from European Social Fund and JCCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pbio.1001259","2012-02-14T00:00:00Z",202167
"129",129,"
        The research has been funded by the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement n° HEALTH-F2-2007-202224 eurIPFnet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024663","2011-10-03T00:00:00Z",202224
"564",564,"
        This work was supported by grants from the Academy of Finland (grant 121457 to V.M.O.), from NSFC, China (grant 30971104 to D.Y.), the Fundamental Research Funds for the Central Universities, China (to D.Y.), the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, The Novo Nordisk Foundation (V.M.O.), the Liv och Hälsa Foundation, the Magnus Ehrnrooth Foundation (V.M.O.), and the European Union FP7 (LipidomicNet, agreement no. 202272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021078","2011-06-15T00:00:00Z",202272
"683",683,"This research was supported by the Swiss National Foundation (through an individual research grant to U.S. and the National Center of Competence in Research Program Frontiers in Genetics), the State of Geneva, the Louis Jeantet Foundation of Medicine, the Bonizzi-Theler Stiftung, and the 6th European Framework Project EUCLOCK. D. G. received long-term fellowships from The Federation of European Biochemical Societies (FEBS) and The International Human Frontier Science Program Organization (HFSP). Research in A. M.'s laboratory is funded by the Italian Association for Cancer Research (AIRC, Milan, Italy), the European Research Council Starting Independent Grant - IDEAS 2008, the European Community's Seventh Framework Programme FP7/2007 - 20013 under Grant Agreement No. 202272 (LipidomicNet), Italian Ministry of Health and Education (Finanziamenti per la Ricerca di Base), Cariplo Fundation Milan, Telethon Fundation (GGP08259). G. Lo Sasso is a fellow of AIRC-FIRC (Milan, Italy). Thierry Claudel was supported by the SFB LIPOTOX, grant n° F30008-B05, funded by the Austrian Science Foundation (FWF)","10.1371/journal.pbio.1000181","2009-09-01T00:00:00Z",202272
"685",685,"The European Special Populations Research Network (EUROSPAN) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). High-throughput genome-wide association analysis of the data was supported by joint grant from Netherlands Organisation for Scientific Research and the Russian Foundation for Basic Research (NWO-RFBR 047.017.043). Lipidomic analysis was supported by the European Commission FP7 grant LipidomicNet (2007-202272). The NSPHS study was supported by grants from the Swedish Natural Sciences Research Council, the European Commission through EUROSPAN, the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). The ORCADES study was supported by the Scottish Executive Health Department and the Royal Society. DNA extractions were performed at the Wellcome Trust Clinical Research Facility in Edinburgh. The VIS study in the Croatian island of Vis was supported through the grants from the Medical Research Council UK to HC, AW, and IR and the Ministry of Science, Education, and Sport of the Republic of Croatia to IR (number 108-1080315-0302). The MICROS study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The ERF study was supported by grants from the NWO, Erasmus MC, and the Centre for Medical Systems Biology (CMSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000798","2010-01-08T00:00:00Z",202272
"704",704,"EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). High-throughput genome-wide association analysis of the data was supported by joint grant from Netherlands Organisation for Scientific Research and the Russian Foundation for Basic Research (NWO-RFBR 047.017.043). Lipidomic analysis was supported by the European Commission FP7 grant LipidomicNet (2007-202272). The ERF study was supported by grants from the NWO, Erasmus MC, and the Centre for Medical Systems Biology (CMSB). In South Tyrol, the study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. The Northern Swedish Population Health Study was supported by grants from the Swedish Natural Sciences Research Council, the European Commission through EUROSPAN, the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). ORCADES was supported by the Scottish Executive Health Department and the Royal Society. The VIS study in the Croatian island of Vis was supported through the grants from the Medical Research Council UK to HC, AFW, and IR and Ministry of Science, Education, and Sport of the Republic of Croatia to IR (number 108-1080315-0302). GerMIFS I, II & III (KORA). The German Studies were supported by the Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research in the context of the German National Genome Research Network, and Cardiogenics. Cardiogenics is an EU-funded integrated project (LSHM-CT- 2006-037593). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the GSF-National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and of the State of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000672","2009-10-02T00:00:00Z",202272
"710",710,"
        EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). High-throughput genome-wide association analysis of the data was supported by a joint grant from the Netherlands Organisation for Scientific Research and the Russian Foundation for Basic Research (NWO-RFBR 047.017.043). Lipidomic analysis was supported by the European Commission FP7 grant LipidomicNet (2007-202272). The ERF study was supported by grants from the Netherlands Organisation for Scientific Research (Pionier, 047.016.009, 047.017.043), Erasmus MC, and the Centre for Medical Systems Biology (CMSB; National Genomics Initiative). In South Tyrol, the MICROS study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. The Northern Swedish Population Health Study (NSPHS) was supported by grants from the Swedish Natural Sciences Research Council, Swedish Medical Research Council, the European Commission through EUROSPAN, the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). The ORCADES study was supported by the Scottish Executive Health Department, the Royal Society, and the Wellcome Trust Clinical Research Facility in Edinburgh. The CROATIA_Vis study in the Croatian island of Vis was supported through grants from the Medical Research Council UK and Ministry of Science, Education, and Sport of the Republic of Croatia (number 108-1080315-0302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002490","2012-02-16T00:00:00Z",202272
"501",501,"This study has been financially supported by the Netherlands Organization for Scientific Research (NWO-Genomics 050-10-053; NWO-Toptalent 021.001.011; ZonMw/NGI Horizon 93511023) and the European Commission (BioMalPar LSHP-CT-2004-503578; ATLAS EU-FP7_221952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001223","2010-12-16T00:00:00Z",221952
"254",254,"This work was supported by FP6 Marie Curie Excellence grant Trans-Tar to GN (MEXT-CT-2006-042393); FP7 Collaborative Project Model-In to GN and JR (grant #222008); and Italian Association for Research on Cancer (AIRC). JR received support from the Wellcome Trust through grant 075491/Z/04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pbio.1000384","2010-05-11T00:00:00Z",222008
"457",457,"OJR is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. This research was supported by grants to OJR and SLS from the NIGMS, to OJR from HFSP, and to NF from the Israeli Science Foundation. The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007–2013 under grant agreement number 222008. SLS is a Howard Hughes Medical Institute investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000837","2010-02-05T00:00:00Z",222008
"378",378,"
        This project was funded by the Graduate College “Molecular Complexes of Biomedical Relevance” of the Land Niedersachsen, Germany, and the EU consortia Affinomics (Project No. 222635) and Affinity Proteome (Project No 24181) within the FP7 (http://www.affinomics.org/ and http://www.proteomebinders.org/apframestarthome.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030684","2012-01-24T00:00:00Z",222635
"37",37,"
         A.C. Fluit was in part supported by European Union FP7 Grant no. HEALTH-F3-2008-222718. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0011841","2010-07-29T00:00:00Z",222718
"380",380,"This work was supported by the Centre National de la Recherche Scientifique (CNRS; PR), the Institut National pour la Recherche Medicale (INSERM; FV), the Agence Nationale pour la Recherche (ANR09-BLAN-0024-01; PR & FV), and the European Community (FP6-018618; PR; FP7-EC222718; TG), Region Alsace (CC, CR) and DGA (CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1000809","2010-03-12T00:00:00Z",222718
"437",437,"
        JS was supported by a generous grant from the China Scholarship Council (CSC) and from the ‘Fondation pour la Recherche Médicale’ (FRM). This work was supported by the ‘Institut National pour la Recherche Medicale’ (INSERM; FV & TG), the ‘Centre National de la Recherche Scientifique’ (CNRS; PR), the ‘Agence Nationale pour la Recherche’ (ANR09-BLAN-0024-01; ANR10-Pathogenomics-ARMSA; PR, FV & SB) and the European Community (CONCORD, FP7-EC222718; TG & GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037294","2012-05-22T00:00:00Z",222718
"491",491,"
        This work was partially supported by Project CONCORD (Ref. FP7-Health-F3-2008-222718) from the European Community to HL and by grant Ref: 053/BI-BTI/2009 from the same Project to OB. Additional funding was provided by project Tunisia-Portugal MESRST/GRICES ref. Proc°4. 1. 5. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.
      ","10.1371/journal.pone.0021940","2011-07-08T00:00:00Z",222718
"366",366,"
        The research leading to these results received funding from the European Union Seventh Framework Programme FP7/2007–2013 under grant agreement n° 222773, and from the National Institute of Allergy and Infectious Diseases under contract n° HHSN 272 2009 00045C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026781","2011-11-02T00:00:00Z",222773
"23",23,"
        This investigation was funded by the EU project KalaDrug-R (EC-FP7-222895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001405","2011-11-29T00:00:00Z",222895
"54",54,"
        This work was funded by Kaladrug-R (grant number EC-FP7-222895, www.leishrisk.net/kaladrug). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001657","2012-05-22T00:00:00Z",222895
"569",569,"
        This research was funded by the EC-INCO-Dev project LeishNatDrug-R (contract ICA4-CT-2001–10076), the FWO Flanders (contract G.0103.06) and the EC-FP7 project Kaladrug-R (contract 222895). Manu Vanaerschot has a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT) and Saskia Decuypere has a grant from the Baillet-Latour Foundation. (EC: http://cordis.europa.eu/home_en.html, FWO Flanders: http://www.fwo.be/, IWT: http://www.iwt.be/, Baillet-Latour Foundation: http://www.inbevbailletlatour.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023120","2011-08-01T00:00:00Z",222895
"594",594,"
        This work received financial support from the European Commission (INCO-Dev project LeishNatDrug-R contract FP5-ICA4-CT-2001-10076, Marie Curie IEF contract FP6 - DonNA-R – 041465, and INCO-Dev project Kaladrug-R contract FP7-222895) and the Baillet–Latour Foundation. This work was also supported by the Wellcome Trust (WT061173MA-SM). The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001514","2012-02-28T00:00:00Z",222895
"630",630,"
         This work was supported by the EC project LeishNatDrug-R (programme INCO-Dev FP5: contract ICA4-CT-2001-10076), the EC project Kaladrug-R (programme INCO-Dev FP7: grant 222895), the Genome and Metabolome Initiative of the Institute of Tropical Medicine Antwerp (GeMInI, http://www.leishrisk.net/gemini/), FP6 Marie Curie Intra-European Fellowships (IEF) (contract DonNA-R-041465) and the Baillet-Latour Foundation for Saskia Decuypere, a Netherlands Organisation for Scientific Research (NWO)-Vidi grant for RB, an NWO-Vici grant to Ritsert Jansen (University of Groningen) for RAS, and a Research Foundation Flanders Grant for a long stay in Glasgow for RtK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0000904","2010-11-30T00:00:00Z",222895
"636",636,"This research was funded by the EC-INCO-Dev project LeishNatDrug-R (contract ICA4-CT-2001–10076), the FWO Flanders (contract G.0103.06 and 1.5.147.09) and the EC-FP7 project Kaladrug-R (contract 222895). Manu Vanaerschot has a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT) and Saskia Decuypere has a grant from the Baillet-Latour Foundation. (EC: http://cordis.europa.eu/home_en.html, FWO Flanders: http://www.fwo.be/, IWT: http://www.iwt.be/, Baillet-Latour Foundation: http://www.inbevbailletlatour.com/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012211","2010-08-17T00:00:00Z",222895
"121",121,"
        This work was financially supported by the Swedish Research Council, SNISS, SciLifeLab, Knut & Alice Wallenberg Foundation, and European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 222913. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021910","2011-07-07T00:00:00Z",222913
"139",139,"
        The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007–2013] under grant agreement n° 222916. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027704","2011-11-16T00:00:00Z",222916
"219",219,"This work was supported by the Agence Nationale pour la Recherche (French National agency for Research, ANR-08-MNPS-037-01 - SynGen) and European Commission (contract number 222918 - REPLACES - FP7 - Thematic priority HEALTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0009755","2010-03-18T00:00:00Z",222918
"445",445,"
        This work was supported by grants from: European Community (EC) contract number 222918 (REPLACES) FP7 - Thematic priority HEALTH (PC), Italian Ministery of Health “Progetto Strategico 2007” (PC, BP), Italian Ministery of Health “Progetti Finalizzati 2006-2008” (PC, BP), Fondazione Cassa di Risparmio di Perugia (PC) and Progetti Finalizzati Multicentrici Programma Neuroscienze Compagnia di San Paolo (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038312","2012-06-08T00:00:00Z",222918
"7",7,"
        This research was funded by grants of the General Secretariat for Research and Technology, Greek Ministry of Development (Greece-USA grant No 052) and the European Union (FP7/2007-2013, grant agreement No FP7-222927) to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015428","2010-11-03T00:00:00Z",222927
"250",250,"This work was supported by grants from the General Secretariat of Science and Technology, Greek Ministry of Development to K.I. (grant number GR-USA 052); the National Institute of Health (NIAID grant 2R01AI051485-06A1 to H.B. and grant R56AI051485 to H.B. and M.F.W.); the Director's Initiative Fund, UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) to P.M.G.; the European Community's Seventh Framework Programme (FP7/2007-2013 to K.I., P.M.G., E.E. and D.F.W. under grant agreement FP7-222927). The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.","10.1371/journal.pone.0009471","2010-03-01T00:00:00Z",222927
"66",66,"
        This work was supported by Instituto Salud Carlos III (PI081162)(MC);
                    Agència de Gestió d'Ajuts Universitaris i de Recerca
                    (SGR-2009-1300)(MC); the Association Française contre les Myopathies
                    (AFM#12277) (MC); BrainCAV an EC-FP7 project (FP7-222992)(AB); CAV-4-MPS an
                    E-Rare project (ISCIII PS09/02674)(AB); and NIH AI041636 (PH). RA was a
                    recipient of a FI-Generalitat fellowship #2003-0367. The funders had no role in
                    study design, data collection and analysis, decision to publish, or preparation
                    of the manuscript.
      ","10.1371/journal.pone.0019564","2011-05-18T00:00:00Z",222992
"69",69,"This work was supported by Cancer Research UK (GS and SS), the Motor Neurone Disease Association and the Jean Coubrough Charitable Trust (LB), the Association Française contre les Myopathies (EJK), Vaincre les Maladies Lysosomales (EJK), the Region Languedoc Roussilon (EJK) and BrainCAV, an EC-FP7 project (FP7-222992). EJK, SS and AK are Inserm fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1000442","2009-05-22T00:00:00Z",222992
"87",87,"This research was supported by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (project CoReNe) and by the European Union (mdDANEURODEV FP7-Health-2007-B-222999, and EuTRACC LSHG-CT-2006-037445) (WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000569","2009-11-20T00:00:00Z",222999
"180",180,"
        The research leading to these results has received funding from the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant agreement n° HEALTH-F2-2009-223004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038240","2012-05-30T00:00:00Z",223004
"92",92,"
        The work was funded by the University of Bath Overseas Research Studentship. LDH is a Royal Society Wolfson Research Merit Award Holder. EJF is funded by the TROCAR consortium (EU FP7-HEALTH #223031), http://www.trocarproject.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002283","2011-09-15T00:00:00Z",223031
"150",150,"
        SCR and EF are funded by the TROCAR consortium (EU FP7-HEALTH #223031). http://www.trocarproject.eu/ The Sanger Institute is core funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002129","2011-07-14T00:00:00Z",223031
"52",52,"
        This study was funded by the European Community’s Seventh Framework Programme (FP7) under agreement 223034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036578","2012-05-09T00:00:00Z",223034
"94",94,"
        This study was supported by the European Community's Seventh Framework Programme [FP7] under grant agreement No. 223034 (fellowship and disposal), the “Fonds Emile Defay 2007” (disposal, ULB) and the “Fondation Van Buuren 2007” (equipment, ULB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001216","2011-06-28T00:00:00Z",223034
"192",192,"
        This work was supported by the BBSRC (http://www.bbsrc.ac.uk/), the Wellcome Trust (http://www.wellcome.ac.uk/) and the European Union Seventh Framework Programme (http://cordis.europa.eu/fp7) grant 223034 (“ChagasEpiNet”). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001363","2011-10-11T00:00:00Z",223034
"48",48,"
        This work was supported by EU FP7 grants EVIMalaR (contract 242095), PITN InterMalTraining (contract 215281) and MALSIG (contract 223044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031567","2012-02-21T00:00:00Z",223044
"465",465,"
        This work was supported by the UK Medical Research Council (U117532063) and Cancer Research UK. AO was in receipt of a Fellowship from the Cenci Bolognetti Foundation, and support from the European Union FP7 programme MALSIG (223044). The study is part of the activities of the BioMalPar European Network of Excellence supported by grant LSHP-CT-2004-503578 from the Priority 1 ""Life Sciences, Genomics and Biotechnology for Health"" in the 6th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002448","2011-12-15T00:00:00Z",223044
"667",667,"
        MB and SS are honorary research staff at UCL, funded by Legal & General Assurance Society Limited (L&G) as part of its wider research collaboration with UCL on longevity research. RR and SC are supported by the Higher Education Funding Council and RR is partly funded by the National Institute for Health Research University College London Hospital/University College London Comprehensive Biomedical Research Centre. MOF is partly funded by the UK Medical Research Council and by European Community's Seventh Framework Programme (FP7/2007–2013) grant agreement n°223075 – the MedCHAMPS project. NH is funded by the NHS and HL by L&G. The IMPACTSEC team had access to all data sources and has the responsibility for the contents of the report and the decision to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pmed.1001237","2012-06-12T00:00:00Z",223075
"88",88,"PA acknowledges the financial support received from the Spanish Ministerio de Innovación y Ciencia through the grants BIO2007-62426 and PSS-010000-2009, and the European Commission under FP7 Grant Agreement 223101(AntiPathoGN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000789","2010-05-20T00:00:00Z",223101
"156",156,"
        This work was partially supported by the Spanish Ministerio de Ciencia e Innovación (PSE-010000-2009-1; BIO2010-22073) and the European Commission under FP7 Grant Agreement 223101 (AntiPathoGN). RAP is a recipient of the Spanish FPU fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031220","2012-02-21T00:00:00Z",223101
"259",259,"PA acknowledges the financial support received from the Spanish Ministerio de Educación y Ciencia through the grants PSE-010000-2007-1 and BIO2007-62426 and the European Commission under FP6 contract LSHG-CT-2005-512028 (3D-Repertoire) and FP7 Grant Agreement 223101(AntiPathoGN). JF-R acknowledges financial support from Spanish Ministerio de Educación y Ciencia grant BIO2008-02882. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000490","2009-08-28T00:00:00Z",223101
"654",654,"
                This study was supported by grants from Spanish ministries (BIO2006-02668,
                    BFU2006-09593, BIO2009-XXXXX, PSE-010000-2007-1, and CONSOLIDER-INGENIO 2010
                    Project “La Factoría de
                    Cristalización” (CSD2006-00015)) and by grant 2005SGR00280
                    from the Generalitat de Catalunya. Additional funding was obtained from grants
                    N401 029 32/0742 and 1642/B/P01/2008/35 from the Department of Scientific
                    Research, Polish Ministry of Science and Higher Education; from US National
                    Institutes of Health grant DE 09761; and from the European Union through EU FP6
                    Strep Project LSHG-2006-018830 “CAMP” and EU FP7
                    Collaborative Project 223101 “AntiPathoGN”. Further funding
                    was provided by ESRF (http://www.esrf.eu/) for data
                    collection. The funders had no role in study design, data collection and
                    analysis, decision to publish, or preparation of the manuscript.
            ","10.1371/journal.ppat.1000419","2009-05-08T00:00:00Z",223101
"382",382,"This work was funded by a Wellcome Trust senior fellowship (WT076608) to GJT, the Medical Research Council, the Department of Health, the National Institute for Health Research UCLH/UCL Comprehensive Biomedical Research Centre and the European Community's Seventh Framework Programme (FP7/2007-2013) under the project Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) grant agreement 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001062","2010-08-19T00:00:00Z",223131
"515",515,"
        This study was supported by Agence Nationale de Recherches Sur le sida et les hepatites virales (ANRS) (ANRS 12159). PB was supported by a fellowship from the European Community's Seventh Framework Program (FP7/2007–2013) under the “Collaborative HIV and Anti-HIV Drug Resistance Network” project (grant no. 223131). The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.
      ","10.1371/journal.pone.0026244","2011-10-19T00:00:00Z",223131
"549",549,"This work was funded by the French Ministry of Education and Research through the quadrennial contract of the EA2968 and by grant number AI18-3-01354 from Sidaction. The research leading to these results received funding from the European Community's Seventh Framework Program (FP7/2007–2013) under the project “Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)” - grant agreement no 223131. The authors also thank the Agence Nationale de Recherche sur le SIDA et les Hépatites virales (ANRS, France) and the Centre National de la Recherche Scientifique (CNRS, France) for support and funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0010311","2010-04-26T00:00:00Z",223131
"554",554,"The work was funded by DynaNets project (www.dynanets.org), a Future and Emerging Technologies (FET)-Open grant # 233847; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) project (http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/185_en.htm), Seventh Framework Programme (FP7 2007–2013), grant # 223131; NIH, NINDS GRANTR01 NS063897-01A2 (Feb 2009–Jan 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013619","2010-10-25T00:00:00Z",223131
"566",566,"
        This study was financed by Swiss National Science Foundation (SNF) grant 324700-120793 (to H.F.G. and K.J.M.), SNF grants 324730-130865 (to H.F.G.), and an unrestricted research grant from Gilead Sciences Switzerland. The research leading to these results has received further funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project “Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)” - grant agreement n° 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021734","2011-07-06T00:00:00Z",223131
"598",598,"
        Grants were obtained from the Swedish Research Council (grant no. K2008-56X-09935-17-3 and K2001-56X-0095-20-6); the Swedish International Development Cooperation Agency (grant no. SWE-2006-018); as well as the EU projects: SPREAD (QLK2-CT-2001-01344); EHR (LSHP-CT-2006-518211) and CHAIN (FP7/2007–2013) “Collaborative HIV and Anti-HIV Drug Resistance Network” grant agreement n° 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033484","2012-03-20T00:00:00Z",223131
"607",607,"
        This work was supported in the framework of the Swiss HIV Cohort Study, by the Swiss National Science Foundation (SNF grant #33CS30–134277). Further support was provided by SNF grant #3247B0–112594 (to HFG, SY and BL), SNF grant # 324730–130865 and the SHCS projects # 470, 528, 569, 683 the SHCS Research Foundation, the European Community’s Seventh Framework Programme (grant FP7/2007–2013), under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; grant 223131). VvW was supported by a fellowship of the Novartis Foundation (formerly Ciba-Geigy Jubilee Foundation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037983","2012-06-18T00:00:00Z",223131
"634",634,"
         M. Mild was funded by a post doctoral fellowship grant from The Swedish Research Council. The research leading to these results has received funding from the Swedish Research Council (grant no. 2007-1131-49460-36); Swedish International Development Cooperation Agency (grant no. SWE-2006-018), a non-commercial organization working according to directives of the Swedish Parliament and Government (http://www.sida.se/English/); Europe HIV Resistance (EHR) (LSHP-CT-2006-518211) and CHAIN (FP7/2007-2013) ˝Collaborative HIV and Anti-HIV Drug Resistance Network˝ grant agreement n° 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0011345","2010-07-07T00:00:00Z",223131
"644",644,"
        Mattias Mild was funded by a post doctoral fellowship grant from The Swedish Research Council. The research leading to these results has received funding from the Swedish Research Council (grant no. 2007-1131-49460-36); Swedish International Development Cooperation Agency (grant no. SWE-2006-018), a non-commercial organization working according to directives of the Swedish Parliament and Government (http://www.sida.se/English/); and the EU projects Europe HIV Resistance (EHR) (LSHP-CT-2006-518211) and CHAIN (FP7/2007-2013) “Collaborative HIV and Anti-HIV Drug Resistance Network” grant agreement n° 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022741","2011-07-25T00:00:00Z",223131
"647",647,"
        The United Kingdom HIV Drug Resistance Database is partly funded by the Department of Health; the views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Additional support is provided by Bristol-Myers Squibb, Gilead, Pfizer, and Tibotec (a division of Janssen-Cilag Ltd). Primary support for EuroSIDA is provided by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773), the 6th Framework (LSHP-CT-2006-018632) and the 7th Framework (FP7/2007-2013, EuroCoord n° 260694) programmes. Current support also includes unrestricted grants by Gilead, Pfizer, and Merck and Co.; The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). Additional funding provided to Deenan Pillay from the EU FP 7 CHAIN grant ( 223131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025665","2011-11-16T00:00:00Z",223131
"6571",657,"
        The project was funded by the Fondo de Investigación Sanitaria (FIS) (CP09/00279). JGP holds a Miguel Servet contract funded by “Fondo de Investigación Sanitaria” FIS-ISCIII. This study was supported by the Spanish AIDS network “Red Temática Cooperativa de Investigación en SIDA” (RD06/0006), the European Community's Seventh Framework Program (FP7/2007-2013) under the project “Collaborative HIV-1 and Anti-HIV-1 Drug Resistance Network (CHAIN)” grant agreement number 223131, and the “HIV Vacine Catalonian Program” (HIVACAT Program). FMC was supported by the Marie Curie European Reintegration Grant number 238885, ‘HIV-1 Coevolution’, and by the European Commission Framework 7 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032714","2012-02-29T00:00:00Z",223131
"659",659,"
        This study has been supported by the Swiss National Science Foundation (SNF grant #3247B0-112594 to HFG, SY, BL, #324730-120793 to HFG, #324730-130865 to HFG, and financed in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (SNF grant #33CS30-134277) and the SHCS projects #470, 528, 569, the SHCS Research Foundation, the European Community's Seventh Framework Programme (grant FP7/2007–2013), under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; grant 223131), and by a further research grant of the Union Bank of Switzerland, in the name of a donor to HFG, and an unrestricted research grant from Tibotec, Switzerland to HFG. Further support was provided by the Novartis Foundation, formerly Ciba-Geigy Jubilee Foundation and by a Swiss National Science Foundation Grant (PBEZP3-125726) to VvW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002413","2012-03-08T00:00:00Z",223131
"670",670,"This study has been financed in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (SNF # 33CSC0-108787). Further support was provided by the SNF grants # 3247B0-112594 (to HFG, SY, SB) and # 324730-130865 (to HFG), by the Union Bank of Switzerland in the name of a donor to H. Günthard, by an unrestricted research grant from Tibotec (Switzerland), by the SHCS research foundation and SHCS projects 470 and 528. VvW is supported by a fellowship of the Novartis Foundation, formerly Ciba-Geigy Jubilee Foundation. The research leading to these results has received further funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project ‘Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)’ - grant agreement # 223131. SB acknowledges support from the SNF (3100A0-116408). SA was funded by an ETH fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001123","2010-09-30T00:00:00Z",223131
"692",692,"
        This Study has been supported by the Swiss National Science Foundation (SNF grant # PA00P3_131498 to RDK, SNF grant # NF 3100A0-116408 to SB, SNF grant # 3247B0-112594 to HFG, SY, BL, # 324730-120793 to HFG, # 324730-130865 to HFG, and financed in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (SNF grant #33CS30-134277) and the SHCS projects # 470, 528, 569, the SHCS Research Foundation, the European Community's Seventh Framework Programme (grant FP7/2007–2013), under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; grant 223131), and by a further research grant of the Union Bank of Switzerland, in the name of a donor to HFG, and an unrestricted research grant from Tibotec, Switzerland to HFG. Further support was provided by the Novartis Foundation, formerly Ciba-Geigy Jubilee Foundation and by a Swiss National Science Foundation Grant (PBEZP3-125726) to VvW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002321","2011-11-03T00:00:00Z",223131
"44",44,"
        This work was funded by European Commission FP7 program grant “INFLA-CARE” (EC contract number 223151) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025942","2011-10-14T00:00:00Z",223151
"537",537,"
        This work was supported by European Commission FP7 Grant RETICIRC HEALTH-F2-2009-223156 (coordinator: MK) to MK and Dr. R. Weiler. The tilling mutant was generated via a NWO grant to Drs F. van Eeden, R. Plasterk, and D. Zivkovic and a grant by the European Commission LSHG-CT-2003-503496. MK was supported by ALW-NWO, FOM. and ZonMW-NWO. CRS was supported by NWO VENI #916.66.079. GZ was supported in part by SFB 509 “Neurovision.” DGM was supported by NEI grant R01 EY09256 and by the Vanderbilt Vision Research Core P30 EY008126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pbio.1001107","2011-07-19T00:00:00Z",223156
"716",716,"
        This work was funded by the Spanish Ministries of Health, and Science ane Innovation (CB07/02/2005; FIS 08/1120, 08/1359, 08/1635, and 09/02483; RTICCC RD06/0020/1060 and RD06/0020/0028; Transversal Action Against Cancer; the Spanish Biomedical Research Centre Networks for Epidemiology and Public Health, and Rare Diseases; and the “Ramón y Cajal” Young Investigator Program), the Spanish National Society of Medical Oncology (2010), the Spanish Association Against Cancer (AECC 2010), the AGAUR Catalan Government Agency (2009SGR1489 and 2009SGR293; and the Beatriu Pinós Postdoctoral Program), the Ramón Areces Foundation (XV), the “Roses Contra el Càncer” Foundation, the Michael Cuccione Foundation for Childhood Cancer Research, Cancer Research–UK (C490/A10119, C1287/A8874, C1287/A10118, C5047/A8385, and C8197/A10123), the National Institute for Health Research (UK), the Association for International Cancer Research (AICR-07-0454), the Ligue National Contre le Cancer (France), the Association “Le cancer du sein, parlons-en!”, the Dutch Cancer Society (NKI 1998–1854, 2004–3088, and 2007–3756), the Fondazione Italiana per la Ricerca sul Cancro (“Hereditary Tumors”), the Associazione Italiana per la Ricerca sul Cancro (4017), the Italian Ministero della Salute (RFPS-2006-3-340203 and “Progetto Tumori Femminili”), the Italian Ministero dell'Universita' e Ricerca (RBLAO3-BETH), the Fondazione IRCCS Istituto Nazionale Tumori (INT “5×1000”), the Fondazione Cassa di Risparmio di Pisa (Istituto Toscano Tumori), the National Breast Cancer Foundation (Australia), the Australian National Health and Medical Research Council (145684, 288704, and 454508), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, the Cancer Foundation of Western Australia, the German Cancer Aid (107054), the Center for Molecular Medicine Cologne (TV93), the National Cancer Institute (USA; CA128978 and CA122340), National Institutes of Health (RFA-CA-06-503, BCFR U01 CA69398, CA69417, CA69446, CA69467, CA69631, and CA69638), the Research Triangle Institute Informatics Support Center (RFP N02PC45022-46), the Specialized Program of Research Excellence (SPORE P50 CA83638 and CA113916), the Department of Defense Breast Cancer Research Program (05/0612), the Eileen Stein Jacoby Fund, the Breast Cancer Research Foundation, the Marianne and Robert MacDonald Foundation, the Komen Foundation, the Helsinki University Central Hospital Research Fund, the Academy of Finland (110663), the Finnish Cancer Society, the Sigrid Juselius Foundation, and the EU FP7 (223175, HEALTH-F2-2009-223175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pbio.1001199","2011-11-15T00:00:00Z",223175
"662",662,"
        This work was funded in Oxford by the Medical Research Council (81696), the European Foundation for the Study of Diabetes (Albert Renold Travel Fellowship awarded to LV), and the Wellcome Trust (095101/Z/10/Z). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement n°223211, CEED3. ALG is a Wellcome Trust Senior Fellow in Basic and Biomedical Science. This work was funded in Slovakia by the Slovak Diabetes Association and the Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic, and the Slovak Academy of Sciences VEGA2/0151/11. This publication is also the result of the project implementation TRANSENDOGEN/26240220051/supported by the Research & Development Operational Programme funded by the European Regional Development Fund ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034541","2012-04-06T00:00:00Z",223211
"203",203,"
        The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 223241, “AnoPopAge.” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001024","2011-04-26T00:00:00Z",223241
"238",238,"
        The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2007-B), Grant agreement no. 223254. The content of this article reflects only the authors’ views and the European Community is not liable for any use that may be made of the information contained therein. In the Netherlands, the ENERGY-project was additionally supported by a grant from the Netherlands Organization for Health Research and Development (Grant number 50-50150-98-002). The contribution of MvS was supported by a fellowship of the EMGO Institute for Health and Care Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034742","2012-04-25T00:00:00Z",223254
"283",283,"This work is supported by the Israeli Science Foundation, the Israeli Ministry of Science, through a grant from the National Gene Therapy Knowledge Center and through grants LSHB-CT-2004-512034 (MOLEDA), LSHB-CT-2005-018961 (INTHER) and the FP7 program LSHB-CT-2008- 223317 (LIV-ES). Additional support was provided through grants from Lille and Alfy Nathan, Barbara Fox Miller, the Horowitz and the Wolfson Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0003726","2008-11-18T00:00:00Z",223317
"287",287,"This work was supported by the Framework Program 7 (FP7) of the European Community, program Life Science Health B (LSHB-CT-2008- 223317, LIV-ES) and through grants from Lille and Alfy Nathan, Barbara Fox Miller and the Horowitz and the Wolfson Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0007511","2009-10-20T00:00:00Z",223317
"608",608,"
        This work is funded by European Commission FP7 Grant Agreement HEALTH-F2-2009-223323, “Pricing Policies and Control of Tobacco in Europe (PPACTE).” AG is supported by grant no. R01CA160695 from the National Cancer Institute and is a member of the UK Centre for Tobacco Control Studies (UKCTCS), a UK Centre for Public Health Excellence funded by the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Medical Research Council, and the National Institute of Health Research. KS is supported by an ESRC-MRC Postdoctoral Fellowship grant (grant no. PTA-037-27-0181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pmed.1001248","2012-06-26T00:00:00Z",223323
"275",275,"
        This work was supported by grants EU FP6 (EUROHEAD, LSHM-CT-2004-504837), EU FP7 (EUROVISION - n. 223326 and PLASTICISE - n. 223524), Telethon Foundation-Italy (GGP06234), Italian Ministry of University and Research (PRIN2007), University of Padova (Strategic Project: Physiopathology of signaling in neuronal tissue), Fondazione CA.RI.PA.RO., and IIT-Genova Seed Project EXTRAPLAST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002129","2011-06-23T00:00:00Z",223326
"423",423,"
        JPS and CNL were funded by a governmental non-commercial grant from AgentschapNL of the Ministry of Health, Welfare and Sports (VWS) to the NeuroBasic PharmaPhenomics Consortium. CNL was funded by an FP7 grant from the European Commission (number 223326, “EuroV1sion”) and an “Open Competition” grant from the Netherlands Organization for Scientific Research (NWO-ALW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035323","2012-04-23T00:00:00Z",223326
"309",309,"
        This work was supported by the UK government under BBSRC grant BB/E021182/1 to R.H.ff-C and N.R.W. and by the European Community Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 223328 (GAMEXP) to R.H.ff-C and N.W. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015693","2010-12-22T00:00:00Z",223328
"458",458,"
         This study was co-supported by the Centre National de la Recherche Scientifique (CNRS), Institut de Recherche pour le Développement (IRD), Centre de cooperation internationale en recherche agronomique pour le developpement (CIRAD), Institut National de la Sante Et de la Recherche Medicale (INSERM) and by EU (RAPSODI project, FP7), grant N°223341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0013518","2010-10-20T00:00:00Z",223341
"89",89,"This work was funded by the European Commission (FP6-2005-NEST-PATH, No. 043241 - ComplexDis and FP7-2008, No 223367- MultiMod) and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1001032","2010-12-16T00:00:00Z",223367
"370",370,"
        Funding provided by the Center of Excellence grant from the Swedish Foundation for Strategic Research grant number A3 02:094, The Swedish Research Council grant number K2010-65X-21408-01-3, The Swedish heart-Lung Foundation grant number 20080850, The Juvenile Diabetes Research Foundation grant number 529-2005-8327 and the European Comission FP7 Grant 223372 CardioCell Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027500","2011-11-28T00:00:00Z",223372
"645",645,"
        This work was funded by a program grant to Dr. Shaw from the Wellcome Trust (http://www.wellcome.ac.uk/), an NC3Rs project grant (http://www.nc3rs.org.uk/) to Dr. Grierson, Dr. Mead, Dr. Azzouz and Dr. Sharp, an EPSRC/BBSRC collaborative project grant (EP/G062137/1, http://www.epsrc.ac.uk/) to Dr. Battaglia, Dr. Mead, Dr. Azzouz and Dr. Shaw, and by the European Union under the 7th Framework Program for RTD (http://cordis.europa.eu/fp7/home_en.html) - Project MitoTarget - Grant Agreement HEALTH-F2-2008-223388 awarded to Dr. Shaw, Dr. Grierson, Dr. Sunyach and Dr. Pettmann and the Moody Trust (Dr. Kasher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023244","2011-08-18T00:00:00Z",223388
"301",301,"The work published in this manuscript was supported through the Dutch Organisation for Scientific Research (VICI grant), the Centre for Medical Systems Biology (CMSB) within the framework of the Netherlands Genomics Initiative (NGI), the Dutch Arthritis Association (Reumafonds grant) and the European Union-funded FP7-integrated project Masterswitch no. 223404. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.","10.1371/journal.pone.0013173","2010-10-05T00:00:00Z",223404
"350",350,"
        This work was funded by (1) The Wellcome Trust: http://www.wellcome.ac.uk/ (2) Arthritis Research UK: http://www.arthritisresearchuk.org/ (3) The European Community's Seventh Framework Programme FP7 under grant agreement no. HEALTH-F2-2008-223404 (http://www.Masterswitchproject.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024504","2011-09-06T00:00:00Z",223404
"420",420,"
        The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7 under grant agreement no. HEALTH-F2-2008-223404 (Masterswitch). This study is a publication of the Joint and Bone Center – Center for musculoskeletal research of the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035194","2012-04-18T00:00:00Z",223404
"682",682,"
        RMP was supported by grants from the NIH (R01-AR057108, R01-AR056768, U01-GM092691) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. SR is supported by an NIH Career Development Award (1K08AR055688-01A1). FK is supported by a Marie Curie International Outgoing Fellowship for Career Development from the European Community's FP7 (Grant Agreement number PIOF-GA-2009-237280). The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The work presented is made possible by grants from the Coeliac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative, and partially funded by the Dutch Government (BSIK03009 to CW) and by the Netherlands Organisation for Scientific Research (NWO, VICI grant 918.66.620 to CW). LF received a Horizon Breakthrough grant from the Netherlands Genomics Initiative (93519031) and a VENI grant from NWO (ZonMW grant 916.10.135). AZ received a Rubicon grant from NWO (825.10.002). GT received a Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences (KNAW). RMcM is supported by a Science Foundation Ireland Grant 09/IN.1/B2640. KAS is supported by a Canada Research Chair, Sherman Family Chair in Genomic Medicine, CIHR grants MOP79321 and IIN84042, and ORF grant RE01061. This work is partly supported by Coordination Theme 1 (Health) of the European Community's FP7, Grant Agreement number HEALTH-F2-2008-223404 (MASTERSWITCH project); by the EU FP6 supported AutoCure; and by the intramural program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002004","2011-02-24T00:00:00Z",223404
"263",263,"This work has been supported by funds provided by the Local Government Junta de Castilla y León (JCyL, ref. project: CSI07A09), by the Spanish Ministry of Science and Innovation (MICINN - ISCiii, ref. projects: PI061153 and PS09/00843) and by the European Commission Research Grant PSIMEx (ref. FP7-HEALTH-2007-223411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000807","2010-06-24T00:00:00Z",223411
"389",389,"
        This study was supported by funds from the National Institutes of Health grants DE019085 (R.S.), GM092829 (D.J.L) and GM071909 (L.S.)), the Burroughs Wellcome Fund (R.S.), the Ralph W. and Grace M. Showalter Research Trust (D.J.L.) and the European Commission contract FP7-HEALTH-2007-223411(L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002297","2011-10-20T00:00:00Z",223411
"496",496,"
        This study was supported by the National Institutes of Health/National Institute on Deafness and Other Communication Disorders Grant R01DC004295 to BS (http://www.nidcd.nih.gov/Pages/default.aspx). SO is supported by the European Commission under PSIMEx, contract number FP7-HEALTH-2007-223411 http://www.psimex.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028532","2011-12-09T00:00:00Z",223411
"619",619,"
        Dr. De Las Rivas receives financial support provided by EU FP7-HEALTH-2007-B (project 223411), by Spanish Ministry of Science and Innovation MICINN-ISCiii (projects PI061153 and PS09/00843), and by the Regional Government, Junta de Castilla y Leon JCyL (project CSI07A09). Dr. Pascual-Montano receives financial support provided by MICINN grant BIO2010-17527. Dr. Nogales-Cadenas thanks the Juan de la Cierva Program (MICINN-JDC 2010) and Dr. Fontanillo thanks the CSIC JAE-PREDOC Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024289","2011-09-16T00:00:00Z",223411
"635",635,"Work done at the Instituto de Tecnologia Química e Biológica was funded by an ITQB start-up grant, and by the Fundação para a Ciência e Tecnologia (FCT) through a Ciência2007 fellowship and project grant PTDC/BIA-MIC/098637/2008 (to DJS). Work done in the Sir William Dunn School of Pathology was supported by a BBSRC grant to Jeff Errington. Work done at VU University Amsterdam was supported by European Framework Program DIVINOCELL HEALTH-F3-2009-223431 (to JL) and a VENI grant from the Netherlands Organisation for Scientific Research (to DJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders' websites: FCT (http://alfa.fct.mctes.pt/), BBSRC (http://www.bbsrc.ac.uk/), EU (http://cordis.europa.eu/fp7/home_en.html), NWO (www.nwo.nl).","10.1371/journal.pone.0012048","2010-08-11T00:00:00Z",223431
"279",279,"
        This work was conducted as part of the MITIN project and partially funded by the European Commission under the 7th Framework Programme (Grant no. HEALTH-F4-2008-223450) (http://cordis.europa.eu/fp7/home_en.html). BPC was supported by a Diabetes UK grant to SM (grant number 06/0003416) (http://www.diabetes.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002478","2012-01-19T00:00:00Z",223450
"47",47,"
        This work was funded by the Seventh Framework Program of the European Commission (FP7/2007-2013) under grant agreement no 223461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031133","2012-02-16T00:00:00Z",223461
"127",127,"
        This research has been funded by the Wellcome Trust (grant no. 082596 and 083481) and European Commission Seventh Framework Programme (FP7/2007-2013, AEROPATH grant no. 223461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024158","2011-09-15T00:00:00Z",223461
"9",9,"
        This work was supported by the German Ministry of Education (project code SARS II 01KI1005A) and grants from the European Commission (contracts FP7-EVA number 228292 and FP7-EMPERIE number 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028131","2011-11-30T00:00:00Z",223498
"166",166,"
        This work was funded by the European Community's Seventh Framework Programme (FP7/2007–2013) under the project “European Management Platform for Emerging and Re-emerging Infectious Disease Entities” European Commission grant agreement no. 223498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034961","2012-04-04T00:00:00Z",223498
"190",190,"
        GD, NB, SS and AM are funded by the Wellcome Trust. AP and PK are funded by the Wellcome Trust and part of this work is supported by funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under the project EMPERIE, EC grant agreement number 223498'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028879","2011-12-21T00:00:00Z",223498
"240",240,"The authors acknowledge support from the Bill & Melinda Gates Foundation (MDVK, CF, NMF); Royal Society (CF); Medical Research Council (MDVK, CF, PJW, NMF); EU FP7 programme (NMF); UK Health Protection Agency (PJW); US National Institutes of Health Models of Infectious Disease Agent Study program through cooperative agreement 1U54GM088588 (ML); NIH Director's Pioneer Award, DP1-OD000490-01 (DS); EU FP7 grant EMPERIE 223498 (DS); the Wellcome Trust (DS); 3R01TW008246-01S1 from Fogerty International Center and RAPIDD program from Fogerty International Center with the Science & Technology Directorate, Department of Homeland Security (SR); and the Institut de Veille Sanitaire Sanitaire funded by the French Ministry of Health (J-CD). The funders played no role in the decision to submit the article or in its preparation.","10.1371/journal.pmed.1000275","2010-06-01T00:00:00Z",223498
"312",312,"
        This study was supported by funding from the European Community's Seventh
                    Framework Programme (FP7/2007–2013) under the project EMPERIE, EC grant
                    agreement number 223498, European Community's Sixth Framework Programme
                    under the project GRACE, EC grant agreement number LSHM-CT-2005-518226 and VIDI
                    grant 016.066.318 from the Netherlands Organization for Scientific Research
                    (NWO). The funders had no role in study design, data collection and analysis,
                    decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016118","2011-01-24T00:00:00Z",223498
"3871",387,"
        This work was supported by grants from Ministry of Science and Innovation of Spain (BIO2007-60978, BIO2010-16705), U.S. National Institutes of Health (ARRA-W000151845), and the European Community’s Seventh Framework Programme (FP7/2007-2013) under the projects “EMPERIE” (EC Grant Agreement number 223498), and “PoRRSCon” (EC Grant Agreement number 245141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002090","2011-06-09T00:00:00Z",223498
"390",390,"
        This work was supported by grants from the Ministry of Science and Innovation of Spain (BIO2007-60978 and BIO2010-16705), the European Community's Seventh Framework Programme (FP7/2007-2013) under the project “EMPERIE” EC Grant Agreement number 223498, and U.S. National Institutes of Health (R56 AI079424-01A1 and 2PO1 AI060699). Marta L. DeDiego received a contract from the project “EMPERIE” EC Grant Agreement number 223498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002315","2011-10-20T00:00:00Z",223498
"400",400,"
        This work was funded by the Wellcome Trust of Great Britain and The South East Asian Infectious Diseases Clinical Research Network. AF was supported by the European Union FP7 project “European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE)” (no. 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031535","2012-02-20T00:00:00Z",223498
"519",519,"
        This project was supported by the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Germany (project no. FSI 1-1.1.2.) and by the European Union FP7 project “European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE)” (no. 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019075","2011-04-29T00:00:00Z",223498
"543",543,"
        This project was supported by the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (grants PHE-20 and 10090272), the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant AoE/M-12/06), the Harvard Center for Communicable Disease Dynamics from the US National Institutes of Health Models of Infectious Disease Agent Study program (grant 1 U54 GM088558), EMPERIE (EU FP7 grant 223498), and the National Institute of Allergy and Infectious Diseases, NIH (contract HHSN266200700005C; ADB No. N01-AI-70005). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.
      ","10.1371/journal.pmed.1001103","2011-10-04T00:00:00Z",223498
"577",577,"
        This work was supported by the Medical Research Centre [G0900950], Wellcome Trust [WT081703MA] and the European Community's Seventh Framework Programme [FP7/2007–2013] under the project EMPERIE, EC grant agreement number 223498. DPD is funded by the Medical Research Council Centre for Molecular Medical Virology [G07008], JB and ERG receive funding from the UCL/UCLH National Institute for Health Research Comprehensive Biomedical Research Centre. PK, ALP, SJW and IY-CL are funded by the Wellcome Trust Sanger Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027805","2011-11-18T00:00:00Z",223498
"675",675,"
        This study was supported by funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under the project EMPERIE, EC grant agreement number 223498, VIDI grant 016.066.318 from the Netherlands Organization for Scientific Research (NWO). Grants from the Arthur von Gwinner Foundation (Max Planck Society), the Boehringer Ingelheim Fonds for Basic Research in Medicine (BIF) and trust funds from the Smithsonian Tropical Reserarch Institute (STRI) contributed to field work in Panama. Work in Ghana was supported by grants from the German Ministry of Education and Research (BMBF) (01KIO701) and the German Research Foundation (DFG) (DR 772/3-1 KA 1241/18-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029140","2011-12-27T00:00:00Z",223498
"2751",275,"
        This work was supported by grants EU FP6 (EUROHEAD, LSHM-CT-2004-504837), EU FP7 (EUROVISION - n. 223326 and PLASTICISE - n. 223524), Telethon Foundation-Italy (GGP06234), Italian Ministry of University and Research (PRIN2007), University of Padova (Strategic Project: Physiopathology of signaling in neuronal tissue), Fondazione CA.RI.PA.RO., and IIT-Genova Seed Project EXTRAPLAST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002129","2011-06-23T00:00:00Z",223524
"303",303,"This work was funded by the Klaus Tschira Foundation http://www.klaus-tschira-stiftung.de/english/index.html, the Helmholtz Alliance for Systems Biology http://www.helmholtz.de/en/joint_initiative_for_innovation_and_research/initiating_and_networking/helmholtz_alliances/systems_biology/helmholtz_alliance_on_systems_biology/ and the European Community's Seventh Framework Programme (grant no. FP7-223539) http://www.phenoxigen.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013920","2010-11-10T00:00:00Z",223539
"394",394,"
        The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement No. HEALTH-F4-2008-223545. The research is also supported by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029218","2012-02-10T00:00:00Z",223545
"553",553,"Part of this work was performed when IU was a fellow of the Edmond J. Safra Bioinformatics Program at Tel-Aviv University. This research was supported in part by the “GENEPARK: GENomic Biomarkers for PARKinson's disease” project that is funded by the European Commission within its FP6 Programme (contract number EU-LSHB-CT-2006-037544) and by the Israeli Science Foundation (grant no. 802/08). RS was supported in part by the European Community's FP6 Programme (contract EU-LSHB-CT-2006- 0375 for the Genepark project) and FP7 Programme (grant HEALTH-F4-2009-223575 for the TRIREME project) and by the Israel Science Foundation (grant 802/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013367","2010-10-19T00:00:00Z",223575
"408",408,"
        The research leading to these results has received funding from the European Union′s Seventh Framework Programme (FP7/2007-2011) under grant agreements IDEAL (n° 259679) and MYOAGE (n° 223576) to CF, and Roberto and Cornelia Pallotti Legacy for cancer research to CF and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032678","2012-03-05T00:00:00Z",223576
"341",341,"
        This research has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 223585, the Medical Research Council (grant no. G0601176) and the Wellcome Trust (grant no. WT078131AIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023014","2011-08-18T00:00:00Z",223585
"253",253,"This work was supported by the Medical Research Council Career Development Award (Agreement ID: 78415, File Number: G0600062), EC FP7 Collaborative Project 223601 “Malvecblok,” Royal Society International Research Travel grant (Ref. 2007/R2-IJP), Biotechnology and Biological Sciences Research Council (Ref. BB/E021794/1), Biotechnology and Biological Sciences Research Council (grants SF19107, B19088 and BBF0083091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pbio.1000272","2009-12-22T00:00:00Z",223601
"439",439,"
        This work was supported by funds from the Institut de Recherche pour le Développement (IRD), the French Agence Nationale pour la Recherche (ANR-11-BSV7-009-01 grant “GIME” to IM), and has received funding from the European Community's Seventh Framework Programme (FP7) under grant agreements N° 242095 (EviMalaR, IM and EAL) and N° 223601 (MALVECBLOK, IM and EAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002742","2012-05-31T00:00:00Z",223601
"331",331,"
        The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007–2010) under grant agreement n° 223608 (SP, GU and JP). Also supported by grants from Institut Pasteur, Association pour la Recherche sur le Cancer (grant 3158 to SP and GU) and Centre National pour la Recherche Scientifique. VFN was supported by the Ministère de l' Education Nationale, de la Recherche et de la Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022200","2011-07-14T00:00:00Z",223608
"53",53,"
        This work was funded by European Commission (grant NABATIVI, EU-FP7-HEALTH-2007-B contract number 223670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036553","2012-05-10T00:00:00Z",223670
"74",74,"
        The study was supported by the European Commission (http://cordis.europa.eu/fp7/dc/index.cfm) (Grant NABATIVI, EU-FP7-HEALTH-2007-B, contract number 223670) and Italian Cystic Fibrosis Research Foundation (FFC#20/2011) (http://www.fibrosicisticaricerca.it/) with the contribution of the Delegazione FFC di Bergamo Villa d'Almè, Amici della Ricerca di Milano, Latteria Montello 70° compleanno nonno Armando. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035648","2012-04-25T00:00:00Z",223670
"384",384,"This work has been supported by the Marie Curie Reintegration grant (MERG-CT-2004-510584), Human Frontier Science Programme Fellowship (87/2005), Italian Cystic Fibrosis Research Foundation (FFC#8/2006), European Commission (NABATIVI-223670, EU-FP7-HEALTH-2007-B),  Fondazione Cariplo (2007.5725), and Canadian Institute for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001270","2011-02-03T00:00:00Z",223670
"13",13,"
        For this publication, the research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement FP7-223681. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032723","2012-03-28T00:00:00Z",223681
"451",451,"
        This work was supported by U.S. National Institutes of Health (NIH) grant AI067027 to D.G.R., European Community Seventh Framework Programme (FP7-223681), NIH Director's New Innovator Award Program (1DP2 OD006481-01), and NHLBI TB latency consortium (1-RO1-HL106788) to G.B.. D.F.T.V. was supported by a CAPES/Fulbright doctoral scholarship (Brazilian Ministry of Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002769","2012-06-21T00:00:00Z",223681
"399",399,"
        This work was supported by the European Union-FP7 Project EPILEPSIAE (Evolving Platform for Improving Living Expectation of Subjects Suffering from IctAl Events, Grant No 211713) and by contracts FIS2007-60133 (MCyT/FEDER, Spain) and AYA2010-22111-C03-02 (MICINN, Spain). VBS thanks Generalitat Valenciana for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030757","2012-02-17T00:00:00Z",211713
"419",419,"
        This work was partially supported by the European Union-FP7 Project EPILEPSIAE (Evolving Platform for Improving Living Expectation of Subjects Suffering from IctAl Events, Grant No 211713). Mario Valderrama thanks the University of Los Andes and the Administrative Department for Science, Technology and Innovation (COLCIENCIAS), Colombia, for financial support. Vicente Botella-Soler thanks Generalitat Valenciana for financial support. Vincent Navarro was supported by Contrat d'Interface INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033477","2012-04-04T00:00:00Z",211713
"62",62,"
        This work is supported by the European Commission under project grant FP7-214668 for ITALK: Integration and Transfer of Action and Language Knowledge in Robots. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038236","2012-06-13T00:00:00Z",214668
"1861",186,"
        The authors were supported by the European Projects VIACTORS (FP7-ICT-2007-3, contract N231554) and ITALK (ICT-214668) and by the Italian government through the IIT foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002183","2011-10-13T00:00:00Z",214668
"41",41,"
        This work was funded by EU project ChiRoPing (FP7-ICT-2007-1 STREP project 215370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020627","2011-06-17T00:00:00Z",215370
"76",76,"
        This research has been supported by EU-FP7 grant [LarKC, url: http://www.larkc.eu][FP7-215535]. Funding for study coordination, genotyping of replication studies and statistical analysis was provided by the United States National Cancer Institute (R01 CA092039 05) and the National Institute of Dental and Craniofacial Research (1R03DE020116). Support for the central Europe and ARCAGE genome-wide studies was provided by INCa (Institut National du Cancer, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036888","2012-05-25T00:00:00Z",215535
"45",45,"
        This work was supported by the EU FP7 ICT-215554 LIREC, the Hungarian Scientific Research Fund (K 84036) and the Bolyai Foundation of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030271","2012-01-17T00:00:00Z",215554
"488",488,"
        This work was supported by The European Union (FP7-ICT-2007 LIREC-215554), the ETOCOM Project (TÁMOP-4.2.2-08/1/KMR-2008-0007) through the Hungarian National Development Agency in the framework of Social Renewal Operative Programme supported by EU and co-financed by the European Social Fund, The Hungarian National Science Foundation (OTKA K82020), AKTION Österreich-Ungarn Foundation (No. 74öu3), and Royal Canin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015175","2010-12-15T00:00:00Z",215554
"12",12,"
        This work has been supported by European Union (EU) FP7 grant SIEMPRE (project number: 250026), awarded to L.F., and EU FP7 grant POETICON (project number: 215843) to L.F. and Y.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035757","2012-05-09T00:00:00Z",215843
"2511",251,"
         Our research, upon which this Primer is based, is supported by Human Frontier Science Program grant RG0043/2004-C, European Community FP7 grant BIOTACT (ICT-215910), Ministero per l'Istruzione, l'Università e la Ricerca grant 2006050482_003, Regione Friuli Venezia Giulia, and the Italian Institute of Technology. EA is the recipient of a Long-Term Fellowship from the Human Frontier Science Program.
      ","10.1371/journal.pbio.0060220","2008-08-26T00:00:00Z",215910
"211",211,"
        This work was supported by the Israel Science Foundation (Israel Academy of Sciences, Grant 348/09) and by the 7th EU project POCEMON (FP7-ICT-2007-216088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029228","2012-01-11T00:00:00Z",216088
"183",183,"
        This work was supported by the FP7 project ROSSI, Emergence of communication in RObots through Sensorimotor and Social Interaction, European Commission grant agreement no. 216125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0039629","2012-06-21T00:00:00Z",216125
"187",187,"
        Dr. Gianelli was supported by the EU funded project ROSSI (FP7-216125), Dr. Farnè and Dr. Salemme by INSERM and the DISCOS Marie Curie RTN. Dr. Jeannerod and Dr. Roy were supported by CNRS and the UCB Lyon 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025036","2011-09-23T00:00:00Z",216125
"300",300,"This work was supported by MUR (Ministry of University and Research) and the European Union FP7 (Seventh Framework Programme) project ROSSI (Emergence of Communication in RObots through Sensorimotor and Social Interaction) grant agreement number 216125. FF and VG were also supported by the EU grant DISCOS (Disorders and Coherence of the Embodied Self). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013126","2010-10-01T00:00:00Z",216125
"15",1,"
        This paper was written under partial support by the European Union project #FP7-237955 (FACETS-ITN), project #FP7-269921 (BrainScaleS), project #FP7-216593 (SECO), project #FP7-506778 (PASCAL2) and project #FP7-243914 (BRAIN-I-NETS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002211","2011-11-03T00:00:00Z",216593
"225",225,"This work was supported by a grant from Deutsche Forschungsgemeinschaft (NI 708/2-1), by the German Federal Ministry of Education and Research (BMBF) within the “Bernstein Focus: Neurotechnology”, through research grant 01GQ0840, Alexander von Humboldt Stiftung, and Hertie Stiftung. Additional partial support was obtained also from the Austrian Science Fund FWF # S9102-N13 and project # FP6-015879 (FACETS), project # FP7-216593 (SECO), and project # FP7-506778 (PASCAL2) of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pbio.1000260","2009-12-22T00:00:00Z",216593
"29",29,"
                Written under partial support by the Austrian Science Fund FWF, project #
                    P17229-N04, project # S9102-N04, as well as project # FP6-015879 (FACETS) and
                    project # FP7-216886 (PASCAL2) of the European Union.
            ","10.1371/journal.pcbi.1000180","2008-10-10T00:00:00Z",216886
"81",81,"This work was partly supported by the European Information and Communication Technologies (ICT) Programme Project FP7-224631 and 216886, by grants of the Deutsche Forschungsgemeinschaft (DFG) (MU 987/3-1) and Bundesministerium für Bildung und Forschung (BMBF) (FKZ 01IB001A, 01GQ0850) and by the FP7-ICT Programme of the European Community, under the PASCAL2 Network of Excellence, ICT-216886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0009813","2010-04-01T00:00:00Z",216886
"330",330,"
        The authors received an academic MOE software license from Chemical Computing Group Inc., Montreal, Canada. M.R. acknowledges partial support from DFG grant MU 987/4-2 and the FP7-ICT programme of the European Community under the PASCAL2 network of excellence, ICT-216886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021554","2011-07-27T00:00:00Z",216886
"261",261,"The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the NEUROCHEM grant agreement no. 216916, SYNTHETIC FORAGER grant agreement no. 217148, and under the IST FET Programme (IST-2001.33066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000701","2010-03-12T00:00:00Z",216916
"448",448,"
        The authors are members of a consolidated research group by the Generalitat de Catalunya (2009SGR-0753). This work has been partially funded by European Project NEUROCHEM: Biologically Inspired Computation for Chemical Sensing (FP7-216916), and Spanish projects SMART-IMS (TEC2011-26143) and BIOENCODE (TEC2011-26988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037809","2012-06-18T00:00:00Z",216916
"306",306,"
        This research was supported by European Union FP7-ICT-217077-EYESHOTS (http://www.eyeshots.it/), Ministero dell'Università e della Ricerca (www.miur.it), and Fondazione del Monte di Bologna e Ravenna, Italy (http://www.fondazionedelmonte.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015078","2010-11-29T00:00:00Z",217077
"342",342,"
        This work was supported by the European Union (FP7-ICT-217077-‘EYESHOTS’, www.eyeshots.it), Italian Ministry of Education, University and Research (MIUR,www.miur.it), Fondazione del Monte di Bologna e Ravenna, Italy (www.fondazionedelmonte.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023335","2011-08-17T00:00:00Z",217077
"30",30,"This work was supported by the EU research project Synthetic Forager, FP7 ICT-2007.2.1 #217148 (http://cordis.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000791","2010-05-20T00:00:00Z",217148
"35",35,"This work was supported by European Commission FP7-ICT-2007-1 (Grant Agreement Number 217148 (PK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0010377","2010-04-28T00:00:00Z",217148
"252",252,"This work was supported by Human Frontier Science Program grant RGP0127/2001, NWO-VICI grant 918.46.609, Senter Novem BSIK grant 03053 and EU grant FP7, #217148 to CMAP and grant MH046823 from the National Institute of Mental Health to BLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pbio.1000173","2009-08-18T00:00:00Z",217148
"2611",261,"The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the NEUROCHEM grant agreement no. 216916, SYNTHETIC FORAGER grant agreement no. 217148, and under the IST FET Programme (IST-2001.33066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000701","2010-03-12T00:00:00Z",217148
"86",8,"
        This work was supported by grants from the German Ministry for Education and Research (BMBF, “German Competence Network Multiple Sclerosis” (KKNMS), 01GI0920), EU FP7 (NETSIM (215820-2) and VPHOP (FP7-223865)). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023080","2011-08-05T00:00:00Z",223865
"2271",227,"
        This work was partly supported by grants from the German Ministry for Education and Research (BMBF, “German Competence Network Multiple Sclerosis” (KKNMS), 01GI0920), EU FP7 (NETSIM (215820-2) and VPHOP (FP7-223865)). The Cambridge CardioResource study was funded by the UK Medical Research Council/Wellcome Trust. Additional support was provided by NHS Blood and Transplant, National Institute for Health Research and British Heart Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michaela Schimpl and Martin Daumer are employees of Trium Analysis Online GmbH and contributed to all aspects of the study. No additional external funding was received for this study.
      ","10.1371/journal.pone.0023299","2011-08-10T00:00:00Z",223865
"319",319,"
        This work was supported in part by the European Commission under the projects “ACGT: Advancing Clinicogenomic Trials on Cancer” (FP6-2005-IST-026996, http://eu-acgt.org/) and “ContraCancrum: Clinically OrientedTranslationalCancerMultilevel Modeling” (FP7-ICT-2007-2-223979, http://contracancrum.eu/?q=node/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017594","2011-03-03T00:00:00Z",223979
"106",106,"This work was partially supported by the Future and Emerging Technologies programme (FP7-COSI-ICT) of the European Commission through the project QLectives (grant number 231200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013471","2010-10-27T00:00:00Z",231200
"265",265,"The research of AF and MM has been supported by the Netherlands Organization for Scientific Research, NWO (VIDI Grant 452-04-351). DH acknowledges partial financial support by the Future and Emerging Technologies program FP7-COSI-ICT of the European Commission through the project QLectives (grant no.: 231200) and by the ETH Competence Center ‘Coping with Crises in Complex Socio-Economic Systems’ (CCSS) through ETH Research Grant CH1-01 08-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000959","2010-10-21T00:00:00Z",231200
"298",298,"Partial support was provided by the Future and Emerging Technologies programme FP7-COSI-ICT of the European Commission through the project QLectives (grant no.: 231200) and the ETH Competence Center “Coping with Crises in Complex Socio-Economic Systems” (CCSS) through ETH Research Grant CH1-01 08-2 (Eidgenoessische Technische Hochschule/Swiss Federal Institute of Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012530","2010-10-12T00:00:00Z",231200
"322",322,"
        A.M., S.L. and D.H. were partially supported by the Future and Emerging
                    Technologies programme FP7-COSI-ICT of the European Commission through the
                    project QLectives (grant no.: 231200). Y.-H. E. and S. F. gratefully acknowledge
                    ICTeCollective, grant 238597 of the European Commission. The funders had no role
                    in study design, data collection and analysis, decision to publish, or
                    preparation of the manuscript. No additional external funding was received for
                    this study.
      ","10.1371/journal.pone.0018975","2011-05-04T00:00:00Z",231200
"555",555,"
        This work was partially supported by Ministerio de Ciencia e Innovación (Spain) through Grants MOSAICO (to C.P.R. and A.S.), FIS2009-13730-C02-02 (to A.A.), by Comunidad de Madrid (Spain) through Grant MODELICO-CM (to A.S.) and by Generalitat de Catalunya (Spain) through Grant 2009 SGR 838. S.L. was partially supported by the Future and Emerging Technologies programme FP7-COSI-ICT of the European Commission through project QLectives (grant no. 231200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015210","2010-12-09T00:00:00Z",231200
"43",43,"
        Funding was provided by FP7 E-FLUX (Evolutionary microfluidix), FET Open Contract no, 225167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023534","2011-08-26T00:00:00Z",225167
"274",274,"This work was supported by the Netherlands Organisation for Scientific Research (grant 813.04.003) and by the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 225167. DST is the incumbent of the Nella and Leo Benoziyo Professorial Chair and acknowledges a research grant from Meil de Botton Aynsley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1001321","2011-03-03T00:00:00Z",225167
"456",456,"
        This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de) within SFB 680 “Molecular Basis of Evolutionary Innovations” and by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant Agreement 225167 “e-FLUX.” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002783","2012-06-28T00:00:00Z",225167
"614",614,"
        Results have received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no. 225167 (project e-Flux). Support by the COST D27 action (prebiotic chemistry and early evolution) and COST CM0703 (systems chemistry) are also gratefully acknowledged. The views expressed in this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. Additional support was provided by the National Office for Research and Technology (NAP 2005/KCKHA005) and by the National Scientific Research Fund (OTKA 73047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021380","2011-07-19T00:00:00Z",225167
"5541",554,"The work was funded by DynaNets project (www.dynanets.org), a Future and Emerging Technologies (FET)-Open grant # 233847; Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) project (http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/185_en.htm), Seventh Framework Programme (FP7 2007–2013), grant # 223131; NIH, NINDS GRANTR01 NS063897-01A2 (Feb 2009–Jan 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013619","2010-10-25T00:00:00Z",233847
"4751",475,"
        This work was supported by grant BFU2008-00995/BMC from Ministerio de Ciencia e Innovación (MCINN, Spain), grant RD06/0008/1012 from Instituto de Salud Carlos III, and grant 248919/FP7-ICT-2009-4 from the European VII Framework Program. CG was the recipient of fellowships from Fondation pour la Recherche Médicale (SPE20080512320) and European Molecular Biology Organization (157-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002073","2011-05-19T00:00:00Z",248919
"542",542,"
        The work of JG, LQ, and EPCR is supported by the CNRS and the Institut Pasteur. Work in the FdlC laboratory was supported by grant BFU2008-00995/BMC from Ministerio de Ciencia e Innovación (MCINN, Spain), grant REIPI RD06/0008/1012 from Instituto de Salud Carlos III, and grant 248919/FP7 ICT-2009-4 from the European VII Framework Program. MPG-B was the recipient of a JAE-Doc postdoctoral contract from Consejo Superior de Investigaciones Científicas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002222","2011-08-18T00:00:00Z",248919
"609",609,"
        This work was partially supported by the research projects BFU2009-12895-C02-02 and FFI2011-25665 (Ministerio de Economía y Competitividad, Spain). KRM also acknowledges support by grant IT 505-10 (Gobierno Vasco, Spain). PAM acknowledges support by the Danish National Research Foundation and by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 249032. GP holds a FPU PhD scholarship (Ministerio de Educación, Cultura y Deporte, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0039480","2012-06-27T00:00:00Z",249032
"613",613,"Maik Hadorn was partly funded by the Swiss National Foundation Project 200020-118127: ‘Embryogenic Evolution: From Simulations to Robotic Applications’ (http://www.projectdb.snf.ch/WebForms/Frameset.aspx). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 249032 (http://cordis.europa.eu/fetch?CALLER=PROJ_ICT&ACTION=D&CAT=PROJ&RCN=92864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0009886","2010-03-26T00:00:00Z",249032
"200",200,"
        This study was supported by the following project: RECOGNITION: Relevance and Cognition for Self-Awareness in a Content-Centric Internet (257756), which is funded by the European Commission within the 7th Framework Programme (FP7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022220","2011-07-18T00:00:00Z",257756
"503",503,"
        CP was supported by Graduate Fellowship from King Abdullah University of Science and Technology. CP and XJ were supported by the National Science Foundation of China under Grant No. 61070069. PL was supported by the following project: RECOGNITION: Relevance and Cognition for Self-Awareness in a Content-Centric Internet (257756), which is funded by the European Commission within the 7th Framework Programme (FP7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034487","2012-04-18T00:00:00Z",257756
"398",398,"
        The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007- 2013) under grant agreements no. 269921(BrainScaleS) and no. 269459 (Coronet), from the Spanish Research Project SAF2010-16085 and from the CONSOLIDER-INGENIO 2010 Programme CSD2007-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030723","2012-02-16T00:00:00Z",269459
"16",1,"
        This paper was written under partial support by the European Union project #FP7-237955 (FACETS-ITN), project #FP7-269921 (BrainScaleS), project #FP7-216593 (SECO), project #FP7-506778 (PASCAL2) and project #FP7-243914 (BRAIN-I-NETS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002211","2011-11-03T00:00:00Z",269921
"21",2,"
        This paper was written under partial support by the European Union project FP7-243914 (BRAIN-I-NETS), project 269921 (BrainScaleS), project FP7-248311 (AMARSI) and project FP7-506778 (PASCAL2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002294","2011-12-15T00:00:00Z",269921
"831",83,"
        This project was supported by the Austrian Science Fund (FWF P20882-B09) to HR, the Austrian Academy for Sciences and the Karl-Franzens-University of Graz to ABL. MP has been supported by a Forschungskredit grant of the University of Zurich. Written under partial support by the European Union project # FP7-506778 (PASCAL2), project #FP7-243914 (BRAIN-I-NETS), and project #269921 (BrainScaleS) to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037354","2012-06-06T00:00:00Z",269921
"164",164,"
        The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007- 2013) under grant agreement no. 269921 (BrainScaleS). AL is supported by the Ramon y Cajal program from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032466","2012-03-16T00:00:00Z",269921
"270",270,"
        The research leading to these results has received funding in part from the European Union Seventh Framework Program (FP7/2007–2013) under grant agreement no. 269921 (BrainScaleS) and the Brain NRG Phase II, James S McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002198","2011-09-29T00:00:00Z",269921
"3981",398,"
        The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007- 2013) under grant agreements no. 269921(BrainScaleS) and no. 269459 (Coronet), from the Spanish Research Project SAF2010-16085 and from the CONSOLIDER-INGENIO 2010 Programme CSD2007-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030723","2012-02-16T00:00:00Z",269921
"4171",417,"
        The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreements HEALTH F2 2008 200728 (Brainsync) and no. 269921 (BrainScaleS), from the Spanish Research Project SAF2010-16085 and from the CONSOLIDER-INGENIO 2010 Programme CSD2007-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002395","2012-03-29T00:00:00Z",269921
"6841",684,"This work was supported by the European Commission (http://cordis.europa.eu/fp7) Diaprepp Health-F2-2008-202013, Etherpaths KBBE-grant n°222639, Synergy, FP7grant n° 270086; the Spanish Government and the European Union FEDER funds (http://ec.europa.eu/regional_policy/funds/feder/index_es.htm) SAF2008-00164 and Instituto de Salud Carlos III; Spanish Ministry of Science and Innovation & European Regional Development Fund (ERDF) “Una manera de hacer Europa” ISCIII-RTICC (RD06/0020/0046); Generalitat de Catalunya-AGAUR, (http://www.gencat.cat/) 2009SGR1308 and 2009 CTP 00026; Foundation Marato TV3-042010 (http://www.tv3.cat/marato/missio); the National Institutes of Health (http://www.nih.gov/)AG 20899 and U01 DK61058-01; and the Department of Defense W81XWH-06-1-0317. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1001115","2011-03-31T00:00:00Z",270086
"673",673,"
        This research project received funding from the European Union Seventh Framework Programme FP7/2007–2013 under grant agreement n° 270194, as part of the Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling (AirPROM) project (www.airprom.eu). It also received funding from the Västra Götaland Region Research Council, Sweden. The authors acknowledge the support of the European Respiratory Society, Fellowship STRTF fellowship n°81-2011, and the Federal Department of Economic Affairs Switzerland, Commission for Technology and Innovation (CTI), Innovation Promotion Agency (http://www.bbt.admin.ch/kti/), unrestricted educational grant no. 11661.1 PFLS-LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036083","2012-04-27T00:00:00Z",270194
"56",56,"
        Financial support came from EU's FP7 FET-Open to ICTeCollective project no. 238597 and OTKA grant no. 82333. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038869","2012-06-20T00:00:00Z",238597
"3221",322,"
        A.M., S.L. and D.H. were partially supported by the Future and Emerging
                    Technologies programme FP7-COSI-ICT of the European Commission through the
                    project QLectives (grant no.: 231200). Y.-H. E. and S. F. gratefully acknowledge
                    ICTeCollective, grant 238597 of the European Commission. The funders had no role
                    in study design, data collection and analysis, decision to publish, or
                    preparation of the manuscript. No additional external funding was received for
                    this study.
      ","10.1371/journal.pone.0018975","2011-05-04T00:00:00Z",238597
"514",514,"
        S.M.A. was funded by the Istituto Italiano di Tecnologia (IIT) SEED (Prot. Num. 21538) and the European FP7 grant Tango. The project Tango acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: 249858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016855","2011-02-11T00:00:00Z",249858
"337",337,"
        Funding (1): Niedersächsisch-Israelisches Gemeinschaftsvorhaben “Does the study of simple visual stimuli assess the primitives of natural vision” (Prof. König, Prof. Ahissar). Funding (2): Research Training Group “Adaptivity in Hybrid Cognitive Systems” of the Institute of Cognitive Science, University of Osnabrück. Funding (3): eSMCs (Extending Sensorimotor Contingencies to Cognition) project (FP7-ICT-2009-6, #270212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022614","2011-07-25T00:00:00Z",270212
"7161",716,"
        This work was funded by the Spanish Ministries of Health, and Science ane Innovation (CB07/02/2005; FIS 08/1120, 08/1359, 08/1635, and 09/02483; RTICCC RD06/0020/1060 and RD06/0020/0028; Transversal Action Against Cancer; the Spanish Biomedical Research Centre Networks for Epidemiology and Public Health, and Rare Diseases; and the “Ramón y Cajal” Young Investigator Program), the Spanish National Society of Medical Oncology (2010), the Spanish Association Against Cancer (AECC 2010), the AGAUR Catalan Government Agency (2009SGR1489 and 2009SGR293; and the Beatriu Pinós Postdoctoral Program), the Ramón Areces Foundation (XV), the “Roses Contra el Càncer” Foundation, the Michael Cuccione Foundation for Childhood Cancer Research, Cancer Research–UK (C490/A10119, C1287/A8874, C1287/A10118, C5047/A8385, and C8197/A10123), the National Institute for Health Research (UK), the Association for International Cancer Research (AICR-07-0454), the Ligue National Contre le Cancer (France), the Association “Le cancer du sein, parlons-en!”, the Dutch Cancer Society (NKI 1998–1854, 2004–3088, and 2007–3756), the Fondazione Italiana per la Ricerca sul Cancro (“Hereditary Tumors”), the Associazione Italiana per la Ricerca sul Cancro (4017), the Italian Ministero della Salute (RFPS-2006-3-340203 and “Progetto Tumori Femminili”), the Italian Ministero dell'Universita' e Ricerca (RBLAO3-BETH), the Fondazione IRCCS Istituto Nazionale Tumori (INT “5×1000”), the Fondazione Cassa di Risparmio di Pisa (Istituto Toscano Tumori), the National Breast Cancer Foundation (Australia), the Australian National Health and Medical Research Council (145684, 288704, and 454508), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, the Cancer Foundation of Western Australia, the German Cancer Aid (107054), the Center for Molecular Medicine Cologne (TV93), the National Cancer Institute (USA; CA128978 and CA122340), National Institutes of Health (RFA-CA-06-503, BCFR U01 CA69398, CA69417, CA69446, CA69467, CA69631, and CA69638), the Research Triangle Institute Informatics Support Center (RFP N02PC45022-46), the Specialized Program of Research Excellence (SPORE P50 CA83638 and CA113916), the Department of Defense Breast Cancer Research Program (05/0612), the Eileen Stein Jacoby Fund, the Breast Cancer Research Foundation, the Marianne and Robert MacDonald Foundation, the Komen Foundation, the Helsinki University Central Hospital Research Fund, the Academy of Finland (110663), the Finnish Cancer Society, the Sigrid Juselius Foundation, and the EU FP7 (223175, HEALTH-F2-2009-223175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pbio.1001199","2011-11-15T00:00:00Z",288704
"122",12,"
        This work has been supported by European Union (EU) FP7 grant SIEMPRE (project number: 250026), awarded to L.F., and EU FP7 grant POETICON (project number: 215843) to L.F. and Y.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035757","2012-05-09T00:00:00Z",250026
"126",126,"
        The authors acknowledge the support of the European Commission project CONTACT (grant agreement NEST-5010) and SIEMPRE (grant agreement number FP7-IST- 250026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024055","2011-09-01T00:00:00Z",250026
"468",468,"
        The authors acknowledge financial support from the ETH Competence Center “Coping with Crises in Complex Socio-Economic Systems” (CCSS) through ETH Research Grant CH1-01-08-2; the European Commission FP7 FET Open Project “FOC” No. 255987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025995","2011-10-26T00:00:00Z",255987
"235",235,"
        This work was supported by grant TIN2006-12860 from the Spanish Ministerio de Ciencia e Innovación), the Structural Funds of the European Regional Development Fund (ERDF), FP7-ICT-043338 (BACTOCOM), the FP7-ICT-265505 (CADMAD), the ATIGE-Genopole, and the Fondation pour la Recherche Medicale grants to AJ, and by grant BFU2009-06993 from the Spanish Ministerio de Ciencia e Innovación to SFE and ESPSOL Fundación Genoma España and EUSOL European Commission Contract number: FOOD-CT-2006-016214, to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002528","2012-06-07T00:00:00Z",265505
"10",10,"
        Funding was provided by EU FP7 project CRISIS, agreement no. 288501, homepage: http://cordis.europa.eu/fp7/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038924","2012-06-18T00:00:00Z",288501
"7252",725,"
        The AGES study has been funded by NIH contract N01-AG-1-2100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Amish study was supported by grants and contracts from the NIH including R01 AG18728 (Amish Longevity Study), R01 HL088119 (Amish Calcification Study), U01 GM074518-04 (PAPI Study), U01 HL072515-06 (HAPI Study), U01 HL084756 and NIH K12RR023250 (University of Maryland MCRDP), the University of Maryland General Clinical Research Center, grant M01 RR 16500, the Baltimore Veterans Administration Medical Center Geriatrics Research and Education Clinical Center, and the Paul Beeson Physician Faculty Scholars in Aging Program. The ASPS research reported in this article was funded by the Austrian Science Fund (FWF) grant number P20545-P05 and P13180. The Medical University of Graz supported the databank of the ASPS. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. A Köttgen and C Hundertmark were supported by the grant KO3598/2-1 (Emmy Noether Programme) of the German Research Foundation. The BLSA was supported in part by the Intramural Research Program of the NIH (National Institute on Aging). The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The ERF study was supported by grants from the Netherlands Organization for Scientific Research (NWO; Pioneergrant), Erasmus Medical Center, the Centre for Medical Systems Biology (CMSB), and the Netherlands Kidney Foundation. The Family Heart Study (FHS) work was supported in part by NIH grants 5R01HL08770003, 5R01HL08821502 (M Province) from the NHLBI and 5R01DK07568102, 5R01DK06833603 from the NIDDK (I Borecki). The Framingham Heart Study research reported in this paper was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The GENOA research was partially supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health R01 HL-87660. The Health Aging and Body Composition Study (Health ABC) was funded by the National Institutes of Aging. This research was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. The GWAS was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. For the KORA F3 and F4 studies, the genetic epidemiological work was funded by the NIH subcontract from the Children's Hospital, Boston, US, (HE Wichmann, IM Heid, prime grant 1 R01 DK075787-01A1), the German National Genome Research Net NGFN2 and NGFNplus (H.E.Wichmann 01GS0823; WK project A3, number 01GS0834), the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ, and by the Else Kröner-Fresenius-Stiftung (P48/08//A11/08; CA Böger, BK Krämer). The kidney parameter measurements in F3 were funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer) and the Regensburg University Medical Center, Germany; in F4 by the University of Ulm, Germany (W Koenig). Genome-wide genotyping costs in F3 and F4 was in part funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). De novo genotyping in F3 and F4 was funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). The KORA research platform and the MONICA Augsburg studies were initiated and financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, by the German Federal Ministry of Education and Research, and by the State of Bavaria. Genotyping was performed in the Genome Analysis Center (GAC) of the Helmholtz Zentrum München. The LINUX platform for computation was funded by the University of Regensburg for the Department of Epidemiology and Preventive Medicine at the Regensburg University Medical Center. The NHS/HPFS type 2 diabetes GWAS (U01HG004399) is a component of a collaborative project that includes 13 other GWAS (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033; National Institute of Dental and Craniofacial Research: U01DE018993, U01DE018903) funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI). Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Genotyping was performed at the Broad Institute of MIT and Harvard, with funding support from the NIH GEI (U01HG04424), and Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438) and the NIH contract “High-throughput genotyping for studying the genetic contributions to human disease” (HHSN268200782096C). Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). We thank the staff and participants of the NHS and HPFS for their dedication and commitment. The Korcula study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan and by Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302). The MICROS study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, the South Tyrolean Sparkasse Foundation, and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The Northern Swedish Population Health Study was supported by grants from the Swedish Natural Sciences Research Council, the European Union through the EUROSPAN project (contract no. LSHG-CT-2006-018947), the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). The NHS renal function and albuminuria work was supported by DK66574. Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). ORCADES was supported by the Chief Scientist Office of the Scottish Government, the Royal Society and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). DNA extractions were performed at the Wellcome Trust Clinical Research Facility in Edinburgh. The popgen study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the Ministry of Science, Commerce, and Transportation of the State of Schleswig-Holstein. The project has also received infrastructure support through the DFG excellence cluster “Inflammation  at Interfaces.” The Sorbs study was funded by grants from the German Research Council KFO-152 (to M Stumvoll) and the IFB (Integrated Research and Treatment Center) AdiposityDiseases (K7-37 to M Stumvoll and A Tönjes). We also thank Dr. Knut Krohn (Microarray Core Facility of the Interdisciplinary Centre for Clinical Research, University of Leipzig, Germany) for providing the genotyping platform. The research of Inga Prokopenko is funded in part through the European Community's
Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. R Mägi acknowledges financial support from the European Commission under a Marie Curie Intra-European Fellowship. For the Rotterdam Study-I and Rotterdam Study-II, the GWAS was funded by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The Erasmus Computing Grid, Rotterdam (The Netherlands) and the national German MediGRID and Services@MediGRID part of the German D-Grid were both funded by the German Bundesministerium fuer Forschung und Technology under grants #01 AK 803 A-H and # 01 IG 07015 G, for access to their grid resources. A Dehghan is supported by NWO grant (vici, 918-76-619). The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research net of the University of Greifswald, Germany, funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the ‘Center of Knowledge Interchange’ program of the Siemens AG. The Vis study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan; and Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302) and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The 3 City Study was supported by the National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Génotypage. The 3 City Study was performed as part of a collaboration between the Institut National de la Santé et de la Recherche Médicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthélabo. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM “Cohortes et collections de données biologiques” programme. Lille Génopôle received an unconditional grant from Eisai. The Blue Mountains Eye Study (BMES) has been supported by the Australian RADGAC grant (1992–94) and Australian National Health and Medical Research Council, Canberra Australia (Grant Nos: 974159, 211069, 991407, 457349). The GWAS studies of BMES population are supported by the Australian National Health and Medical Research Council (Grant Nos: 512423, 475604, 529912) and the Wellcome Trust, UK (2008), as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster, grant numbers 085475/B/08/Z and 085475/08/Z). EG Holliday and JJ Wang are funded by the Australian National Health and Medical Research Council Fellowship Schemes. The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). M Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The Cardiovascular Risk in Young Finns study (YFS) is supported by the Academy of Finland (grant no. 117797, 121584, and 126925), the Social Insurance Institution of Finland, University Hospital Medical funds to Tampere and Turku University Hospitals, and the Finnish Foundation of Cardiovascular Research. The Emil Aaaltonen Foundation (T Lehtimäki). EGCUT received support from FP7 grants ((201413 ENGAGE, 212111 BBMRI, 205419 ECOGENE, 245536 OPENGENE) and also received targeted financing from Estonian Government SF0180142s08 and from the European Union through the European Regional Development Fund, in the frame of Centre of Excellence in Genomics. The research of the FamHS-II was conducted in part using data and resources from the NHLBI Family Heart Study supported in part by NIH grant 5R01HL08770002. For the GoDARTs study, the Wellcome Trust provides support for Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection and the informatics support is provided by the Chief Scientist Office, and the Wellcome Trust funded Scottish Health Informatics Programme (SHIP). The INGI-Carlantino and INGI-FVG studies were supported by grants from Telethon, FVG region, and Fondo Trieste. The INGI-Cilento study was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano, and the Fondazione Banco di Napoli to M Ciullo. The INGI – Val Borbera Study was supported from Compagnia di San Paolo, Torino, Italy, the Cariplo Fundation, Milano, Italy, and Italian Ministry of Health Progetto Finalizzato 2007 and 2009. The JUPITER trial and the genotyping were supported by AstraZeneca. The Ogliastra Genetic Park (OGP) - Replication Study and OGP - Talana study were supported by grants from the Italian Ministry of Education, University, and Research (MIUR) no. 5571/DSPAR/2002 and (FIRB) D. M. no. 718/Ric/2005. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) trial was supported by an investigator initiated grant from Bristol-Myers Squibb, USA. The study was conducted, analyzed, and reported independently of the company. The SAPALDIA study was supported by the Swiss National Science Foundation (grants no 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the Federal Office for Forest, Environment, and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, and Zurich. The SAPHIR-study was partially supported by a grant from the Kamillo Eisner Stiftung to B Paulweber and by grants from the “Genomics of Lipid-associated Disorders – GOLD” of the “Austrian Genome Research Programme GEN-AU” to F Kronenberg. eQTL analysis: HJ Gierman received support from the AFAR/EMF postdoctoral fellowship and the Stanford Dean's postdoctoral fellowship. HE Wheeler and SK Kim were supported by grants from the NIA, NHGRI and NIGMS.
      ","10.1371/journal.pgen.1002584","2012-03-29T00:00:00Z",212111
"320",320,"
        This work was supported by the Netherlands Organization for Scientific Research (VICI grant #700.56.442 to AMJJB) and by the European Community (Integrated Project SPINE2-COMPLEX contract no. 032220 and FP7 e-Infrastructure grant, contract no. 213010 - e-NMR). The work was carried out under the HPC-EUROPA2 project (project number: 228398) with the support of the European Commission Capacities Area - Research Infrastructures Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017695","2011-03-25T00:00:00Z",213010
"469",469,"
        This work was partly supported by the Intramural Research Program of the NIH, NLM, NCBI, and by funds awarded to the EMBL-European Bioinformatics Institute by the European Commission under SLING, grant agreement number 226073 (Integrating Activity) within Research Infrastructures of the FP7 Capacities Specific Programme EMBL-EBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002245","2011-10-27T00:00:00Z",226073
"678",678,"
        YW was supported by the China Scholarship Council (CSC). WLL (Wenlian Lu) was jointly supported by the Marie Curie International Incoming Fellowship from the European Commission (FP7-PEOPLE-2011-IIF-302421), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 200921), the Shanghai Rising-Star Program (No. 11QA1400400), and the Shanghai Guidance of Science and Technology (SGST) (No. 09DZ2272900). WL (Wei Lin) was supported by the NSF of China (No. 10971035) and the Talent Programs (Nos. 10SG02, NCET-11-0109 and 11QH1400200). GL was supported by the Wellcome Trust. JF is a Royal Society Wolfson Research Merit Award holder, partially supported by a EU Grant BION, a UK EPSRC grant and National Centre for Mathematics and Interdisciplinary Sciences (NCMIS) in the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038402","2012-06-07T00:00:00Z",227290
"125",125,"
        This work was supported by the Italian FIRB PROTEOMICA MIUR contract RBRN07BMCT, and is part of the JRA2 of the Bio-Nuclear Magnetic Resonance project (European Commission's FP7, project number 261863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023561","2011-08-24T00:00:00Z",261863
"391",391,"
        This work was supported by funds from the Spanish Ministries of Science and Innovation (BIO2010–15683 and CSD2008–00013), EC FP7 BIO-NMR (contract 261863), the Generalitat de Catalunya (SGR2009–1352) and the Max Planck Society (to C.G.). T.N.C. gratefully acknowledges a doctoral fellowship by the Fundação para a Ciêancia e a Tecnologia (FCT). P.B was supported Ramón y Cajal contract that was partially financed by the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002380","2011-11-17T00:00:00Z",261863
"223",223,"
        This work was supported by Agence Nationale de la Recherche Miniclock F005466, EU FP7 ASSEMBLE (227799) and by a CNRS-Region Languedoc Roussillon doctoral fellowship to EBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028471","2011-12-12T00:00:00Z",227799
"91",9,"
        This work was supported by the German Ministry of Education (project code SARS II 01KI1005A) and grants from the European Commission (contracts FP7-EVA number 228292 and FP7-EMPERIE number 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028131","2011-11-30T00:00:00Z",228292
"63",63,"This study was supported by the German Ministry of Education and Research (Project Code “Oekologie und Pathogenese von SARS”), the European Commission (contracts SSPE-CT-2005-022639, FP7-INFRASTRUCTURES-2008-No 228292, and FP7 framework program EMPERIE) and the Bundesamt fuer Bevoelkerungsschutz und Katastrophenhilfe (contract BBK-F-440-00-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0006367","2009-07-28T00:00:00Z",228292
"101",101,"This study was partly funded by AP-HM Public Hospital system and by the FP7 European project n°228292 European Virus Archive (EVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0009215","2010-02-17T00:00:00Z",228292
"385",385,"
        This work was supported by BMRC grants (08/1/22/19/589) a CRP grant CRP4-2008-2 and an ATIP from the CNRS to the laboratory of JL. This work was also supported by the European Virus Archive (EVA) project (European FP7 Capacities Project no 228292, http://www.european-virus-archive.com/). TW is an investigator in the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002030","2011-05-12T00:00:00Z",228292
"424",424,"
        The current work was funded by Deutsche Forschungsgemeinschaft (Research Training Group 1121 and grant no. KR1293/9-1), European Commission (European Virus Archive, FP7 CAPACITIES project - GA n° 228292), Slovak Research and Development Agency (DO7RP-0008-09), and Slovak scientific grant agency VEGA (grant no. 2/0189/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035587","2012-04-24T00:00:00Z",228292
"525",525,"This work was supported by EU initially through the VIZIER integrated project (LSHG-CT-2004-511960) of the European Union 6th Framework, then the European Virus Archive (EVA) project (European FP7 Capacities Project no 228292, http://www.european-virus-archive.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pntd.0000936","2011-01-04T00:00:00Z",228292
"563",563,"
        The study was supported by grants INCO-DEV ICA4-CT2002-10050, 228292 (European Virus Archive), and Marie-Curie PIEF-GA-2009-235164 from the European Community (http://ec.europa.eu/research/fp6/index_en.cfm; http://ec.europa.eu/research/fp7/), and grant GU 883/1-1 from the German Research Foundation (DFG) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Department of Virology of the Bernhard-Nocht-Institute is a WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research (DEU-000115).
      ","10.1371/journal.pone.0020893","2011-06-09T00:00:00Z",228292
"655",655,"This work was supported by the European Community 7th framework program (“European Virus Archive”, grant number 228292, to S.G. and D.D.P.; http://cordis.europa.eu/fp7). D.M. was supported by the German Research Foundation (SFB TR43; http://www.dfg.de), A.B. held PhD fellowships from the Boehringer Ingelheim Fonds (http://www.bifonds.de) and from the Roche Research Foundation (www.research-foundation.org). The Bernhard-Nocht-Institute is supported by the Bundesministerium fuer Gesundheit and by the Freie und Hansestadt Hamburg. D.D.P. holds a stipendiary professorship (No. PP00A--114913/1) of the Swiss National Science Foundation (http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1000836","2010-03-26T00:00:00Z",228292
"681",681,"Toscana virus and H5N1 influenza endonuclease domains were produced as part of the European Virus Archive (EVA) project (European FP7 Capacities Project no 228292, http://www.european-virus-archive.com/). This work was supported in part by the VIZIER integrated project (LSHG-CT-2004-511960) of the European Union 6th Framework Programme (FP6), the Direction Générale de l'Armement (DGA 09cà402), the Fondation pour la Recherche Médicale (FRM-Aide aux équipes), the German Research Foundation grant GU 883/1-1, and a grant from the “Vereinigung der Freunde des Tropeninstituts Hamburg e.V.” to ML. JL was supported by grant 08/1/22/19/589 from BMRC and an ATIP from CNRS. We gratefully acknowledge the ID14-4 beamline staff and equipment at the European Syncrotron Radiation facility, Grenoble, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001038","2010-09-16T00:00:00Z",228292
"75",75,"
        This work was supported by an AIP Bioresources INRA grant. This work has received funding from the European Community's Seventh Framework Programme (FP7, 2007–2013), Research Infrastructures action, under grant agreement No. FP7-228310 (EMbaRC project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035842","2012-05-04T00:00:00Z",228310
"78",78,"
        This study was supported by project (SE0778) from the Department for Environment, Food and Rural Affairs of the United Kingdom. http://www.defra.gov.uk/. Pathological investigations were supported by the European Commission's Seventh Framework Programme (FP7/2007–2013) under grant agreement n° 228394 (NADIR) (http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029310","2012-01-03T00:00:00Z",228394
"133",133,"
        This work was partly carried out under the HPC-EUROPA2 project (project number 228398), with the support of the European Community – Research Infrastructure Action of the FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025375","2011-09-23T00:00:00Z",228398
"3201",320,"
        This work was supported by the Netherlands Organization for Scientific Research (VICI grant #700.56.442 to AMJJB) and by the European Community (Integrated Project SPINE2-COMPLEX contract no. 032220 and FP7 e-Infrastructure grant, contract no. 213010 - e-NMR). The work was carried out under the HPC-EUROPA2 project (project number: 228398) with the support of the European Commission Capacities Area - Research Infrastructures Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017695","2011-03-25T00:00:00Z",228398
"6",6,"This study was funded as part of the EU research infrastructures project INFRAVEC (FP7; 228421) and by Oxitec's core investment. The funding agencies (EU-FP7 and Oxitec's external financial investors) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pntd.0000788","2010-08-17T00:00:00Z",228421
"305",305,"
         This investigation received financial support from the Wellcome Trust (grant numbers 077593 and 069162), the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) and from the EU:FP7 Infrastructures Programme (grant number 228421). The CEPIA received financial support from Fonds Dedie Sanofi-Aventis/Ministere de la Recherche (Combattre les Maladies Parasitaires). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0014587","2011-01-25T00:00:00Z",228421
"447",447,"
        This work was supported by grants from the Spanish Ministerio de Ciencia e Innovation (BFU2007-63110/BFU2010-17794), from the European Community's Seventh Framework Programme (FP7/2007-2013)), under grant agreement KBBE-211691- ASFRISK, and by an institutional grant from the Fundación Ramón Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002754","2012-06-14T00:00:00Z",211691
"98",98,"This work was supported in part by grants from the NGFN, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung, Forschung, Wissenschaft und Technologie and the European Union (EU FP7 LipiDiDiet, Grant Agreement No 211696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0006779","2009-08-26T00:00:00Z",211696
"416",416,"
        The research leading to these results has received funding from the EU FP7 project LipiDiDiet, Grant Agreement No 211696 (TH), the Deutsche Forschungsgemeinschaft (TH), the Bundesministerium für Bildung, Forschung, Wissenschaft und Technologie via NGFNplus and Kompetenznetz degenerative Demenzen (TH), the HOMFOR 2008 (MG) and Homburger Forschungsförderungsprogramm 2009 (MG, TH) (Saarland University research grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034095","2012-03-28T00:00:00Z",211696
"171",171,"
        The research leading to these results has received funding from the European Union’s Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 211820 and the Teagasc Walsh Fellowship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033668","2012-05-04T00:00:00Z",211820
"198",198,"
        The research leading to these results has received funding from the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 211820 and the Teagasc Walsh Fellowship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036141","2012-05-04T00:00:00Z",211820
"516",516,"
        The research leading to these results received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211820 and the Teagasc Walsh Fellowship programme and independently of any commercial input, financial or otherwise. The authors have no financial or personal conflict of interest in regard to the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027177","2011-11-23T00:00:00Z",211820
"345",345,"
        This research was supported by grants from INRA (innovative project 2010) and the European Union: i) the provenance trial was set up in 2003 by the experimental unit at INRA Pierroton, as part of the TREESNIP-QLK3-CT2002-01973 project. ii) measurements of carbon isotope discrimination and cavitation resistance were funded by the NOVELTREE project (FP7-211868). J-BL was supported by a doctoral fellowship from INRA and the Auvergne Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023476","2011-08-12T00:00:00Z",211868
"508",508,"
         This research was supported by grants from Agence Nationale de la Recherche Génoplante (GenoQB project, GNP05013C) and Agence Nationale de la Recherche Plates-Formes Technologiques du Vivant (BOOST-SNP project, 07PFTV002), the Aquitaine Region (20061201004PFM) and the European Union (NOVELTREE project, FP7-211868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0011034","2010-06-09T00:00:00Z",211868
"371",371,"
        The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement n° KBBE-212399 (FishPopTrace). Financial support for GAII sequencing and SNP discovery was provided by the MerSnip project funded by the Joint Research Council (JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028008","2011-11-22T00:00:00Z",212399
"130",130,"
        This study was supported by grants from Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA MCINN; Project FAU 2006-00017-C03-01), EU FP7 Grant TB-STEP 212414, and Santander - Fundación Marcelino Botín, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024905","2011-09-14T00:00:00Z",212414
"545",545,"We greatly acknowledge support for this work from the National Natural Science Foundation of China (30730074 and 30525009), a French grant from the “Partenariat Hubert Curien of the programme de recherches avancees franco-chinois” (phc pra AHH610548C- INVACHINE ), and the EU projects ALARM GOCE-CT-2003-506675 (FP6 Integrated Project, Assessing large-scale environmental risks with tested methods; www.alarmproject.net [69]) and PRATIQUE KBBE-2007-212459 (FP7 Project, Enhancements of pest risk analysis techniques). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0004646","2009-02-27T00:00:00Z",212459
"666",666,"
        This work was supported financially in part by the “Kompetenznetz Adipositas” (“Competence Network Obesity”) funded by the German Federal Ministry of Education and Research (FKZ: 01GI0826) and by the Munich Center of Health Sciences (MCHEALTH). The LISAplus study was funded by grants of the Federal Ministry for Education, Science, Research and Technology (Grant No. 01 EG 9705/2 and 01EG9732) and the 6 years follow-up of the LISAplus study was partly funded by the Federal Ministry of Environment (IUF, FKS 20462296). BK is the recipient of a Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY, USA. The authors gratefully acknowledge partial financial support from the Commission of the European Communities, specific RTD Programme “Quality of Life and Management of Living Resources”, within the 7th Framework Programme NUTRIMENTHE, FP7-212652. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037780","2012-05-21T00:00:00Z",212652
"539",539,"Financial support was provided by grants BFU2006/06003/BMC and BFU2009-12895-C02-01/BMC (Ministerio de Ciencia e Innovación Spain) to A. Latorre and European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement number 212894 and Prometeo/2009/092 (Conselleria D'Educació, Generalitat Valenciana, Spain) to A. Moya. M. J. López-Sánchez and R. Patiño-Navarrete were recipients of a fellowship from Ministerio de Educación y Ciencia, Spain. A. Neef is supported by an Intra-European Marie Curie fellowship (LSHM-CT-2005_019023) from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1000721","2009-11-13T00:00:00Z",212894
"604",604,"
        The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 221948 (ICONZ). SACEMA receives core funding from the Department of Science and Technology, Government of South Africa. Financial support for this investigation was received from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) and DFiD Research into Use Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001615","2012-05-15T00:00:00Z",221948
"521",521,"
        This project was supported by grants from the United Kingdom Biotechnology and Biological Sciences Research Council (grant reference: BBSRC BB/F003498/1) and the European Union's 7th Framework Programme for Research and Technological Development (grant agreement no. 222625 METAEXPLORE, EU FP7 Theme KBBE-2007-3-3-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035756","2012-04-23T00:00:00Z",222625
"2391",239,"This work was supported by the European Commission (FP6, http://cordis.europa.eu/fp6/) BioBridge LSHG-CT-2006-037939, (FP7, http://cordis.europa.eu/fp7/) Diaprepp Health-F2-2008-202013, Etherpath KBBE-grant agreement n°222639; the Spanish Government and the European Union FEDER funds (http://ec.europa.eu/regional_policy/funds/feder/index_es.htm) SAF2008-00164 and ISCIII-RTICC (RD06/0020/0046); Generalitat de Catalunya, http://www.gencat.cat/ (2005SGR00204; 2006ITT-10007); Foundation Marato TV3-042010 (http://www.tv3.cat/marato/missio) and the National Institutes of Health (http://www.nih.gov/), AG 20899 and U01 DK61058-01; and the Department of Defense W81XWH-06-1-0317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000619","2009-12-24T00:00:00Z",222639
"536",536,"
                This work was supported by the EU-funded projects ETHERPATHS (FP7-KBBE-222639,
                        http://www.etherpaths.org/) and HEPADIP
                    (FP6-LSHM-CT-2005-018734, http://www.hepadip.org/),
                    the Centre of Excellence in Computational Nanoscience grant by the Academy of
                    Finland, Helsinki University Central Hospital grants, the Centre of Excellence
                    in Complex Disease Genetics grant by the Academy of Finland, and KHP by Jalmari
                    and Rauha Ahokas, Yrjö Jahnsson, Biomedicum Helsinki, and Novo Nordisk
                    Foundations. TVP is funded by BBSRC project and MRC programme grant. The funders
                    had no role in study design, data collection and analysis, decision to publish,
                    or preparation of the manuscript.
            ","10.1371/journal.pbio.1000623","2011-06-07T00:00:00Z",222639
"6842",684,"This work was supported by the European Commission (http://cordis.europa.eu/fp7) Diaprepp Health-F2-2008-202013, Etherpaths KBBE-grant n°222639, Synergy, FP7grant n° 270086; the Spanish Government and the European Union FEDER funds (http://ec.europa.eu/regional_policy/funds/feder/index_es.htm) SAF2008-00164 and Instituto de Salud Carlos III; Spanish Ministry of Science and Innovation & European Regional Development Fund (ERDF) “Una manera de hacer Europa” ISCIII-RTICC (RD06/0020/0046); Generalitat de Catalunya-AGAUR, (http://www.gencat.cat/) 2009SGR1308 and 2009 CTP 00026; Foundation Marato TV3-042010 (http://www.tv3.cat/marato/missio); the National Institutes of Health (http://www.nih.gov/)AG 20899 and U01 DK61058-01; and the Department of Defense W81XWH-06-1-0317. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1001115","2011-03-31T00:00:00Z",222639
"112",112,"
        This work was supported by an INRA - IFREMER PhD fellowship to TD. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 222719 - LIFECYCLE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015506","2010-11-11T00:00:00Z",222719
"152",152,"
        This work was funded by EUFP7/2007–2014 grant KBBE-2009-222883 (http://cordis.europa.eu/fp7/home_en.html); Biotechnology and Biological Sciences Research Council, United Kingdom, supported JDH and CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002507","2012-02-02T00:00:00Z",222883
"168",168,"
        Parts of this work have been supported by the FP6 Network of Excellence ENFIN (contract # LSHG-CT-2005-518254) and the FP7 Collaborative Project MICROME (grant agreement # 222886-2), both funded by the European Commission. The funders had no role in the preparation of the manuscript.
      ","10.1371/journal.pcbi.1002487","2012-04-26T00:00:00Z",222886
"181",181,"
        The funding for this project was provided by the CEA DSV International Doctoral Program and by a Collaborative Project called MICROME, which is supported by the European Commission within its FP7 Programme (Grant Agreement Number 222886-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002540","2012-05-31T00:00:00Z",222886
"561",561,"
        Xiaoli Xue was supported by a Chinese Academy of Science (CSC)-Helmholtz Joint Fellowship. IWD acknowledges the support of the German State Ministry for Research and Education (BMBF), grant FK 0315411A, and the support of the German Research Organisation (DFG) for the Special Research Program (SFB), grant DFG TRR 51. The research leading to the Phenotype Microarray (PM) results has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement number 222886-2 (Microme project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020075","2011-05-19T00:00:00Z",222886
"103",103,"The research leading to presented results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n. 222887 - the PRIORITY project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0011715","2010-07-22T00:00:00Z",222887
"158",158,"
        This study was funded with grant BFU2006-04588/BMC from the Spanish Ministry of Science and Education and grants FOOD-CT-2006-023183 (StrainBarrrier) and FP7 222887 (Priority) from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002547","2012-03-01T00:00:00Z",222887
"213",213,"
        This work was supported by European Union grants StrainBarrier FOOD-CT-2006-023183, ImmunoPrion FOOD-CT-2006-023144 and Priority FP7 222887, and Institute Strategic Grant funding from the Biotechnology and Biological Research Council (NAM). The funders have no role in study design, data collection and analysis, no decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002449","2011-12-22T00:00:00Z",222887
"299",299,"This work was supported by grants from the Ministerio de Educacion y Ciencia e Innovacion (SAF2006-00906, SAF2009-12249-C02-02 to J.J.G. and SAF2006-12782-C03-C01 and SAF2009-12249-C02-01 to F.W.) and EU-FP7-2009-CT222887; and by the Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED). M.T. is supported by a JAE fellowship from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012908","2010-09-23T00:00:00Z",222887
"481",481,"This study was supported by grants from MICINN, FISS, Generalitat de Catalunya (SGR2009-366), Junta de Andalucía (CVI-02487), Instituto Carlos III, UE CT2004-506579 and by FP7-EU program (PRIORITY-222887). RG and FLL are Juan de la Cierva researchers from MEC, and AR was supported by the Programme Alban, the European Union Programme of High Level Scholarships for Latin America (E04D034892VE) and the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0007592","2009-10-26T00:00:00Z",222887
"621",621,"
        This work was supported by grants from “Online"" Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED)(which was an initiative of the ISCIII); National Grants from “Direccion General"" of Science and Technology-DGCYT (references: SAF2009-12249-C02-01 to F.W. and SAF2009-12249-C02-02 to J.J.G.) and EU-FP7-2009-CT222887 to F.W.; and by an Institutional grant from the Areces Foundation. H.D. was supported by CSIC through the I3P program (co-funded by the European Social Fund) and by CIBERNED. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.
      ","10.1371/journal.pone.0032715","2012-04-11T00:00:00Z",222887
"232",232,"
        This research is supported by the Swedish Medical Research Council (K2007-54X-20328–013; K2009-67X-21128-01-3; K2010-55X-20328-04-3; K2010-54X-09894-19-3), European Union 6th and 7th Framework (LSHM-CT-2003–503041, FP7- HEALTH- 2009- 241592, FP7-KBBE-2009-3-245009); Novo Nordisk Fonden (GeA/AIR); ALF Göteborg (SU7601); Cancerfonden (090717); Polysackaridforskning AB (Uppsala); and the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research (A305-188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034313","2012-03-27T00:00:00Z",245009
"506",506,"
        This work was supported by the National Science Foundation of Hungary (OTKA K81226, K81845, K69127), the Medical Research Council (ETT Grant 02-121/2009) and the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 259772 and 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037860","2012-06-18T00:00:00Z",245009
"6981",698,"
        The authors acknowledge the research infrastructure provided by the Norwegian Microarray Consortium (NMC; www.microarray.no), a national FUGE technology platform (Functional Genomics in Norway; www.fuge.no). The present study has been supported by grants from the Research Council of Norway (incl. the FUGE program and “PSYKISK HELSE” program), Norwegian Council for Mental Health, Extrastiftelsen Helse og Rehabilitering (JF), Helse Vest RHF, Dr. Einar Martens Fund, European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements n° 245009 and 223713 (CD, ML and RN) and n° 018734 (AVP), Xunta de Galicia (ML: 10PXIB208164PR; RN: 2010/14)), Fondo Investigationes Sanitarias (ML: PS09/01880), Ministerio de Educacion y Ciencia (CD: BFU2008-02001; ML: RyC-2007-00211; RN: RyC-2008-02219 and SAF2009-07049;), Medical Research Council (AVP) and Welcome Trust (AVP). CIBER de Fisiopatología de la Obesidad y Nutrición is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020571","2011-06-13T00:00:00Z",245009
"711",711,"
        This study was supported by a grant from the Bergen Research Foundation and the University of Bergen to S.L.H. The genotyping of the Norwegian ADHD sample was performed on the Sequenom platform in CIGENE (FUGE/Research Council of Norway-funded national SNP platform) and the SCOPE sample was genotyped using the infrastructure provided by the Norwegian Microarray Consortium FUGE technology platform (www.microarray.no), funded by the FUGE program of the Research Council of Norway. The study was also supported by grants from the Research Council of Norway (incl. FUGE grant nos. 151904 and 183327, and Psykisk Helse grant no. 175345), Helse Vest RHF (Western Norway Regional Health Authority) and Dr. Einar Martens Fund. The GWAS of the German ADHD samples was supported by the grant He 1446/9-1 of the DFG (Deutsche Forschungsgemeinschaft). This study was also supported by the German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2), the National Genome Research Network plus (NGFNplus), and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to S.C. and M.N.N., grant 01GS08147 to M.R.) and the European Community 's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 245009 to J.H. and O.A. M.M.N. also received support from the Alfried Krupp von Bohlen und Halbach-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035424","2012-04-23T00:00:00Z",245009
"535",535,"This work was funded by EU project PITN-GA-2009-238017 HARVEST; EU project 245070 FP7-KBBE-2009-3 SUNBIOPATH; FONDAZIONE CARIVERONA 2009; and Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy (FWP number 449B); the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231 and the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-AC03-76SF000098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pbio.1000577","2011-01-18T00:00:00Z",245070
"434",434,"
        This work was partly supported by the ANR project “Gametogenes” (contract n° ANR-08-GENM-041), the GIS Europole Mer project “OxyGenes” and the European program FP7-KBBE-2009-3 “Reproseed” (Proposal n° 245119). NMD was funded by post-doctoral grants provided by Ifremer and Région Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036353","2012-05-09T00:00:00Z",245119
"494",494,"
        This work was supported by grants from the French National Research Agency (ANR -08-GENM-041 “Gametogenes”), the European 7th Framework Program (FP7 ref 245119 “REPROSEED”) and the Regional Council of Basse-Normandie (France) (fifth research regional program and a doctoral grant to AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027833","2011-12-09T00:00:00Z",245119
"148",148,"
        This work was supported by grants from MAREX: Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications (Call FP7-KBBE-2009-3, Project nr. 245137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030443","2012-01-23T00:00:00Z",245137
"358",358,"
        The research was partially granted by EUBerry Project: EU FP7 KBBE–2010-4 Grant Agreement No. 265942. The GIP-USAL is financially supported by the Consolider-Ingenio 2010 Programme (FUN-C-FOOD, CSD2007-00063) and Junta de Castilla y León (Grupo de Investigación de Excelencia GR133). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025878","2011-10-07T00:00:00Z",265942
"505",505,"
        This work was supported by collaborative project n°214402 Acronym Angioscaff (EU-FP7), SAF2009-07102 (Ministerio de Ciencia e Innovacio), Red Tematica de Investigacion Cooperativa TerCel (Instituto de Salud Carlos III), SAF2009-07315E Acción Explora (Ministerio de Ciencia e Innovación). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035148","2012-04-17T00:00:00Z",214402
"484",484,"
        This study was supported by the following grants: Italian Ministry of Education, University and Research PRIN 062944 2005, European Commission CORDIS FP7-BIOSCENT, NMP-214539 2007, Italian Ministry of Health THEAPPL 2008, and funding by “Fondazione Cassa di Risparmio di Parma”, “Ente Cassa di Risparmio di Firenze”, “Compagnia di San Paolo”, and “Istituto Nazionale di Ricerche Cardiovascolari.” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017750","2011-03-18T00:00:00Z",214539
"260",260,"The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 213382 (FUNMOL). This work has also been supported by the grant N N202 0852 33 from the Ministry of Science and Higher Education in Poland and the Center for Theoretical Biological Physics at the UCSD sponsored by the NSF (Grant PHY-0822283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000547","2009-10-30T00:00:00Z",213382
"661",661,"
        National Institute for Occupational Safety and Health OH008282, National Institutes of Health HL70755, HL094488, U19AI068021, National Institute of Environmental Health Sciences R01ES019304, National Library of Medicine LM007994-05, National Occupational Research Agenda 927000Y, 927Z1LU, Nanotechnology Research Center 927ZJHF, National Science Foundation CAREER 0449117, Air Force Office of Scientific Research FA9550-09-1-0478, 7th Framework Program of the European Commission (EC-FP7-NANOMMUNE-214281),Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning and by the Science Foundation of Ireland, Strategic Research Cluster BioNanointeract and Centre for Research on Adaptive Nanostructures and Nanodevices, Higher Education Authority (Ireland) and Programme for Research in Third-Level Institutions (PRTLI) (Ireland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030923","2012-03-30T00:00:00Z",214281
"355",355,"
        This research was supported by The Converging Technologies Program (Grant No 1694/07) of The Israel Science Foundation, The European Union FP7-ERC-AdG, Miel de Botton Aynsley and Paul Sparr Foundations, Excell project 214706 to Dr. Benayahu. Dr. Shapiro is the Incumbent of The Harry Weinrebe Professorial Chair of Computer Science and Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025605","2011-10-14T00:00:00Z",214706
"482",482,"This work was supported by grants from the US-Israel Binational Science Foundation (BSF, grant number 2005132) to DB and ZYR, from the Ministry of Health (grant number3-00000-4398) and EU-FP7, Excell project 214706 to DB, and by a grant from the National Institute on Aging (5RO1 AG021566) to ZYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0013307","2010-10-12T00:00:00Z",214706
"141",141,"
        This work was supported by the French National Research Agency under grant agreement ANR-09-BLAN-0051-04 and by the European Community's Seventh Framework Programme under grant agreement FP7-246513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028210","2011-12-21T00:00:00Z",246513
"2211",221,"
        The study was supported by EU FP6 and FP7 research projects IMAGE (044227), MEECE
                    (212085) and VECTORS (266445), Estonian Ministry of Education and Research
                    (SF0180005s10), and Danish Network for Fisheries and Aquaculture Research
                    (FISHNET). The funders had no role in study design, data collection and
                    analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019231","2011-04-29T00:00:00Z",266445
"471",471,"
        MT, AE and FA were supported by Portuguese Fundacao para a Ciencia e a Technologia and Fondo Europeo de Desarrollo Regional through project INVASEA (PTDC/MAR/098069/2008). MT was also supported by the Danish National Science Research Foundation. JK was supported by the European Union FP7 research project VECTORS (266445) and the Estonian research projects SF0180013s08 and ESF8254. BS was supported in part by a National Science Foundation CAREER grant (BIO-OCE 105690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028595","2012-01-10T00:00:00Z",266445
"642",642,"
        We thank the Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation), EU UNCOVER project (BRM), and Estonian Ministry of Education and Research (grant no. SF0180005s10 to HO) for support. DTU Aqua (BRM, ME) has received funding from the European Community's Seventh Framework Programme (FP/2007–2013) under grant agreement n° 217246 made with the joint Baltic Sea research and development programme BONUS, and from the Danish National Science Foundation (ECOSUPPORT project). We thank the Danish National Research Foundation (Dansk Grundforskningsfond) for support to the Center for Macroecology, Evolution and Climate, University of Copenhagen. The study contributes to the EU FP7 project VECTORS (266445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0018998","2011-05-09T00:00:00Z",266445
"233",233,"
        M.R. was supported by a Marie Curie International Outgoing fellowship (EU - FP7 - PEOPLE - 2009 - IOF, 254634) from the European Community's Seventh Framework Programme. This research was funded by projects CTM2010 - 22218 of the Spanish Government, project 287844 (COCONET, EU - FP7), BIOCON08-187 from the Fundación Banco Bilbao Vizcaya Argentaria (FBBVA) and a FPU (Formación del Profesorado Universitario) scholarship to V.O. (AP2008 - 04209, 2009) from the Spanish Ministerio de Educación. The authors are part of the research groups 2009SGR - 636, and 2009SGR - 484 of the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035815","2012-04-24T00:00:00Z",287844
"243",243,"
        The authors thank the “Red Española de Esclerosis Múltiple (REEM)” sponsored by the “Fondo de Investigación Sanitaria” (FIS), Ministry of Science and Innovation, Spain, and the “Ajuts per donar Suport als Grups de Recerca de Catalunya (SGR 2005-1081)”, sponsored by the “Agència de Gestió d'Ajuts Universitaris i de Recerca” (AGAUR), Generalitat de Catalunya, Spain. This work was supported by a grant from Merck-Serono (Ayudas a la Investigación - Fundación Salud 2000). SM is early stage researcher funded by the European Community's Seventh Framework Programme ([FP7/2007–2013] under grant agreement n° 212877 (UEPHA*MS). RN is an experienced researcher also funded by the European Community's Seventh Framework Programme ([FP7/2007–2013] under grant agreement n° 212877 (UEPHA*MS), and has a contract with INSERM U563, University of Toulouse, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023634","2011-08-23T00:00:00Z",212877
"596",596,"
        FLM was supported by the International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC). DW received funding from the European Community's Seventh Framework Programme under grant agreement no. PIEF-GA-2008-219406. PM was supported by the EU FINSysB Marie Curie Research Training Network project no. FP7-214004. IDJ and KG were supported by the Federal Ministry of Education and Health (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002592","2012-03-15T00:00:00Z",214004
"362",362,"
        The work presented has received funding from BioMar A/S and the EU under the Seventh Framework Programme FP7/2007-2013 under grant agreement number 214505.10. http://biomar.com/. http://epp.eurostat.ec.europa.eu/portal/page/portal/research_methodology/research/seventh_framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026492","2011-10-21T00:00:00Z",214505
"49",49,"
        This work was supported by FP7 EU contract PITN-GA-2008-215148 and the Israel Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002527","2012-02-23T00:00:00Z",215148
"483",48,"
        This work was supported by EU FP7 grants EVIMalaR (contract 242095), PITN InterMalTraining (contract 215281) and MALSIG (contract 223044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031567","2012-02-21T00:00:00Z",215281
"650",650,"
        The work was supported by Fundação para a Ciência e Tecnologia (FCT) of the Portuguese Ministry of Science (PTDC/SAU-GMG/100313/2008), the Federal German Ministry of education and Science (Biofuture) C.S.S.G-S. was supported by an FCT fellowship (SFRH/BD/15888/2005). M.A.I. was funded by the EU FP 7 Marie Curie Initial Training Network “Intervention Strategies against Malaria (InterMalTraining)”, contract no. 215281. L.F.M. is a Young Investigator from the Human Frontier Science Program and receives support from Fundação Luso-Americana para o Desenvolvimento and Fundação para a Ciência e a Tecnologia (PTDC/SAU-MII/69280/2006 and PTDC/SAU-MII/78333/2006). F.F. thanks the Chica and Heinz Schaller Foundation for support. M.M.M. and F.F. are members of the EU FP7 Network of Excellence EVIMalaR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029408","2012-01-06T00:00:00Z",215281
"97",97,"This work was supported by the Swiss National Science Foundation, NCCR “Frontiers in Genetics”, the EU FP6 Integrated project “AnEUploidy” grants to SEA, and funding from the EU FP7 under grant agreement 219250 (to A.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0006659","2009-08-17T00:00:00Z",219250
"352",352,"
        This study was supported by grants from Telethon, Italy (TIGEM-TNP42TELC and GTB07001), from FP7/2007-2013 under grant agreement n° 223143 (project acronym: TECHGENE), and from Ministero della Salute (Ricerca Finalizzata RF-MUL-2007-666195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024729","2011-09-09T00:00:00Z",223143
"578",578,"
        The data were collected and analysed within the framework of the EU FP6 and FP7 projects HERMES (Hotspot Ecosystem Research on the Margins of European Seas, Contract number GOCE-CT-2005-511234) and HERMIONE (Hotspot Ecosystem Research and Man's Impact ON European Seas, Contract number 226354), the European Research Council Starting Grant Project CODEMAP (Complex Deep-Sea Environments: Mapping habitat heterogeneity As Proxy for biodiversity, Starting Grant no: 258482) and with support of the UK NERC (Natural Environment Research Council) OCEANS2025 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028755","2011-12-14T00:00:00Z",226354
"640",640,"
        The support of a SYNTHESYS Grant financed by European Community Research Infrastructure Action under the FP6 ""Structuring the European Research Area"" Program to visit to the Zoological Museum in Amsterdam (JR) is acknowledged. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under the HERMIONE project, grant 517 agreement n° 226354. JR had a Special Research Fund (BOF) from Ghent University. The study benefited from funding by the EUROMARGIN Programme of the European Science Foundation (Moundforce 2004 Project, 813.03.006/855.01.040) and the Netherlands Organisation for Scientific Research (BIOSYS project 814.01.005/835.20.024) to support sponge material collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016533","2011-02-09T00:00:00Z",226354
"641",641,"
        Participation of P. Cárdenas at the ‘Molecular Evolution
                    Workshop’ (Woods Hole, 2009) was made possible by the Bergen
                    Forskningsstiftelse (“Mohn Grant”, to C. Schander). Visit to the
                    Zoological Museum in Amsterdam (P. Cárdenas) received support from the
                    SYNTHESYS Project which is financed by European Community Research
                    Infrastructure Action under the FP6 “Structuring the European Research
                    Area” Program. J.R. Xavier is funded by the Science and Technology
                    Foundation (FCT-Portugal, grant no. SFRH/BPD/62946/2009). J. Reveillaud has
                    received funding from the European Community's Seventh Framework Program
                    (FP7/2007-2013) under the HERMIONE project, grant agreement no. 226354. This
                    work was supported by a grant from the ‘Norwegian Deep Sea Program’
                    and by the Norwegian Research Council (project number 158923/S40, to H.T. Rapp).
                    The funders had no role in study design, data collection and analysis, decision
                    to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0018318","2011-04-08T00:00:00Z",226354
"68",68,"
        Funding for KAA and TAW was obtained from the European Research Development Fund and Highland and Islands Enterprise. TGO was funded from the European Community's Seventh Framework Programme [FP7/2007-2013] (grant: 226675). RJ and GA were funded by the European Community's Seventh Framework Programme [FP7/2007-2013](grant: 226675), and the Knowledge for Climate Research Programme. TE was funded by the Knowledge for Climate Research Programme. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030031","2012-01-11T00:00:00Z",226675
"136",136,"
        The research leading to these results has received funding from the European Community’s Seventh Framework Programme [FP7/2007-2013] under grant agreement number 226675. The KnowSeas project is affiliated with LOICZ and LWEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026149","2011-10-14T00:00:00Z",226675
"617",617,"
        This study was fifty percent funded by the Oak Foundation. Match funding for J.J.
                    Heymans was obtained from the European Research Development Fund, the Scottish
                    Association for Marine Science, and the European Union Seventh Framework
                    Programme (FP7/2007–2013) under grant agreement n° 226675. U.R.
                    Sumaila and A. Dyck were match funded by the Global Ocean Economics Project
                    funded by the Pew Charitable Trusts, Philadelphia. S. Mackinson was match funded
                    from the United Kingdom Department for Environment Food and Rural Affairs
                    project M1202. No additional external funding was received for this study. The
                    funders had no role in study design, data collection and analysis, decision to
                    publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020239","2011-05-26T00:00:00Z",226675
"188",188,"
        This research was partially funded by the European Commission's Seventh Framework Programme FP7/2007–2013) under grant agreement number 231500. The work described in this paper is conducted within the EU project RoboSKIN. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026561","2011-11-10T00:00:00Z",231500
"72",72,"
        This work was supported by the Bundesministerium für Bildung und Forschung (http://www.bmbf.de/) project “Bernstein Focus: Neurotechnology Frankfurt, FKZ 01GQ0840” and by the European Union (http://ec.europa.eu/research/fp7/) under grant IM-CLeVeR, FP7-ICT-IP-231722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030884","2012-02-17T00:00:00Z",231722
"442",442,"
        TS, MT, KG and PR are supported by the European Community 7th Framework Programme (FP7/2007–2013), “Challenge 2 - Cognitive Systems, Interaction, Robotics,” grant agreement No. ICT-IP-231722, project “IM-CLeVeR - Intrinsically Motivated Cumulative Learning Versatile Robots.” NV was supported by Wellcome Trust grant 091409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.
      ","10.1371/journal.pone.0037749","2012-06-04T00:00:00Z",231722
"46",46,"
        This work was supported in part by the EU, under FP7 project HUMOUR (grant n. ICT-231724), and the Whitaker International Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030301","2012-01-18T00:00:00Z",231724
"161",161,"
        This work was supported by grants from The Netherlands Organisation for Scientific Research through NWO-VENI grant 91610121 (DB) and ZonMw grant 91209010 (XW and GB) and EU FP7 grant Antiresdev 241446 (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032942","2012-03-06T00:00:00Z",241446
"104",104,"This work was supported by grant from the European Community (PAR, FP7-HEALTH-2009-241476). URL of funder's website: http://cordis.europa.eu/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0011960","2010-08-05T00:00:00Z",241476
"679",679,"
        This work was supported by the Swiss National Science Foundation [grant number 324730-12544], the Swiss HIV Cohort Study [grant number 588], and the Federal Office of Public Health [grant number 09.007368, the National Center for Mycobacteria]. Dr. Fenner and Dr. Egger are also supported by the National Institute of Allergy and Infectious Diseases [IeDEA Southern Africa, grant number 5U01-AI069924-5], and Dr. Gagneux by the National Institutes of Health [grant number R01-AI090928-01] and the Swiss National Science Foundation [grant number PP00A-119205]. Dr. Böttger was supported by the University of Zürich, the European Community (PAR, FP7-HEALTH-2009-241476) and the Federal Office of Public Health (National Center for Mycobacteria). The Swiss HIV Cohort Study is supported by the Swiss National Science Foundation [grant no. 33CS30-134277]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034186","2012-03-30T00:00:00Z",241476
"411",411,"
        The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007–2013) under grant agreement N° 241500 (BuruliVac). This work was additionally supported by a Grant from the Health Services of Fundação Calouste Gulbenkian, and by the Portuguese Science and Technology Foundation (FCT) fellowships SFRH/BPD/68547/2010, SFRH/BD/41598/2007 to A. G. Fraga and T. G. Martins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033406","2012-03-08T00:00:00Z",241500
"497",497,"
        This study was supported by a fellowship to LB by the “Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen),” and by grants from the Belgian Science Policy program (IUAP, P6/31) and the European Union (LSHM-CT-2005-018833, EUGeneHeart) and from the EC FP7/2007-2013 under grant agreement no HEALTH-F2-2009-241526, EUTrigTreat (to K.R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025100","2011-10-13T00:00:00Z",241526
"18",18,"
        This work was supported by the European Union FP7 program (SysteMTb 241587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034302","2012-04-02T00:00:00Z",241587
"2321",232,"
        This research is supported by the Swedish Medical Research Council (K2007-54X-20328–013; K2009-67X-21128-01-3; K2010-55X-20328-04-3; K2010-54X-09894-19-3), European Union 6th and 7th Framework (LSHM-CT-2003–503041, FP7- HEALTH- 2009- 241592, FP7-KBBE-2009-3-245009); Novo Nordisk Fonden (GeA/AIR); ALF Göteborg (SU7601); Cancerfonden (090717); Polysackaridforskning AB (Uppsala); and the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research (A305-188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034313","2012-03-27T00:00:00Z",241592
"67",67,"
        This study was supported by grants from the Italian Ministry of Health: 'Ricerca Corrente', Ricerca Finalizzata 06.76.1, 07.103, RF-IMI-2009-1302952, and grants from the European Community (HEALTH-F3-2009-241642 and 40H58 and EU-FP7 NEWTBVAC as well as EU-FP7 IDEA project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027539","2011-11-10T00:00:00Z",241642
"71",71,"
        This work was supported by the FP6 funded TREAT-NMD network of excellence (LSHM-CT-2006-036825), the FP7 BIO-NMD project (FP7-HEALTH-241665), the Dutch organization for scientific research (NWO/ZonMW, 95100102), and the Dutch Duchenne Parent Project (www.duchenne.nl) and utilizes the infrastructure of the Center for Biomedical Genetics (the Netherlands) and the Center for Medical Systems Biology (the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031937","2012-02-16T00:00:00Z",241665
"105",105,"This work was supported by the Spanish Ministerio de Educacion y Ciencia (BES-2003-1088), Ministerio de Ciencia e Innovacion (BIO2005-07949-C02-01, BIO2008-01561) and by the European TBVAC FP6-503367 and NEWTBVAC FP7 241745 Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012978","2010-09-24T00:00:00Z",241745
"5821",582,"This work was supported by INSERM, CNRS, Fondation pour la Recherche Medicale, Institut Pasteur Paris (incl. Programme Transversal de Recherche nr 253), Institut Pasteur Korea, and the European Community (TB-MACS, Grant nr LSHP-CT-2006-037732; TB-VIR, Grant nr 200973; and EU-FP7 NEWTBVAC project, Grant nr 241745) and the Korea Research Foundation Grant (K20802001409-09B1300-03700). P.B. is a fellow of an INSERM-Avenir fellowship; O.N. is a fellow of a CNRS-ATIP fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001100","2010-09-09T00:00:00Z",241745
"593",593,"
        This work was funded by and carried out as a part of two related projects supported by the European Union: Hepadip (Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome) under the 6th Framework Program (contract LSHM-CT-2005-018734) and Flip (fatty liver inhibition of progression) under the Seventh Framework Programme (FP7/2007-2013, grant agreement n° Health-F2-2009-241762. This work was also supported by the Danish Obesity Research Centre (DanORC; www.danorc.dk), which is supported by the Danish Council for Strategic Research (contract 2101-06-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032213","2012-02-24T00:00:00Z",241762
"677",677,"
        The research leading to these results has received funding from the National Health and Medical Research Council (NHMRC, Australia) as part of an agreement with the European Union Seventh Framework Program (FP7/2007–2013) under grant agreement No. HEALTH-F2-2009-241778. SL was funded by a Company of Biologists Travelling Fellowship and an American-Australian Neurological Fellowship. SL, KD, HB, H-CB, RG, AW and NS are members of the Neurobid Consortium, funded by the Seventh Framework Program (EU) and NHMRC. KM is an adviser to the Neurobid Consortium. The project was also supported by funding from the Regenerative Research Foundation and Grant Number NS033529 from NIH/NINDS to ST. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033554","2012-03-21T00:00:00Z",241778
"153",153,"
        This article was supported in part by the 7th Framework Programme of the European Community in the context of the project “Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria” (acronym SATURN, FP7-HEALTH-2009 contract N°241796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pmed.1001171","2012-02-07T00:00:00Z",241796
"618",618,"This study benefited from support by the Research Foundation Flanders (www.fwo.be Grants G.0374.08 and G.0428.09), by the Interuniversity Attraction Poles Programme of the Belgian Science Policy (www.belspo.be Grant IUAP P6/40), by the Agency for Innovation by Science and Technology (www.iwt.be Grant IWT 40084), by the Juvenile Diabetes Research Foundation (Center grant 4-2005-1327) and the European Union (FP7-project 241883). These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.","10.1371/journal.pone.0014214","2010-12-06T00:00:00Z",241883
"247",247,"
        This work was funded through a grant by the BBSRC (www.bbsrc.ac.uk)(BB/E009085/1) and Wellcome Trust (www.wellcome.ac.uk) VIP funding (092403/Z/10/Z) to AP, and FP7 Gencodys (Health-241995)(http://cordis.europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=1&CAT=PROJ&RCN=94690) and NWO VIDI grants (http://www.nwo.nl/nwohome.nsf/pages/nwop_5vtgqw_eng) to AS. The EM Facilities used for this project are supported by grants from the BBSRC, The Wellcome Trust and the University of Manchester Strategic Fund. The Drosophila core facility is supported by the Wellcome Trust (www.wellcome.ac.uk)(087742/Z/08/Z). The publication costs were paid for by The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036339","2012-04-30T00:00:00Z",241995
"210",210,"
        RGW is funded by a Medical Research Council (UK) Methodology Research Fellowship (G0802414) and the European Commission Seventh Framework Programme FP7 (242061). All authors were supported by the Bill and Melinda Gates Foundation (19790.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029130","2011-12-22T00:00:00Z",242061
"697",697,"
        KK (087262/Z/08/Z) and SDL (088590/Z/09/Z) are funded by the Wellcome Trust, London, United Kingdom. RGW is funded by a Medical Research Council (UK) Methodology Research Fellowship (G0802414), the Bill and Melinda Gates Foundation (19790.01), and the EU FP7 (242061). JJL is funded by the Consortium to Respond Effectively to the AIDS TB Epidemic, United States, funded by the Bill and Melinda Gates Foundation. RW is funded by IEDEA (International epidemiologic Databases to Evaluate AIDS) (5U01AI069924-02, CEPAC (Cost Effectiveness of Preventing AIDS Complications) (5 R01 AI058736-02), USAID Right to Care (CA 674 A 00 08 0000 700), CIPRA (Comprehensive International Programme of Research on AIDS) (IU19AI53217-07). LGB is funded by the National Institutes of Health (NIH) CIPRA (Comprehensive International Programme of Research on AIDS) (1U19AI53217). KM is funded by the NIH CIPRA (Comprehensive International Programme of Research on AIDS) (1U19AI53217), Wellcome Trust Strategic award CIDRI, Cape Town (WT084323MA). Funding for the CIPRA-SA trial was provided by the Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, through the grant number 1U19AI53217-01. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.
      ","10.1371/journal.pone.0027763","2011-11-17T00:00:00Z",242061
"485",48,"
        This work was supported by EU FP7 grants EVIMalaR (contract 242095), PITN InterMalTraining (contract 215281) and MALSIG (contract 223044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031567","2012-02-21T00:00:00Z",242095
"114",114,"
        This project was supported by grants from the Wellcome Trust, BBSRC and from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N° 242095. FC received a bursary from the Fondazione Cenci Bolognetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016471","2011-02-04T00:00:00Z",242095
"307",307,"
        This study was performed within the framework of Top Institute Pharma (Netherlands) project: T4-102. Chris J. Janse received financial support from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N° 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015121","2010-11-30T00:00:00Z",242095
"315",315,"
        This work was supported by the French National Research Agency (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes, grant ANR-07-MIME-021-0), which provided a fellowship to A. J.. The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement N° 242095 (Evimalar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016544","2011-01-27T00:00:00Z",242095
"375",375,"
        This work was supported by a Gates Foundation Grand Challenges Explorations Grant (to SMK; KHAN OPP1008310). JWL is supported by the China Scholarship Council-Leiden University Joint Program, and CJJ by a grant of the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029289","2011-12-27T00:00:00Z",242095
"3791",379,"
        The research leading to these results has received funding from the French “Agence Nationale pour la Recherche” (ANR-06-MIME-001-01) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements N° 242095 and N°223736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030849","2012-01-26T00:00:00Z",242095
"3811",381,"The work on P. berghei sequestration was supported by grants of The Netherlands Organization for Scientific Research (ZonMw TOP grant number 9120_6135), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements N°201222 and N° 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001032","2010-09-30T00:00:00Z",242095
"393",393,"
        This work was supported by the UK Medical Research Council (http://www.mrc.ac.uk), (G0900109 to RT; U117532067 to AAH), a MRC programme grant (G0900278 to RT and AAH), and also the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement (N° 242095 to AAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002404","2012-01-19T00:00:00Z",242095
"405",405,"
        DSG, BP, ZX, US, SMS, DB and RT are funded by an MRC Investigator Award to RT (G0900109) and an MRC grant (G0900278) to RT and AAH. AAH is funded by an MRC grant (U117532067). ABT and LS are funded by the Wellcome trust (090313). DJPF is funded by a Wellcome Trust equipment grant. CAN is a David Phillips Fellow (BBSRC). OK and CJJ are supported by grants of the European Community's Seventh Framework Programme (FP7/2007–2013) (242095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002554","2012-02-23T00:00:00Z",242095
"4391",439,"
        This work was supported by funds from the Institut de Recherche pour le Développement (IRD), the French Agence Nationale pour la Recherche (ANR-11-BSV7-009-01 grant “GIME” to IM), and has received funding from the European Community's Seventh Framework Programme (FP7) under grant agreements N° 242095 (EviMalaR, IM and EAL) and N° 223601 (MALVECBLOK, IM and EAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002742","2012-05-31T00:00:00Z",242095
"474",474,"
        Funding for this work was provided in part by the NIH (RO1 AI47953; PI: J.
                    Smith). OMP is supported by the Agence Nationale de la Recherche (contract
                    ANR-07-MIME-021-0) and the 7th European Framework Program (FP7/2007–2013,
                    contract N°242095, Evimalar). The funders had no role in study design, data
                    collection and analysis, decision to publish, or preparation of the
                    manuscript.
      ","10.1371/journal.ppat.1002032","2011-05-05T00:00:00Z",242095
"504",504,"
        MAMR was in receipt of a studentship and granted a full time study leave from the Ministry of Science, Technology and Innovation (MOSTI) and the Director of Institute for Medical Research, Ministry of Health, Malaysia, respectively. This work was funded by the Medical Research Council (U117532067) and the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 242095. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033845","2012-03-30T00:00:00Z",242095
"529",529,"
        This work was partially supported by Grants-in-Aid for Scientific Research (KAKENHI 23248024 and 23380092) (http://www.jsps.go.jp/) and research grant #200704 of FFPRI (http://www.ffpri.affrc.go.jp/). TK was supported by JSPS Postdoctoral Fellowships for Research Abroad (http://www.jsps.go.jp/). JAC, IJT, SAS, AJR, AS-F, and MB are supported by the Wellcome Trust [grant WT 085775/Z/08/Z] (http://www.wellcome.ac.uk/). TDO is supported by European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n°242095: EVIMalaR - Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR) (http://cordis.europa.eu/fp7/). JH Institute receives funding from the Scottish Government. This work benefited from links funded though COST Action 872 (http://www.cost.esf.org/) and through ERASMUS MUNDUS project 2008-102 (EUMAINE) (http://www.eumaine.ugent.be). Swedish University of Agricultural Sciences was supported by Swedish Science Council, Carl Trygger Foundation (http://www.carltryggersstiftelse.se/), the Linnaeus initiative “Insect Chemical Ecology, Ethology and Evolution” (ICE3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002219","2011-09-01T00:00:00Z",242095
"574",574,"
        MF is a recipient of a graduate fellowship from the Generalitat de Catalonia. ICA was partially supported by National Institutes of Health (NIH) grants Nos 5G12RR008124-16A1 and 5G12RR008124-16A1S1. The biomedical Analysis Care Facility/BBRC/UTEP is funded by NIH grants 5G12RR008124-16A1 and 5G12RR008124-16A1S1. HAP is an ICREA Research Professor. Work in the laboratory of HAP is funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement N° 242095, by the Private Foundation CELLEX (Catalonia, Spain), and by the Spanish Ministry of Science and Innovation (SAF2009-07760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026588","2011-10-26T00:00:00Z",242095
"584",584,"
                This work was supported by the UK Medical Research Council (http://www.mrc.ac.uk), and the Wellcome Trust
                        (http://wellcome.ac.uk) through their core funding to the
                    Wellcome Trust Sanger Institute (WTSI) and from the European Community's
                    Seventh Framework Programme (FP7/2007-2013) under grant agreement number 242095
                    (Evimalar). Thomas D. Otto was funded by the European Union 6th Framework
                    Program grant to the BioMalPar Consortium (http://www.biomalpar.org,
                    grant number LSHP-LT-2004-503578). The funders had no role in study design, data
                    collection and analysis, decision to publish, or preparation of the
                    manuscript.
            ","10.1371/journal.ppat.1001288","2011-02-17T00:00:00Z",242095
"625",625,"
        This work was supported by grants from the Swedish Agency for Research and Development with Developing Countries, http://www.sida.se (Sida/SAREC SWE 1995-117), the European and Developing Countries Clinical Partnership's grant, http://www.edctp.org (EDCTP CG-TA 05 40204_003), as well as a grant within the BioMalPar European Network of Excellence, http://www.biomalpar.org (LSHP-CT-2004-503578) and from the European Community's Seventh Framework Programme, http://www.evimalar.org/ (FP7/2007-2013) under grant agreement N°242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0018319","2011-03-31T00:00:00Z",242095
"669",669,"
        This project received financial support from the European Community's
                    Seventh Framework Programme (FP7/2007-2013) under grant agreement N° 242095
                    (C.J. and M.M.), the Fundação para a Ciência e Tecnologia
                    (FCT) of the Portuguese Ministry of Science and Technology (G.R.M., C.C., M.P.)
                    and the British Council (G.R.M., C.C.). C.S.S.G-S. was supported by an FCT Ph.D.
                    fellowship (SFRH/BD/15888/2005). M.P. and G.R.M. were hired under the
                    Ciência 2007 Programme of the Portuguese Ministry of Science and
                    Technology. The funders had no role in study design, data collection and
                    analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002046","2011-05-19T00:00:00Z",242095
"118",118,"
        This work was supported by the DFG SPP1356 ‘Pluripotency and cellular reprogramming’; DFG-SFB 655 BU1400/3-1 ‘Cells into tissues’; EU FP7 (242129) ‘SyBoSS’ and NGFN DiGtoP (01GS0859) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019470","2011-05-12T00:00:00Z",242129
"19",19,"
        SB is funded by the EU FP7 grant “EPIAF” (n° 242131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pbio.1001297","2012-04-03T00:00:00Z",242131
"329",329,"
        This research was supported by the Swedish Research Council, Swedish International Development Cooperation Agency/Department for Research Cooperation, Hedlunds Foundation, SLL 20050348, European Commission; EC-FP6-018953 Auto/AlloCell, EC-FP6-037611 EUROPRISE, EC-FP7- 242135 CHAARM and Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021171","2011-06-16T00:00:00Z",242135
"450",450,"
        JL and PK were supported by the Neuromics Marie Curie Early stage Training grant (MEST-CT_2005-020919), MV, ABS, KWL and RK are supported by the EU FP7-HEALTH-2009-2.1.2-1 SynSys grant (242167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.
      ","10.1371/journal.pone.0039420","2012-06-20T00:00:00Z",242167
"313",313,"
        This work was supported by the French National Agency for Research (ANR-05-MRAR-013-01) and the EC under the European Research Council (ERC) grant 206634/ISCATAXIA and under the FP7 grant 242193/EFACTS to H.P. S.S. was supported by the French Ministry for Research (MRT award), A.M. by the American Friedreich Ataxia Research Alliance, and M.W.D. by the Association Française pour l'Ataxie de Friedreich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016199","2011-01-26T00:00:00Z",242193
"229",229,"The studies were supported by the Specific Targeted Research Project 'ALLFUN' (FP7–HEALTH–2009 Contract number 260338 to LR), ""SYBARIS"" (FP7–HEALTH–2009 Contract number 242220 to LR), the Italian Grant Application 2010 Fondazione per la ricerca sulla Fibrosi Cistica (Research Project number FFC#21/2010 to LR) and by the Italian Projects of the Fondazione Cassa di Risparmio di Perugia (2007.0218.020 and 2009.020.0021 to RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001315","2011-03-10T00:00:00Z",242220
"376",376,"
        This work was supported in part by the Swiss National Science Foundation (SNSF) Sinergia grants [CRSIKO_122691, CRSI33_130080 to D.Q. and A.P.]; the National Centre of Competence in Research (NCCR) Synapsy, and the 7th framework programme of the European Union (ADAMS) [242257, FP7-HEALTH-2009 to D.Q. and A.P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029337","2011-12-21T00:00:00Z",242257
"674",674,"
        This work was supported in part by the Swiss National Science Foundation (SNSF) grants PP00B-106708 (D.Q.) and Sinergia CRSIKO_122691 (D.Q. and A.P.). This work is part of the National Centre of Competence in Research (NCCR) Swiss Etiological Study of Adjustment and Mental Health (sesam), The Swiss National Science Foundation (SNF) (project no. 51A240-104890); the University of Basel, the F. Hoffmann-La Roche Corp. and the Freie Akademische Gesellschaft provided core support for the NCCR sesam. This work is also part of the 7th framework programme of the European Union (ADAMS, project number 242257, FP7-HEALTH-2009) and of the European Science Foundation grant, EUROStress (D.Q. and A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015246","2010-12-16T00:00:00Z",242257
"339",339,"
        Support comes from the EU projects THESEUS (EU - FP7 - ENV2009-1, grant 244104) and DELOS (EVK3-CT-2000-00041), The MIAT project MED RED and from the MIUR projects COFIN (ex 40%) and PRIN (BIORES). F.B. was further supported by Assegni di Ricerca of the University of Pisa and University of Sassari, respectively, and L.A. was supported by an Eastern College Consortium (E.C.Co) Scholarship at Wesleyan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022985","2011-08-03T00:00:00Z",244104
"22",2,"
        This paper was written under partial support by the European Union project FP7-243914 (BRAIN-I-NETS), project 269921 (BrainScaleS), project FP7-248311 (AMARSI) and project FP7-506778 (PASCAL2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002294","2011-12-15T00:00:00Z",248311
"404",404,"
        Research was supported by grants from the European Union FP7-ICT program (Adaptive Modular Architectures for Rich Motor skills, AMARSI, Grant 248311), the Italian Ministry of Health, the Italian University Ministry (PRIN project), and Italian Space Agency (CRUSOE grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031770","2012-02-22T00:00:00Z",248311
"601",601,"
        This work was supported by the Spanish Ministerio de Ciencia e Innovación (SAF2008-02251; SAF2011-30518; RD06/0020/1037 from Red Temática de Investigación Cooperativa en Cáncer, Instituto de Salud Carlos III, cofunded by the Fondo Europeo de Desarrollo Regional of the European Union; and TRA2009-0275), European Community's Seventh Framework Programme FP7-2007-2013 (grant HEALTH-F2-2011-256986), Junta de Castilla y León (CSI052A11-2; GR15-Experimental Therapeutics and Translational Oncology Program) and Spain-UK International Joint Project grant from The Royal Society-CSIC (2004GB0032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pntd.0001612","2012-04-10T00:00:00Z",256986
"530",530,"
        This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area “Life sciences, genomics and biotechnology for health,” contract number LSHG-CT-2005-518254. This project was also supported by Interaction Proteome (contract number LSHG-CT-2003-505520). AR is funded by Spanish Ministry of Science and Innovation FIS PS09/02111. AC acknowledges funding from the EMBRACE European Network of Excellence. AMR acknowledges funding from PS09/02111 from the Spanish Ministry of Science and Innovation. JAGR is funded by EU-FP7-Systems Microscopy NoE (grant agreement n°258068), by the SAF2009-09839 project and the Ramon y Cajal program (RYC-2007-01649) from Ministerio de Ciencia e Innovación, Spain. This study is also funded by FP7–HEALTH–2010-two-stage Grant Agreement Number 259348 ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours (HEALTH-F4-2010-259348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031813","2012-03-09T00:00:00Z",258068
"5301",530,"
        This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area “Life sciences, genomics and biotechnology for health,” contract number LSHG-CT-2005-518254. This project was also supported by Interaction Proteome (contract number LSHG-CT-2003-505520). AR is funded by Spanish Ministry of Science and Innovation FIS PS09/02111. AC acknowledges funding from the EMBRACE European Network of Excellence. AMR acknowledges funding from PS09/02111 from the Spanish Ministry of Science and Innovation. JAGR is funded by EU-FP7-Systems Microscopy NoE (grant agreement n°258068), by the SAF2009-09839 project and the Ramon y Cajal program (RYC-2007-01649) from Ministerio de Ciencia e Innovación, Spain. This study is also funded by FP7–HEALTH–2010-two-stage Grant Agreement Number 259348 ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours (HEALTH-F4-2010-259348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031813","2012-03-09T00:00:00Z",259348
"4081",408,"
        The research leading to these results has received funding from the European Union′s Seventh Framework Programme (FP7/2007-2011) under grant agreements IDEAL (n° 259679) and MYOAGE (n° 223576) to CF, and Roberto and Cornelia Pallotti Legacy for cancer research to CF and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032678","2012-03-05T00:00:00Z",259679
"461",461,"
        This study was supported by a grant from the European Union-funded Network of Excellence LifeSpan [FP6 036894], the European Union's Seventh Framework Program IDEAL [FP7/2007-2011] under grant agreement n° 259679, the Netherlands Consortium for Healthy Ageing [Grant 05060810] in the framework of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research and the United States National Institutes of Health ([R01-HL067914 to LHL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037933","2012-05-30T00:00:00Z",259679
"343",343,"
        Institut Pasteur (http://www.pasteur.fr), FLUINNATE SP5B-CT-2006-044161 EU program (http://www.fluinnate.org/), and FLUPHARM FP7-INFLUENZA-2010-259751 (http://flupharm.eu). X.G. was supported by a fellowship from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023368","2011-08-10T00:00:00Z",259751
"392",392,"
        This work was supported by grants BFU2007-60046 and BFU2010-17540 (MICINN), CIBER de Enfermedades Respiratorias (Instituto de Salud Carlos III), VIRHOST Program (S-SAL-0815-2006) (Comunidad de Madrid), FLUPOL (SP5B-CT-2007-044263) and FLUPHARM (FP7-259751) (European Union) and Fundación Marcelino Botin. S. L-B and N. J. were supported by predoctoral FPU fellowships (MICINN) and M. P-C was supported by a fellowship of the Spanish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002397","2011-11-17T00:00:00Z",259751
"395",395,"
        This study was funded by the European Commission funded project Switchbox (FP7, Health-F2-2010-259772), the Innovation Oriented research Program on Genomics (SenterNovem; IGE01014 and IGE5007), the Centre for Medical Systems Biology, the Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO; 05040202 and 050-060-810. NCHA). PES is supported by an unrestricted grant from the Netherlands Genomics Initiative (NCHA 050-060-810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031166","2012-02-13T00:00:00Z",259772
"5061",506,"
        This work was supported by the National Science Foundation of Hungary (OTKA K81226, K81845, K69127), the Medical Research Council (ETT Grant 02-121/2009) and the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 259772 and 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037860","2012-06-18T00:00:00Z",259772
"571",571,"
        This study is integrated in the “Maintaining health in old age through homeostasis (SWITCHBOX)” collaborative project funded by the European Commission FP7 initiative (grant HEALTH-F2-2010-259772). NS, JAP and JC are main team members of the European consortium SWITCHBOX (http://www.switchbox-online.eu/). The study was also supported by the Calouste Gulbenkian Foundation (grant JG0495). ACP and AS were supported by “Compromisso com a Ciência 2007” and NCS by SFRH/BPD/51057/2010, post-doctoral fellowships, funded by the Fundação para a Ciência e Tecnologia (FCT), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024553","2011-09-08T00:00:00Z",259772
"2451",245,"
        This project was supported by funding from the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/), as well as by the Swedish Research Council (http://www.vr.se/), Vinnova/Uppsala Bio (http://www.vinnova.se/), Uppsala Berzelii Center (http://www.berzelii.uu.se/), the European Community's 6th and 7th Framework Programs and European Community's Seventh Framework Program (http://cordis.europa.eu/fp7/home_en.html) (FP7/2007-2013) under grant agreement n° Health-F4-2008-201418 – READNA (REvolutionary Approaches and Devices for Nucleic Acid analysis) and grant agreement n 259796 (DiaTools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025583","2011-09-29T00:00:00Z",259796
"462",462,"
        This work was funded by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/), The Swedish Foundation for Strategic Research (http://www.stratresearch.se/), the Swedish Research Council (http://www.vr.se/), and the European Union Seventh Framework Programme (http://cordis.europa.eu/fp7/home_en.html) under grant agreement no. 259796 (DiaTools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020148","2011-05-25T00:00:00Z",259796
"5281",528,"
        This work was supported by IOP Genomics grant IGE05012A, the Netherlands Organisation for Scientific Research (NWO) VICI grant 918.66.620 (CW), a European Union FP7 COPACETIC grant 201379 (CW), the Dutch Diabetes Foundation (2006.00.007), the Wellcome Trust (084743 to DvH), the Medical Research Council UK (G1001158 to DvH), Juvenile Diabetes Research Foundation (33-2008-402 to DvH), a NWO VENI grant 863.09.007 (JF), a NWO VENI grant 916.10.135, a Horizon Breakthrough grant 92519031 from the Netherlands Genomics Initiative (LF), a NWO clinical fellowship grant 90.700.281 (RKW), the Netherlands ALS foundation and the Adessium Foundation (LHvdB), the Thierry Latran Foundation (JV), and a Transnational University Limburg (TUL) grant (SSMR). The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007–2013) under grant agreement n° 259867. This study was financed in part by the SIA-raakPRO subsidy for project BioCOMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002431","2012-01-19T00:00:00Z",259867
"572",572,"
        This work was supported by Telethon Foundation (S01010 and TCR08002 to V.B.), Cariplo Foundation (to V.B. and C.B.), Compagnia San Paolo Foundation (to V.B.), Fondazione Aldo e Cele Daccò per la ricerca scientifica (to V.B.), Vialli and Mauro Foundation for Research and Sport (to S.P. and V.B.), and the European Community's Seventh Framework Programme (FP7/2007–2013) under the Health Cooperation Programme, grant agreement n° 259867 (to V.B. and C.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025545","2011-10-05T00:00:00Z",259867
"671",671,"
        This work was supported by Swedish Research Council (SIMSAM grant number 80748301). Drs. Fang Fang and Karin Wirdefeldt were supported by Hjärnfonden and the Svenska Sällskapet för Medicinsk Forskning (SSMF). Drs. Honglei Chen and Freya Kamel were supported by the intramural research program of National Institutes of Health, the National Institute of Environmental Health Sciences of the United States. We also thank the NIHR specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, King's College London. The research leading to these results also received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 259867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029749","2011-12-27T00:00:00Z",259867
"7071",707,"
        The genotype and gene expression generation was funded in part by COPACETIC (EU grant 201379), the Wellcome Trust (084743 to DAvH), and the Coeliac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative, as well as partially funded by the Dutch Government (BSIK03009 to CW) and by the Netherlands Organization for Scientific Research (NWO, VICI grant 918.66.620 to CW). LHvdB acknowledges funding from the Prinses Beatrix Fonds, the Adessium Foundation, and the Amyotrophic Lateral Sclerosis Association. JHV was supported by the Brain Foundation of the Netherlands. MHH received a grant from the Dutch Diabetes Foundation (2006.00.007) and IOP genomics (IGE05012A). LF received a Horizon Breakthrough grant from the Netherlands Genomics Initiative (93519031) and a VENI grant from NWO (ZonMW grant 916.10.135). GT received a Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences (KNAW). JF received a VENI grant from NWO (ALW 863.09.007). RKW is supported by a clinical fellowship grant (90.700.281) from the Netherlands Organization for Scientific Research (NWO). We acknowledge funding from the NIH: NS058980 (to RAO). The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007–2013) under grant agreement 259867. This study was financed in part by the SIA-raakPRO subsidy for project BioCOMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002197","2011-08-04T00:00:00Z",259867
"712",712,"
        This work was supported by the Prinses Beatrix Fonds (Kersten Foundation); VSB fonds; The Netherlands ALS Foundation and J.R. van Dijk; and the Adessium Foundation to [LHB]. JHV is supported by the Brain Foundation of The Netherlands; and the Thierry Latran Foundation. The GWA study was funded by the Netherlands Organization of Scientific Research NWO Investments [grant numbers 175.010.2005.011, 911-03-012]; the Research Institute for Diseases in the Elderly (014-93-015; RIDE); and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [project number 050-060-810]. In addition, the research leading to these results has received funding from the European Community’s Health Seventh Framework Programme (FP7/2007-2013) [grant agreement number 259867]. SH is supported by National Institutes of Health [grant numbers IU19A1063603-01, 5P30CA016042-28, P50CA092131, and DK072206]. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. The Irish study was funded by The Muscular Dystrophy Association (USA); The Health Research Board of Ireland; The Irish Neurological Association Travel Award; and The Irish Motor Neuron Disease Research Foundation. In Sweden, this project was supported by the Swedish Brain Research Foundation; the Hållstens Research Foundation; the Swedish Medical Society; the Björklund Foundation for ALS Research; and the Swedish Association for the Neurologically Disabled to [PMA]. WR was supported by grants from the University of Leuven (Methusalem); and the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office. In France, this study was funded by the Association pour la Recherche sur la SLA; and the Association Réseau SLA Ile de France. Support was also provided by the ALS Therapy Alliance; Project ALS; the Angel Fund; the Pierre L. de Bourgknecht ALS Research Foundation; the Al-Athel ALS Research Foundation; the ALS Family Charitable Foundation and the National Institute of Neurological Disorders and Stroke [NS050557].” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035333","2012-04-11T00:00:00Z",259867
"605",605,"
        This work was supported by grants from l'Agence Nationale de la Recherche – Santé-Environnement et Santé-Travail(ANR-SEST, Neurorad), Electricité de France and Association pour la Recherche sur le Cancer (ARC3900). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement [HEALTH-F2-2010-259893] and from grants from the Netherlands Organization for Scientific Research:De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) and Netherlands Genomics Initiative/NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037194","2012-05-29T00:00:00Z",259893
"2291",229,"The studies were supported by the Specific Targeted Research Project 'ALLFUN' (FP7–HEALTH–2009 Contract number 260338 to LR), ""SYBARIS"" (FP7–HEALTH–2009 Contract number 242220 to LR), the Italian Grant Application 2010 Fondazione per la ricerca sulla Fibrosi Cistica (Research Project number FFC#21/2010 to LR) and by the Italian Projects of the Fondazione Cassa di Risparmio di Perugia (2007.0218.020 and 2009.020.0021 to RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001315","2011-03-10T00:00:00Z",260338
"236",236,"
        This work was supported by the Specific Targeted Research Projects “ALLFUN” (FP7-HEALTH-2010-single-stage, contract number 260338) and “SYBARIS” (FP7-HEALTH-2009-single-stage contract number 037899), by the Fondazione per la Ricerca sulla Fibrosi Cistica (FFC#21/2010) and by the Fondazione Cassa di Risparmio di Perugia (2009.020.0021). CC and AC were financially supported by fellowships from Fundação para a Ciência e Tecnologia, Portugal (contracts SFRH/BD/65962/2009 and SFRH/BPD/46292/2008, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027962","2011-11-17T00:00:00Z",260338
"414",414,"
        The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NARG was funded by a Wellcome Trust Programme grant (080088) and an equipment grant (075470) (for DeltaVision), and by a FP7-2007–2013 grant (HEALTH-F2-2010-260338-ALLFUN). LPE is a Scottish Senior Clinical Fellow and acknowledges the support of the Chief Scientist Office (SCD/03). This work was funded by Wellcome Trust Project Grant to LPE 089930.
      ","10.1371/journal.ppat.1002578","2012-03-15T00:00:00Z",260338
"523",523,"
        This work was supported by ANR-10-Blanc SVSE 3-009 HYDROPHOBIN; European Community's Seventh Framework Programme [FP7/2007-2013] under Grant Agreement No: 260338 ALLFUN; and the Commonwealth of Australia under the International Science Linkages program (French-Australian Science & Technology Program 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002700","2012-05-31T00:00:00Z",260338
"178",178,"
        This work was supported by EU FP7 project SILVER (n°260644), GOA (geconcerteerde onderzoeksactie, n°10/014), The Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW), and the Erasmus Mundus External Cooperation Window. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037244","2012-05-18T00:00:00Z",260644
"595",595,"
        The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007–2013) under EuroCoord grant agreement n° 260694. This work was also supported by funding from the Fogarty AIDS International Training and Research Program (AITRP) FIC 2D43 TW001042. This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032369","2012-03-06T00:00:00Z",260694
"6471",647,"
        The United Kingdom HIV Drug Resistance Database is partly funded by the Department of Health; the views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Additional support is provided by Bristol-Myers Squibb, Gilead, Pfizer, and Tibotec (a division of Janssen-Cilag Ltd). Primary support for EuroSIDA is provided by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773), the 6th Framework (LSHP-CT-2006-018632) and the 7th Framework (FP7/2007-2013, EuroCoord n° 260694) programmes. Current support also includes unrestricted grants by Gilead, Pfizer, and Merck and Co.; The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). Additional funding provided to Deenan Pillay from the EU FP 7 CHAIN grant ( 223131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025665","2011-11-16T00:00:00Z",260694
"660",660,"
        The COHERE study group has received generic funding from: Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS), France; HIV Monitoring Foundation, The Netherlands; and the Augustinus Foundation, Denmark COHERE, which receives funding from the European Union Seventh Framework Programme (FP7/2007–2013) under EuroCoord grant agreement n° 260694. A list of the funders of the participating cohorts can be found on the Regional Coordinating Centre websites at http://www.cphiv.dk/COHERE/tabid/295/Default.aspx and http://etudes.isped.u-bordeaux2.fr/cohere. This project was funded by unrestricted grants from the Emile Dreyfuss Foundation, Basel, Switzerland and the Stiftung für Infektiologie Beider Basel, Basel, Switzerland. Jim Young and Heiner C. Bucher are supported by Santésuisse and the Gottfried and Julia-Bangerter-Rhyner-Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pmed.1001194","2012-03-20T00:00:00Z",260694
"664",664,"
        HB is supported by a Medical Research Council (MRC) Doctoral Training Account Ph.D. Studentship. CLT is funded by the WellChild Trust through a research training Fellowship. CT holds a Wellcome Trust Research Career Development Fellowship (grant number 081082) which supports the postnatal cohort. The ECS has previously received funding from the European Union FP6 (PENTA/ECS018865) and receives funding from the EU Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement n° 260694. Some of this work was undertaken at GOSH/UCL Institute of Child Health which received a proportion of funding from the UK Department of Health's NIHR Biomedical Research Centres funding scheme. The Centre for Paediatric Epidemiology and Biostatistics also benefits from funding support from the MRC in its capacity as the MRC Centre of Epidemiology for Child Health (grant number G0400546). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034706","2012-04-24T00:00:00Z",260694
"2481",248,"
        This work was supported by: European Union grants (IMECS n. 201169, FP7-Health-2007-A and SPHYNX n. 261365, FP7-Health-2010); Ministero della Sanità (Ricerca finalizzata [RFPS-2006-3-337923 and RFPS-2007-1-636647]; Istituto Superiore di Sanità [Progetti AIDS-2006 and -2008]); Ministero dell'Istruzione, dell'Università e della Ricerca (MIUR) (Programmi di ricerca di interesse nazionale [PRIN]-2008/10 n. 7245/1; Fondo per gli investimenti di ricerca di base [FIRB]-2011/13 n. RBAP10TPXK); Fondazione Cariplo (progetti n. 13535 and 3603 2010/12); Associazione Italiana per la Ricerca sul Cancro (AIRC) (progetto “Investigator Grant” [IG]-2010/13 n. 10756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002759","2012-06-21T00:00:00Z",261365
"452",452,"
        This work was partially supported by projects RNM118, RNM157 and P07-RNM-02511 of the Junta de Andalucía, the European Union FP7 grants HEALTH.2010.2.3.3-3 Project 261391 EuroWestNile, and HEALTH.2010.Single-stage Project 261504 EDENEXT, and the Spanish Ministry of Science project (CGL2009-11445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.
      ","10.1371/journal.pone.0039549","2012-06-22T00:00:00Z",261391
"7142",714,"
        This research was supported through funds from The European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. SR was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680), Academy of Finland (251217), the Finnish foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. The ATFS cohort was funded by the Australian National Health and Medical Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498), the Australian Research Council (A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921), the EU 5th Framework Programme GenomEUtwin Project (QLG2-CT-2002-01254), and the U.S. National Institutes of Health (AA07535, AA10248, AA11998, AA13320, AA13321, AA13326, AA14041, AA17688, DA12854, MH66206). RPSM and GWM are supported by National Health and Medical Research Council (NHMRC) Fellowship Schemes. Special Population Research Network (EUROSPAN) was supported b' European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). In South Tyrol, the MICROS Study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Vis Study in the Croatian island of Vis was supported through the grants from the Medical research Council UK to HC and IR and from the Ministry of Science, Education, and Sport of the Republic of Croatia to IR (number 108-1080315-0302). Erasmus Ruchpen Family (ERF) was supported by grants from The Netherlands Organization for Scientific Research (NOW; Pionier Grant), Erasmus MC, and the Netherlands Genomics Initiative (NGI)–sponsored Center for Medical Systems Biology (CMSB). The Northern Swedish Population Health Study (NSPHS) was funded by the Swedish Medical Research Council (Project Number K2007-66X-20270-01-3) and the Foundation for Strategic Research (SSF). The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823) and by the “Genomics of Lipid-associated Disorders - GOLD” of the “Austrian Genome Research Programme GEN-AU.” The KORA research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The Northern Finland Birth Cohort 1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269 (SALVE), 114194, and Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland, NHLBI grant 5R01HL087679 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, the Medical Research Council (grant G0500539, centre grant G0600705, PrevMetSyn), and the Wellcome Trust (project grant GR069224), UK. The genotyping of NFBC1966 was funded by NHLBI grant 5R01HL087679, the Academy of Finland, and Biocentrum Helsinki. Helsinki Birth Cohort Study has been supported by grants from Academy of Finland (project numbers 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225, 216374), Finnish Diabetes Research Society, Samfundet Folkhälsan, Juho Vainio Foundation, Novo Nordisk Foundation, Finska Läkaresällskapet, Päivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, and Yrjö Jahnsson Foundation. The Young Finns Study has been financially supported by the Academy of Finland (grants 126925, 121584, and 124282), Finnish Cultural Foundation, Emil Aaltonen Foundation, the Social Institution of Finland, Kuopio, Tampere (grants for TL and MK) and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research (TL and OTR). The GenomEUtwin project is supported by the European Commission under the programme ‘Quality of Life and Management of the Living Resources’ of 5th Framework Programme (no. QLG2-CT-2002-01254). JK has been supported by the Academy of Finland Centre of Excellence in Complex Disease Genetics. The Swedish Twin Cohort has been financially supported by the Swedish Research Council and Swedish Foundation for Strategic Research. The Danish Twin Registry has been supported by the Danish Medical Research Council, the Danish Diabetes Foundation, the Danish Heart Association, and the Novo Nordic Foundation. The TWINSUK study was funded by the Wellcome Trust (Grant ref. 079771); European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-ENGAGE and Framework 6 Project EUroClot. The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. NS acknowledges financial support from the Wellcome Trust (Grant 091746/Z/10/Z). NTR, NTR2, and NLDTWIN funding was obtained from the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression (904-61-090); Genetics of individual differences in smoking initiation and persistence (NWO 985-10-002); Resolving cause and effect in the association between exercise and well-being (904-61-193); Twin family database for behavior genomics studies (480-04-004); Twin research focusing on behavior (400-05-717); Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder (Addiction-31160008); Genotype/phenotype database for behavior genetic and genetic epidemiological studies (911-09-032); Spinozapremie (SPI 56-464-14192); CMSB: Center for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/2008.024); BBMRI –NL: Biobanking and Biomolecular Resources Research Infrastructure; the VU University: Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Science Foundation (ESF): Genomewide analyses of European twin and population cohorts (EU/QLRT-2001-01254); European Community's Seventh Framework Program (FP7/2007-2013): ENGAGE (HEALTH-F4-2007-201413); the European Science Council (ERC) Genetics of Mental Illness (230374); Rutgers University Cell and DNA Repository cooperative agreement (NIMH U24 MH068457-06); Collaborative study of the genetics of DZ twinning (NIH R01D0042157-01A); the Genetic Association Information Network, a public–private partnership between the NIH and Pfizer, Affymetrix, and Abbott Laboratories. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The LifeLines Cohort Study, and generation and management of GWAS genotype data for the LifeLines Cohort Study is supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. PREVEND genetics is supported by the Dutch Kidney Foundation (Grant E033), the EU project grant GENECURE (FP-6 LSHM CT 2006 037697), the National Institutes of Health (grant LM010098), The Netherlands organisation for health research and development (NWO VENI grant 916.761.70), and the Dutch Inter UniversityCardiology Institute Netherlands (ICIN). EGCUT was supported by the Estonian Ministry of E&R (SF0180142s08), EU FP7 OPENGENE (#245536) and ENGAGE (201413), by EurRDF grant to the Centre of Excellence in Genomics, Estonian Biocentre and University of Tartu and by Estoinian Research Infrastructure's Roadmap. Genmets was supported through funds from The European Community's Seventh Framework Programme (FP7/2007-2013), BioSHaRE Consortium, grant agreement 261433. VS was supported by the Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular research, and the Finnish Academy (grant number 129494). The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). EPIC–Norfolk is supported by programme grants from the Medical Research Council UK (G9502233, G0300128) and Cancer Research UK (C865/A2883). Adipose Tissue eQTL dataset has been funded by Finnish Foundation for Cardiovascular Research, Helsinki University, Sigrid Juselius Foundation Central Hospital Research Foundation. Metabonomic datasets are supported by the Academy of Finland (grant number 137870 to PS) and the Responding to Public Health Challenges Research Programme of the Academy of Finland (grant number 129429 to MA-K), the Finnish Cardiovascular Research Foundation
(MA-K), and the Jenny and Antti Wihuri Foundation (AJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002333","2011-10-20T00:00:00Z",261433
"696",696,"
        This work was supported by the Swedish Foundation for Strategic Research, Swedish Medical Research Council (K2009-68X-14928-06-3), Foundations of Österlund, Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg as well as research grants from the Skåne University Hospital (to A.B.) and grants from the Royal Physiographic Society in Lund and the Greta and Johan Kock Foundation (to S.M.). JP acknowledges support from the Foundation for Polish Science (TEAM project DPS/424-329/10), the European Commission (FP7-HEALTH-2010-261460 “Gums&Joints""), and the National Institutes of Health (DE 09761, United States). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficent of the structural funds from the European Union (grant no. POIG.02.01.00-12-064/08 – “Molecular Biotechnology for Health""). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034852","2012-04-13T00:00:00Z",261460
"159",159,"
        This work was supported by grants from the German Federal Government (DLR FKZ 01KI0503) and from the European Commission (FP6 MVACTOR LHSP-CT-2006-037536, FP7 VECTORIE Project Number 261466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002557","2012-03-01T00:00:00Z",261466
"4521",452,"
        This work was partially supported by projects RNM118, RNM157 and P07-RNM-02511 of the Junta de Andalucía, the European Union FP7 grants HEALTH.2010.2.3.3-3 Project 261391 EuroWestNile, and HEALTH.2010.Single-stage Project 261504 EDENEXT, and the Spanish Ministry of Science project (CGL2009-11445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.
      ","10.1371/journal.pone.0039549","2012-06-22T00:00:00Z",261504
"453",453,"
        Sen Li is a research fellow (aspirant) in F.R.S-FNRS. This study was partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext012 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don’t necessarily reflect the views of the European Commission. This study was also partially funded by the Special Research Fund (FSR) of the French Community of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0039612","2012-06-25T00:00:00Z",261504
"668",668,"
        This study was financially supported by Maj and Tor Nessling Foundation (www.nessling.fi/en), Kone Foundation (www.koneensaatio.fi/en), Emil Aaltonen Foundation (www.emilaaltonen.fi/eng.htm), Jenny and Antti Wihuri Foundation (www.wihurinrahasto.fi/foundation.html), Finnish Game and Fisheries Research Institute (www.rktl.fi/english), and the EU 6th Framework Programme (GOCE-2003-010284 EDEN, www.eden-fp6project.net). This study was partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext014 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0039452","2012-06-20T00:00:00Z",261504
"409",409,"
        This work was supported in part by grants from UTE project of Centro de Investigación Médica Aplicada, University of Navarra, Spanish Fondo de Investigación Sanitaria (PI061475 & PS09/02639), Spanish Fundación Mutua Madrileña de Investigación Médica and from the European Project AIPGENE (FP7-Health-2010-261506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032978","2012-03-06T00:00:00Z",261506
"841",84,"
        Research was funded by EURO-BASIN (FP7 #264933) and Department of Environment, Fisheries and Rural Affairs (Defra) who funded the analysis of fish larvae samples from 1979 to 2005 through project MF1101. The long-term ECOSMO model simulation was funded by the projects EU-MEECE (FP7# 212085) and the Norwegian Research Council (MarinEra project ECODRIVE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038758","2012-06-21T00:00:00Z",264933
"6511",651,"
        This work was performed thanks to an ASSEMBLE grant to SD and within the Linnaeus Centre for Marine Evolutionary Biology at the University of Gothenburg (http://www.cemeb.science.gu.se/), and supported by a Linnaeus-grant from the Swedish Research Councils VR and Formas. This paper is a contribution to the “European Project on Ocean Acidification” (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 211384 and the “Sub-seabed carbon storage and the marine environment” (ECO2) a Collaborative Project funded under the European Commission's Framework Seven Programme Topic OCEAN.2010.3, project number 265847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029568","2012-01-09T00:00:00Z",265847
"5431",543,"
        This project was supported by the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR (grants PHE-20 and 10090272), the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant AoE/M-12/06), the Harvard Center for Communicable Disease Dynamics from the US National Institutes of Health Models of Infectious Disease Agent Study program (grant 1 U54 GM088558), EMPERIE (EU FP7 grant 223498), and the National Institute of Allergy and Infectious Diseases, NIH (contract HHSN266200700005C; ADB No. N01-AI-70005). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.
      ","10.1371/journal.pmed.1001103","2011-10-04T00:00:00Z",266200
"1381",138,"
        This work was supported by the Italian Space Agency (ASI) PR-DCMC-GO-1B1125-003, by the Italian MIUR 2006052343 and 2008J7YFNR002, by the Italian Institute of Technology program (Motor cognition), and by the European project FP7 270108 “Goal-Leaders”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027652","2011-11-28T00:00:00Z",270108
"169",169,"
        This research was supported by funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreements 224919 (WoRHD, supporting L.B.), and 270108 (Goal-Leaders, supporting G.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035932","2012-04-26T00:00:00Z",270108
"454",454,"
        This work was supported by: La Ligue nationale contre le cancer (comité de la Drôme), NETSARC, RREPS, LYRIC, CONTICANET, EUROSARC (European Union Seventh Framework Programme (FP7/2007–2013) under Grant Agreement n°278742 ). JP was supported by a grant Cible from the region Rhône Alpes, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032458","2012-06-27T00:00:00Z",278742
"610",610,"
        This work was supported by the European Union Sixth Framework Programme “Approaches to Control multi-resistant Enterococci (ACE): Studies on molecular ecology, horizontal gene transfer, fitness, and prevention” under contract LSHE-CT-2007-037410; by the European Union Seventh Framework Programme (FP7-HEALTH-2011-single-stage) “Evolution and Transfer of Antibiotic Resistance” (EvoTAR) under grant agreement number 282004; by a NWO-VICI grant (918.76.611) to MJMB; and by a NWO-VENI grant (916.86.044) and a NWO Valorisation grant (91501008) to WvS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002804","2012-06-28T00:00:00Z",282004
"5961",596,"
        FLM was supported by the International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) as part of the excellence graduate school Jena School for Microbial Communication (JSMC). DW received funding from the European Community's Seventh Framework Programme under grant agreement no. PIEF-GA-2008-219406. PM was supported by the EU FINSysB Marie Curie Research Training Network project no. FP7-214004. IDJ and KG were supported by the Federal Ministry of Education and Health (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002592","2012-03-15T00:00:00Z",219406
"479",479,"MarUrbe - Sustainable management of urban marine structures: EU - FP7-PEOPLE-2007-2-1-IEF-219818 (Marie Curie Fellowship - SPF). BIORES -The resistance and resilience of coastal biodiversity to synergic effects of global and local environmental changes (PRIN 2007, Italian Ministry of Education, University, and Research, Italy). AdriaBio - Past, present and future of marine biodiversity in the Adriatic sea (University of Bologna Strategic Project, University of Bologna, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0010791","2010-05-24T00:00:00Z",219818
"323",323,"
        This research was funded by institutional grants from the CNRS and INSERM and by the ANR FUNGENOMICS grant. IE received funding from the European Community's FP7/2007-2013 (grant agreement n° PIEF-GA-2008-220008). LWH, VR and RWH were supported by funding from the modENCODE Project at the National Human Genome Research Institute in the National Institutes of Health (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019055","2011-05-13T00:00:00Z",220008
"365",365,"
        This work was supported by the University of Lausanne, Canton de Vaud (Switzerland), by grants from the Swiss National Science Foundation to PF (130825 and 111974), a fellowship from the National Sciences and Engineering Research Council of Canada to VM, and a Marie Curie Intra-European program fellowship to TC (IEF-FP7-Project Number: 221254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026622","2011-10-24T00:00:00Z",221254
"276",276,"
        This work was supported by European Community FP7 Marie Curie Fellowship PIEF-GA-2008-221553 and an EMBO Long-Term fellowship (LMS), European Community FP6 IP AGRON-OMICS (contract LSHG-CT-2006-037704), a Gottfried Wilhelm Leibniz Award of the DFG), and the Max Planck Society (DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002164","2011-07-14T00:00:00Z",221553
"570",570,"
        This study has been funded by the Direcció General de Pesca Marítima (Generalitat de Catalunya, PCC68003/9), the Direcció de Medi Natural (Generalitat de Catalunya, 10.05.227.07/5), the Agence National de la Recherche (Medchange project), Marie Curie Reintegration Grant Mechanisms (FP7- N° 207632), and Total Foundation (medDIVERSA project, http://meddiversa.medrecover.org). N. Teixidó was partially funded by I3P-CSIC and Beatriu de Pinós (2009-BP-263) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023744","2011-08-24T00:00:00Z",207632
"1691",169,"
        This research was supported by funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreements 224919 (WoRHD, supporting L.B.), and 270108 (Goal-Leaders, supporting G.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035932","2012-04-26T00:00:00Z",224919
"326",326,"
        This work was supported by the Austrian National Science Fund by the
                    Translational Research-Programme (L518-N20) and partly by the company Ionicon
                    Analytik as one of the partners involved in the Marie Curie Industry-Academia
                    Partnership and Pathways (IAPP) project 218065 “PTR-TOF” funded by
                    the European Commission within the Seventh Framework Programme (FP7 - People).
                    The funders had no role in study design, data collection and analysis, decision
                    to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020419","2011-05-26T00:00:00Z",218065
"526",526,"This work was supported by grants from Italian Association for Cancer Research (AIRC), Italian Ministry of Health, Regione Piemonte, Italian Ministry of University and Research, CRT Progetto Alfieri, Fondazione Monte dei Paschi di Siena, Association for International Cancer Research (AICR-UK) , EU FP6 contract n 037297 (MCSC), EU FP7 Marie Curie, contract n 218071 (Cancer-Gene). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0006833","2009-08-31T00:00:00Z",218071
"629",629,"This research was supported in part by a grant from the United States Army Medical Research and Materiel Command number W81XWH-08-1-0740 (to SNS), in part by contract number 018827 (FP6-POLYGENE) from the 6th Framework Programme of the European Union (to SNS, TR, and LAK), in part by contract number 218071 (FP7-MC-IAPP CancerGene) from the 7th Framework Programme of the European Union (to deCODE Genetics), and in part by United States National Cancer Institute (NCI) Grants R01 CA89085 and P50 CA125183-03 (to OIO). The MCBCS was supported by United States National Institutes of Health grant, R01 CA122340 (to FJC), and an NCI Specialized Program of Research Excellence (SPORE) award in breast cancer to the Mayo Clinic, P50 CA116201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1001029","2010-07-22T00:00:00Z",218071
"534",534,"Funding to CM, RAM, and BW was provided by the Sloan Foundation through the Future of Marine Animal Populations Project. KJG holds a Royal Society-Wolfson Research Merit Award. Funding to RUS was provided by the Pew Fellowship for Marine Conservation. Funding to DZ, RUS, and RW was provided by the Pew Charitable Trust, Philadelphia through the Sea Around Us Project. Funding to MC was provided by the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement #GA-2008-219265 for the implementation of ECOFUN Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pbio.1000131","2009-06-23T00:00:00Z",219265
"428",428,"
        This work was supported by Marie Curie International Outgoing Fellowship No. FP7-PEOPLE-2007-4-1-IOF-ENV-219786 from the European Commission. SE was supported by an award from DTRA BO742081 under DOE prime contract No. DEAC02-98CH10886 with Brookhaven National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036017","2012-04-27T00:00:00Z",219786
"258",258,"This work was funded by NIH NIGMS Grant GM032877 to GC; NSF Arabidopsis 2010 Genome Grant (IOB 0519985) to GC, DS; NSF (DBI0445666) to GC, DS and RG; MILLENIUM NUCLEUS (P06-009F), FONDECYT (1060457), ICGEB (CRPCHI0501) to RG. GK research is supported by a European-FP7-International Outgoing Fellowships (Marie Curie) (AtSYSTM-BIOL; PIOF-GA-2008-220157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000326","2009-03-20T00:00:00Z",220157
"60",60,"
        DG was supported by a Marie Curie fellowship (FP7-people-IOF), project no. 221081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023294","2011-08-24T00:00:00Z",221081
"579",579,"
        This work was funded by the Juvenile Diabetes Research Foundation (S.L.S., B.K.W.), the NIGMS (National Institute of General Medical Sciences) (GM38627 to S.L.S.) and a Type 1 Diabetes Pathfinder Award (DP2-DK083048, NIH-NIDDK, to B.K.W.). S.K. acknowledges support by the Ernst Schering Research Foundation and the European Union FP7 Marie Curie program (PIOF-GA-2008-221135). D.F.-Y. acknowledges support from MCO training grant at Harvard University. S.L.S. is an Investigator at the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028808","2012-01-05T00:00:00Z",221135
"209",209,"
        The European Union International Outgoing Fellowship Marie Curie number 221146 (DynaCa-DA) both funded this project and supported EI (http://ec.europa.eu/research/fp7/understanding/marie-curieinbrief/europe-world_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028685","2011-12-28T00:00:00Z",221146
"262",262,"The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. PIIF-GA-2008-220274. We would also like to acknowledge support from Swiss National Science Foundation grants 315200-116814 and 315200-119697, as well as from the YeastX program of The Swiss Initiative in Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000719","2010-03-26T00:00:00Z",220274
"522",522,"
         This work has been funded by the New Zealand Ministry of Fisheries (ZBD2001/02, ZBD2002/01 and ZBD2006/03), National Institute of Water and Atmospheric Research-Non-Specific Output Funding and the NZ Foundation for Research Science and Technology International Polar Year project COX01707. Write up was partially funded by Marie Curie International Incoming Fellowship (FP7-PEOPLE-2007-4-2-IIF-ENV221065) to SFT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0011899","2010-07-30T00:00:00Z",221065
"201",201,"
        This work was supported by research grants from EU FP7 Marie-Curie (IRG200632), Royal Society (2008/R1) and Biotechnology and Biological Sciences Research Council (BB/G008973/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023898","2011-09-07T00:00:00Z",200632
"137",137,"
        The work was supported by the grant from the Polish Ministry of Science and Education (NN 518 409238), and by the Marie Curie Actions EU grant FP7-PEOPLE-2007-IRG-210538. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026709","2011-10-28T00:00:00Z",210538
"214",214,"
        The work was supported by the grant from the Polish Ministry of Science and Education (NN 518 409238), and by the Marie Curie Actions EU grant FP7-PEOPLE-2007-IRG-210538. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033425","2012-03-27T00:00:00Z",210538
"356",356,"
        This work was supported by the British Heart Foundation (grant number PG/07/059/23259). Dr. Jun Tan and Dr. Suat Tan thank the Malaysian Ministry of Higher Education for studentships. Dr. Ellison is a recipient of a Marie Curie International Re-integration grant from the FP7 EU Marie Curie Actions (PIRG02-GA-2007-224853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025669","2011-10-17T00:00:00Z",224853
"407",407,"
        This work was supported by a Marie Curie Reinstallation grant (http://cordis.europa.eu/fp7/people/) [PIRG02-GA-2007-224874], by grants from the Fundação para a Ciência e a Tecnologia (http://www.fct.pt/) [BIA-BCM/100557/2008 and BIA-PRO/100537/2008], and by an EMBO installation grant (http://www.embo.org/programmes/installation-grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032646","2012-02-29T00:00:00Z",224874
"321",321,"
        This work was funded by Conselho Nacional de Desensolvimento Científico e Tecnológico (www.cnpq.br); Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (www.faperj.br); and Marie Curie Actions FP7-PEOPLE-2009-IEF (contract nr 250589) (http://ec.europa.eu/research/mariecurieactions/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0018149","2011-03-31T00:00:00Z",250589
"177",177,"
        This work has been supported by EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) grant no. 253483, and by the French National Research Agency (grant reference “ANR-08-MIE-007”). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036858","2012-05-18T00:00:00Z",253483
"429",429,"
        This investigation received financial support from the UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR)/International Development Research Center (IDRC), Project #A90276, and by EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) grant no. 253483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036207","2012-04-27T00:00:00Z",253483
"113",113,"
        This study was funded by the European Community's 7th Framework program FP7 under grant agreement n°254619 and the AAP-FRB2009-PICOPOP (http://www.fondationbiodiversite.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016342","2011-02-10T00:00:00Z",254619
"154",154,"
        ET was funded by the European network of excellence Marine Genomics Europe (GOGE-CT-505403) and the Agence Nationale de la Recherche (ANR-08-BLAN-0309). GP is funded by European Union FP7 program under grant agreement 254619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030931","2012-02-17T00:00:00Z",254619
"79",79,"
        This work was funded by the Fund for Scientific Research Flanders (FWO), http://www.fwo.be/; Federal Office for Scientific Affairs (IUAP), http://www.belspo.be/; Seventh Framework Programme - Marie Curie FP7-PIIF-GA-2009-252375, http://cordis.europa.eu/fp7/people/home_en.html and Katholieke Universiteit Leuven (KULeuven) research grant OT/08/33, http://www.kuleuven.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024190","2011-09-14T00:00:00Z",252375
"455",455,"
        This research was partially supported by grants from the USDA-CSREES, Citrus Research and Development Foundation and start up funding provided by the University of Florida to LLS. RCH was supported by the Seventh Framework Programme of the European Union (FP7-PEOLE-2009-10F-252980). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038146","2012-06-27T00:00:00Z",252980
"3961",396,"
        Supported by grants from Ministerio de Ciencia e Innovación (BFU2010-15832, BFU2008-03488, BFU2008-04196, CSD2010-00045), Spain, European Union (HEALTH-F2-2007-202167) and Cajal Blue Brain. G.P. is supported by a Marie Curie Fellowship (FP7-253635). E.D.M. is supported by INCRECyT project from European Social Fund and JCCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pbio.1001259","2012-02-14T00:00:00Z",253635
"2331",233,"
        M.R. was supported by a Marie Curie International Outgoing fellowship (EU - FP7 - PEOPLE - 2009 - IOF, 254634) from the European Community's Seventh Framework Programme. This research was funded by projects CTM2010 - 22218 of the Spanish Government, project 287844 (COCONET, EU - FP7), BIOCON08-187 from the Fundación Banco Bilbao Vizcaya Argentaria (FBBVA) and a FPU (Formación del Profesorado Universitario) scholarship to V.O. (AP2008 - 04209, 2009) from the Spanish Ministerio de Educación. The authors are part of the research groups 2009SGR - 636, and 2009SGR - 484 of the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0035815","2012-04-24T00:00:00Z",254634
"512",512,"
        KB was supported by a National Institutes of Health grant (GM029860), ADD by a Department of Defense Breast Cancer Predoctoral Fellowship (BC051092), RGM by an AHA Beginning Grant in Aid, EB by a Fondation pour la Recherche Médicale Fellowship, an AHA Postdoctoral Fellowship, and an Allocation INSERM InCa/AVENIR (R08227AS), and CG by a Marie Curie Outgoing International Fellowship from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 254747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017380","2011-02-24T00:00:00Z",254747
"165",165,"
        This work was financially supported by the Austrian Science Fund (FWF): P22889-B11 and from the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement no. [254897]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032559","2012-03-20T00:00:00Z",254897
"7222",722,"
        JRB Perry is supported by the Wellcome Trust as a Sir Henry Wellcome Postdoctoral Research Fellow (092447/Z/10/Z). This work was partially funded by grants from the Wellcome Trust 083270/Z/07/Z and MRC G0601261. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; National Institutes of Health contract HHSN268200625226C; and grants DK062370 and DK072193. ARIC: Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. Work at Lund University diabetes centre was funded by several grants from the Swedish Research Council (LG prject grant, Linné, Exodiab). Norfolk Diabetes Case-Control and ADDITION-Ely Studies: The work on Ely, ADDITION, and EPIC-Norfolk studies was funded by support from the Wellcome Trust and MRC. The Norfolk Diabetes study is funded by the MRC with support from NHS Research and Development and the Wellcome Trust. This research was conducted in part using data and resources from the Framingham Heart Study of the National Heart, Lung, and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II), funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Also supported by National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK078616 to JB Meigs and J Dupuis, and NIDDK K24 DK080140 to JB Meigs. The research performed at deCODE Genetics was part funded through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The DGDG study was supported by the French Government (Agence Nationale de la Recherche), the French Region of Nord Pas De Calais (Contrat de Projets État-Région), Programme Hospitalier de Recherche Clinique (French Ministry of Health), and the following charities: Association Française des Diabétiques, Programme National de Recherche sur le Diabète, Association de Langue Française pour l'Etude du Diabète et des Maladies Métaboliques, Association Diabète Risque Vasculaire (Paris, France), and Groupe d'Etude des Maladies Métaboliques et Systémiques. This study was also supported in part by a grant from the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European Community). The D.E.S.I.R. study was supported by the Caisse Nationale d'Assurance Maladie des Travailleurs Salariés, Lilly, Novartis Pharma and Sanofi-Aventis, Institut National de la Santé et de la Recherche Médicale (INSERM) (Réseaux en Santé Publique, Interactions entre les déterminants de la santé, Cohortes Santé TGIR 2008), Association Diabète Risque Vasculaire, Fédération Française de Cardiologie, Fondation de France, Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques, Office National Interprofessionnel des Vins, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Santé, Novo Nordisk, Pierre Fabre, Roche and Topcon. The D.E.S.I.R. Study Group: INSERM 1018: B Balkau, P Ducimetière, E Eschwège; INSERM U367: F Alhenc-Gelas; Centre Hospitalier Universitaire D'Angers: Y Gallois, A Girault; Bichat Hospital: F Fumeron, M Marre, R Roussel; CHU de Rennes: F Bonnet; CNRS UMR8199, Lille: P Froguel; Medical Examination Services: Alençon, Angers, Blois, Caen, Chartres, Chateauroux, Cholet, Le Mans, Orléans and Tours; Research Institute for General Medicine: J Cogneau; General practitioners of the region; Cross-Regional Institute for Health: C Born, E Caces, M Cailleau, JG Moreau, F Rakotozafy, J Tichet, S. Vol. We are grateful to all patients for participation in the genetic study. We also thank Marianne Deweirder, Frédéric Allegaert (UMR CNRS 8199, Genomic and Metabolic Disease, Lille, France) for their technical assistance and their precious management of DNA samples. This work was partially funded by grants from the Wellcome Trust 083270/Z/07/Z and MRC G0601261. This work was presented as a poster at the American Diabetes Association's scientific sessions June 2011. The NHS/HPFS T2D GWA study (U01HG004399) is a component of a collaborative project that includes 13 other GWA studies funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI) (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033) with additional support from individual NIH (NIDCR:U01DE018993, U01DE018903; NIAAA: U10AA008401, NIDA: P01CA089392,R01DA013423; NCI: CA63464, CA54281, CA136792, Z01CP010200). EUROSPAN cohorts were supported by the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The ERF study was supported by grants from the NWO, Erasmus MC and the Centre for Medical Systems Biology (CMSB). We are grateful to all patients and their relatives, general practitioners and neurologists for their contributions and to P Veraart for her help in genealogy, Jeannette Vergeer for the supervision of the laboratory work and P Snijders for his help in data collection. MICROS: The MICROS study is part of the genomic health care program ‘GenNova’ and was carried out in three villages of the Val Venosta on the populations of Stelvio, Vallelunga and Martello. In South Tyrol, the study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The VIS study in the Croatian island of Vis was supported through the grants from the Medical Research Council UK and Ministry of Science, Education and Sport of the Republic of Croatia (number 108-1080315-0302). The research within the KORA study was partially funded by the German Center for Diabetes Research (DZD), the Helmholtz Zentrum München, Neuherberg, Germany, and supported by grants from the German Federal Ministry of Education and Research the Federal Ministry of Health, the Ministry of Innovation, Science, Research, and Technology of the state North Rhine-Westphalia, the German National Genome Research Network (NGFN), and the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The research of I Prokopenko is funded in part through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002741","2012-05-31T00:00:00Z",268201
"7253",725,"
        The AGES study has been funded by NIH contract N01-AG-1-2100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Amish study was supported by grants and contracts from the NIH including R01 AG18728 (Amish Longevity Study), R01 HL088119 (Amish Calcification Study), U01 GM074518-04 (PAPI Study), U01 HL072515-06 (HAPI Study), U01 HL084756 and NIH K12RR023250 (University of Maryland MCRDP), the University of Maryland General Clinical Research Center, grant M01 RR 16500, the Baltimore Veterans Administration Medical Center Geriatrics Research and Education Clinical Center, and the Paul Beeson Physician Faculty Scholars in Aging Program. The ASPS research reported in this article was funded by the Austrian Science Fund (FWF) grant number P20545-P05 and P13180. The Medical University of Graz supported the databank of the ASPS. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. A Köttgen and C Hundertmark were supported by the grant KO3598/2-1 (Emmy Noether Programme) of the German Research Foundation. The BLSA was supported in part by the Intramural Research Program of the NIH (National Institute on Aging). The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The ERF study was supported by grants from the Netherlands Organization for Scientific Research (NWO; Pioneergrant), Erasmus Medical Center, the Centre for Medical Systems Biology (CMSB), and the Netherlands Kidney Foundation. The Family Heart Study (FHS) work was supported in part by NIH grants 5R01HL08770003, 5R01HL08821502 (M Province) from the NHLBI and 5R01DK07568102, 5R01DK06833603 from the NIDDK (I Borecki). The Framingham Heart Study research reported in this paper was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The GENOA research was partially supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health R01 HL-87660. The Health Aging and Body Composition Study (Health ABC) was funded by the National Institutes of Aging. This research was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. The GWAS was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. For the KORA F3 and F4 studies, the genetic epidemiological work was funded by the NIH subcontract from the Children's Hospital, Boston, US, (HE Wichmann, IM Heid, prime grant 1 R01 DK075787-01A1), the German National Genome Research Net NGFN2 and NGFNplus (H.E.Wichmann 01GS0823; WK project A3, number 01GS0834), the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ, and by the Else Kröner-Fresenius-Stiftung (P48/08//A11/08; CA Böger, BK Krämer). The kidney parameter measurements in F3 were funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer) and the Regensburg University Medical Center, Germany; in F4 by the University of Ulm, Germany (W Koenig). Genome-wide genotyping costs in F3 and F4 was in part funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). De novo genotyping in F3 and F4 was funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). The KORA research platform and the MONICA Augsburg studies were initiated and financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, by the German Federal Ministry of Education and Research, and by the State of Bavaria. Genotyping was performed in the Genome Analysis Center (GAC) of the Helmholtz Zentrum München. The LINUX platform for computation was funded by the University of Regensburg for the Department of Epidemiology and Preventive Medicine at the Regensburg University Medical Center. The NHS/HPFS type 2 diabetes GWAS (U01HG004399) is a component of a collaborative project that includes 13 other GWAS (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033; National Institute of Dental and Craniofacial Research: U01DE018993, U01DE018903) funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI). Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Genotyping was performed at the Broad Institute of MIT and Harvard, with funding support from the NIH GEI (U01HG04424), and Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438) and the NIH contract “High-throughput genotyping for studying the genetic contributions to human disease” (HHSN268200782096C). Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). We thank the staff and participants of the NHS and HPFS for their dedication and commitment. The Korcula study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan and by Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302). The MICROS study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, the South Tyrolean Sparkasse Foundation, and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The Northern Swedish Population Health Study was supported by grants from the Swedish Natural Sciences Research Council, the European Union through the EUROSPAN project (contract no. LSHG-CT-2006-018947), the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). The NHS renal function and albuminuria work was supported by DK66574. Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). ORCADES was supported by the Chief Scientist Office of the Scottish Government, the Royal Society and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). DNA extractions were performed at the Wellcome Trust Clinical Research Facility in Edinburgh. The popgen study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the Ministry of Science, Commerce, and Transportation of the State of Schleswig-Holstein. The project has also received infrastructure support through the DFG excellence cluster “Inflammation  at Interfaces.” The Sorbs study was funded by grants from the German Research Council KFO-152 (to M Stumvoll) and the IFB (Integrated Research and Treatment Center) AdiposityDiseases (K7-37 to M Stumvoll and A Tönjes). We also thank Dr. Knut Krohn (Microarray Core Facility of the Interdisciplinary Centre for Clinical Research, University of Leipzig, Germany) for providing the genotyping platform. The research of Inga Prokopenko is funded in part through the European Community's
Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. R Mägi acknowledges financial support from the European Commission under a Marie Curie Intra-European Fellowship. For the Rotterdam Study-I and Rotterdam Study-II, the GWAS was funded by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The Erasmus Computing Grid, Rotterdam (The Netherlands) and the national German MediGRID and Services@MediGRID part of the German D-Grid were both funded by the German Bundesministerium fuer Forschung und Technology under grants #01 AK 803 A-H and # 01 IG 07015 G, for access to their grid resources. A Dehghan is supported by NWO grant (vici, 918-76-619). The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research net of the University of Greifswald, Germany, funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the ‘Center of Knowledge Interchange’ program of the Siemens AG. The Vis study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan; and Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302) and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The 3 City Study was supported by the National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Génotypage. The 3 City Study was performed as part of a collaboration between the Institut National de la Santé et de la Recherche Médicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthélabo. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM “Cohortes et collections de données biologiques” programme. Lille Génopôle received an unconditional grant from Eisai. The Blue Mountains Eye Study (BMES) has been supported by the Australian RADGAC grant (1992–94) and Australian National Health and Medical Research Council, Canberra Australia (Grant Nos: 974159, 211069, 991407, 457349). The GWAS studies of BMES population are supported by the Australian National Health and Medical Research Council (Grant Nos: 512423, 475604, 529912) and the Wellcome Trust, UK (2008), as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster, grant numbers 085475/B/08/Z and 085475/08/Z). EG Holliday and JJ Wang are funded by the Australian National Health and Medical Research Council Fellowship Schemes. The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). M Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The Cardiovascular Risk in Young Finns study (YFS) is supported by the Academy of Finland (grant no. 117797, 121584, and 126925), the Social Insurance Institution of Finland, University Hospital Medical funds to Tampere and Turku University Hospitals, and the Finnish Foundation of Cardiovascular Research. The Emil Aaaltonen Foundation (T Lehtimäki). EGCUT received support from FP7 grants ((201413 ENGAGE, 212111 BBMRI, 205419 ECOGENE, 245536 OPENGENE) and also received targeted financing from Estonian Government SF0180142s08 and from the European Union through the European Regional Development Fund, in the frame of Centre of Excellence in Genomics. The research of the FamHS-II was conducted in part using data and resources from the NHLBI Family Heart Study supported in part by NIH grant 5R01HL08770002. For the GoDARTs study, the Wellcome Trust provides support for Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection and the informatics support is provided by the Chief Scientist Office, and the Wellcome Trust funded Scottish Health Informatics Programme (SHIP). The INGI-Carlantino and INGI-FVG studies were supported by grants from Telethon, FVG region, and Fondo Trieste. The INGI-Cilento study was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano, and the Fondazione Banco di Napoli to M Ciullo. The INGI – Val Borbera Study was supported from Compagnia di San Paolo, Torino, Italy, the Cariplo Fundation, Milano, Italy, and Italian Ministry of Health Progetto Finalizzato 2007 and 2009. The JUPITER trial and the genotyping were supported by AstraZeneca. The Ogliastra Genetic Park (OGP) - Replication Study and OGP - Talana study were supported by grants from the Italian Ministry of Education, University, and Research (MIUR) no. 5571/DSPAR/2002 and (FIRB) D. M. no. 718/Ric/2005. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) trial was supported by an investigator initiated grant from Bristol-Myers Squibb, USA. The study was conducted, analyzed, and reported independently of the company. The SAPALDIA study was supported by the Swiss National Science Foundation (grants no 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the Federal Office for Forest, Environment, and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, and Zurich. The SAPHIR-study was partially supported by a grant from the Kamillo Eisner Stiftung to B Paulweber and by grants from the “Genomics of Lipid-associated Disorders – GOLD” of the “Austrian Genome Research Programme GEN-AU” to F Kronenberg. eQTL analysis: HJ Gierman received support from the AFAR/EMF postdoctoral fellowship and the Stanford Dean's postdoctoral fellowship. HE Wheeler and SK Kim were supported by grants from the NIA, NHGRI and NIGMS.
      ","10.1371/journal.pgen.1002584","2012-03-29T00:00:00Z",268201
"533",533,"
        This work was supported by Helsinki Biomedical Graduate School (J. Viiliäinen); European Commission FP7 (Reintegration Grant FP7-268301) and the Fondation pour la Recherche Médicale (A. Fender); European Commission FP6 Integrated Project SIROCCO LSHG-CT-2006-037900 (O. Voinnet); Swiss National Fund grant 3100A0-114001 (M. Zavolan); grants from the Academy of Finland for the Center of Excellence in Translational Genome-Scale Biology, the Finnish Cancer Foundation, Sigrid Juselius Foundation, University of Helsinki Foundations and from the European Union FP6 INCA project LSHC-CT-2005-018704 (P.M. Ojala); DFG (SFB 576, HA1754-6), BMBF (NGFN-Plus, 01GS0801) and MRC (G0501453) (J. Haas); and the European Research Council (ERC Starting Grant ncRNAVIR 260767), an ATIP starting grant from CNRS and the Ligue Nationale contre le Cancer (S. Pfeffer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002405","2011-12-08T00:00:00Z",268301
"402",402,"
        This work was funded by a research grant from Harvard University's Berkman Center for Internet and Society (http://cyber.law.harvard.edu) and DR is supported by a grant from the John Templeton Foundation (http://www.templeton.org). YG is supported by FP7 Marie Curie Reintagration Grant no. 268362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031461","2012-02-21T00:00:00Z",268362
"327",327,"
        This work was supported by NIH Grant GM026020 and AG032303 and an Ellison Medical Foundation Senior Scholar in Aging Award. CLL is supported by the Fonds de le Recherche Scientifique (FNRS) and by the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement 276814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020850","2011-06-13T00:00:00Z",276814
"5021",502,"
        This work is a contribution to the “European Project on OCean Acidification” (EPOCA), which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 211384. In addition, financial support from the German Research Foundation (DFG) as part of the priority program 1162 AQUASHIFT and the Marie Curie IRG grant n° 276917 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034737","2012-04-11T00:00:00Z",276917
"347",347,"
        This research was funded by the Marie Curie International Reintegration Grant FP7-PEOPLE-2010-RG 277038 (within the 7th European Community Framework Program), by a Systematics Research grant from the Linnean Society and the Systematics Association, and by the Spanish Government project CTM2010-17755. Use of the UNOLS Research Vessel Walton Smith was funded by a grant from the US National Science Foundation (OCE 0550468 to JRP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023938","2011-08-22T00:00:00Z",277038
"354",354,"
        This study was funded by the Marie Curie International Reintegration Grant FP7-PEOPLE-2010-RG 277038 (within the 7th European Community Framework Program), by the Spanish Government projects CTM2010-22218 and CTM2010-17755, and by an APIF fellowship of the University of Barcelona to MCP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025495","2011-09-23T00:00:00Z",277038
"38",38,"This work was supported by FP7-People-ERG-2008-228583 and MNiSW/999/7.PR/UE/2009/7 (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012384","2010-08-26T00:00:00Z",228583
"39",39,"
        EBS was supported by an Endeavour Research Award (Austraining International). DC was supported by a Marie Curie Reintegration Grant (FP7-PEOPLE-ERG-230944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0018839","2011-04-19T00:00:00Z",230944
"146",146,"
        Financial sources that have supported the work: Marie Curie European Reintegration Grant (N. 239324) within the 7th European Community Framework Program. URL: http://cordis.europa.eu/fp7/dc/index.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029759","2012-01-17T00:00:00Z",239324
"5631",563,"
        The study was supported by grants INCO-DEV ICA4-CT2002-10050, 228292 (European Virus Archive), and Marie-Curie PIEF-GA-2009-235164 from the European Community (http://ec.europa.eu/research/fp6/index_en.cfm; http://ec.europa.eu/research/fp7/), and grant GU 883/1-1 from the German Research Foundation (DFG) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Department of Virology of the Bernhard-Nocht-Institute is a WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research (DEU-000115).
      ","10.1371/journal.pone.0020893","2011-06-09T00:00:00Z",235164
"658",658,"
        This work was supported by the Fondation pour la Recherche Médicale (www.frm.org)(DCV20070409276, B.S.), an EFSD/GlaxoSmithKline Research Grant (http://www.europeandiabetesfoundation.org/GSK/EFSD-GSK-RFA10.html)(B.S. and K.W.), the Cost Action (BM0602), and the Conseil régional Nord Pas-de-Calais and FEDER. K.W. was supported by a European FP7 Marie Curie grant (http://cordis.europa.eu/mariecurie-actions/) (PIEF-GA-2009-235221) and a European Atherosclerosis Society grant. C.C. was supported by a doctoral fellowship from the Nouvelle Société Française d'Athérosclérose/Schering-Plough/MSD (www.nsfa.asso.fr). M.W. is an established investigator of the Netherlands Heart Foundation (2007T067)(www.hartstichting.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032440","2012-03-05T00:00:00Z",235221
"65",65,"
        This research was supported by a grant to LRG from the National Science
                    Foundation (Animal Behavior, Biological Oceanography, and International
                    Programs; Award # 0347960; www.nsf.gov) and a grant to MGS
                    by the European Community's Seventh Framework Programme (FP7/2007-2013;
                        http://cordis.europa.eu/fp7) under grant agreement n°
                    235897, and the Spanish Ministry of Science and Innovation (Project:
                    CGL2009-07301/BOS). The funders had no role in study design, data collection and
                    analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017686","2011-03-16T00:00:00Z",235897
"231",231,"
        The research was supported by the National Science Foundation (Grant no. 0347960 to LG). Dr. González-Suárez was funded in part by the European Community's Seventh Framework Programme (FP7/2007-2013; http://cordis.europa.eu/fp7) under grant agreement n° 235897 and the Spanish Ministry of Science and Innovation (CGL2009-07301/BOS and BES-2010-034151). The authors are grateful for a grant provided to Dr. Hernández-Camacho from Consejo Nacional de Ciencia y Tecnología (Scholarship No. 95802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033654","2012-03-14T00:00:00Z",235897
"296",296,"This work was supported by the National Science Foundation (NSF), Grant No. 0347960. LRG was supported as a National Center for Ecological Analysis and Synthesis (NCEAS) sabbatical fellow while writing this paper. MGS was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 235897, and the Spanish Ministry of Science and Innovation (Project: CGL2009-07301/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012230","2010-08-17T00:00:00Z",235897
"602",602,"
        This research was supported by Forskningsrådet for Natur og Univers (FNU) research grant 272-08-0575 and the Danish National Research Foundation (which supports MEMPHYS - Center for Biomembrane Physics). Dr. Stock was supported by a sabbatical grant from the Mexican Consejo Nacional de Ciencia y Tecnología (CONACyT, 146899). Dr. Jernshøj and Dr. Olsen acknowledges support from the Danish Research Council for Technology and Innovation (project NaKIM). Dr. Wagner was supported by the European Community's Seventh Framework Program FP7/2007–2013 under grant agreement no. 236688. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0036003","2012-04-25T00:00:00Z",236688
"117",117,"
        This work was supported by a Marie Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-IEF-2008; Grant Agreement No. 236809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0018970","2011-04-19T00:00:00Z",236809
"637",637,"The research was supported by the European Commission, FP6, Integrated Project “EVI-GENORET” (LSHG-CT-2005-512036), EU FP7 Marie Curie Intra-European Fellowship 237238; Lowy Medical Research Institute (The Macular Telangiectasia Project); Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award of the National Neurovision Research Institute/Foundation Fighting Blindness (FFB Grant No: NNCD-CL-0310.0049-JHU-WG); Macular Degeneration Research Award (M2010042) of the American Health Assistance Foundation (AHAF). The contents of this publication reflect only the authors' views and not the views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0012864","2010-09-22T00:00:00Z",237238
"588",588,"
        Financial support for this work came from the European Commission FP7 Marie Curie IEF fellowship number 237265 to MP (http://cordis.europa.eu/mariecurie-actions), from the NIAID NIH grants AI077412 to HG and NIAID NIH grant RO1AI59159 to JL (http://grants.nih.gov/grants/oer.htm) and from the Swiss National Science Foundation grant 3100A0-128655 to JL (http://www.snf.ch/E/funding/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002442","2011-12-15T00:00:00Z",237265
"397",397,"
        This study was supported by grants from the Ministerio de Ciencia e Innovacion, Spain (CSD2007-0002 and AGL2009-07006) to JVP. LJM was supported by a FP7-PIIF-2009 fellowship (Marie Curie Action) from the European Commission (GLUCOSE USE IN FISH) with grant agreement number 235581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0031219","2012-02-16T00:00:00Z",235581
"6821",682,"
        RMP was supported by grants from the NIH (R01-AR057108, R01-AR056768, U01-GM092691) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. SR is supported by an NIH Career Development Award (1K08AR055688-01A1). FK is supported by a Marie Curie International Outgoing Fellowship for Career Development from the European Community's FP7 (Grant Agreement number PIOF-GA-2009-237280). The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The work presented is made possible by grants from the Coeliac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative, and partially funded by the Dutch Government (BSIK03009 to CW) and by the Netherlands Organisation for Scientific Research (NWO, VICI grant 918.66.620 to CW). LF received a Horizon Breakthrough grant from the Netherlands Genomics Initiative (93519031) and a VENI grant from NWO (ZonMW grant 916.10.135). AZ received a Rubicon grant from NWO (825.10.002). GT received a Ter Meulen Fund grant from the Royal Netherlands Academy of Arts and Sciences (KNAW). RMcM is supported by a Science Foundation Ireland Grant 09/IN.1/B2640. KAS is supported by a Canada Research Chair, Sherman Family Chair in Genomic Medicine, CIHR grants MOP79321 and IIN84042, and ORF grant RE01061. This work is partly supported by Coordination Theme 1 (Health) of the European Community's FP7, Grant Agreement number HEALTH-F2-2008-223404 (MASTERSWITCH project); by the EU FP6 supported AutoCure; and by the intramural program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002004","2011-02-24T00:00:00Z",237280
"373",373,"
        This study was supported by grants from the Israel Science Foundation and the Swiss Society of Friends of the Weizmann Institute of Science. Additionally, financial support by Eidgenössische Technische Hochshule Zürich (grant No. TH-31 06-2) and the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 237946 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028583","2011-12-05T00:00:00Z",237946
"5972",1,"
        This paper was written under partial support by the European Union project #FP7-237955 (FACETS-ITN), project #FP7-269921 (BrainScaleS), project #FP7-216593 (SECO), project #FP7-506778 (PASCAL2) and project #FP7-243914 (BRAIN-I-NETS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pcbi.1002211","2011-11-03T00:00:00Z",237955
"5351",535,"This work was funded by EU project PITN-GA-2009-238017 HARVEST; EU project 245070 FP7-KBBE-2009-3 SUNBIOPATH; FONDAZIONE CARIVERONA 2009; and Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy (FWP number 449B); the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231 and the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through Grant DE-AC03-76SF000098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pbio.1000577","2011-01-18T00:00:00Z",238017
"620",620,"
        This work was supported by the Spanish Ministerio de Ciencia e Innovación and the FEDER programme (grants BFU2006-10934 and BFU2009-08013 to A.G.-R. and BFU2005-04183 and BFU2008-03320 to I. G., and the CONSOLIDER programme CSD-2007-00008), the EU (Marie Curie RTN FP6 (RTN 035528-2) and FP7 (ITN 238186) to I. G.) and by the Junta de Andalucía (Proyectos de Excelencia P06-CVI-01592 and P09-CVI-5058 to A.G.-R.). P.R.-R. was funded by an I3P-CSIC studentship and by the CONSOLIDER programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pbio.1001298","2012-04-03T00:00:00Z",238186
"363",363,"
        This work was funded in part by grants of the Deutsche Forschungsgemeinschaft to H.L. and M.C.C. and the E-Rare EuroRETT network to M.C.C. P.P. has a fellowship from the FP7 DisChrom Project (PITN-GA-2009-238242), which is funded by the European Commission, and J.S. is a Juan de la Cierva researcher (JCI-2009-04490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0026499","2011-11-28T00:00:00Z",238242
"31",3,"
        This work was supported by the European Union (SENSOPAC, FP6-IST028056; CEREBNET FP7-ITN238686, REALNET FP7-ICT270434) to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021928","2011-07-19T00:00:00Z",238686
"7011",701,"This research was supported by the EU European Regional Development Fund through the Centre of Excellence in Genomics, Estonian Biocentre and University of Tartu. MN, TE and AM were supported by Enterprise Estonia project EU19955 and by the Estonian Ministry of Education and Research grant 0180142s08. RM was financed through European Commission grant 205419 (ECOGENE) to Estonian Biocentre and EU FP6 project “LifeSpan”. RM and MR were also supported by the Estonian Ministry of Education and Research grant 0182649s04. Part of the financing came from the EU funded ENGAGE project (grant 201413) of the FP7. DToncheva and SK were supported by the “Characterization of the anthropo-genetic identity of Bulgarians” Project of the Bulgarian Ministry of Education and Science, reference No. TK01-487/16.06.2008. LP was funded by the Center of Excellence in Common Disease Genetics of the Academy of Finland. RR is a “Ramon y Cajal” postdoctoral fellow supported by the Spanish Ministry of Science and Innovation. MM was supported by grants VZFNM00064203 and NS NS9488/3 provided by the Ministry of Health of the Czech Republic. Research on the French sample has been supported by the French Ministry of Higher Education and Research. Research on samples from Northern Italy has been supported by the Compagnia di San Paolo Foundation and Health Ministry grant PS-CARDIO ex 56//05/7. Research on the Spanish sample has been supported by grants from the Spanish Ministry of Science and Innovation (SAF2008-00357 to XE and PSE-01000-2006-6 to SM), ENGAGE (FP7/2007-201413) and AnEUploidy (FP6/2006-037627) EU grants to XE. The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The work of KORA is supported by the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). Swiss sample provision has been supported by grants from the National Science Foundation, Infectigen Foundation, and AnEUploidy EU IP (037627) grants to SEA. Research on the Latvian sample has been supported by Ministry of Health, Republic of Latvia (agreement No. 3308/IGDB-1/2008). This research was also supported by the Russian Academy of Sciences, Program “Molecular and Cell Biology”, and the Russian Basic Research Foundation. The study has also been supported by a research grant of the Italian Ministry of Health (Ricerca Corrente 2007 and Ricerca Finalizzata Cardiovascolare).","10.1371/journal.pone.0005472","2009-05-08T00:00:00Z",205419
"7254",725,"
        The AGES study has been funded by NIH contract N01-AG-1-2100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Amish study was supported by grants and contracts from the NIH including R01 AG18728 (Amish Longevity Study), R01 HL088119 (Amish Calcification Study), U01 GM074518-04 (PAPI Study), U01 HL072515-06 (HAPI Study), U01 HL084756 and NIH K12RR023250 (University of Maryland MCRDP), the University of Maryland General Clinical Research Center, grant M01 RR 16500, the Baltimore Veterans Administration Medical Center Geriatrics Research and Education Clinical Center, and the Paul Beeson Physician Faculty Scholars in Aging Program. The ASPS research reported in this article was funded by the Austrian Science Fund (FWF) grant number P20545-P05 and P13180. The Medical University of Graz supported the databank of the ASPS. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. A Köttgen and C Hundertmark were supported by the grant KO3598/2-1 (Emmy Noether Programme) of the German Research Foundation. The BLSA was supported in part by the Intramural Research Program of the NIH (National Institute on Aging). The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The ERF study was supported by grants from the Netherlands Organization for Scientific Research (NWO; Pioneergrant), Erasmus Medical Center, the Centre for Medical Systems Biology (CMSB), and the Netherlands Kidney Foundation. The Family Heart Study (FHS) work was supported in part by NIH grants 5R01HL08770003, 5R01HL08821502 (M Province) from the NHLBI and 5R01DK07568102, 5R01DK06833603 from the NIDDK (I Borecki). The Framingham Heart Study research reported in this paper was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The GENOA research was partially supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health R01 HL-87660. The Health Aging and Body Composition Study (Health ABC) was funded by the National Institutes of Aging. This research was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. The GWAS was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. For the KORA F3 and F4 studies, the genetic epidemiological work was funded by the NIH subcontract from the Children's Hospital, Boston, US, (HE Wichmann, IM Heid, prime grant 1 R01 DK075787-01A1), the German National Genome Research Net NGFN2 and NGFNplus (H.E.Wichmann 01GS0823; WK project A3, number 01GS0834), the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ, and by the Else Kröner-Fresenius-Stiftung (P48/08//A11/08; CA Böger, BK Krämer). The kidney parameter measurements in F3 were funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer) and the Regensburg University Medical Center, Germany; in F4 by the University of Ulm, Germany (W Koenig). Genome-wide genotyping costs in F3 and F4 was in part funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). De novo genotyping in F3 and F4 was funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). The KORA research platform and the MONICA Augsburg studies were initiated and financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, by the German Federal Ministry of Education and Research, and by the State of Bavaria. Genotyping was performed in the Genome Analysis Center (GAC) of the Helmholtz Zentrum München. The LINUX platform for computation was funded by the University of Regensburg for the Department of Epidemiology and Preventive Medicine at the Regensburg University Medical Center. The NHS/HPFS type 2 diabetes GWAS (U01HG004399) is a component of a collaborative project that includes 13 other GWAS (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033; National Institute of Dental and Craniofacial Research: U01DE018993, U01DE018903) funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI). Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Genotyping was performed at the Broad Institute of MIT and Harvard, with funding support from the NIH GEI (U01HG04424), and Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438) and the NIH contract “High-throughput genotyping for studying the genetic contributions to human disease” (HHSN268200782096C). Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). We thank the staff and participants of the NHS and HPFS for their dedication and commitment. The Korcula study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan and by Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302). The MICROS study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, the South Tyrolean Sparkasse Foundation, and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The Northern Swedish Population Health Study was supported by grants from the Swedish Natural Sciences Research Council, the European Union through the EUROSPAN project (contract no. LSHG-CT-2006-018947), the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). The NHS renal function and albuminuria work was supported by DK66574. Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). ORCADES was supported by the Chief Scientist Office of the Scottish Government, the Royal Society and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). DNA extractions were performed at the Wellcome Trust Clinical Research Facility in Edinburgh. The popgen study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the Ministry of Science, Commerce, and Transportation of the State of Schleswig-Holstein. The project has also received infrastructure support through the DFG excellence cluster “Inflammation  at Interfaces.” The Sorbs study was funded by grants from the German Research Council KFO-152 (to M Stumvoll) and the IFB (Integrated Research and Treatment Center) AdiposityDiseases (K7-37 to M Stumvoll and A Tönjes). We also thank Dr. Knut Krohn (Microarray Core Facility of the Interdisciplinary Centre for Clinical Research, University of Leipzig, Germany) for providing the genotyping platform. The research of Inga Prokopenko is funded in part through the European Community's
Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. R Mägi acknowledges financial support from the European Commission under a Marie Curie Intra-European Fellowship. For the Rotterdam Study-I and Rotterdam Study-II, the GWAS was funded by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The Erasmus Computing Grid, Rotterdam (The Netherlands) and the national German MediGRID and Services@MediGRID part of the German D-Grid were both funded by the German Bundesministerium fuer Forschung und Technology under grants #01 AK 803 A-H and # 01 IG 07015 G, for access to their grid resources. A Dehghan is supported by NWO grant (vici, 918-76-619). The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research net of the University of Greifswald, Germany, funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the ‘Center of Knowledge Interchange’ program of the Siemens AG. The Vis study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan; and Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302) and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The 3 City Study was supported by the National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Génotypage. The 3 City Study was performed as part of a collaboration between the Institut National de la Santé et de la Recherche Médicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthélabo. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM “Cohortes et collections de données biologiques” programme. Lille Génopôle received an unconditional grant from Eisai. The Blue Mountains Eye Study (BMES) has been supported by the Australian RADGAC grant (1992–94) and Australian National Health and Medical Research Council, Canberra Australia (Grant Nos: 974159, 211069, 991407, 457349). The GWAS studies of BMES population are supported by the Australian National Health and Medical Research Council (Grant Nos: 512423, 475604, 529912) and the Wellcome Trust, UK (2008), as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster, grant numbers 085475/B/08/Z and 085475/08/Z). EG Holliday and JJ Wang are funded by the Australian National Health and Medical Research Council Fellowship Schemes. The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). M Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The Cardiovascular Risk in Young Finns study (YFS) is supported by the Academy of Finland (grant no. 117797, 121584, and 126925), the Social Insurance Institution of Finland, University Hospital Medical funds to Tampere and Turku University Hospitals, and the Finnish Foundation of Cardiovascular Research. The Emil Aaaltonen Foundation (T Lehtimäki). EGCUT received support from FP7 grants ((201413 ENGAGE, 212111 BBMRI, 205419 ECOGENE, 245536 OPENGENE) and also received targeted financing from Estonian Government SF0180142s08 and from the European Union through the European Regional Development Fund, in the frame of Centre of Excellence in Genomics. The research of the FamHS-II was conducted in part using data and resources from the NHLBI Family Heart Study supported in part by NIH grant 5R01HL08770002. For the GoDARTs study, the Wellcome Trust provides support for Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection and the informatics support is provided by the Chief Scientist Office, and the Wellcome Trust funded Scottish Health Informatics Programme (SHIP). The INGI-Carlantino and INGI-FVG studies were supported by grants from Telethon, FVG region, and Fondo Trieste. The INGI-Cilento study was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano, and the Fondazione Banco di Napoli to M Ciullo. The INGI – Val Borbera Study was supported from Compagnia di San Paolo, Torino, Italy, the Cariplo Fundation, Milano, Italy, and Italian Ministry of Health Progetto Finalizzato 2007 and 2009. The JUPITER trial and the genotyping were supported by AstraZeneca. The Ogliastra Genetic Park (OGP) - Replication Study and OGP - Talana study were supported by grants from the Italian Ministry of Education, University, and Research (MIUR) no. 5571/DSPAR/2002 and (FIRB) D. M. no. 718/Ric/2005. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) trial was supported by an investigator initiated grant from Bristol-Myers Squibb, USA. The study was conducted, analyzed, and reported independently of the company. The SAPALDIA study was supported by the Swiss National Science Foundation (grants no 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the Federal Office for Forest, Environment, and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, and Zurich. The SAPHIR-study was partially supported by a grant from the Kamillo Eisner Stiftung to B Paulweber and by grants from the “Genomics of Lipid-associated Disorders – GOLD” of the “Austrian Genome Research Programme GEN-AU” to F Kronenberg. eQTL analysis: HJ Gierman received support from the AFAR/EMF postdoctoral fellowship and the Stanford Dean's postdoctoral fellowship. HE Wheeler and SK Kim were supported by grants from the NIA, NHGRI and NIGMS.
      ","10.1371/journal.pgen.1002584","2012-03-29T00:00:00Z",205419
"3721",372,"
        This work was supported by the Regional Council of Reunion Island, the French Ministry of Overseas, the ‘Run Sea Science’ (Theme - Capacity Building, contract 229968) and the ‘MADE: Mitigating adverse ecological impacts of open ocean fisheries’ (Theme 2 Food, Agriculture, Fisheries and Biotechnology, contract 210496) FP7 European projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028109","2011-12-12T00:00:00Z",229968
"7143",714,"
        This research was supported through funds from The European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. SR was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680), Academy of Finland (251217), the Finnish foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. The ATFS cohort was funded by the Australian National Health and Medical Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498), the Australian Research Council (A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921), the EU 5th Framework Programme GenomEUtwin Project (QLG2-CT-2002-01254), and the U.S. National Institutes of Health (AA07535, AA10248, AA11998, AA13320, AA13321, AA13326, AA14041, AA17688, DA12854, MH66206). RPSM and GWM are supported by National Health and Medical Research Council (NHMRC) Fellowship Schemes. Special Population Research Network (EUROSPAN) was supported b' European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). In South Tyrol, the MICROS Study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Vis Study in the Croatian island of Vis was supported through the grants from the Medical research Council UK to HC and IR and from the Ministry of Science, Education, and Sport of the Republic of Croatia to IR (number 108-1080315-0302). Erasmus Ruchpen Family (ERF) was supported by grants from The Netherlands Organization for Scientific Research (NOW; Pionier Grant), Erasmus MC, and the Netherlands Genomics Initiative (NGI)–sponsored Center for Medical Systems Biology (CMSB). The Northern Swedish Population Health Study (NSPHS) was funded by the Swedish Medical Research Council (Project Number K2007-66X-20270-01-3) and the Foundation for Strategic Research (SSF). The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823) and by the “Genomics of Lipid-associated Disorders - GOLD” of the “Austrian Genome Research Programme GEN-AU.” The KORA research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The Northern Finland Birth Cohort 1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269 (SALVE), 114194, and Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland, NHLBI grant 5R01HL087679 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, the Medical Research Council (grant G0500539, centre grant G0600705, PrevMetSyn), and the Wellcome Trust (project grant GR069224), UK. The genotyping of NFBC1966 was funded by NHLBI grant 5R01HL087679, the Academy of Finland, and Biocentrum Helsinki. Helsinki Birth Cohort Study has been supported by grants from Academy of Finland (project numbers 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225, 216374), Finnish Diabetes Research Society, Samfundet Folkhälsan, Juho Vainio Foundation, Novo Nordisk Foundation, Finska Läkaresällskapet, Päivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, and Yrjö Jahnsson Foundation. The Young Finns Study has been financially supported by the Academy of Finland (grants 126925, 121584, and 124282), Finnish Cultural Foundation, Emil Aaltonen Foundation, the Social Institution of Finland, Kuopio, Tampere (grants for TL and MK) and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research (TL and OTR). The GenomEUtwin project is supported by the European Commission under the programme ‘Quality of Life and Management of the Living Resources’ of 5th Framework Programme (no. QLG2-CT-2002-01254). JK has been supported by the Academy of Finland Centre of Excellence in Complex Disease Genetics. The Swedish Twin Cohort has been financially supported by the Swedish Research Council and Swedish Foundation for Strategic Research. The Danish Twin Registry has been supported by the Danish Medical Research Council, the Danish Diabetes Foundation, the Danish Heart Association, and the Novo Nordic Foundation. The TWINSUK study was funded by the Wellcome Trust (Grant ref. 079771); European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-ENGAGE and Framework 6 Project EUroClot. The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. NS acknowledges financial support from the Wellcome Trust (Grant 091746/Z/10/Z). NTR, NTR2, and NLDTWIN funding was obtained from the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression (904-61-090); Genetics of individual differences in smoking initiation and persistence (NWO 985-10-002); Resolving cause and effect in the association between exercise and well-being (904-61-193); Twin family database for behavior genomics studies (480-04-004); Twin research focusing on behavior (400-05-717); Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder (Addiction-31160008); Genotype/phenotype database for behavior genetic and genetic epidemiological studies (911-09-032); Spinozapremie (SPI 56-464-14192); CMSB: Center for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/2008.024); BBMRI –NL: Biobanking and Biomolecular Resources Research Infrastructure; the VU University: Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Science Foundation (ESF): Genomewide analyses of European twin and population cohorts (EU/QLRT-2001-01254); European Community's Seventh Framework Program (FP7/2007-2013): ENGAGE (HEALTH-F4-2007-201413); the European Science Council (ERC) Genetics of Mental Illness (230374); Rutgers University Cell and DNA Repository cooperative agreement (NIMH U24 MH068457-06); Collaborative study of the genetics of DZ twinning (NIH R01D0042157-01A); the Genetic Association Information Network, a public–private partnership between the NIH and Pfizer, Affymetrix, and Abbott Laboratories. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The LifeLines Cohort Study, and generation and management of GWAS genotype data for the LifeLines Cohort Study is supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. PREVEND genetics is supported by the Dutch Kidney Foundation (Grant E033), the EU project grant GENECURE (FP-6 LSHM CT 2006 037697), the National Institutes of Health (grant LM010098), The Netherlands organisation for health research and development (NWO VENI grant 916.761.70), and the Dutch Inter UniversityCardiology Institute Netherlands (ICIN). EGCUT was supported by the Estonian Ministry of E&R (SF0180142s08), EU FP7 OPENGENE (#245536) and ENGAGE (201413), by EurRDF grant to the Centre of Excellence in Genomics, Estonian Biocentre and University of Tartu and by Estoinian Research Infrastructure's Roadmap. Genmets was supported through funds from The European Community's Seventh Framework Programme (FP7/2007-2013), BioSHaRE Consortium, grant agreement 261433. VS was supported by the Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular research, and the Finnish Academy (grant number 129494). The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). EPIC–Norfolk is supported by programme grants from the Medical Research Council UK (G9502233, G0300128) and Cancer Research UK (C865/A2883). Adipose Tissue eQTL dataset has been funded by Finnish Foundation for Cardiovascular Research, Helsinki University, Sigrid Juselius Foundation Central Hospital Research Foundation. Metabonomic datasets are supported by the Academy of Finland (grant number 137870 to PS) and the Responding to Public Health Challenges Research Programme of the Academy of Finland (grant number 129429 to MA-K), the Finnish Cardiovascular Research Foundation
(MA-K), and the Jenny and Antti Wihuri Foundation (AJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002333","2011-10-20T00:00:00Z",245536
"7255",725,"
        The AGES study has been funded by NIH contract N01-AG-1-2100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Amish study was supported by grants and contracts from the NIH including R01 AG18728 (Amish Longevity Study), R01 HL088119 (Amish Calcification Study), U01 GM074518-04 (PAPI Study), U01 HL072515-06 (HAPI Study), U01 HL084756 and NIH K12RR023250 (University of Maryland MCRDP), the University of Maryland General Clinical Research Center, grant M01 RR 16500, the Baltimore Veterans Administration Medical Center Geriatrics Research and Education Clinical Center, and the Paul Beeson Physician Faculty Scholars in Aging Program. The ASPS research reported in this article was funded by the Austrian Science Fund (FWF) grant number P20545-P05 and P13180. The Medical University of Graz supported the databank of the ASPS. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. A Köttgen and C Hundertmark were supported by the grant KO3598/2-1 (Emmy Noether Programme) of the German Research Foundation. The BLSA was supported in part by the Intramural Research Program of the NIH (National Institute on Aging). The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00425 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The ERF study was supported by grants from the Netherlands Organization for Scientific Research (NWO; Pioneergrant), Erasmus Medical Center, the Centre for Medical Systems Biology (CMSB), and the Netherlands Kidney Foundation. The Family Heart Study (FHS) work was supported in part by NIH grants 5R01HL08770003, 5R01HL08821502 (M Province) from the NHLBI and 5R01DK07568102, 5R01DK06833603 from the NIDDK (I Borecki). The Framingham Heart Study research reported in this paper was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The GENOA research was partially supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health R01 HL-87660. The Health Aging and Body Composition Study (Health ABC) was funded by the National Institutes of Aging. This research was supported by NIA contracts N01AG62101, N01AG62103, and N01AG62106. The GWAS was funded by NIA grant 1R01AG032098-01A1 to Wake Forest University Health Sciences and genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. This research was supported in part by the Intramural Research Program of the NIH, National Institute on Aging. For the KORA F3 and F4 studies, the genetic epidemiological work was funded by the NIH subcontract from the Children's Hospital, Boston, US, (HE Wichmann, IM Heid, prime grant 1 R01 DK075787-01A1), the German National Genome Research Net NGFN2 and NGFNplus (H.E.Wichmann 01GS0823; WK project A3, number 01GS0834), the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ, and by the Else Kröner-Fresenius-Stiftung (P48/08//A11/08; CA Böger, BK Krämer). The kidney parameter measurements in F3 were funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer) and the Regensburg University Medical Center, Germany; in F4 by the University of Ulm, Germany (W Koenig). Genome-wide genotyping costs in F3 and F4 was in part funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). De novo genotyping in F3 and F4 was funded by the Else Kröner-Fresenius-Stiftung (CA Böger, BK Krämer). The KORA research platform and the MONICA Augsburg studies were initiated and financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, by the German Federal Ministry of Education and Research, and by the State of Bavaria. Genotyping was performed in the Genome Analysis Center (GAC) of the Helmholtz Zentrum München. The LINUX platform for computation was funded by the University of Regensburg for the Department of Epidemiology and Preventive Medicine at the Regensburg University Medical Center. The NHS/HPFS type 2 diabetes GWAS (U01HG004399) is a component of a collaborative project that includes 13 other GWAS (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, U01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, RFAHG006033; National Institute of Dental and Craniofacial Research: U01DE018993, U01DE018903) funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment and Health Initiative (GEI). Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the GENEVA Coordinating Center (U01HG004446). Assistance with data cleaning was provided by the National Center for Biotechnology Information. Genotyping was performed at the Broad Institute of MIT and Harvard, with funding support from the NIH GEI (U01HG04424), and Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438) and the NIH contract “High-throughput genotyping for studying the genetic contributions to human disease” (HHSN268200782096C). Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). We thank the staff and participants of the NHS and HPFS for their dedication and commitment. The Korcula study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan and by Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302). The MICROS study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, the South Tyrolean Sparkasse Foundation, and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The Northern Swedish Population Health Study was supported by grants from the Swedish Natural Sciences Research Council, the European Union through the EUROSPAN project (contract no. LSHG-CT-2006-018947), the Foundation for Strategic Research (SSF), and the Linneaus Centre for Bioinformatics (LCB). The NHS renal function and albuminuria work was supported by DK66574. Additional funding for the current research was provided by the National Cancer Institute (P01CA087969, P01CA055075) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058845). ORCADES was supported by the Chief Scientist Office of the Scottish Government, the Royal Society and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). DNA extractions were performed at the Wellcome Trust Clinical Research Facility in Edinburgh. The popgen study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the Ministry of Science, Commerce, and Transportation of the State of Schleswig-Holstein. The project has also received infrastructure support through the DFG excellence cluster “Inflammation  at Interfaces.” The Sorbs study was funded by grants from the German Research Council KFO-152 (to M Stumvoll) and the IFB (Integrated Research and Treatment Center) AdiposityDiseases (K7-37 to M Stumvoll and A Tönjes). We also thank Dr. Knut Krohn (Microarray Core Facility of the Interdisciplinary Centre for Clinical Research, University of Leipzig, Germany) for providing the genotyping platform. The research of Inga Prokopenko is funded in part through the European Community's
Seventh Framework Programme (FP7/2007–2013), ENGAGE project, grant agreement HEALTH-F4-2007- 201413. R Mägi acknowledges financial support from the European Commission under a Marie Curie Intra-European Fellowship. For the Rotterdam Study-I and Rotterdam Study-II, the GWAS was funded by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Consortium for Healthy Aging (NCHA) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture, and Science, the Ministry for Health, Welfare, and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The Erasmus Computing Grid, Rotterdam (The Netherlands) and the national German MediGRID and Services@MediGRID part of the German D-Grid were both funded by the German Bundesministerium fuer Forschung und Technology under grants #01 AK 803 A-H and # 01 IG 07015 G, for access to their grid resources. A Dehghan is supported by NWO grant (vici, 918-76-619). The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research net of the University of Greifswald, Germany, funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the ‘Center of Knowledge Interchange’ program of the Siemens AG. The Vis study was supported through the grants from the Medical Research Council UK to H Campbell, AF Wright, and I Rudan; and Ministry of Science, Education, and Sport of the Republic of Croatia to I Rudan (number 108-1080315-0302) and the European Union framework program 6 EUROSPAN project (contract no. LSHG-CT-2006-018947). The WGHS is supported by HL 043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The 3 City Study was supported by the National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Génotypage. The 3 City Study was performed as part of a collaboration between the Institut National de la Santé et de la Recherche Médicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthélabo. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM “Cohortes et collections de données biologiques” programme. Lille Génopôle received an unconditional grant from Eisai. The Blue Mountains Eye Study (BMES) has been supported by the Australian RADGAC grant (1992–94) and Australian National Health and Medical Research Council, Canberra Australia (Grant Nos: 974159, 211069, 991407, 457349). The GWAS studies of BMES population are supported by the Australian National Health and Medical Research Council (Grant Nos: 512423, 475604, 529912) and the Wellcome Trust, UK (2008), as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster, grant numbers 085475/B/08/Z and 085475/08/Z). EG Holliday and JJ Wang are funded by the Australian National Health and Medical Research Council Fellowship Schemes. The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). M Bochud is supported by the Swiss School of Public Health Plus (SSPH+). The Cardiovascular Risk in Young Finns study (YFS) is supported by the Academy of Finland (grant no. 117797, 121584, and 126925), the Social Insurance Institution of Finland, University Hospital Medical funds to Tampere and Turku University Hospitals, and the Finnish Foundation of Cardiovascular Research. The Emil Aaaltonen Foundation (T Lehtimäki). EGCUT received support from FP7 grants ((201413 ENGAGE, 212111 BBMRI, 205419 ECOGENE, 245536 OPENGENE) and also received targeted financing from Estonian Government SF0180142s08 and from the European Union through the European Regional Development Fund, in the frame of Centre of Excellence in Genomics. The research of the FamHS-II was conducted in part using data and resources from the NHLBI Family Heart Study supported in part by NIH grant 5R01HL08770002. For the GoDARTs study, the Wellcome Trust provides support for Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection and the informatics support is provided by the Chief Scientist Office, and the Wellcome Trust funded Scottish Health Informatics Programme (SHIP). The INGI-Carlantino and INGI-FVG studies were supported by grants from Telethon, FVG region, and Fondo Trieste. The INGI-Cilento study was supported by grants from the EU (Vasoplus-037254), the Italian Ministry of Universities (FIRB -RBIN064YAT), the Assessorato Ricerca Regione Campania, the Ente Parco Nazionale del Cilento e Vallo di Diano, and the Fondazione Banco di Napoli to M Ciullo. The INGI – Val Borbera Study was supported from Compagnia di San Paolo, Torino, Italy, the Cariplo Fundation, Milano, Italy, and Italian Ministry of Health Progetto Finalizzato 2007 and 2009. The JUPITER trial and the genotyping were supported by AstraZeneca. The Ogliastra Genetic Park (OGP) - Replication Study and OGP - Talana study were supported by grants from the Italian Ministry of Education, University, and Research (MIUR) no. 5571/DSPAR/2002 and (FIRB) D. M. no. 718/Ric/2005. The Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) trial was supported by an investigator initiated grant from Bristol-Myers Squibb, USA. The study was conducted, analyzed, and reported independently of the company. The SAPALDIA study was supported by the Swiss National Science Foundation (grants no 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099), the Federal Office for Forest, Environment, and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Zurich, the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, and Zurich. The SAPHIR-study was partially supported by a grant from the Kamillo Eisner Stiftung to B Paulweber and by grants from the “Genomics of Lipid-associated Disorders – GOLD” of the “Austrian Genome Research Programme GEN-AU” to F Kronenberg. eQTL analysis: HJ Gierman received support from the AFAR/EMF postdoctoral fellowship and the Stanford Dean's postdoctoral fellowship. HE Wheeler and SK Kim were supported by grants from the NIA, NHGRI and NIGMS.
      ","10.1371/journal.pgen.1002584","2012-03-29T00:00:00Z",245536
"592",592,"
        This work was supported by the Foundation for Polish Science, programme WELCOME, no. WELCOME/2010-4/3 entitled “Nutrition and ambient temperature during early development can reduce susceptibility to obesity” financed by EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project (FP7-REGPOT-2010-1-264103). This research was also supported by National Institutes of Health (NIH) 1P30-DK072476 and NIH P20-RR0021954 to the Pennington Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030392","2012-02-24T00:00:00Z",264103
"6621",662,"
        This work was funded in Oxford by the Medical Research Council (81696), the European Foundation for the Study of Diabetes (Albert Renold Travel Fellowship awarded to LV), and the Wellcome Trust (095101/Z/10/Z). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement n°223211, CEED3. ALG is a Wellcome Trust Senior Fellow in Basic and Biomedical Science. This work was funded in Slovakia by the Slovak Diabetes Association and the Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the Slovak Republic, and the Slovak Academy of Sciences VEGA2/0151/11. This publication is also the result of the project implementation TRANSENDOGEN/26240220051/supported by the Research & Development Operational Programme funded by the European Regional Development Fund ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034541","2012-04-06T00:00:00Z",262402
"172",172,"
        Support (to VT) was provided by the European Commission FP7 Programme under project 223263 (PhenoScale). Support (to AB) was provided by University of Minnesota Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002706","2012-05-10T00:00:00Z",223263
"811",81,"This work was partly supported by the European Information and Communication Technologies (ICT) Programme Project FP7-224631 and 216886, by grants of the Deutsche Forschungsgemeinschaft (DFG) (MU 987/3-1) and Bundesministerium für Bildung und Forschung (BMBF) (FKZ 01IB001A, 01GQ0850) and by the FP7-ICT Programme of the European Community, under the PASCAL2 Network of Excellence, ICT-216886. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0009813","2010-04-01T00:00:00Z",224631
"142",142,"
        This work was supported by SYNTHESYS2 made available by the European Community Research Infrastructure under FP7 [‘Synthesis of Systematic Resources’, 226506-CP-CSA-Infra]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028448","2011-12-05T00:00:00Z",226506
"5",5,"This work was supported by grants from the Swiss National Science Foundation (31003A-125005) and the European Commission through the AENEAS collaborative project (FP7 226477), the RECBREED consortium (FP7 227190), and the Epigenome Network of Excellence (FP6 503433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1001175","2010-10-28T00:00:00Z",226477
"80",80,"
        TN was a research fellow of the Japan Society for the Promotion of Science. This work was supported by grants from the Swiss National Science Foundation (31003A-125005 to JP, 3100A_112434 to TDH, and 31003A_124909 to ST), the European Commission to JP through the AENEAS collaborative project (FP7 226477), and the RECBREED consortium (FP7 227190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002484","2012-02-09T00:00:00Z",226477
"228",228,"
        This work was supported by grants from the European Community's Seventh Framework Programme (FP7/2007–2013)(No. 226556) http://ec.europa.eu/research/fp7/index_en.cfm, Chinese “863” National Programs for High Technology Research and Development (Grant No.: 2011AA10A211) http://www.most.gov.cn/, and the International Science and Technology Cooperation Program of Gansu Province (Grant No. 1011WCGA160) http://www.gsstc.gov.cn/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027605","2011-11-15T00:00:00Z",226556
"102",102,"This study was funded by the mixed CNRS-MNHN research unit 7179. MB was partly funded by the EU FP7 SCALES project (Securing the conservations of biodiversity across Administrative levels and spatial, temporal and Ecological Scales; project #226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0011123","2010-06-15T00:00:00Z",226852
"334",334,"
        The work was conducted within GP's postdoctoral position at the Department of Ecological Modelling, as part of the BioCAPSP project “Biodiversity Conservation in Fragmented Landscapes at the Atlantic Plateau of São Paulo” (funded by the German Federal Ministry of Education and Research (BMBF), project number 01 LB 0202 A1) and its onward development and application occurs within the EU FP7 Large-scale integrating project “SCALES” (grant number 226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022355","2011-08-01T00:00:00Z",226852
"4121",412,"
        Vincent Devictor received financial support from the Fondation pour la Recherche sur la Biodiversité (project FABIO and PHYBIO). Jean-Yves Barnagaud received financial support from the Région Centre (No. 200800033784), Isabelle Le Viol from Scales project (FP7-ENV-2008-1, No. 226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032819","2012-03-12T00:00:00Z",226852
"4851",485,"
        I.S.-D. and J.K. acknowledge project funding from the European Community's Seventh Framework Programme (FP7/2007–2013) under grant agreement no. 226852, Scales Project (http://www.scales-project.net). The publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0019502","2011-05-18T00:00:00Z",226852
"246",246,"
        Synchrotron data collection was supported by the European Community (FP7/2007-2013) under grant agreement n° 226716 (MAX-Lab). In addition, this work has been financially supported by the Academy of Finland (I.K., P.K.), the European Commission FP7 Marie Curie European Reintegration (I.K.) and International Incoming Fellowship (A.I.) programs, the Centre for International Mobility and the Finnish Cultural Foundation (S.P.B.), the Sigrid Jusélius Foundation (I.K., P.K.), the City of Hamburg Research and Science Foundation (P.K.), and the German Federal Ministry of Education and Research (I.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033586","2012-03-13T00:00:00Z",226716
"406",406,"
        This work was supported by grants from the Academy of Finland, the Sigrid Jusélius Foundation (Finland), the Magnus Ehrnrooth Foundation (Finland), the Department of Biochemistry, University of Oulu (Finland), and the Science and Research Foundation of the City of Hamburg (Germany). The research leading to these results received funding from the European Community Seventh Framework Programme (FP7/2007–2013) under grant agreement #226716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032336","2012-02-29T00:00:00Z",226716
"600",600,"
        This work was partially supported by the grant THALES. The grant THALES falls under the Operational Programme “Education and Lifelong Learning” and is co-financed by the European Social Fund and National Resources. Dr. Papageorgiou thanks the Academy of Finland for financial support (grant number 121278). Access to EMBL Hamburg (c/o DESY) was provided by the European Community's Seventh Framework Programme (FP7/2007-2012) under grant agreement no. 226716. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0034263","2012-04-04T00:00:00Z",226716
"51",5,"This work was supported by grants from the Swiss National Science Foundation (31003A-125005) and the European Commission through the AENEAS collaborative project (FP7 226477), the RECBREED consortium (FP7 227190), and the Epigenome Network of Excellence (FP6 503433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pgen.1001175","2010-10-28T00:00:00Z",227190
"801",80,"
        TN was a research fellow of the Japan Society for the Promotion of Science. This work was supported by grants from the Swiss National Science Foundation (31003A-125005 to JP, 3100A_112434 to TDH, and 31003A_124909 to ST), the European Commission to JP through the AENEAS collaborative project (FP7 226477), and the RECBREED consortium (FP7 227190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002484","2012-02-09T00:00:00Z",227190
"421",421,"
        This work was partly financed by a European Union research grant (FP7-KBBE-2008-227190), a French Government ANR grant (ANR-07-BLAN-0068), the Centre National de la Recherche Scientifique (CNRS), the Université Blaise Pascal, the Université d'Auvergne, and the Institut National de la Santé et de la Recherche Médicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002636","2012-04-19T00:00:00Z",227190
"7144",714,"
        This research was supported through funds from The European Community's Seventh Framework Programme (FP7/2007–2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. SR was supported by the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680), Academy of Finland (251217), the Finnish foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. The ATFS cohort was funded by the Australian National Health and Medical Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498), the Australian Research Council (A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921), the EU 5th Framework Programme GenomEUtwin Project (QLG2-CT-2002-01254), and the U.S. National Institutes of Health (AA07535, AA10248, AA11998, AA13320, AA13321, AA13326, AA14041, AA17688, DA12854, MH66206). RPSM and GWM are supported by National Health and Medical Research Council (NHMRC) Fellowship Schemes. Special Population Research Network (EUROSPAN) was supported b' European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947). In South Tyrol, the MICROS Study was supported by the Ministry of Health of the Autonomous Province of Bolzano and the South Tyrolean Sparkasse Foundation. The Vis Study in the Croatian island of Vis was supported through the grants from the Medical research Council UK to HC and IR and from the Ministry of Science, Education, and Sport of the Republic of Croatia to IR (number 108-1080315-0302). Erasmus Ruchpen Family (ERF) was supported by grants from The Netherlands Organization for Scientific Research (NOW; Pionier Grant), Erasmus MC, and the Netherlands Genomics Initiative (NGI)–sponsored Center for Medical Systems Biology (CMSB). The Northern Swedish Population Health Study (NSPHS) was funded by the Swedish Medical Research Council (Project Number K2007-66X-20270-01-3) and the Foundation for Strategic Research (SSF). The KORA research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823) and by the “Genomics of Lipid-associated Disorders - GOLD” of the “Austrian Genome Research Programme GEN-AU.” The KORA research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The Northern Finland Birth Cohort 1966 received financial support from the Academy of Finland (project grants 104781, 120315, 129269 (SALVE), 114194, and Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland, NHLBI grant 5R01HL087679 through the STAMPEED program (1RL1MH083268-01), ENGAGE project and grant agreement HEALTH-F4-2007-201413, the Medical Research Council (grant G0500539, centre grant G0600705, PrevMetSyn), and the Wellcome Trust (project grant GR069224), UK. The genotyping of NFBC1966 was funded by NHLBI grant 5R01HL087679, the Academy of Finland, and Biocentrum Helsinki. Helsinki Birth Cohort Study has been supported by grants from Academy of Finland (project numbers 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225, 216374), Finnish Diabetes Research Society, Samfundet Folkhälsan, Juho Vainio Foundation, Novo Nordisk Foundation, Finska Läkaresällskapet, Päivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, and Yrjö Jahnsson Foundation. The Young Finns Study has been financially supported by the Academy of Finland (grants 126925, 121584, and 124282), Finnish Cultural Foundation, Emil Aaltonen Foundation, the Social Institution of Finland, Kuopio, Tampere (grants for TL and MK) and Turku University Hospital Medical Funds, Juho Vainio Foundation, Paavo Nurmi Foundation, Finnish Foundation of Cardiovascular Research (TL and OTR). The GenomEUtwin project is supported by the European Commission under the programme ‘Quality of Life and Management of the Living Resources’ of 5th Framework Programme (no. QLG2-CT-2002-01254). JK has been supported by the Academy of Finland Centre of Excellence in Complex Disease Genetics. The Swedish Twin Cohort has been financially supported by the Swedish Research Council and Swedish Foundation for Strategic Research. The Danish Twin Registry has been supported by the Danish Medical Research Council, the Danish Diabetes Foundation, the Danish Heart Association, and the Novo Nordic Foundation. The TWINSUK study was funded by the Wellcome Trust (Grant ref. 079771); European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-ENGAGE and Framework 6 Project EUroClot. The study also receives support from the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. NS acknowledges financial support from the Wellcome Trust (Grant 091746/Z/10/Z). NTR, NTR2, and NLDTWIN funding was obtained from the Netherlands Organization for Scientific Research (NWO: MagW/ZonMW): Genetic basis of anxiety and depression (904-61-090); Genetics of individual differences in smoking initiation and persistence (NWO 985-10-002); Resolving cause and effect in the association between exercise and well-being (904-61-193); Twin family database for behavior genomics studies (480-04-004); Twin research focusing on behavior (400-05-717); Genetic determinants of risk behavior in relation to alcohol use and alcohol use disorder (Addiction-31160008); Genotype/phenotype database for behavior genetic and genetic epidemiological studies (911-09-032); Spinozapremie (SPI 56-464-14192); CMSB: Center for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/2008.024); BBMRI –NL: Biobanking and Biomolecular Resources Research Infrastructure; the VU University: Institute for Health and Care Research (EMGO+) and Neuroscience Campus Amsterdam (NCA); the European Science Foundation (ESF): Genomewide analyses of European twin and population cohorts (EU/QLRT-2001-01254); European Community's Seventh Framework Program (FP7/2007-2013): ENGAGE (HEALTH-F4-2007-201413); the European Science Council (ERC) Genetics of Mental Illness (230374); Rutgers University Cell and DNA Repository cooperative agreement (NIMH U24 MH068457-06); Collaborative study of the genetics of DZ twinning (NIH R01D0042157-01A); the Genetic Association Information Network, a public–private partnership between the NIH and Pfizer, Affymetrix, and Abbott Laboratories. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The LifeLines Cohort Study, and generation and management of GWAS genotype data for the LifeLines Cohort Study is supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. PREVEND genetics is supported by the Dutch Kidney Foundation (Grant E033), the EU project grant GENECURE (FP-6 LSHM CT 2006 037697), the National Institutes of Health (grant LM010098), The Netherlands organisation for health research and development (NWO VENI grant 916.761.70), and the Dutch Inter UniversityCardiology Institute Netherlands (ICIN). EGCUT was supported by the Estonian Ministry of E&R (SF0180142s08), EU FP7 OPENGENE (#245536) and ENGAGE (201413), by EurRDF grant to the Centre of Excellence in Genomics, Estonian Biocentre and University of Tartu and by Estoinian Research Infrastructure's Roadmap. Genmets was supported through funds from The European Community's Seventh Framework Programme (FP7/2007-2013), BioSHaRE Consortium, grant agreement 261433. VS was supported by the Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular research, and the Finnish Academy (grant number 129494). The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). EPIC–Norfolk is supported by programme grants from the Medical Research Council UK (G9502233, G0300128) and Cancer Research UK (C865/A2883). Adipose Tissue eQTL dataset has been funded by Finnish Foundation for Cardiovascular Research, Helsinki University, Sigrid Juselius Foundation Central Hospital Research Foundation. Metabonomic datasets are supported by the Academy of Finland (grant number 137870 to PS) and the Responding to Public Health Challenges Research Programme of the Academy of Finland (grant number 129429 to MA-K), the Finnish Cardiovascular Research Foundation
(MA-K), and the Jenny and Antti Wihuri Foundation (AJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pgen.1002333","2011-10-20T00:00:00Z",230374
"3701",370,"
        Funding provided by the Center of Excellence grant from the Swedish Foundation for Strategic Research grant number A3 02:094, The Swedish Research Council grant number K2010-65X-21408-01-3, The Swedish heart-Lung Foundation grant number 20080850, The Juvenile Diabetes Research Foundation grant number 529-2005-8327 and the European Comission FP7 Grant 223372 CardioCell Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027500","2011-11-28T00:00:00Z",200808
"627",627,"This work was supported by the Giovanni Armenise-Harvard Foundation: Career Development Award (AB); European Commission: Marie Curie International Reintegration Grant (AB); European Research Council (ERC) under the European Community's 7th Framework Programmme (FP7/2007–2013)/ERC grant agreement no. 200808; The European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063; AB); Italian Institute of Technology (IIT, AB); NIH grant NS39579 from the NINDS (DAP and JRH) and the Morris and Pimley research funds (DAP). AB is the 2007/2008 NARSAD Henry and William Test Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pbio.1000492","2010-09-28T00:00:00Z",200808
"328",328,"
        Initial funding was provided by EC Grant FP6-012948-Netsensor. MI is funded by FP7 ERC 201249 ZINC-HUBS, Ministerio de Ciencia e Innovación Grant MICINN BFU2010-17953 and the MEC-EMBL agreement. FH was funded by a Juan de la Cierva Fellowship 2007-43-786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0020913","2011-06-09T00:00:00Z",201249
"346",346,"
        MC has a PhD fellowship from the Portuguese Fundaçao para a Ciência e Tecnologia (FCT). RG has a postdoctoral fellowship from the Human Frontiers Science Program. MI is funded by the European Research Council, FP7-ERC-201249-ZINC-HUBS, Ministerio de Ciencia e Innovación grant MICINN BFU2010-17953, and the MEC-EMBL agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023685","2011-08-25T00:00:00Z",201249
"128",128,"
        AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement n° 203413. THR is supported by a fellowship from the ISEF foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0024655","2011-09-20T00:00:00Z",203413
"308",308,"
        DH has received financial support from the Israel Science Foundation (ISF grant No. 1011/07). AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007–2013)/ERC Grant agreement no. 203413. The Fritz Haber Research Center is supported by the Minerva Foundation, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015608","2011-01-10T00:00:00Z",203413
"438",438,"
        AF is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007–2013)/ERC Grant agreement n° 203413. RG is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. TB is supported by the Cambridge European Trust and the Medical Research Council. This research was supported by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0038060","2012-05-31T00:00:00Z",203413
"861",86,"This work was supported by a grant from the Novo Nordisk Foundation and the Novo scholarship programme. The European Research Council has provided financial support to AS under the EU 7th Framework Programme (FP7/2007–2013)/ERC grant agreement 204135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pcbi.1000562","2009-11-13T00:00:00Z",204135
"344",344,"
        This work was supported by a grant from the Novo Nordisk Foundation, http://www.novonordiskfonden.dk/. The European Research Council (http://erc.europa.eu/) has provided financial support to Dr. Sandelin under the EU 7th Framework Programme (FP7/2007-2013)/ERC grant agreement 204135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0023409","2011-08-24T00:00:00Z",204135
"632",632,"This work was supported by BBSRC grant BBC5185731 (GKT/RJB) and the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 204513 to GKT. RJB holds an EPSRC Career Acceleration Fellowship and a supernumerary fellowship at St Anne's College, Oxford. SMW was supported by EPSRC grant GR/S23049/01 under the EPSRC-MoD Joint Grant Scheme. GKT is a Royal Society University Research Fellow and RCUK Academic Fellow at Jesus College, Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.bbsrc.ac.uk/ http://www.epsrc.ac.uk/ http://www.rcuk.ac.uk/ http://royalsociety.org/ http://www.epsrc.ac.uk/ http://www.rcuk.ac.uk/ http://royalsociety.org/","10.1371/journal.pone.0007852","2009-11-18T00:00:00Z",204513
"559",559,"
        This research was supported by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement number 205557 [EMPATHICBRAIN] (http://erc.europa.eu); by the Swiss National Science Foundation through the National Centre of Competence in Research ""Neural Plasticity and Repair,"" Project 5: Cortical Plasticity (http://www.nccr-neuro.ethz.ch); by the University of Zurich (http://www.uzh.ch); and by the Mind and Life Institute (http://www.mindandlife.org). The authors gratefully acknowledge support by the Research Priority Program ""Foundations of Human Social Behavior"" at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0017798","2011-03-09T00:00:00Z",205557
"3131",313,"
        This work was supported by the French National Agency for Research (ANR-05-MRAR-013-01) and the EC under the European Research Council (ERC) grant 206634/ISCATAXIA and under the FP7 grant 242193/EFACTS to H.P. S.S. was supported by the French Ministry for Research (MRT award), A.M. by the American Friedreich Ataxia Research Alliance, and M.W.D. by the Association Française pour l'Ataxie de Friedreich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0016199","2011-01-26T00:00:00Z",206634
"626",626,"
        This work was supported by Fundação para a Ciência e a Tecnologia (FCT) PTDC/SAU/OBD/65872/2006, European Research Fund, ERC-208631-RESEAL, and Marie Curie/FP7. JAG was supported by a FCT fellowship, SFRH/BD/21895/2005, LC by a FCT fellowship, SFRH/BPD/62896/2009, and by Marie Curie Intra-European Fellowship, IC by a FCT fellowship, SFRH/BPD/17729/2004, and ACS by a FCT fellowship, SFRH/BPD/24976/2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028349","2011-11-29T00:00:00Z",208631
"110",110,"
        This work was supported by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 209540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0015231","2010-12-03T00:00:00Z",209540
"511",51,"
        This work was supported by the European Research Council (FP7/2007–2013)/Programme IDEAS GA n°210103 to GEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033027","2012-03-12T00:00:00Z",210103
"17",17,"
        This work was supported by the EU FP7 COLLMOT Grant No: 227878. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0033799","2012-03-28T00:00:00Z",227878
"676",676,"
        This research was funded under the following projects: Empathic avatars: input, processing and output of emotional state (EPSRC (Engineering and Physical Sciences Research Council), UK) EP/D505542/1; Visual and Behavioural Fidelity of Virtual Humans with Applications to Bystander Intervention in Violent Emergencies (EPSRC, UK) EP/F032420/1 (http://www.epsrc.ac.uk); PRESENCCIA funded under the European Sixth Framework Program, Future and Emerging Technologies (FET), Contract Number 27731 (http://cordis.europa.eu/fp7/ict/programme/fet_en.html); and TRAVERSE funded by the European Research Council (ERC) (under the Advanced Grant scheme), grant agreement number 227985. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0032931","2012-04-11T00:00:00Z",227985
"57",57,"
        This study was partially supported by the EC project STANIB (FP7-ERC, n. 229445), and the PRIN2009 grant from the Italian Ministry for Universities and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025599","2011-10-13T00:00:00Z",229445
"3572",357,"
        MB's laboratory is funded by the Spanish Ministry of Science and Innovation Projects SAF2008-05384 and CSD2007-00017, European Union FP7 Projects 2007-A-201630 (GENICA) and 2007-A-200950 (TELOMARKER), European Research Council Advanced Grant GA#232854, Körber Foundation, Fundación Botín and Fundación Lilly (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025680","2011-10-12T00:00:00Z",232854
"42",42,"
        This work was supported by the European Research Council (FP7/2007/2013/ERC Grant TRACSYMBOLS n°249587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0021545","2011-06-29T00:00:00Z",249587
"333",333,"
        The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement n° [249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0022338","2011-07-22T00:00:00Z",249930
"440",440,"
        The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement n° [249930 – CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea]. This research was financed by the Associazione dei Tour Operator Italiani (ASTOI), the Marine and Freshwater Science Group Association, and the Ministry of Education, University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037848","2012-06-01T00:00:00Z",249930
"473",473,"
        This work was financially supported by the French Agence Nationale de la Recherche (ANR-09-394 JCJC-0045-01) and the European Research Council (FP7/2007-2013 ERC 242703) to M.C.S., and a VIDI fellowship from the Netherlands Organization for Scientific Research (project number 864.08.003) and Horizon Breakthrough fellowship from the Netherlands Genomics Initiative (project number 93519018) to RPvR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030861","2012-01-24T00:00:00Z",242703
"493",493,"
        The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement n° 269502 (PASCAL) to J.M.; and a grant from Ministerio de Ciencia y TecnologÚa (MICIT) and Consejo Nacional de Investigaciones Cient$ficas y Tecnológicas (CONICIT) of Costa Rica to S.B.V. The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0027497","2011-11-07T00:00:00Z",269502
"5781",578,"
        The data were collected and analysed within the framework of the EU FP6 and FP7 projects HERMES (Hotspot Ecosystem Research on the Margins of European Seas, Contract number GOCE-CT-2005-511234) and HERMIONE (Hotspot Ecosystem Research and Man's Impact ON European Seas, Contract number 226354), the European Research Council Starting Grant Project CODEMAP (Complex Deep-Sea Environments: Mapping habitat heterogeneity As Proxy for biodiversity, Starting Grant no: 258482) and with support of the UK NERC (Natural Environment Research Council) OCEANS2025 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0028755","2011-12-14T00:00:00Z",258482
"353",353,"
        B.C. was funded by a grant from the IZKF Aachen (Interdisciplinary Centre for Clinical Research, grant number 520806). A.S. received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement number 263472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0025453","2011-09-30T00:00:00Z",263472
"5331",533,"
        This work was supported by Helsinki Biomedical Graduate School (J. Viiliäinen); European Commission FP7 (Reintegration Grant FP7-268301) and the Fondation pour la Recherche Médicale (A. Fender); European Commission FP6 Integrated Project SIROCCO LSHG-CT-2006-037900 (O. Voinnet); Swiss National Fund grant 3100A0-114001 (M. Zavolan); grants from the Academy of Finland for the Center of Excellence in Translational Genome-Scale Biology, the Finnish Cancer Foundation, Sigrid Juselius Foundation, University of Helsinki Foundations and from the European Union FP6 INCA project LSHC-CT-2005-018704 (P.M. Ojala); DFG (SFB 576, HA1754-6), BMBF (NGFN-Plus, 01GS0801) and MRC (G0501453) (J. Haas); and the European Research Council (ERC Starting Grant ncRNAVIR 260767), an ATIP starting grant from CNRS and the Ligue Nationale contre le Cancer (S. Pfeffer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002405","2011-12-08T00:00:00Z",260767
"386",386,"
        The research leading to these results has received funding in part from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 260864; NIH grant R01 GM080533; NSF grant DMS 0856099; NIH grant R01 GM086887; and the National Evolutionary Synthesis Center (NESCent), NSF EF-0423641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002077","2011-06-09T00:00:00Z",260864
"436",436,"
        DGS was funded by a University of Georgia Dissertation Completion Award (http://www.grad.uga.edu/) and National Science Foundation Grant DEB-1020966 (http://www.nsf.gov/). The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007–2013) Grant agreements 278443 and 260864 (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.ppat.1002720","2012-05-17T00:00:00Z",260864
"583",583,"This work was supported by the European Union Project RABMEDCONTROL (FP6 Project: INCO-CT-2006-517727). PL was supported by a postdoctoral fellowship from the Fund for Scientific Research (FWO) Flanders. ECH was supported by National Institutes of Health (NIH) grant R01 GM080533, while MAS was partially supported by NIH grant R01 GM086887 and National Science Foundation grant DMS 0856099. The European Research Council has provided financial support under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no \#260864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.ppat.1001166","2010-10-28T00:00:00Z",260864
"179",179,"
        The research leading to these results received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement n°263067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0037959","2012-05-29T00:00:00Z",263067
"212",212,"
        The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement n° 263067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0029557","2012-01-17T00:00:00Z",263067
"590",590,"
        NMP is supported by “Metrology on a Cellular and Macromolecular Scale for Regenerative Medicine” - Metregen (2009–2012), supporting theoretical research for scaffold design. The research related to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007–2013)/ERC Grant agreement n° [279985] (ERC StG Ideas Award to NMP on “Bio-inspired hierarchical super nanomaterials”; the funding will officially start in 2012). MJB acknowledges support from an ONR-PECASE award (award number N00014-10-1-0562), no role in the results reported in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0030500","2012-02-08T00:00:00Z",279985
"6421",642,"
        We thank the Census of Marine Life-History of Marine Animal Populations (CoML-HMAP; Sloan Foundation), EU UNCOVER project (BRM), and Estonian Ministry of Education and Research (grant no. SF0180005s10 to HO) for support. DTU Aqua (BRM, ME) has received funding from the European Community's Seventh Framework Programme (FP/2007–2013) under grant agreement n° 217246 made with the joint Baltic Sea research and development programme BONUS, and from the Danish National Science Foundation (ECOSUPPORT project). We thank the Danish National Research Foundation (Dansk Grundforskningsfond) for support to the Center for Macroecology, Evolution and Climate, University of Copenhagen. The study contributes to the EU FP7 project VECTORS (266445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
      ","10.1371/journal.pone.0018998","2011-05-09T00:00:00Z",217246
"821",82,"At Tampere University of Technology, this work was supported by the Academy of Finland, (http://www.aka.fi, application number 213462, Finnish Programme for Centres of Excellence in Research 2006–2011). Some of the work done at Medicel on data integration is supported by EU/FP7/HEALTH grant (http://cordis.europa.eu/fp7/health/, APO-SYS/200767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","10.1371/journal.pone.0010662","2010-05-14T00:00:00Z",213462
